Food Additive by unknown
Food Additive
Edited by Yehia El-Samragy
Edited by Yehia El-Samragy
A food additive is defined as a substance not normally consumed as a food in itself and 
not normally used as a characteristic ingredient of food whether or not it has nutritive 
value. Food additives are natural or manufactured substances, which are added to food 
to restore colors lost during processing. They provide sweetness, prevent deterioration 
during storage and guard against food poisoning (preservatives).  This book provides a 
review of traditional and non-traditional food preservation approaches and ingredients 
used as food additives. It also provides detailed knowledge for the evaluation of the 
agro-industrial wastes based on their great potential for the production of industrially 
relevant food additives. Furthermore the assessment of potential reproductive and 
developmental toxicity perspectives of some newly synthesized food additives on 
market has been covered. Finally, the identification of the areas relevant for future 
research has been pointed out indicating that there is more and more information 
needed to explore the possibility of the implementation of some other materials to be 
used as food additives.
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Preface 
Food additives are natural or manufactured substances, which are added to foods to 
restore colors lost during processing, provide sweetness, prevent deterioration during 
storage and guard against food poisoning (preservatives). A food additive is defined 
as “any substance not normally consumed as a food in itself and not normally used as 
a characteristic ingredient of food, whether or not it has nutritive value, the intentional 
addition of which to food for a technological purpose in the manufacture, processing, 
preparation, treatment, packaging, transport or storage of such food results, or may be 
reasonably expected to result, in it or its by-products becoming directly or indirectly a 
component of such foods.” (Food Safety Authority of Ireland, 2011). 
This book provides a review of traditional and non-traditional food preservation 
approaches, including physical methods such as non-thermal pasteurization, chemical 
methods using natural food preservatives and their combinations for extension of shelf 
life of fruit juices and beverages. Evaluation of agro-industrial wastes, considering 
their great potential for the production of industrially relevant food additives, has 
been presented. The isolation of an albumin fraction with high foaming ability and 
foam stabilizing ability from guar meal, and designated guar foaming albumin as food 
additive was studied. Detailed knowledge about the composition, structure, 
classification, biosynthesis, genetic determinants, mechanisms of production, 
secretion, enzymes for production, methods of production, purification, analysis and 
characterization of exopolysaccharides, as well as the potential applications for 
production of functional food, e.g. prebiotics and immunomodulators, have been 
covered. Effects of some food colorings such as tartrazine, as food additives, on 
hepatic function, lipid profile, and biomarkers of oxidative stress in blood and 
different tissues, have been evaluated. The problems and control of contamination of 
other enzymes during phytase preparation have been inspected for the possibility of 
using fungal phytase preparation as food additive. Exposure of humans to aluminum 
from different sources, i.e. food, water, airborne dust, antiperspirants etc., and related 
immunizations, allergy injections, and elevated antacids, were investigated. It was 
concluded that there is no good evidence of adverse health effects attributed to 
aluminum from food, that this issue has not been adequately assessed and that those 
who lack good renal function are at greatest risk of aluminum-induced toxicity, 
perhaps from food. The assessment of potential reproductive and developmental 
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toxicity perspectives of some newly synthesized food additives on the market, i.e. 
lutein, caramel colors, erythrosine, green S, amaranth, brilliant blue FCF, curcumin, 
canthaxanthin, aspartame, paraben, coriander essential oil, allyl isothiocyanate, and 
tricalcium phosphate were overviewed in relevance to the six main categories of 
traditional food additives. 
Furthermore, potential utilization of lactophorin and lactadherin from sweet whey, a 
byproduct of cheese manufacturing against human rotavirus gastroenteritis in infants 
and young children, was discussed.  
In the attempt to identify future research areas of interest, it should be mentioned that 
this book pointed out the fact that more information is needed to explore the 
possibility of using some other materials as food additives. One of these issues is the 
full potential of the cell wall degrading enzymes in cereal processing such as bio-
polishing of cereal grain and pre-degradation for animal feeds using enzymatic 
polishing technique. More and more information on Spirulina is becoming available, 
which is essentially an exceptional simple extract of blue-green algae used worldwide 
as a food product and as a dietary supplement. It also has biological, biotechnological 
and nutrition applications, as well as some remote applications like bio-fuel 
production and functioning as a life support system in space studies. This interest will 
continue without any doubt. Research along these lines will be rewarding both socially 
and professionally. Another area of microorganism use proves that Lactobacillus 
strains play an important role in food fermentation processes and L. rhamnosus is a 
potential candidate for probiotic product preparation or as food additives as proven 
by its ability to acid-bile tolerance, salt, antimicrobial activity against human 
pathogens and food spoilage organisms. The characteristics of the antimicrobial 
protein(s) that are produced at different growth phases of LAB, require more work in 
the future. 
Prof. Dr. Yehia El-Samragy 
Ain Shams UniversityFaculty of Agriculture  





R. M. Pandey and S. K. Upadhyay 
Division of Genetics, Plant breeding & Agrotechnology,  
National Botanical Research Institute, Lucknow,  
India 
1. Introduction 
Substances which are of little or no nutritive value, but are used in the processing or storage 
of foods or animal feed, especially in the developed countries; includes antioxidants; food 
preservatives; food coloring agents; flavoring agents; anti-infective agents; vehicles; 
excipients and other similarly used substances. Many of the same substances are 
pharmaceutics aids when added to pharmaceuticals rather than to foods. Food additives are 
substances added to food to preserve flavor or enhance its taste and appearance. Some 
additives have been used for centuries; for example, preserving food by pickling with 
vinegar, salting, as with bacon, preserving sweets or using sulfur dioxide as in some wines. 
With the advent of processed foods in the second half of the 20th century, many more 
additives have been introduced, of both natural and artificial origin. It is sometimes wrongly 
thought that food additives are a recent development, but there has certainly been an 
increase in public interest in the topic. Not all of this has been well-informed, and there are 
signs that commercial interests have been influenced by consumer pressure, as well as food  
producers manipulating the situation by marketing techniques. Various labeling 
regulations have been put into effect to ensure that contents of processed foods are known 
to consumers, and to ensure that food is fresh-important in unprocessed foods and 
probably important even if preservatives are used. In addition, we also need to add some 
preservatives in order to prevent the food from spoiling. Direct additives are intentionally 
added to foods for a particular purpose. Indirect additives are added to the food during 
its processing, packaging and storage. Food Preservatives are the additives that are used 
to inhibit the growth of bacteria, molds and yeasts in the food. Some of the additives are 
manufactured from the natural sources such as corn, beet and soybean, while some are 
artificial, man-made additives.  Most people tend to eat the ready-made food available in 
the market, rather than preparing it at home. Such foods contain some kind of additives 
and preservatives, so that their quality and flavor is maintained and they are not spoiled 
by bacteria and yeasts. More than 3000 additives and preservatives are available in the 
market, which are used as antioxidants and anti-microbial agents. Salt and sugar the most 
commonly used additives. Some of the commonly used food additives and preservatives 
are aluminum silicate, amino acid compounds, ammonium carbonates, sodium nitrate, 
propyl gallate, butylated hydrozyttoluene (BHT), butylated hydroxyanisole (BHA), 
monosodium glutamate, white sugar, potassium bromate, potassium sorbate, sodium 





look. These coloring substances are erythrosine (red), cantaxanthin (orange), amaranth 
(Azoic red), tartrazine (Azoic yellow) and annatto bixine (yellow orange). When the food 
is to be stored for a prolonged period, use of additives and preservatives is essential in 
order to maintain its quality and flavor. The excess water in the foods can cause the 
growth of bacteria, fungi and yeasts. Use of additives and preservatives prevents spoiling 
of the foods due to the growth of bacteria and fungi. Additives and preservatives 
maintain the quality and consistency of the foods. They also maintain palatability and 
wholesomeness of the food, improve or maintain its nutritional value, control appropriate 
pH, provide leavening and color, and enhance its flavor. There are even foods products 
that are made entirely from chemicals. Coffee creamers, sugar substitutes, and candies 
consist almost completely of artificial ingredients. Such manipulation of our food can 
have a profound effect on our body’s unique biochemical balance. When we need to store 
any food for a longer time, it should be properly processed. During this processing, some 
substances and chemicals, known as additives, are added to the food. Additives 
consistently maintain the high quality of foods. 
Food additives
Vegetable gums Tracer gas  Thickeners
Sweeteners Stabilizers Sequestrants Seasonings   Propellants   Preservatives   
  Mineral salts      
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Fig. 1. Showing classification of food additives 
2. Classification of food additives 
Additives are classified as antimicrobial agents, antioxidants, artificial colors, artificial 
flavors and flavor enhancers, chelating agents and thickening and stabilizing agents (Fig. 





in the products such as salad dressings, baked goods, margarine, cheese and pickled 
foods. Antioxidants including vitamin C, E, BHT and BHA are used in the foods 
containing high fats. Chelating agents such as malic acid, citric acid and tartaric acid are 
used to prevent the flavor changes, discoloration and rancidity of the foods. These are 
very important in food manufacturing companies. The food Additives is used to retard 
spoilage, enhance food flavors, replace nutrient lost in processing and makes the food 
more visually appealing. 
2.1 Acidity regulator  
Acidity regulators are used to change or otherwise control the acidity and alkalinity of foods.  
Types of acidity regulator 
i. acid  
ii. acidifier  
iii. acidity regulator  
iv. alkali  
v. base  
vi. buffer  
vii. buffering agent  
viii. pH adjusting agent 
2.2 Anti-caking agents  
Anti caking agents, prevents the formation of lumps making these products manageable for 
packaging, transport, and for use by end consumer. Anticaking Agent is the food additive 
that prevents agglomeration in certain solids, permitting a free-flowing condition. It reduces 
the tendency of particles of food to adhere to one another.  
Types of anti-caking agent 
i. Anti-caking agent  
ii. Anti-stick agent  
iii. Drying agent  
iv. Dusting agent  
Anti-caking agents consist of such substances as starch, magnesium carbonate, and silica 
and are added to fine-particle solids, such as food products like table salt, flours, coffee, and 
sugar. Some of the common examples of foods that contain anti-caking agents include:  
i. Vending machine powders (coffee, cocoa, soup) 
ii. Milk and cream powders 
iii. Grated cheese 
iv. Icing sugar 
v. Baking powder 
vi. Cake mixes 
vii. Instant soup powders 
viii. Drinking chocolate 
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2.3 Antifoaming agents  
Antifoaming agents reduce or prevent foaming in foods.  
Types of anti- foaming agent  
i. Antifoaming agent  
ii. Defoaming agent  
2.4 Antioxidants  
A food additive, which prolongs the shelf-life of foods by protecting against deterioration 
caused by oxidation. Antioxidants are used to preserve food for a longer period of time. 
Antioxidants act as oxygen scavengers as the presence of oxygen in the food helps the 
bacteria to grow that ultimately harm the food. In the absence of antioxidant food additive 
oxidation of unsaturated fats takes place rendering to foul smell and discoloration of food.  
Different kinds of antioxidants foods act in a different ways but the end result is to delay or 
minimize the process of oxidation in food. Some antioxidants foods additives combine with 
oxygen to prevent oxidation and other prevent the oxygen from reacting with the food 
leading to its spoilage.  
Types of anti-oxidant agent 
i. Anti-browning agent  
ii. Antioxidant  
iii. Antioxidant synergist  
Some popular antioxidant foods 
Antioxidant vitamins 
a) Ascorbic acid- E300 
Antioxidant vitamins include Ascorbic acid (vitamin C) this antioxidant vitamin is used in 
beers, cut fruits, dried potatoes and jams. The antioxidant vitamins in these foods helps in 
preventing the discoloration of food by preventing the oxidation. It can also act as a 
substitute of vitamin C in potatoes that is lost during processing.  
b) Citric acid - E330 
It is used in biscuits, jams, tinned fruits, alcoholic drinks, cheese and dried soup. It has many 
uses like it prevents the discoloration of food, increases the anti-oxidant effect of other 
substances and regulates pH in jams and jellies.  
c) Tocopherols – E307  
(307a, d-alpha-Tocopherol; 307b, Tocopherol concentrate and  307c, dl-alpha-Tocopherol) 
This antioxidant food additive is used in the meat pies and oils to reduce the oxidation of 
fatty acids and vitamins.  
d) Butylated hydroxyanisole (BHA) - E320 
It is used in margarine, oils, crisps and cheese. This antioxidant helps in preventing the 






There are many benefits of using antioxidant food additives. Antioxidants prevent the 
blockage of arteries with fatty deposits that prevents the heart-attacks. Also these are 
associated with the prevention of certain types of cancers, arthritis and more conditions of 
these kinds. 
2.5 Bulking agents  
A food additive, which contributes to the bulk of a food without contributing significantly 
to its available energy value. Bulking agents such as starch are additives that increase the 
bulk of a food without affecting its nutritional value. 
Types of bulking agents 
i. Bulking agent  
ii. Filler  
2.6 Color retention agents  
A food additive, which stabilizes, retains or intensifies the colour of a food. In contrast to 
colorings, color retention agents are used to preserve a food's existing color. 
Types of color retention agents  
i. Color adjunct  
ii. Colour fixative  
iii. Colour retention agent  
iv. Colour stabilizer  
2.7 Coloring  
A food additive, which adds or restores colour in a food. Colorings are added to food to 
replace colors lost during preparation, or to make food look more attractive, more visually 
appealing. 
Types of coloring agents 
i. Colour  
ii. Decorative pigment  
iii. Surface colorant  
Beta carotene, Caramel, Carrot oil, Citrus red # 1, Dehydrated beets, FD&C colors: Blue # 1, 2; 
Red # 3, 40; Yellow # 5, 6 - used in processed foods, especially sweets and products 
marketed for children, soft drinks, baked goods, frosting, jams, and margarine. 
Though there is a growing realization that the color additives should be used to the 
minimum, the fact is that the food doesn't even look presentable at times without it and 
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2.8 Emulsifiers  
A food additive, which forms or maintains a uniform emulsion of two or more phases in a 
food. Emulsifiers allow water and oils to remain mixed together in an emulsion, as in 
mayonnaise, ice cream, and homogenized milk. It stops fats from clotting together. 
Types of emulsifiers 
i. Clouding agent  
ii. Crystallization inhibitor  
iii. Density adjustment agent (flavouring oils in beverages)  
iv. Dispersing agent  
v. Emulsifier  
vi. Plasticizer  
vii. Surface active agent  
viii. Suspension agent  
2.9 Emulsifying salt  
A food additive, which, in the manufacture of processed food, rearranges proteins in order 
to prevent fat separation. 
Types of emulsifying salt 
i. Emulsifying salt  
ii. Melding salt 
2.10 Firming agents  
A food additive, which makes or keeps tissues of fruit or vegetables firm and crisp, or 
interacts with gelling agents to produce or strengthen a gel. 
2.11 Flavors  
Flavors are additives that give food a particular taste or smell, and may be derived from 
natural ingredients or created artificially. 
2.12 Flavor enhancers  
Flavor enhancers enhance a food's existing flavors. They may be extracted from natural 
sources (through distillation, solvent extraction, maceration, among other methods) or 
created artificially.  
Types of flavor enhancing agents 
i. Flavour enhancer  
ii. Flavour synergist 
Some flavor enhancers are as follows: 
a) Dioctyl sodium-sulfosuccinate - used in processed foods.  





c) Hydrolyzed vegetable - used in mixes, stock, processed meats. 
d) Monosodium glutamate (MSG) - used in Chinese food, dry mixes, stock cubes, and 
canned, processed, and frozen meats. 
2.13 Flour treatment agents  
A food additive, which is added to flour or dough to improve its baking quality or colour. 
Types of flour treatment agent 
i. Dough conditioner  
ii. Dough strengthening agent  
iii. Flour bleaching agent  
iv. Flour improver  
v. Flour treatment agent  
2.14 Food acids  
Food acids are added to make flavors "sharper", and also act as preservatives and 
antioxidants. Common food acids include vinegar, citric acid, tartaric acid, malic acid, 
fumaric acid, and lactic acid. 
2.15 Gelling agents  
Gelling agents are food additives used to thicken and stabilize various foods, like jellies, 
desserts and candies. The agents provide the foods with texture through formation of a gel. 
Some stabilizers and thickening agents are gelling agents. 
2.16 Glazing agents  
A food additive, which when applied to the external surface of a food, imparts a shiny 
appearance or provides a protective coating. Glazing agents provide a shiny appearance or 
protective coating to foods. 
Types of glazing agent  
i. Coating agent  
ii. Film forming agent  
iii. Glazing agent  
iv. Polishing agent  
v. Sealing agent  
vi. Surface-finishing agent  
2.17 Humectants  
A food additive, which prevents food from drying out by counteracting the effect of a dry 
atmosphere. 
Types of humectants 
i. Humectant  
ii. Moisture/water retention agent  
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2.18 Mineral salts  
Mineral salts are added as nutritional additives though they may have other properties like 
an anti-oxidant or a preservative. Many of them are essentials that need to be included in 
our daily diets, as they are the source of important nutrients required for the body. The 
important natural mineral salts that should be consumed are sodium, phosphorus, 
potassium, chlorine, sulphur and calcium. While the above mentioned happen to be the 
macro elements of the natural mineral salts, the micro elements are the ones that are 
essential nutrients for the human body. The micro elements in the minerals salts consist of 
iodine, iron, fluoride and zinc.  
2.19 Preservatives  
A food additive, which prolongs the shelf-life of a food by protecting against deterioration 
caused by microorganisms. It prevents or inhibits spoilage of food due to fungi, bacteria and 
other microorganisms. It stops microbes from multiplying and spoiling the food. 
Types of preservatives 
i. Antimicrobial preservative  
ii. Antimicrobial synergist  
iii. Antimould and antirope agent  
iv. Antimycotic agent  
v. Bacteriophage control agent  
vi. Fungistatic agent  
vii. Preservative  
Some preservatives are:  
a) Benzoic acid and benzoates - are found in soft-drinks, beer, margarine and acidic foods. 
They are use to extend shelf life and protect food from fungi and bacteria.  
b) Nitrites and nitrates - are found in processed meats, such as sausages, hot dogs, bacon, 
ham, and luncheon meats, smoked fish. They are used to extend shelf life and protect 
food from fungi and bacteria; preserve color in meats and dried fruits.  
c) Sulfites - are found in dried fruits, shredded coconut, fruit based pie fillings. They are 
used to extend shelf life and protect food from fungi and bacteria. 
2.20 Propellants  
It helps propel food from a container. 
2.21 Seasonings  
Seasoning is the process of imparting flavor to, or improving the flavor of food.  
2.22 Sequestrants  
A sequestrant is a food additive whose role is to improve the quality and stability of the 
food products. Sequestrants form chelate complexes with polyvalent metal ions, especially 
copper, iron and nickel, which serve as catalysts in the oxidation of the fats in the food. 





2.23 Stabilizers  
A food additive, which makes it possible to maintain a uniform dispersion of two or more 
components. Stabilizers, like agar or pectin (used in jam for example) give foods a firmer 
texture. While they are not true emulsifiers, they help to stabilize emulsions. 
i. Colloidal stabilizer  
ii. Emulsion stabilizer  
iii. Foam stabilizer  
iv. Stabilizer  
2.24 Sweeteners  
Sweeteners are added to foods for flavoring. Sweeteners other than sugar are added to keep 
the food energy (calories) low, or because they have beneficial effects for diabetes mellitus 
and tooth decay and diarrhea. These are the substances that sweeten food, beverages, 
medications, etc., such as sugar, saccharine or other low-calorie synthetic products. They in 
general can be termed as sweetening agents. They all are called artificial sweeteners as they 
are usually not a component of the product they are added to. As per the source, these 
substances can be classified as natural and artificial sweeteners. Natural sweeteners are 
obtained from the natural sources like sugarcane and sugar beet and from fruits (fructose) 
and the artificial ones have a chemical origin. Artificial sweeteners are further of two type 
namely non-caloric sweeteners and sugar alcohols. Noncaloric sweeteners do not add 
calories to foods. They are used in snack foods and drinks. Sweeteners like saccharine and 
aspartame fall under this category. Sugar alcohols are used in chewing gums and hard 
candies and have almost same calories as sugar. Examples of sugar alcohols are sorbitol and 
mannitol.  
Commonly used sweeteners 
a) Acesulfame K - It is a 0 calorie sweetener, 130- 200 times sweeter than sucrose. It is not 
metabolized by the body. The only limitation it has is that if used in large quantities, it 
has an after taste. It is used in fruit preserves, dairy products and all types of beverages. 
It is used to reduce the calories of the products. It is heat resistant and enhances flavors.  
b) Aspartame - It is a low calorie sweetener about 200% more sweet than the sugar. It is 
disintegrated into aspartic acid, fenylalanine and methanol in the body on digestion. It's 
taste is similar to sugar only more sweet. It is used in all types of foods and beverages 
and medicines. It is found naturally in protein rich foods.  
c) Cyclamate - This is a calorie free sweetener 30-50 times sweeter than sugar. It is 
metabolized in the gut by few individuals and generally expelled as such. It is generally 
used in combination with other sweeteners. It has a pleasant taste, and is stable at high 
temperatures and is economical.  
d) Saccharin - It is one of the earliest low calorie sweeteners that is 300-500 times more 
sweet than sugar. It doesn't metabolize and absorption is slow. Owing to this it is 
expelled as such from the body. Saccharin is the most widely used sweetener. It was 
earlier banned in certain countries but now is used quite commonly.  There are other 
sweeteners like Stevioside, Alitame, Thaumatin, Sucralose, Neohesperidine DC and 
Aspartame-Acesulfame Salt. All artificial sweeteners have been approved by the U.S. 
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2.25 Thickeners  
Thickeners are substances which, when added to the mixture, increase its viscosity without 
substantially modifying its other properties. 
Types of thickners 
i. Binder  
ii. Bodying agent  
iii. Texturizing agent  
iv. Thickener  
2.26 Tracer gas  
Tracer gas allows for package integrity testing preventing foods from being exposed to 
atmosphere, thus guaranteeing shelf life. 
2.27 Vegetable gums  
Vegetable gums come from the varied sources that can be on land or in sea. Some of the 
seaweeds are the excellent sources of food gums in which comes the carrageenan and 
alginates. Whereas guar, locust bean gum, pectin are obtained from the plants. Xanthan gum 
is obtained by the process of microbial fermentation. The source of gelatin is animal tissue. 
Vegetable gums are the polysaccharides that have the natural origin and used to increase 
the viscosity of the solution or food even if used in a very small concentration. Major 
Vegetable Gums are: 
a. Cellulose Gum 
b. Xanthan Gum 
c. Locust Bean Gum 
d. Pectin 
3. ‘E’ numbering 
To regulate these additives, and inform consumers, each additive is assigned a unique 
number, termed as "E numbers", which is used in Europe for all approved additives. This 
numbering scheme has now been adopted and extended by the Codex Alimentarius 
Commission to internationally identify all additives, regardless of whether they are 
approved for use. 
E numbers are all prefixed by "E", but countries outside Europe use only the number, 
whether the additive is approved in Europe or not. For example, acetic acid is written as 
E260 on products sold in Europe, but is simply known as additive 260 in some countries. 
Additive 103, alkanet, is not approved for use in Europe so does not have an E number, 
although it is approved for use in Australia and New Zealand. Since 1987, Australia has had 
an approved system of labelling for additives in packaged foods. Each food additive has to 
be named or numbered. The numbers are the same as in Europe, but without the prefix 'E'. 
The United States Food and Drug Administration listed these items as "Generally 
recognized as safe" or GRAS; they are listed under both their Chemical Abstract Services 





4. Dangers of food additives and preservatives 
Although additives and preservatives are essential for food storage, they can give rise to 
certain health problems. They can cause different allergies and conditions such as 
hyperactivity and Attention Deficit Disorder in the some people who are sensitive to specific 
chemicals. The foods containing additives can cause asthma, hay fever and certain reactions 
such as rashes, vomiting, headache, tight chest, hives and worsening of eczema. Some of the 
known dangers of food additives and preservatives are as follows:  
• Benzoates can trigger the allergies such as skin rashes and asthma as well as believed to 
be causing brain damage. 
• Bromates destroy the nutrients in the foods. It can give rise to nausea and diarrhea. 
• Butylates are responsible for high blood cholesterol levels as well as impaired liver and 
kidney function. 
• Caffeine is a colorant and flavorant that has diuretic, stimulant properties. It can cause 
nervousness, heart palpitations and occasionally heart defects. 
• Saccharin causes toxic reactions and allergic response, affecting skin, gastrointestinal 
tract and heart. It may also cause tumors and bladder cancer. 
• Red Dye 40 is suspected to cause certain birth defects and possibly cancer. 
• Mono and di-glycerides can cause birth defects, genetic changes and cancer. 
• Caramel is a famous flavoring and coloring agent that can cause vitamin B6 
deficiencies. It can cause certain genetic defects and even cancer. 
• Sodium chloride can lead to high blood pressure, kidney failure, stroke and heart attack. 
To minimize the risk of developing health problems due to food additives and 
preservatives, you should avoid the foods containing additives and preservatives. Before 
purchasing the canned food, you must check its ingredients. You should buy organic foods, 
which are free from artificial additives. Try to eat the freshly prepared foods as much as 
possible rather than processed or canned foods. 
5. Effects of food additives 
Avoiding or minimizing toxins in your diet is an important step toward enhancing your 
health and lowering your risk of disease. Foods, amongst other things (cosmetics & 
medications), represent a source of these toxins. Effects of food additives may be immediate 
or may be harmful in the long run if you have constant exposure. Immediate effects may 
include headaches, change in energy level, and alterations in mental concentration, 
behavior, or immune response. Long-term effects may increase your risk of cancer, 
cardiovascular disease and other degenerative conditions. Although it may seem difficult to 
change habits and find substitutes for foods you enjoy, remind yourself that you will be 
adding to your diet some new wholesome foods that you will come to enjoy even more. 
Look for foods that are not packaged and processed, but enjoy nature’s own bounty of fresh 
fruits, vegetables, grains, beans, nuts and seeds. Find foods that resemble what they looked 
like when they were originally grown.  
6. Cytotoxic effects of food additives 
Exposure to non-nutritional food additives during the critical development window has 
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deficit hyperactivity disorder (ADHD). Although the use of single food additives at their 
regulated concentrations is believed to be relatively safe in terms of neuronal development, 
their combined effects remain unclear. The neurotoxic effects of four common food additives 
in combinations of two (Brilliant Blue and L-glutamic acid, Quinoline Yellow and 
aspartame) has been assess forpotential interactions. Mouse NB2a neuroblastoma cells were 
induced to differentiate and grow neurites in the presence of additives. After 24 h, cells were 
fixed and stained and neurite length measured by light microscopy with computerized 
image analysis. Neurotoxicity was measured as an inhibition of neurite outgrowth. Two 
independent models were used to analyze combination effects: effect additivity and dose 
additivity. Significant synergy was observed between combinations of Brilliant Blue with L-
glutamic acid, and Quinoline Yellow with aspartame, in both models. Involvement of N-
methyl-D-aspartate (NMDA) receptors in food additive-induced neurite inhibition was 
assessed with a NMDA antagonist, CNS-1102. L-glutamic acid- and aspartame induced 
neurotoxicity was reduced in the presence of CNS-1102; however, the antagonist did not 
prevent food color-induced neurotoxicity. Theoretical exposure to additives was calculated 
based on analysis of content in foodstuff, and estimated percentage absorption from the gut. 
Inhibition of neurite outgrowth was found at concentrations of additives theoretically 
achievable in plasma by ingestion of a typical snack and drink. In addition, Trypan Blue dye 
exclusion was used to evaluate the cellular toxicity of food additives on cell viability of 
NB2a cells; both combinations had a straightforward additive effect on cytotoxicity. These 
data have implications for the cellular effects of common chemical entities ingested 
individually and in combination. (Lau et al., 2006) 
Gallic acid is added to foods to prevent oxygen-induced lipid peroxidation and can be 
obtained by the hydrolysis of tannic acid which can be found in tea, coffee, red wine, and 
immature fruits. Tannic acid has also been used as a food additive. The effect of gallic acid 
on mouse spermatogonia, mouse spermatocytes, and mouse Sertoli cells in vitro was 
investigated. First, each cell line was cultured with predetermined concentrations of gallic 
acid for 3 h to access the effects of gallic acid on in vitro growth of testicular cells and MTT 
cytotoxicity assay was used to measure cell viability. Secondly, intracellular levels of 
hydrogen peroxide in mouse spermatogonia, mouse spermatocytes, and mouse Sertoli cells 
treated with gallic acid were analyzed using dihydrorhodamine 123 as a probe to evaluate 
the pro-oxidative property of gallic acid. The results obtained indicate that gallic acid 
inhibits the growth and proliferation of testicular cells in a dose-dependent manner and 
increases the intracellular level of hydrogen peroxide in mouse spermatogonia significantly 
(p < 0.05). It can be suggested that gallic acid exerts cytotoxic effects on testicular cells by its 
pro-oxidative activity. In conclusion, gallic acid-induced cytotoxicity in mouse 
spermatogonia, mouse spermatocytes, and mouse Sertoli cells in vitro may be of 
toxicological research interest considering the testicular toxic potential of gallic acid. (Park et 
al., 2008) 
In recent years, the use of carthami flos (the flowers of Carthamus tinctorius) as a colouring 
and flavouring agent in foods has increased in Iran. In order to evaluate its safety, the 
teratogenic effects of carthami flos on central nervous system development in mice were 
investigated. Furthermore, its cytotoxic effect on a rat nerve cell culture was studied to 
complete safety evaluations. For teratogenic studies, after natural mating, pregnant mice 





regimens of aqueous carthami flos extract during 0-8 days of gestation. Embryos were then 
isolated at the 13th day of gestation and evaluated for macroscopic, microscopic and 
morphometric characteristics. The results showed that at higher doses (1.6 and 2 
mg/kg/day) the embryos were absorbed, whereas at a lower dose (1.2 mg/kg/day) 
changes in external, internal and longitudinal diameters, open neuropore, changes in 
cellular orientation and cellular degeneration were observed. The results obtained from the 
cytotoxic assay also demonstrated a concentration-dependent cytotoxic effect of carthami 
flos extract. It is concluded that the use of carthami flos as a food additive should be 
reconsidered. (Nobakht et al., 2000) 
The cytotoxicity of 11 dyes, used as food dyes in Japan, on cultured fetal rat hepatocytes was 
studied. Xanthene dyes containing halogen atoms in their molecules such as phloxin, rose 
bengal, and erythrosine were more toxic than other groups of food dyes. The effect of food 
dyes on the cell growth of hepatocytes was also examined. Phloxin was especially toxic to 
the cell growth and a dose-response relation was observed between the concentration of 
phloxin and the cell growth of hepatocytes when the dye was added 3 days after plating. 
(Sako  et al., 1980) 
The synergistic effect of food additives or food colors on the toxicity of 3-amino-1,4-
dimethyl-5H-pyrido[4,3-b]indole (Trp-P-1) was investigated using primary cultured rat 
hepatocytes. When hepatocytes from rats fed a standard diet were treated with a mixture of 
four major food additives (sorbitol, sodium 1.(+)-glutamate, benzoic acid, and propylene 
glycol) or a mixture of six typical artificial food colors (erythrosine, allura red, new coccine, 
brilliant blue, tertrazine, and fast green), the in vitro treated food-color mixture itself 
showed cytotoxicity: the reduction of cell viability and decreases in the activities of 
gluconeogenesis and ureogenesis. The food-color mixture enhanced cytotoxicity of Trp-P-1 
obviously. The effects of in vivo-dosed food additives or food colors on Trp-P-1-caused 
toxicity. Hepatocytes were isolated and cultured from rats fed a diet containing a mixture of 
food additives or a mixture of food colors with half the amount of their respective 
acceptable daily intake for 4 wk. Trp-P-1 was administered to the hepatocytes at various 
concentrations for 12 h. Synergistic effects of in vivo-dosed food additives and food colors 
were not observed on Trp-P-1-caused cytotoxicity as estimated by a loss of cell viability and 
the reductions of DNA and protein syntheses. On the contrary, it was observed that in vivo 
administered food colors synergistically facilitated to reduce the activities of 
gluconeogenesis and ureogenesis in Trp-P-1-treated hepatocytes. These results suggest that 
the daily intake of artificial food colors may impair hepatic functions such as 
gluconeogenesis and ureogenesis, when dietary carcinogens are exposed to the liver cells. 
(Ashida et al., 2000) 
Study was conducted to investigate the impact of food additives like boric acid, citric acid 
and sodium metabisulphite individually, in different concentrations, on root tips of Vicia 
faba L. Cytological studies revealed significant decrease in mitotic index with an increase in 
concentration of the food additives. Most frequent cytological abnormalities observed are 
fragments, disturbed metaphase, C-mitosis, laggards, bridges, stickiness, precocious 
movement of chromosomes, unequal and late separation of chromosomes. Bridges and 
fragments were more frequent at anaphase. The percentage of chromosomal aberrations at 
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Fig. 2. a-i — Showing cytological effects of food additives in Vicia faba L., a. Normal 
metaphase, b. Normal anaphase, c. Disturbed metaphase, d. C-mitosis, e. Late separation at 
anaphase, f. Unequal separation, g. Fragmentation at anaphase, h. Chromatid bridge,  
i. Stickiness and Laggard at anaphase 
Clastogenic properties of the food additive citric acid, commonly used as an antioxidant, 
were analysed in human peripheral blood lymphocytes. Citric acid induced a significant 
increase of chromosomal aberrations (CAs) at all the concentrations and treatment periods 
tested. Citric acid significantly decreased mitotic index (MI) at 100 and 200 lg ml-1 
concentrations at 24 h, and in all concentrations at 48 h. However, it did not decrease the 
replication index (RI) significantly. Citric acid also significantly increased sister chromatid 
exchanges (SCEs) at 100 and 200 lg ml-1 concentrations at 24 h, and in all concentrations at 
48 h. This chemical significantly increased the micronuclei frequency (MN) compared to the 
negative control. It also decreased the cytokinesis-block proliferation index (CBPI), but this 
result was not statistically significant. (Serkan et al., 2008) 
Ester gum (EG) is used in citrus oil-based beverage flavourings as a weighting or colouring 
agent. In this study, concentrations of 50, 100 and 150 mg/kg body weight were 
administered orally to male Swiss albino mice, and sister chromatid exchange and 





and clastogenic potential of the food additive. Although EG was weakly clastogenic and 
could induce a marginal increase in sister chromatid exchange frequencies, it was not a 
potential health hazard at the doses tested. (Mukherjee et al., 1992) 
Acesulfame-K, a sweetening agent, was evaluated in vivo for its genotoxic and clastogenic 
potentials. Swiss albino male mice were exposed to the compound by gavage. Bone marrow 
cells isolated from femora were analysed for chromosome aberrations. Doses of 15, 30, 60, 
450, 1500 and 2250 mg of acesulfame-K/kg body weight induced a positive dose-dependent 
significant clastogenicity (trend test α < 0.05). These doses were within the no-toxic-effect 
levels (1.5-3 g/kg body weight in rats) reported by the Joint Expert Committee for Food 
Additives of the World Health Organization and the Food and Agriculture Organization of 
the United Nations. In view of the present significant in vivo mammalian genotoxicity data, 
acesulfame-K should be used with caution. (Mukherjee and Chakrabarti, 1997) 
Aspartame and acesulfame-K, non-nutritive sweeteners, are permitted individually in diets 
and beverages. These sweeteners of different classes, used in combination, have been found 
to possess a synergistic sweetening effect. Whether they also have a synergistic genotoxic 
effect is unknown. Swiss Albino male mice were exposed to blends of aspartame (3.5, 35, 
350 mg/kg body weight) and acesulfame-K (1.5, 15 and 150 mg/kg body weight) by gavage. 
Bone marrow cells isolated from femora were analyzed for chromosome aberrations. 
Statistical analysis of the results show that aspartame in combination with acesulfame-K is 
not significantly genotoxic. (Mukhopadhyay et al., 2000) 
This work aimed to study some blood indices of rats as affected by saccharin and the 
therapeutic action of vitamins C and E. The used adult female Rattus norvegicus albino rats 
in the present study were weighing 100—120 g. Administration of saccharin at a dose of 35 
mg kg—1 body weight (b.wt.) day—1 for 35 days significantly decreased serum glucose, 
triglycerides, cholesterol, total protein and albumin values. These decrements were by 
20.16%, 22.76%, 44.92%, 20.16% and 40.44%, respectively, compared to control level (p value 
< 0.01). But it increased levels of kidney function indices. The effect of saccharin was more 
pronounced on creatinine. Activities of Alanine aminotranferease (ALT), aspartate 
aminotransferase (AST) and Alkaline phosphatase (ALP) increased significantly following 
saccharin treatment to rats. Concerning hematoligical parameters, the more obvious changes 
were observed in the increment of white blood cell (WBC), mean corpuscular volume 
(MCV) and platelets (PLT) and the decrease in hematocrit, hemoglobin (Hb) and red blood 
cells (RBCs) count in response to the administration of saccharin. In general, vitamin C or E 
(150 mg kg—1 b.wt. day—1 for 35 days) was able to reduce the effects of saccharin intake. 
Both vitamins, however, generally have beneficial effects in reducing the changes in the 
studied parameters. (Abdelaziz et al., 2011) 
Monosodium phosphate (MSP - E339i), disodium phosphate (DSP - E339ii), and trisodium 
phosphate (TSPE339iii) are used as antimicrobials, pH control agents (buffers), boiler water 
additives, cleaners, coagulants, dispersants, leavening agents, stabilizers, emulsifers, 
sequestrants, texturizers, nutrients, and dietary supplements. The effects of these have been 
studied on root tips of Allium cepa L. Roots of A. cepa were treated with a series of 
concentrations, ranging from 300 to 500 ppm for 24, 48 and 72 h. The results indicated that 
these food preservatives reduced mitotic division in A. cepa when compared with the 
respective control. Mitotic index values were generally decreased with increasing 
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350 mg/kg body weight) and acesulfame-K (1.5, 15 and 150 mg/kg body weight) by gavage. 
Bone marrow cells isolated from femora were analyzed for chromosome aberrations. 
Statistical analysis of the results show that aspartame in combination with acesulfame-K is 
not significantly genotoxic. (Mukhopadhyay et al., 2000) 
This work aimed to study some blood indices of rats as affected by saccharin and the 
therapeutic action of vitamins C and E. The used adult female Rattus norvegicus albino rats 
in the present study were weighing 100—120 g. Administration of saccharin at a dose of 35 
mg kg—1 body weight (b.wt.) day—1 for 35 days significantly decreased serum glucose, 
triglycerides, cholesterol, total protein and albumin values. These decrements were by 
20.16%, 22.76%, 44.92%, 20.16% and 40.44%, respectively, compared to control level (p value 
< 0.01). But it increased levels of kidney function indices. The effect of saccharin was more 
pronounced on creatinine. Activities of Alanine aminotranferease (ALT), aspartate 
aminotransferase (AST) and Alkaline phosphatase (ALP) increased significantly following 
saccharin treatment to rats. Concerning hematoligical parameters, the more obvious changes 
were observed in the increment of white blood cell (WBC), mean corpuscular volume 
(MCV) and platelets (PLT) and the decrease in hematocrit, hemoglobin (Hb) and red blood 
cells (RBCs) count in response to the administration of saccharin. In general, vitamin C or E 
(150 mg kg—1 b.wt. day—1 for 35 days) was able to reduce the effects of saccharin intake. 
Both vitamins, however, generally have beneficial effects in reducing the changes in the 
studied parameters. (Abdelaziz et al., 2011) 
Monosodium phosphate (MSP - E339i), disodium phosphate (DSP - E339ii), and trisodium 
phosphate (TSPE339iii) are used as antimicrobials, pH control agents (buffers), boiler water 
additives, cleaners, coagulants, dispersants, leavening agents, stabilizers, emulsifers, 
sequestrants, texturizers, nutrients, and dietary supplements. The effects of these have been 
studied on root tips of Allium cepa L. Roots of A. cepa were treated with a series of 
concentrations, ranging from 300 to 500 ppm for 24, 48 and 72 h. The results indicated that 
these food preservatives reduced mitotic division in A. cepa when compared with the 
respective control. Mitotic index values were generally decreased with increasing 





mitotic stages were observed. The total percentage of aberrations generally increased with 
increasing concentrations of these chemicals and longer period of treatment. Different 
abnormal mitotic figures were observed in all mitotic phases. Among these abnormalities 
were stickiness, anaphase bridges, C-mitosis and micronuclei. These food additives 
remarkably depressed the DNA content in the root meristems of A. cepa. The interphase 
nuclear volume (INV) also varied between the untreated (controls) and the treated plants. 
(Turkoglu Sifa, 2009) 
Citric acid is used widely as an acidulant, pH regulator, flavour enhancer, preservative and 
antioxidant synergist in many foods, like soft drinks, jelly sweet, baked nutrients, jam, 
marmalade, candy, tinned vegetable and fruit food Clastogenic properties of the food 
additive citric acid, commonly used as an antioxidant, were analysed in human peripheral 
blood lymphocytes. Citric acid induced a significant increase of chromosomal aberrations 
(CAs) at all the concentrations and treatment periods tested. Citric acid significantly 
decreased mitotic index (MI) at 100 and 200 lg ml-1 concentrations at 24 h, and in all 
concentrations at 48 h. However, it did not decrease the replication index (RI) significantly. 
Citric acid also significantly increased sister chromatid exchanges (SCEs) at 100 and 200 lg 
ml-1 concentrations at 24 h, and in all concentrations at 48 h. This chemical significantly 
increased the micronuclei frequency (MN) compared to the negative control. It also 
decreased the cytokinesis-block proliferation index (CBPI), but this result was not 
statistically significant. (Serkan Ylmaz et al., 2008) 
7. Food additives and safety 
With the increasing use of processed foods since the 19th century, there has been a great 
increase in the use of food additives of varying levels of safety. This has led to legislation in 
many countries regulating their use. For example, boric acid was widely used as a food 
preservative from the 1870s to the 1920s, but was banned after World War I due to its 
toxicity, as demonstrated in animal and human studies. During World War II the urgent 
need for cheap, available food preservatives led to it being used again, but it was finally 
banned in the 1950s.[2] Such cases led to a general mistrust of food additives, and an 
application of the precautionary principle led to the conclusion that only additives that are 
known to be safe should be used in foods. In the USA, this led to the adoption of the 
Delaney clause, an amendment to the Federal Food, Drug, and Cosmetic Act of 1938, stating 
that no carcinogenic substances may be used as food additives. However, after the banning 
of cyclamates in the USA and Britain in 1969, saccharin, the only remaining legal artificial 
sweetener at the time, was found to cause cancer in rats. Widespread public outcry in the 
USA, partly communicated to Congress by postage-paid postcards supplied in the 
packaging of sweetened soft drinks, led to the retention of saccharin despite its violation of 
the Delaney clause.  
In September 2007, research financed by Britain’s Food Standards Agency and published 
online by the British medical journal The Lancet, presented evidence that a mix of 
additives commonly found in children’s foods increases the mean level of hyperactivity. 
The team of researchers concluded that “the finding lends strong support for the case  
that food additives exacerbate hyperactive behaviors (inattention, impulsivity and 
overactivity) at least into middle childhood.” That study examined the effect of artificial 
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additives commonly found in children’s foods increases the mean level of hyperactivity. 
The team of researchers concluded that “the finding lends strong support for the case  
that food additives exacerbate hyperactive behaviors (inattention, impulsivity and 
overactivity) at least into middle childhood.” That study examined the effect of artificial 










Banned for use in cosmetics 
and external drug, but not 






dairy products  
snack foods. 
Cancer The Washington 
Post, February 7, 
1990 













skin rashes, and migraine 
headaches. 
UK Food Guide. 
http://www.ukfoo
dguide.net/e102.ht





* Banned in Australia, 
Japan, 
Norway and the U.S. 
Restricted to max. 
permitted 






Asthma, rashes and 
hyperactivity. Potential 
carcinogen in animals: 
implicated in bladder and 
liver cancer. Altered 
reproduction in animals. 
efsa.europa.eu - 
EFSA updates 
safety advice on six 








Banned in Norway, Sweden 
and Finland. Restricted to 








AVOID in allergies & 
asthma. 
Cancer – DNA damage, 
increases tumors in 
animals. 
Growth retardation and 









Banned in Canada, Japan, 
Norway, Austria, Sweden 
and the U.S. Restricted to 





DNA damage and 
tumours 
in animals. 
Food additives CBC 







Banned in Denmark, 
Belgium, France, Germany, 
Switzerland, Sweden, 
Austria and Norway 
Carbonated drinks 
Bubble gum, snacks, 
Sauces, preserves, 
Soups, 
wine, cider, etc. 
May worsen or induce 
asthma, rhinitis (including 
hayfever), or urticaria 
(hives). 
UK Food Guide, a 
British food 
additives website. 






Banned in US, Canada, 
Norway, Sweden and 
Japan. Restricted to 
maximum permitted levels 





Cancer - DNA damage and
tumours in animals. Can 
produce bad reactions in 
asthmatics 








Banned in the U.S. Alcoholic drinks 
Fish roe 
May worsen or induce 










Banned in the US, Japan, 
Australia and Norway. UK 







May cause nausea, 
vomiting, skin rashes, and 
brain tumors. DNA 
damage and tumors in 
animals. 







Banned in Austria, Belgium, 
France, Norway, Sweden, 
Switzerland and Germany. 
Restricted to maximum 




Hyperactivity and skin 
rashes. Listed as human 
carcinogen by the US EPA. 
Causes DNA damage and 
tumors in animals 
FDA, 1993 





children. Further studies are needed to find out whether there are other additives that could 
have a similar effect, and it is unclear whether some disturbances can also occur in mood 
and concentration in some adults. In the February 2008 issue of its publication, AAP Grand 
Rounds, the American Academy of Pediatrics concluded that a low-additive diet is a valid 
intervention for children with ADHD: “Although quite complicated, this was a carefully 
conducted study in which the investigators went to great lengths to eliminate bias and to 
rigorously measure outcomes. The results are hard to follow and somewhat inconsistent. 
For many of the assessments there were small but statistically significant differences of 
measured behaviors in children who consumed the food additives compared with those 
who did not. In each case increased hyperactive behaviors were associated with consuming 
the additives. For those comparisons in which no statistically significant differences were 
found, there was a trend for more hyperactive behaviors associated with the food additive 
drink in virtually every assessment. Thus, the overall findings of the study are clear and 
require that even we skeptics, who have long doubted parental claims of the effects of 
various foods on the behavior of their children, admit we might have been wrong.” 
In 2007, Food Standards Australia New Zealand published an official shoppers' guidance 
with which the concerns of food additives and their labeling are mediated.  
There has been significant controversy associated with the risks and benefits of food 
additives. Some artificial food additives have been linked with cancer, digestive problems, 
neurological conditions, ADHD, heart disease or obesity. Natural additives may be similarly 
harmful or be the cause of allergic reactions in certain individuals. For example, safrole was 
used to flavor root beer until it was shown to be carcinogenic. Due to the application of the 
Delaney clause, it may not be added to foods, even though it occurs naturally in sassafras 
and sweet basil.  
Blue 1, Blue 2, Red 3, and Yellow 6 are among the food colorings that have been linked to 
various health risks. Blue 1 is used to color candy, soft drinks, and pastries and there has 
been some evidence that it may cause cancer. Blue 2 can be found in pet food, soft drinks, 
and pastries, and has shown to cause brain tumors in mice. Red 3, mainly used in cherries 
for cocktails has been correlated with thyroid tumors in rats and humans as well. Yellow 6, 
used in sausages, gelatin, and candy can lead to the attribution of gland and kidney tumors 
and contains carcinogens, but in minimal amounts. 
Some studies have linked some food additives to hyperactivity in children. A recent British 
study found that children without a history of any hyperactive disorder showed varying 
degrees of hyperactivity after consuming fruit drinks with various levels of additives. 
Among those that were studied were: Sodium benzoate (E211), Tartrazine (E102), quinoline 
yellow (E104), Sunset yellow (E110), Carmosine (E122), Allura red (E129). See tables below 
for more information. 
8. Joint FAO/WHO Expert Committee on Food Additives (JECFA) 
The Joint FAO/WHO Expert Committee on Food Additives (JECFA) is an international 
scientific expert committee that is administered jointly by the Food and Agriculture 
Organization of the United Nations FAO and the World Health Organization WHO. It has 
been meeting since 1956, initially to evaluate the safety of food additives. Its work now also 
includes the evaluation of contaminants, naturally occurring toxicants and residues of 
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Complications of diabetes 
Fatty liver 
Increased triglycerides 
Increased uric acid 
Chronic diarrhea 





*All of these additives are considered the “Dirty Dozen Food Additives” and are prohibited in the UK 
for foods marketed for children less than 36 months. 
**MSG-intolerant people can develop MSG symptom complex, which is characterized by one of more of 
the following: 
• A burning sensation in the back of the neck, forearms and chest. 
• Numbness in the back of the neck, radiating to the arms and back. 
• A tingling, warmth and weakness in the face, temples, upper back, neck and arms. 
• Facial pressure or tightness, swelling of lips/face 
• Chest pain, rapid heartbeat 
• Headache, nausea, drowsiness 
• Bronchospasm (difficulty breathing) in MSG-intolerant people with asthma. 





JECFA has evaluated more than 1500 food additives, approximately 40 contaminants and 
naturally occurring toxicants, and residues of approximately 90 veterinary drugs. The 
Committee has also developed principles for the safety assessment of chemicals in food that 
are consistent with current thinking on risk assessment and take account of recent 
developments in toxicology and other relevant sciences. 
      Codex
Alimentarius Guidelines
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Fig. 3. Showing flow chart which shows the process flow for JECFA 
The above flow chart shows the process flow for JECFA. 
A brief summary of the purpose, history, and workings of the Joint FAO/WHO Expert 
Committee on Food Additives.  
9. Sites related to JECFA 
• JMPR 
The Joint FAO/WHO Meeting on Pesticide Residues is the related expert committee for 
pesticide residues in food. It is responsible for reviewing and evaluating toxicological 
residue and analytical aspects of the pesticides under consideration.  
• Codex Alimentarius 
The Codex Alimentarius Commission was created in 1963 by FAO and WHO to 
develop food standards, guidelines and related texts such as codes of practice under the 
Joint FAO/WHO Food Standards Programme. The main purposes of this Programme 
are protecting health of the consumers and ensuring fair trade practices in the food 
trade, and promoting coordination of all food standards work undertaken by 
international governmental and non-governmental organizations. Codex standards are 
based on scientific advice as provided by JECFA and JMPR.  
10. General information related to chemical risks in food 
Chemicals are the building blocks of life and are important for many, if not all, aspect of 
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nutritional imbalances, are known or suspected to be involved in causing cancer, 
cardiovascular disease, kidney and liver dysfunction, hormonal imbalance, reproductive 
disorders, birth defects, premature births, immune system suppression, musculoskeletal 
disease, impeded nervous and sensory system development, mental health problems, 
urogenital disease, old-age dementia, and learning disabilities. Possibly a significant part of 
these disorders and diseases can be attributed to chemical exposure, and for many 
(environmental) chemicals food is the main source of human exposure. Consequently, the 
protection of our diet from these hazards must be considered one of the essential public 
health functions of any country. 
Under the World Trade Organization's Agreement on Sanitary and Phytosanitary Measures, 
food traded internationally must comply with Codex Standards that are established to 
protect health of consumers on basis of a sound risk assessment. Such independent 
international risk assessments are performed by Joint FAO/WHO Expert Committee on 
Food Additives (JECFA) and Joint FAO/WHO Meeting on Pesticide Residues (JMPR) as 
well as ad hoc expert meetings to address specific and emerging issues. The experts estimate 
a safe level of exposure (acceptable or tolerable daily intake ADI, TDI) and estimate the 
exposure to chemicals from the diet and from specific foods. Such exposure assessments 
often are based on national data or international data from the WHO Global Environment 
Monitoring System - Food Contamination Monitoring and Assessment Programme 
(GEMS/Food).  
Based on the risk assessments provided through these expert meetings, the Codex 
Alimentarius Commission can recommend specific measures, such as maximum limits in 
foods to assure that exposure do not exceed the acceptable/tolerable level of intake. Other 
measure can be the development of 'Codes of Practices' to reduce levels of contaminants in 
food. Also, levels of use for food additives can be recommended or maximum residue levels 
for pesticides or veterinary drug residues when applied in accordance with good practices. 
The scientific advice provided through these expert meetings also often serves directly as 
the basis for national food safety standards. 
11. Conclusion 
Food additives preserve the freshness and appeal of food between the times it is 
manufactured and when it finally reaches the market. Additives may also improve 
nutritional value of foods and improve their taste, texture, consistency or color. All food 
additives approved for use in the United States are carefully regulated by federal authorities 
to ensure that foods are safe to eat and are accurately labeled. Food additives have been 
used by man since earliest times. Today, food and color additives are more strictly regulated 
than at any time in history. Additives may be incorporated in foods to maintain product 
consistency, improve or maintain nutritional value, maintain palatability and 
wholesomeness provide leavening or control acidity/alkalinity, and/or enhance flavor or 
impart desired color. The Food and Agriculture Organization (FAO), however, recognizes 
additives as any substance whose intended use will affect, or may reasonably be expected to 
affect, the characteristics of any food. FAO law prohibits the use of any additive that has 
been found to cause cancer in humans or animals. To market a new food or color additive, a 





that each substance is safe at its intended levels of use before it may be added to foods. In 
deciding whether an additive should be approved, the agency considers the composition 
and properties of the substance, the amount likely to be consumed, its probable long-term 
effects and various safety factors. Some food additives like boric acid, citric acid and sodium 
metabisulphite showed mitotoxicity and genotoxicity having potential risks for human 
health. Thus, all additives are subject to ongoing safety review as scientific understanding 
and methods of testing continue to improve. 
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1. Introduction 
The overall consumption of food additives is 139 lbs/year/person. If the common additives 
like spices, sugars, salt, honey, pepper, mustard, dextrose etc. are excluded, the 
consumption decreases to 5 lbs/year. Due to widespread consumption, it is necessary to 
evaluate the implications for the health of consumers because of the presence of newly 
synthesized food additives before commence production according to accepted guidelines 
such as Food and Drug Administration (FDA), U.S. Environmental Protection Agency (EPA) 
and European Food Safety Authority (EFSA). “Redbook 2000” is one of the revised form of 
Redbook II guideline published in 1993 by FDA; also defined as “Toxicological Principles 
for the Safety Assessment of Direct Food Additives and Color Additives Used in Food”. 
This document is a guidance for determining toxicity studies, for designing and reporting 
the results of toxicity studies, conducting statistical analyses of data, the review of 
histological data and the submission of this information to FDA. The toxicological testing 
should provide not only information relevant to the average consumer, but also relevant to 
those population groups whose pattern of food consumption, physiological or health status 
may make them vulnerable such as young age, pregnancy and other metabolic disorders. 
Possible toxicological effects due to additive consumption should be tested especially in 
reproduction and developmental studies which are designed to evaluate effects on sexuality 
and fertility of males and females, developing organisms (mortality, structural abnormality 
and functional deficiencies). Besides, multigenerational reproductive toxicity studies 
provide information about the effects of a test substance on gonadal function, estrous cycle, 
mating behavior, lactation and development of the offspring. 
For new food additives, a safety evaluation is obtained generally from experimental data 
derived from investigations in laboratory animals. Although it may be possible to use 
human data derived from medical use, occupational epidemiology or from volunteers, the 
obtained data would be limited. Therefore, the likely effects on man can be estimated by 
intentive extrapolation from laboratory animals. The end points and the indices obtained 
must provide sufficient information and statistical power to permit FDA to determine 
whether the additive is associated with changes in reproduction and fertility.  
                                                 
















The Safety Assessment of  
Food Additives by Reproductive  
and Developmental Toxicity Studies 
Cansn Güngörmüş* and Aysun Klç* 
Hacettepe University/Department of Biology, Ankara 
Turkey 
1. Introduction 
The overall consumption of food additives is 139 lbs/year/person. If the common additives 
like spices, sugars, salt, honey, pepper, mustard, dextrose etc. are excluded, the 
consumption decreases to 5 lbs/year. Due to widespread consumption, it is necessary to 
evaluate the implications for the health of consumers because of the presence of newly 
synthesized food additives before commence production according to accepted guidelines 
such as Food and Drug Administration (FDA), U.S. Environmental Protection Agency (EPA) 
and European Food Safety Authority (EFSA). “Redbook 2000” is one of the revised form of 
Redbook II guideline published in 1993 by FDA; also defined as “Toxicological Principles 
for the Safety Assessment of Direct Food Additives and Color Additives Used in Food”. 
This document is a guidance for determining toxicity studies, for designing and reporting 
the results of toxicity studies, conducting statistical analyses of data, the review of 
histological data and the submission of this information to FDA. The toxicological testing 
should provide not only information relevant to the average consumer, but also relevant to 
those population groups whose pattern of food consumption, physiological or health status 
may make them vulnerable such as young age, pregnancy and other metabolic disorders. 
Possible toxicological effects due to additive consumption should be tested especially in 
reproduction and developmental studies which are designed to evaluate effects on sexuality 
and fertility of males and females, developing organisms (mortality, structural abnormality 
and functional deficiencies). Besides, multigenerational reproductive toxicity studies 
provide information about the effects of a test substance on gonadal function, estrous cycle, 
mating behavior, lactation and development of the offspring. 
For new food additives, a safety evaluation is obtained generally from experimental data 
derived from investigations in laboratory animals. Although it may be possible to use 
human data derived from medical use, occupational epidemiology or from volunteers, the 
obtained data would be limited. Therefore, the likely effects on man can be estimated by 
intentive extrapolation from laboratory animals. The end points and the indices obtained 
must provide sufficient information and statistical power to permit FDA to determine 
whether the additive is associated with changes in reproduction and fertility.  
                                                 





This chapter will highlight the possible health effects of newly synthesized food additives 
on market and focus on their reproductive and developmental toxicity perspectives. 
Considering that food technology is a complex area in which even the simplest additive 
interacts with all the others to produce qualified food; we are expecting that this chapter will 
help to examine food additives that can probably affect the human life.  
2. Overview of food additives 
Advances in food technology have resulted in an increased number of modified foods and 
additives in 20th century. An additive is a substance which may intentionally become a 
component of food or affect its characteristics. There are about 3000 different food additives 
defined up to date. Food additives may be divided in several groups; although there is some 
overlap between them. Main six categories of food additives are classified as preservatives, 
nutritional supplements, flavoring agents, colorings, texturing agents and miscellaneous. 
According to the functional classes, definitions and technological functions, food additives 
are summarized in Figure 1 (COABISCO, 2011). 
 
Fig. 1. Six main categories of food additives 
Each food additive is assigned a unique E number, which have been assessed for use within 
the European Union (EU) to inform consumers (Figure 2). E numbers for European countries 
are all prefixed by “E”; on the other hand non-European countries do not use this prefix. E 
letter stands for the approval of the food additive in Europe. The numbering scheme fallows 
that of the International Numbering System (INS) as determined by Codex Alimentarius 
Committee (Codex Alimentarius, 2009). Though, only a subset of INS additives are 
approved for use in the EU. The United States Food and Drug Administration listed these 
items as “generally recognized as safe” or GRAS. As an example, additive E 341 (Tricalcium 
phosphate) is approved by US so has an “E” prefix and 341 numbering which stands for 
340-349 subset known as “phosphates” under Antioxidants and Acidity Regulators group.  
 




Fig. 2. Classification of additives by numeric range 
In the EU, to authorize a substance as a food additive, a reasonable case of technological 
need, no hazard to consumers at level of proposed use and no misguidance to consumers 
should be demonstrated. To evaluate whether the newly released food additive has an effect 
on health; The European Commission is required a consultancy from Scientific Committee 
on Food (SCF). In this context, SCF deals with questions relating to the toxicology and 
hygiene in the entire food production chain for consumer health and food safety issues. For 
submission of a new food additive, the evaluation process by the SCF requires 
administrative, technical, toxicological data and references (European Commission Health & 
Consumer Protection Directorate, 2011). Among these, toxicological data obtained from 
experimental studies have a crucial role for consumers’ health due to the presence of any 
additive in food. 
During the general toxicological evaluation of food additives, the SCF first issued 
Guidelines for the Safety Assessment of Food Additives in 1980 (Scientific Committee for 
Food, 1980). However, new guidance documents have been published as Joint FAO/WHO 
Expert Committee on Food Additives (JECFA) (IPCS/JECFA, 1987), SCF guideline is still 
applicable. The aim of toxicological testing should provide sufficient information relevant to 
average consumer and vulnerable populations such as young age, pregnancy, diabetes, etc. 
The testing conditions depend on the chemical structure, proposed levels of use in food.  
The human data is derived from occupational epidemiology, medical use and volunteers 
but; for newly submitted food additives experimental data is commonly derived from 
laboratory animals. For evaluation of the safety of food additives, core studies are required 
such as; metabolism/toxicokinetics, subchronic toxicity, genotoxicity, chronic toxicity, 
carcinogenicity, reproduction and developmental toxicity. In this chapter, we are going to 
discuss the significant role of reproductive and developmental toxicity studies for 
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3. Traditional and newly released food additives 
“Toxicological Principles for the Safety Assessment of Food Ingredients” (Redbook 2000) is 
the new name of Redbook I which was previously published in draft form in 1983. Redbook 
2000 provides information about toxicological data of food ingredients which are submitted 
to Center for Food Safety and Applied Nutrition and Office of Food Additive Safety for 
industry and other stakeholders. Food and color additives, food contact substances (which 
are also defined as indirect food additives) and substances classified as generally recognized 
as safe (GRAS) are the components of food ingredients (U.S. Food and Drug Administration, 
2007). 
At the end of the toxicological studies data derived from animal studies can be used to 
extrapolate to give information on human exposure. Therefore, defining the Acceptable 
Daily Intake (ADI), described as the dose level at which the additive causes effects on the 
health of the animals, is important. The highest level at which no adverse effect on the 
health of the animals is observed is called the NOAEL (No-Observed-Adverse-Effect-Level). 
An ADI is derived by dividing the NOAEL obtained from these studies, by an appropriate 
‘uncertainty’ factor, which is intended to take account of differences between the animals on 
which the additive was tested and humans, in order to reduce further possibility of risk to 
humans. This uncertainty factor is commonly 100 (assuming that human beings are 10 times 
more sensitive than test animals and that the different levels of sensitivity within the human 
population is in a 10 fold range), but may be as much as 1,000 (if, for example, the toxic 
effect in animals is found to be particularly severe) or as low as 10 (where it has been found 
that humans are less likely than animals to be affected, based on actual data on the additive 
in humans) (Food Safety Authority of Ireland, 2011). 
4. Assessment of potential reproductive and developmental toxicity of 
recently used food additives 
Before a new food additive is introduced to the market, it should be tested if it causes any 
reproductive and developmental toxicity (EFSA, 2010a). To observe the potential effects, 
multigeneration reproduction studies have to be conducted. Laboratory species such as 
mouse, rabbit and especially rat are used at least for two generations and one litter per 
generation (Scientific Committee for Food, 1980). The test substance should be administrated 
in normal diet. 
On the other hand, two laboratory species, usually a rodent and a non-rodent should be 
used in developmental toxicity studies. The test substance should either be in normal diet or 
administered by oral gavage during whole gestation period in order to detect the potential 
toxicological effects. In addition to a multigenerational and/or developmental toxicity 
study; in order to provide the possible effects after postnatal development and function 
(such as neurological function and behavior), examinations should be continued from the 
beginning of embryogenesis through to weaning. 
4.1 Reproductive toxicity studies 
The aim of a reproductive toxicity study is to ensure data about effects on the sexuality and 
fertility of males and females. These include reproductive behavior, pregnancy carriage  
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ability, pre-postnatal survival rate, reproductive ability-capacity of the offspring and to 
examine major target organs for toxicity including reproductive organs in both parents and 
offspring histopathologically (Scientific Committee for Food, 1980). Besides, multigeneration 
reproductive toxicity studies ensure information about the effects on gonadal function, 
estrous cycles, conception, parturition, lactation (Joint FAO/WHO Expert Committee, 2000). 
Reproductive studies constitutively target multigenerational studies as a result of human 
exposure to most food additives and preservatives during the whole lifetime. Studies 
performed with multigeneration enable researchers to detect any potential effect of a 
specific additive on each litter per generation. The administration of the test substance to 
parental and offspring generations should be continuous via the diet. 
The end point evaluated in the indices calculated must provide sufficient information and 
statistical power to permit FDA whether the additive has effects on reproduction and 
fertility (U.S. Food and Drug Administration, 2007). The minimal reproduction study should 
consist at least two generations with one litter per generation. The reproduction study 
generation number should be expanded if the developmental toxicity effect of food additive 
is observed. A brief summary of the recommended reproduction study design according to 
FDA was given in Figure 3.  
In a basic two generation reproduction and teratology study, the first step is to find the 
appropriate dose range of the compound in order to conduct the main study. The second 
step, includes the selection of experimental animal species due to its’ life span, body size, 
breeding conditions, gestation length, high fertility rate etc. 5-9 weeks of aged animals, 
preferably rats are typically chosen. Each test and control group should include 
approximately 20 males and 20 pregnant females with uniform weight and age. For the 
detection of dose-related responses, minimum three doses of the test substance should be 
used: high, intermediate and low doses. The administration of the test substance may be via 
diet, drinking water or by gavage. In the first parental group (F0), males should be 
administered for the duration of spermatogenesis and epididymal transit before and 
throughout the mating period. First parental females should be administered for the same 
length of time as males and through pregnancy to the weaning of the F1a litter. Litters 
should be exposed throughout their entire lives. A female should be mated with a single 
randomly selected male from the same dose group until the pregnancy occurs or three 
weeks have elapsed. Each morning all females should be examined for the presence of 
vaginal plug or sperm in the vaginal lavage which is considered as “day zero” of gestation. 
Each animal should be observed twice each day at predefined time intervals. All animals 
should be weighted before administration, once weekly thereafter and at necropsy. During 
necropsy, the organs of reproductive system belonging to weanlings and parental animals 
(males-females) should be examined histopathologically. Uterus and ovaries for females; 
testis, seminal vesicle, prostate, epididymis for males should be weighted and evaluated 
separately. Brain, thymus and spleen tissues should also be examined for weanlings. Organ 
weights should be recorded both as absolute and relative weights. Indices which are the 
animal number responding to the test substance during conception until weaning period 
should be calculated for each reproduction study. To evaluate the endpoints of male 
reproductive toxicity, apart from counting testicular spermatid numbers, minimum 200 
sperm per sample from cauda epididymis or proximal vas deferens should be examined. 
Acquired data from control and test groups of animals should be compared statistically 
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Fig. 3. A reproduction study design by FDA 
According to the recommendations of FDA (U.S. Food and Drug Administration, 2007), a 
toxicity study should be conducted according to Good Laboratory Practice Regulations. The 
animals used in the study should be well cared and housed according to the 
recommendations of Guide for the Care and the Use of Laboratory Animals. All test animals 
should be categorized according to their species, strain, sex and weight or age.  
4.2 Pre- and post-natal developmental toxicity studies 
Developmental toxicity studies assess the effects of the test substance on the developing 
organism including the death, structural abnormalities, altered growth and functional 
deficiencies (Joint FAO/WHO Expert Committee, 2000).  
Lethal, teratogenic and other toxic effects on the embryo and fetus are examined under the 
consideration of prenatal developmental toxicity studies (Scientific Committee for Food, 
 
The Safety Assessment of Food Additives by Reproductive and Developmental Toxicity Studies 
 
37 
1980). Besides, postnatal developmental toxicity studies deal with the observed side effects 
caused by maternal or maternal milk way exposure. 
Embryonic and fetal resorptions, death, fetal weight, sex ratio, external and visceral skeletal 
morphology are in the context of prenatal developmental toxicity. The major objectives of 
postnatal developmental studies are physical, functional and behavioral development in 
animals exposed from embryogenesis through to weaning. These tests include neurological 
function, behavior during both early postnatal and adulthood phases, the measurement of 
vaginal opening in female pups, etc.  
4.3 Current studies about recently used food additives 
All food additives prior to their authorization should be evaluated for their safety by SCF or 
EFSA. According to the international legislations, all food additives must be kept under 
continuous observations and must be re-evaluated in the light of new scientific techniques. 
This part will be an overview of commonly used food additives listed below: 
4.3.1 Lutein (E 161b)  
Food colors are the first evaluated additives whose data are old. As soon as new available 
studies are conducted, the results should be renewed with the old ones. This is the reason of 
the evaluation priority of food color additives. 
Lutein (E 161b) is a natural carotenoid dye which is approved as a food additive by the EU. 
In a 90 day rat study, according to NOAEL (No Observed Adverse Effect Level) of 200 
mg/kg bw/day, which was defined by EFSA Panel, there were no developmental toxicity 
effects observed at dose levels up to 1000 mg/kg bw/day, the highest dose tested. 
Additionally, available reported data showed no effects on reproductive organs in oral 90-
day studies. Due to the fact that lutein is a normal constituent of diet, ADI can be altered. 
Lutein is found as a non-genotoxic additive; but the absence of multigeneration reproductive 
toxicity and chronic toxicity/carcinogenicity studies caused EFSA to get the decision for 
ADI of lutein as 1 mg/kg bw/day with the uncertainty factor of 200 (EFSA, 2010a).  
4.3.2 Caramel colours (E 150a,b,c,d)  
Caramel colours are colouring substances approved as food additives according to the 
reactants used in their manufacture. E 150a is Class I Plain Caramel or Caustic Caramel, E 
150b is Class II Caustic Sulphite Caramel, E 150c is Class III Ammonia Caramel and E 150d 
is Class IV Sulphite Ammonnia Caramel. EFSA determined the NOAEL as 30 g/kg bw/day 
with the uncertainty factor of 100 and ADI as 300 mg/kg bw/day for caramel colours. Up to 
date, there are no reproductive and/or developmental study of Class I and II caramels. 
JECFA states that there are only three developmental studies on Class III caramels. For Class 
III and IV caramels, studies with pregnant CD1 mice showed that, after treatment on days 6-
15 of gestation, there were no effects on the number of implantation sites and resorption 
numbers, maternal-fetal survival and fetal skeletal defects (Morgareidge, 1974a; 1974b). In 
other studies conducted with pregnant Wistar rats and Dutch-belted rabbits, no treatment-
related effects of Class III caramels were seen in the dams and fetal parameters 
(Morgareidge, 1974a). In the studies which were conducted on Wistar rats for Class IV 
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4.3.2 Caramel colours (E 150a,b,c,d)  
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150b is Class II Caustic Sulphite Caramel, E 150c is Class III Ammonia Caramel and E 150d 
is Class IV Sulphite Ammonnia Caramel. EFSA determined the NOAEL as 30 g/kg bw/day 
with the uncertainty factor of 100 and ADI as 300 mg/kg bw/day for caramel colours. Up to 
date, there are no reproductive and/or developmental study of Class I and II caramels. 
JECFA states that there are only three developmental studies on Class III caramels. For Class 
III and IV caramels, studies with pregnant CD1 mice showed that, after treatment on days 6-
15 of gestation, there were no effects on the number of implantation sites and resorption 
numbers, maternal-fetal survival and fetal skeletal defects (Morgareidge, 1974a; 1974b). In 
other studies conducted with pregnant Wistar rats and Dutch-belted rabbits, no treatment-
related effects of Class III caramels were seen in the dams and fetal parameters 
(Morgareidge, 1974a). In the studies which were conducted on Wistar rats for Class IV 





sites or sex ratio of the pups (Til and Spanjers, 1973). Available reproduction and 
developmental studies, although limited, do not reveal any effects of concern. The studies 
also did not reveal any effects on reproductive organs. Lymphocytopenia is the only concern 
reported in short term studies with caramel colours (EFSA, 2010b).  
4.3.3 Erythrosine (E 127) 
Erythrosine is a xanthene-dye which was evaluated by JECFA with the ADI of 0-0.1 mg/kg 
bw/day. It is used especially for cocktail and candied cherries. In rats (Collins et al., 1993a; 
1993b) and rabbits (Burnett et al., 1974) exposed to erythrosine by gavage or in drinking 
water, on day 0-19 of gestation, it was found neither fetotoxic nor teratogenic. Vivekanandhi 
et al. conducted a study with Swiss male Albino mice in which 64, 128 and 256 mg/kg 
bw/day erythrosine were administered daily by gavage resulted in decreased sperm 
motility and increased sperm abnormalities in dose dependent manner (Vivekanandhi et al., 
2006). 
4.3.4 Green S (E 142) 
Green S is a triarylmethane dye authorized as a food additive in the EU. JECFA has 
previously established an ADI of 25 mg/kg bw/day in 1975; however, this was re-evaluated 
and later considered to be 5 mg/kg bw/day by SCF. In a previous study established by rats, 
the NOAEL of Green S was derived as 500 mg/kg bw/day, based on the results as increased 
spleen and kidney weight. At the high dose treatment (1000 mg/kg bw/day), there was 
evidence that the amniotic membranes had a green colouring. However, intra-uterine and 
post-natal development was not affected. Within the light of these results, the NOAEL is 
concluded as 1000 mg/kg bw/day for fetal development. In an additional study, 15 male 
and 15 female Wistar rats were administrated Green S in the diet at dose levels of 250, 500 
and 1500 mg/kg bw/day for 13 weeks. When compared with controls, increases in mean 
body weight were observed in all treatment groups (BIBRA, 1978; Clode et al., 1987). Also, 
adequate reproduction and embryotoxicity studies including teratology are still requested 
(EFSA, 2010c). 
4.3.5 Amaranth (E 123) 
Amaranth (E 123) is an azo dye approved as a food additive in the EU. The ADI of 
Amaranth was established as 0-0.5 and 0.08 mg/kg bw/day by JECFA and SCF 
respectively. There are several studies which examined the reproductive and 
developmental toxicity of Amaranth. When all of these studies are taken into account, 
NOAELs for Amaranth is as follows: mouse 100 mg/kg bw/day, rat 15 mg/kg bw/day 
and rabbit 15 mg/kg bw/day (EFSA, 2010d). According to the results of Shtenberg and 
Gavrilenko, oral Amaranth exposure at doses of 1.5 and 15 mg/kg bw/day for 12-14 
months in parental generation causes a significantly higher percentage of unsuccessful 
pregnancies with no live born born pups and increases percentages of stillborns in rats 
(Shtenberg and Gavrilenko, 1970). In the study, 1.5 and 15 mg/kg bw/day administration 
of Amaranth in drinking water was reported to cause increased rate of post-implantation 
death with increased mortality at post-partum in both treatment groups and a higher 
incidence of stillbirth at 15 mg/kg bw/day group rats. Khera et al. administrated 
Amaranth to Wistar rats at dose levels of 15, 30, 100, 200 mg/kg bw/day on Days 0-18 of 
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gestation, either by gavage or in diet (Khera et al., 1974). According to the results, all dams 
were killed on day 19. The Panel considered that the NOAEL of this study is 200 mg/kg 
bw/day Amaranth, which is the highest dose tested. 
4.3.6 Brilliant Blue FCF (E 133) 
Brilliant Blue FCF (E 133) is another commonly used triarylmethane dye which is authorized 
as a food additive by the EU. Both JECFA and SCF established an ADI of 12.5 mg/kg 
bw/day. Depending on the newly conducted long-term studies, the ADI was revised to 10 
mg/kg bw/day by SCI in 1984. The NOAEL was assigned as 2500 mg/kg bw/day by 
JECFA with uncertainty factor of 200. Afterwards, SCF established Brilliant Blue NOAEL as 
1073 mg/kg bw/day in male and female rats with uncertainty factor of 100 (EFSA, 2010e). 
Among few chronic toxicity studies, the lowest NOAEL came from the most recent toxicity 
study (IRCD, 1981; Borzelleca, 1990). The Panel agreed with the authors and considered that 
the new NOAEL as 631 mg/kg bw/day. With uncertainty factor 100, the new established 
ADI for Brilliant Blue is 6 mg/kg bw/day. Data available up to date shows Brilliant Blue is 
poorly absorbed by the body and it is mainly excreted as unchanged in faeces. In addition, 
there have been several rat studies up to date; however in none of the studies treatment-
related abnormalities were observed. 
4.3.7 Curcumin (E 100) 
Curcumin (E 100) is a dicinnamoylmethane dye consisting of three principal colouring 
components. It is also approved by the EU for the use as a food additive. JECFA allocated an 
ADI dose of 0-3 mg/kg bw/day and a NOAEL dose of 250-320 mg/kg bw/day with 
uncertainty factor of 100 depending on the results of a multigeneration study which is 
conducted by Ganiger et al. In the study, rats were fed with Curcumin for 24 weeks at doses 
of 250-320 mg/kg bw/day and 960-100 mg/kg bw/day (Ganiger et al., 2007). In the high 
dose group, there was a decrease in body weight gain. Garg conducted a multigeneration 
study in Wistar rats according to OECD Testing guideline administering curcumin (Garg, 
1974). Rats were fed with diets containing 0, 1500, 3000, and 10000 mg/kg bw/day 
curcumin. At the end of the study, it was reported that there was a dose-related decrease on 
body weight gain in the dams of the parental generation during days 10-15 of gestation. 
However, no other effects were observed. According to its’ chemical composition, Curcumin 
is a rapidly metabolized dye which is later excreted with faeces (EFSA, 2010f).  
4.3.8 Canthaxanthin (E 161 g) 
Canthaxanthin is a carotenoid pigment which is authorized by the EU as a food additive. It 
is mainly composed of all-trans β-carotene-4,4’-dione with other minor carotenoids. The ADI 
dose of canthaxanthin is established as 0.03 mg/kg bw/day. There is no data reporting 
adverse effects of xanthaxanthin on reproductive system or on the developing fetus in high 
doses up to 1000mg/kg bw/day in rats and in high doses up to 400 mg/kg bw/day in 
rabbits. Hoffmann-La Roche reported that there were no adverse effects on fertility, litter 
size, the number of young weaned and their weights after 0 (placebo) and 0.1% 
canthaxanthin exposure in rats (Hoffmann – La, 1990). In a three-generation reproduction 
study by Buser, male and female rats were fed with diet including 0, 250, 500 and 1000 
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treatment-related effects in reproductive system. The EFSA Panel evaluated the highest dose 
tested of 1000 mg/kg bw/day as NOAEL for reproductive system, embryotoxicity and 
teratogenicity (EFSA, 2010g). 
4.3.9 Aspartame 
Nowadays, aspartame (APM) is the most commonly used artificial sweetener in the world 
(Hazardous Substances Data Bank, 2005). APM is approved by both FDA and the EU for 
the use in all foods (FDA, 1996; EFSA, 2006h). According to long term studies, ADI of APM 
is 2.5-5 mg/kg bw/day (Butchko et al., 2002). Long term carcinogenicity bioassays 
performed on rat and mice indicated that APM is a high effective carcinogenic additive 
causing lymphomas, leukemias and neoplastic lesions in females and Schwannomas in 
males (Soffritti et al., 2006). However, recently conducted lifespan studies with Swiss mice 
at dose levels of 0, 2000, 8000, 16000, 32000 ppm resulted that it does not affect the daily 
feed consumptions, mean body weights and the survival of males-females (Soffritti et al., 
2010). 
4.3.10 Paraben 
Parabens have wide range of use in different industrial areas. One of them is its’ use in food 
ingredients as an anti-microbial agent (Hossani et al., 2000). Parabens are lately reported to 
act as xenoestrogens which are a class of endocrine disruptors due to the lengths of their 
alkyl side chains (Okubo et al., 2001). It is known that parabens have an effect on 
reproductive tissues, induce aberrant estrogenic signaling in cells, cause changes in the 
expression patterns of multiple genes in rat fetal reproductive system (Naciff et al., 2003). 
Despite the potential health effects, parabens are approved as food additives by the EU with 
ADI dose of 0-10 mg/kg bw/day (Ishiwatari et al., 2007) and with NOAEL as 1000 mg/kg 
bw/day (Boberg et al., 2010). In a developmental study conducted by Thuy et. al, during 
juvenile-peripubertal period, female rats were administered with methyl-, ethyl-, propyl-, 
isopropyl-, butyl- and isobutylparabens at doses of 62.5, 250, 1000 mg/kg bw/day (Thuy et 
al., 2010). Their results showed that in the highest dose group there was a significant delay 
in the date of vaginal opening, a decrease in length of estrous cycle, morphological changes 
in the uterus and increased number of cystic follicles in ovaries. Additionally, after 10, 100, 
1000 mg/kg bw/day polyparaben treatment, decreases in daily testis sperm production and 
in serum testosterone levels in a dose-dependent manner were observed in all doses (Oishi, 
2002). 
4.3.11 Coriander essential oil 
Coriander essential oil is obtained by steam distillation of the dried fruits (seeds) of 
Coriandrum sativum L. In the food industry, coriander oil is used as a flavoring agent and 
adjuvant. Coriander oil is both approved for the use as food additive by FDA and The EU 
(Vollmuth et al., 1990). While maternal NOAEL of coriander oil was determined as 250 
mg/kg bw/day, developmental NOAEL was established as 500 mg/kg bw/day (FFHPVC, 
2002). Vollmuth et al. administered 250, 500, 100 mg/kg bw/day coriander oil to pregnant 
pregnant Crl CD rats (7 day before cohabitation, during gestation, 4 day post-parturition). 
At the highest dose significant decreases in gestation index, length of gestation, viability of 
pups and litter size were noted.  
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4.3.12 Allyl isothiocyanate (AITC) 
Allyl isothiocyanate (AITC) is used both as a food additive and a flavouring agent. It can 
occur naturally in certain vegetables such as cabbage, mustard and horseradish (EFSA 
2010i). EFSA Panel (2010) established the ADI dose as 0.02 mg/kw bw/day with an 
uncertainty factor of 500 (EFSA, 2010i). The Panel regarded a Low Observed Adverse Effect 
Level (LOAEL) as 12 mg/kw bw/day rather than the NOAEL in order to cover 
uncertainties resulting from extrapolation. Oral doses of AITC up to 18.5, 23.8 and 12.3 
mg/kg bw/day did not cause any developmental toxicity in pregnant rats, hamsters and 
rabbits and may be fetotoxic to mouse at doses higher than 6 mg/kg bw/day without any 
teratogenic effects (EFSA, 2010i). 
4.3.13 Tricalcium phosphate (E 341) 
Tricalcium phosphate (E 341) is a commonly used flavor preservative, anti-caking, 
stabilizing and anti-souring food additive. JECFA reported the ADI dose of E 341 as 70 
mg/kg bw/day (JECFA, 2001). In a recently published study, Wistar rats were treated with 
175 and 350 mg/kg bw/day E 341 during gestation days 0-20. Decrease in placental weights 
and skeletal morphometry in fetus were observed in both doses (Güngörmüş et al., 2010). 
There was also a decrease in trans-umblical cord lengths in treatment group. According to 
these results, it was concluded that rat prenatal development during gestation is sensitive to 
E 341 exposure. 
5. Alternative methods 
To support and explore in more depth of results obtained from fundamental studies; 
immunotoxicity, allergenicity, neurotoxicity, genotoxicity, human volunteer studies, 
predictive mechanistic and special studies may also be helpful. Another recent method for 
developmental toxicity testing is in vitro studies, which are not based on the use of animals. 
In vitro studies provide sufficient data by using cellular and subcellular systems to predict 
the mechanisms involved in early stage of development. As a result of ethical issues about 
animal use, in vitro testing mechanisms will come into prominence in upcoming years. 
Over the past few decades, one of the most notable revolutionized technologies is the 
application of nanotechnology in food sector. Therefore, in this part, concerns and health 
implications on the application of nanotechnology in food will be discussed. The possible 
effects on reproductive system due to consumption of foods involving nanoparticles are 
evaluated. 
5.1 Approaches of in vitro studies for assessing food additives 
Commonly, the toxicological risk to humans from exposure to an individual chemical is 
evaluated using animal data from long-term or acute in vivo toxicity studies. Over the last 20 
years, there has been a clear tendency for increased use of in vitro methods in toxicology as 
supplements to animal tests. Although such studies have previously been considered during 
the hazard characterization of many compounds they generally have had no direct influence 
on the calculation of ADI values. In vitro studies may be a useful perspective in bridging the 
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basis for the use of a specific data. In vitro testing systems are increasingly becoming an 
essential tools as part of integrated toxicology testing strategy and scientific progress in the 
fields of cellular and molecular biology. These studies are used in a wide range of processes 
including the determination of ADI, for reporting suggestions in safety approaches, 
metabolism pathways of specific compounds. According to the limited number of 
toxicological studies, in vitro applications are useful for the prospective toxicological 
classification and characterization of food additives. In vitro studies have the potential for 
calculation and detection of both inter-species and inter-individual variability in 
toxicokinetics and toxicodynamics of food additives (Walton, 1999). 
5.2 Nanoparticle based applications of food additives in food industry 
Public interest in the subject of nanotechnology in the food industry is growing. It opens up 
many new possibilities which are of interest to the food industry. Nanofood market 
potential was predicted as 20.4 billion US dollars for the year 2010 (IFST, 2006). More than 
200 companies worldwide are already believed to be involved in this sector, especially in the 
USA, Japan and China. Several companies are investigating encapsulation technology for 
the delivery of active ingredients in food products (e.g. flavouring agents, vitamins, fatty 
acids). Nanotechnology in the food industry is a sensitive subject. Manufacturers fear a 
blanket rejection of products containing nanomaterials, similar to what has happened with 
genetic engineering. Food products naturally contain nano-sized ingredients. These are 
different from synthetically manufactured nanomaterials. Food proteins can be mentioned 
as examples of natural nanostructures whose size can vary between several hundred 
nanometers such as milk proteins and casein.  
With encapsulation (Figure 4), in which active agents and substances can be encapsulated in 
nanostructured materials, the purpose is to enhance solubility (e.g. of colouring agents), 
facilitate controlled release (e.g. only in certain parts of the alimentary tract, for instance in 
order to prevent the bad taste of an ingredient which in itself is beneficial such as omega-3 
fatty acids in fish oils), improve bioavailability, i.e. the amount of a nutritional ingredient 
which is actually absorbed by the body (e.g. vitamins, minerals), protect micronutrients and 
bioactive compounds during manufacture, storage and retail. The most important 
nanostructured materials are currently nano-capsules (micelles, liposomes) and 
nanoemulsions (Greßler et al., 2010). Nanocarrier systems can be used to mask the 
unpleasant tastes and flavours of ingredients and additives such as fish oils, to protect the 
encapsulated ingredients from degradation during processing and storage, as well as to 
improve dispersion of water-insoluble food ingredients. However, current studies on the 
application of nanoencapsulation mainly address its potential for target delivery of active 
ingredients of functional food and nutraceuticals (Hsieh and Ofori, 2007). 
 
Fig. 4. Schematic diagram of nanoencapsulation (Centre for Food Safety, Hong Kong, 2010) 
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Experimental data demonstrated that the distribution of nanoparticles after oral 
administration is dependent upon particle size. Smaller-sized nanoparticles have a more 
widespread tissue distribution in organs like kidney, liver, lungs and brain while the 
bigger particles (28 nm and 58 nm) remain almost solely inside the gastrointestinal tract 
(The Government of the Hong Kong Centre for Food Safety Food and Environmental 
Hygiene Department, 2010). Studies have been performed on the ability of nanoparticles to 
penetrate the placental barrier. There is also information that certain nanomaterial (C60 
fullerene) can pass across the placenta. However, due to the inconsistent results of some in 
vitro and animal studies, no general conclusion on the penetration power of nanoparticles 
across the placental barrier can be made. There is no information on whether nanomaterials 
are transferred into milk (Tsuchiya et al., 1996; EFSA, 2010j). Because nanoparticle food 
industry is a recently developing field, the reproductive and developmental toxicity 
studies are rare. In one of the few studies conducted by Durnev et al., silicon crystal 2-5 nm 
nanoparticles in the form of 1-5 μ granules in water suspension were injected 
intraperitoneally in a single dose to male F1(CBA×C57Bl/6) mice or to outbred albino rats 
on days 1, 7, and 14 of gestation (Durnev et al., 2010). It was reported that injection of 50 
mg/kg dose of silicon crystal nanoparticles reduced body weight gain in pregnant rats and 
newborn rats at different stages of the experiment, but had no effect on other parameters of 
physical development of rat progeny and caused no teratogenic effects. In a recent study it 
was also reported that nanosized silicon materials are generally nontoxic and 
biodegradable (Fucikova et al., 2011). Nowadays, in comparison to other materials 
currently used in medicine applications, nanosized Si based materials are the only one 
showing complete biodegrability and nontoxicity without any significant inflammatory 
reactions. 
6. Discussion  
Food additives are natural or manufactured substances, which are added to foods for 
restoring colors lost during processing, providing sweetness, preventing deterioration 
during storage and guarding with preservatives against food poisoning. A food additive is 
defined as a substance not normally consumed as a food in itself and not normally used as a 
characteristic ingredient of food whether or not it has nutritive value, the intentional 
addition of which to food for a technological purpose in the manufacture, processing, 
preparation, treatment, packaging, transport or storage of such food results, or may be 
reasonably expected to result, in it or its by-products becoming directly or indirectly a 
component of such foods (Food Safety Authority of Ireland, 2011). 
All food additives undergo a safety assessment that may be used in the manufacture or 
preparation of foodstuffs in the European Union. Up to 2002, this safety assessment was 
carried out by the EU SCF but since 2003, the responsibilities of the SCF have been taken by 
EFSA. 
The safety evaluation of a food additive involves examination of the chemical structure and 
characteristics, including its specifications, its impurities and potential breakdown products. 
Toxicological data is essential to identify and characterize the possible health hazards of an 
additive and to allow extrapolation of the findings in animals and other test systems to 
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Such tests are designed to give information on any possible effects from short-term or long-
term exposure to the additive, including whether it may have any potential to cause cancer 
(carcinogenicity), or to affect male or female reproduction or the development of the embryo 
or the fetus if consumed by a pregnant woman (reproductive or developmental toxicity). 
Other effects include the genotoxicity potential of the compound; which is the ability to 
cause the development of cancer or adverse effects in future generations. 
This chapter is an overview of the developmental and reproductive studies conducted by 
the administration of commonly used food additives. Recent studies show that there is a 
lot of concern about the safety of food additives in toxicological manner. With the 
increasing amount of progression in food additive industry, people who need more 
information about popular additives admit to being confused with the possible health 
effects. There are both safety evaluations and regulations of newly released food 
additives. As a matter of fact, it is inevitable to use food additives with the increasing 
demand of high-quality food. Excessive parental exposure of food additive throughout 
lifespans makes reproductive and developmental endpoints remarkable for investigating. 
This chapter strived to focus on the fine prints of toxicological assessments, especially the 
possible reproductive and developmental effects of food additives and to give 
perspectives for new approaches in the evaluations of food additives in concordance with 
the improvement of food industry. 
7. Acknowledgements 
The authors would like to thank Prof. Dr. Dürdane Kolankaya and Prof. Dr. M. Turan Akay 
for their improving suggestions and advices as supervisors. 
8. References 
British Industrial Biological Research Association (BIBRA). (1978). Report No 196/1/78. 
Short term toxicity of Green S in rats. Clode, SA, Gaunt, IF, Hendy, RJ, Cottrell, RC, 
Gangolli, SD. 
Boberg, J., Camilla, T., Christiansen, S. & Ulla.,  Hass. (2010). Possible endocrine disrupting 
effects of parabens and their metabolites. Reproductive Toxicology, Vol.30, pp.301–
312. 
Borzelleca, J.F., Depukat, K. & Hallagan, J.B. (1990). Lifetime toxicity/carcinogenicity studies 
of FD & C Blue No. 1 (Brilliant blue FCF) in rats and mice. Food and Chemical 
Toxicology. Vol.28, pp.221-234. 
Burnett, C.M., Agersborg, H., Borzelleca, J., Eagle, E., Ebert, A., Pierce, E., Kirschman, J. & 
Scala, R. (1974). Teratogenic studies with certified colors in rats and rabbits. 
Toxicology and Applied Pharmacology. Vol.25, pp.121-128. 
Buser, S. (1987). Canthaxanthin in a three-generation study in rats. Unpublished Report No. 
HLR 138/86755 of Huntingdon Research Centre Ltd. Submitted by Hoffmann-La 
Roche & Co., Basel, Switzerland. 
Butchko, H.H., Stargel, W.W., Comer, C.P., Mayhew, D.A., Benninger, C., Blackburn, G.L., 
De Sonneville, L.M.J., Geha, R.F., Herteley, Z., Kostner, A., Leon, A.S., Liepa, G.U., 
McMartin, K.E., Mendnhall, C.L., Munro, I.C., Novotny, E.J., Renwick, A., Gi 
 
The Safety Assessment of Food Additives by Reproductive and Developmental Toxicity Studies 
 
45 
Schiffman, S.S., Schomer, D.L., Shaywitz, B.A., Spiers, P.A., Tephly, J.A. & Trefz, 
F.K. (2002). Intake of aspartame vs the acceptable daily intake. Regulative Toxicology 
and Pharmacology. Vol.35, pp.13-16. 
CAOBISCO Website. (2011). www.caobisco.com/doc_uploads/legislation/XOT4-EN.pdf, 
Belgium. 
Clode, S.A., Gaunt, I.F., Hendy, R.J., Contrell, R.C. & Gangolli, S.D. (1987). Short-term 
toxicity of Green S in rats. Food and Chemical Toxicology. Vol.25, pp.969-975. 
Codex Alimentarius (2009). “Noms de Categorie et Systeme International de Numerotation 
des Additifs Alimentaries” 
Collins, T.F., Black, T.N., O'Donnell, M.W.J., Shackelford, M.E. & Bulhack, P. (1993a). 
Teratogenic potential of FD & C Red no. 3 when given in drinking water. Food and 
Cosmetics Toxicology. Vol.31, pp.161-167. 
Collins, T.F., Black, T.N. & Ruggles, D.I. (1993b). Teratogenic potential of FD&C Red No. 3 
when given by gavage. Toxicology and Industrial Health. Vol.9, No.4, pp.605-16. 
Durnev, A.D., Solomina, A.S., Daugel-Dauge, N.O., Zhanataev, A.K., Shreder, E.D., 
Nemova, E.P., Shreder, O.V., Veligura, V.A., Osminkina, L.A., Timoshenko, V.Y. & 
Seredenin, S.B. (2010) Evaluation of Genotoxicity and Reproductive Toxicity of 
Silicon Nanocrystals. Bulletin of Experimental Biology and Medicine. Vol.149, No.4, 
pp.445-449. 
EFSA. (2010). Scientific Opinion on the safety of allyl isothiocyanate for the proposed uses as 
a food additive. EFSA Journal. Vol.8, No.12, pp.1943. 
EFSA. (2010). Scientific Opinion on the re-evaluation of Amaranth (E 123) as a food additive. 
EFSA Journal. Vol.8, No.7, pp.1649. 
EFSA. (2010). Scientific Opinion on the re-evaluation of Brilliant Blue FCF (E 133) as a food 
additive. EFSA Journal. Vol.8, No.11, pp.1853. 
EFSA. (2010). Scientific Opinion on the re-evaluation of Canthaxanthin (E 161 g) as a food 
additive. EFSA Journal. Vol.8, No.10, pp.1852. 
EFSA Scientific opinion on the re-evaluation of Caramel colours (E 150 a,b,c,d) as food 
additives  (2011) EFSA Journal, Vol.9, No.3, pp.2004.  
EFSA. (2010). Scientific Opinion on the re-evaluation of Curcumin (E 100) as a food additive. 
EFSA Journal. Vol.8, No.9, pp.1679. 
EFSA. (2010). Scientific Opinion on the re-evaluation of Green S (E 142) as a food additive. 
EFSA Journal. Vol.8, No.11, pp.1851. 
EFSA. (2010). Scientific opinion on the re-evaluation of Lutein (E161b) as a food additive. 
EFSA Journal. Vol.8, No.7, pp.1678. 
EFSA. (2009). Scientific Opinion of the Scientific Committee on the Potential Risks Arising 
from Nanoscience and Nanotechnologies on Food and Feed Safety.  
European Commission Health & Consumer Protection Directorate-General. (2011). 
Guidance on Submissions for Food Additive Evaluations by the Scientific 
Committee on Food. 
European Food Safety Authority (EFSA). (2006). Opinion of the Scientific Panel on Food 
Additives, Flavourings, Processing Aids and Materials in contact with Food (AFC) 
on a request from the Commission related to a new long-term carcinogenicity study 





Such tests are designed to give information on any possible effects from short-term or long-
term exposure to the additive, including whether it may have any potential to cause cancer 
(carcinogenicity), or to affect male or female reproduction or the development of the embryo 
or the fetus if consumed by a pregnant woman (reproductive or developmental toxicity). 
Other effects include the genotoxicity potential of the compound; which is the ability to 
cause the development of cancer or adverse effects in future generations. 
This chapter is an overview of the developmental and reproductive studies conducted by 
the administration of commonly used food additives. Recent studies show that there is a 
lot of concern about the safety of food additives in toxicological manner. With the 
increasing amount of progression in food additive industry, people who need more 
information about popular additives admit to being confused with the possible health 
effects. There are both safety evaluations and regulations of newly released food 
additives. As a matter of fact, it is inevitable to use food additives with the increasing 
demand of high-quality food. Excessive parental exposure of food additive throughout 
lifespans makes reproductive and developmental endpoints remarkable for investigating. 
This chapter strived to focus on the fine prints of toxicological assessments, especially the 
possible reproductive and developmental effects of food additives and to give 
perspectives for new approaches in the evaluations of food additives in concordance with 
the improvement of food industry. 
7. Acknowledgements 
The authors would like to thank Prof. Dr. Dürdane Kolankaya and Prof. Dr. M. Turan Akay 
for their improving suggestions and advices as supervisors. 
8. References 
British Industrial Biological Research Association (BIBRA). (1978). Report No 196/1/78. 
Short term toxicity of Green S in rats. Clode, SA, Gaunt, IF, Hendy, RJ, Cottrell, RC, 
Gangolli, SD. 
Boberg, J., Camilla, T., Christiansen, S. & Ulla.,  Hass. (2010). Possible endocrine disrupting 
effects of parabens and their metabolites. Reproductive Toxicology, Vol.30, pp.301–
312. 
Borzelleca, J.F., Depukat, K. & Hallagan, J.B. (1990). Lifetime toxicity/carcinogenicity studies 
of FD & C Blue No. 1 (Brilliant blue FCF) in rats and mice. Food and Chemical 
Toxicology. Vol.28, pp.221-234. 
Burnett, C.M., Agersborg, H., Borzelleca, J., Eagle, E., Ebert, A., Pierce, E., Kirschman, J. & 
Scala, R. (1974). Teratogenic studies with certified colors in rats and rabbits. 
Toxicology and Applied Pharmacology. Vol.25, pp.121-128. 
Buser, S. (1987). Canthaxanthin in a three-generation study in rats. Unpublished Report No. 
HLR 138/86755 of Huntingdon Research Centre Ltd. Submitted by Hoffmann-La 
Roche & Co., Basel, Switzerland. 
Butchko, H.H., Stargel, W.W., Comer, C.P., Mayhew, D.A., Benninger, C., Blackburn, G.L., 
De Sonneville, L.M.J., Geha, R.F., Herteley, Z., Kostner, A., Leon, A.S., Liepa, G.U., 
McMartin, K.E., Mendnhall, C.L., Munro, I.C., Novotny, E.J., Renwick, A., Gi 
 
The Safety Assessment of Food Additives by Reproductive and Developmental Toxicity Studies 
 
45 
Schiffman, S.S., Schomer, D.L., Shaywitz, B.A., Spiers, P.A., Tephly, J.A. & Trefz, 
F.K. (2002). Intake of aspartame vs the acceptable daily intake. Regulative Toxicology 
and Pharmacology. Vol.35, pp.13-16. 
CAOBISCO Website. (2011). www.caobisco.com/doc_uploads/legislation/XOT4-EN.pdf, 
Belgium. 
Clode, S.A., Gaunt, I.F., Hendy, R.J., Contrell, R.C. & Gangolli, S.D. (1987). Short-term 
toxicity of Green S in rats. Food and Chemical Toxicology. Vol.25, pp.969-975. 
Codex Alimentarius (2009). “Noms de Categorie et Systeme International de Numerotation 
des Additifs Alimentaries” 
Collins, T.F., Black, T.N., O'Donnell, M.W.J., Shackelford, M.E. & Bulhack, P. (1993a). 
Teratogenic potential of FD & C Red no. 3 when given in drinking water. Food and 
Cosmetics Toxicology. Vol.31, pp.161-167. 
Collins, T.F., Black, T.N. & Ruggles, D.I. (1993b). Teratogenic potential of FD&C Red No. 3 
when given by gavage. Toxicology and Industrial Health. Vol.9, No.4, pp.605-16. 
Durnev, A.D., Solomina, A.S., Daugel-Dauge, N.O., Zhanataev, A.K., Shreder, E.D., 
Nemova, E.P., Shreder, O.V., Veligura, V.A., Osminkina, L.A., Timoshenko, V.Y. & 
Seredenin, S.B. (2010) Evaluation of Genotoxicity and Reproductive Toxicity of 
Silicon Nanocrystals. Bulletin of Experimental Biology and Medicine. Vol.149, No.4, 
pp.445-449. 
EFSA. (2010). Scientific Opinion on the safety of allyl isothiocyanate for the proposed uses as 
a food additive. EFSA Journal. Vol.8, No.12, pp.1943. 
EFSA. (2010). Scientific Opinion on the re-evaluation of Amaranth (E 123) as a food additive. 
EFSA Journal. Vol.8, No.7, pp.1649. 
EFSA. (2010). Scientific Opinion on the re-evaluation of Brilliant Blue FCF (E 133) as a food 
additive. EFSA Journal. Vol.8, No.11, pp.1853. 
EFSA. (2010). Scientific Opinion on the re-evaluation of Canthaxanthin (E 161 g) as a food 
additive. EFSA Journal. Vol.8, No.10, pp.1852. 
EFSA Scientific opinion on the re-evaluation of Caramel colours (E 150 a,b,c,d) as food 
additives  (2011) EFSA Journal, Vol.9, No.3, pp.2004.  
EFSA. (2010). Scientific Opinion on the re-evaluation of Curcumin (E 100) as a food additive. 
EFSA Journal. Vol.8, No.9, pp.1679. 
EFSA. (2010). Scientific Opinion on the re-evaluation of Green S (E 142) as a food additive. 
EFSA Journal. Vol.8, No.11, pp.1851. 
EFSA. (2010). Scientific opinion on the re-evaluation of Lutein (E161b) as a food additive. 
EFSA Journal. Vol.8, No.7, pp.1678. 
EFSA. (2009). Scientific Opinion of the Scientific Committee on the Potential Risks Arising 
from Nanoscience and Nanotechnologies on Food and Feed Safety.  
European Commission Health & Consumer Protection Directorate-General. (2011). 
Guidance on Submissions for Food Additive Evaluations by the Scientific 
Committee on Food. 
European Food Safety Authority (EFSA). (2006). Opinion of the Scientific Panel on Food 
Additives, Flavourings, Processing Aids and Materials in contact with Food (AFC) 
on a request from the Commission related to a new long-term carcinogenicity study 





FFHPVC. (2002). The terpene consortium test plan for terpenoid tertiary alcohols and 
related esters. In: Report Submitted to the EPA Under the HPV Challenge Program, 
The Flavor and Fragrance High Production Volume Consortia, Washington, DC. 
Food and Drug Administration (FDA). (1996). Food additives permitted for direct addition 
to food for human consumption: Aspartame. Federal Regulations. Vol.61, pp.33654-
33656. 
Food Safety Authority of Ireland. (2011) Guidance on Food Additives, Revision 1.  
Fucikova, A., Valenta, J., Pelant, I., Kusova, K. & Brezina, V. (2011). Nanocrystalline silicon 
in biological studies. Physica Status Solidi. Vol.8, No.3, pp.1093–1096. 
Ganiger, S., Malleshappa, H.N., Krishnappa, H., Rajahekhar, G.V., Ramakrishna, R. & 
Sullivan, F. (2007). A two generation reproductive toxicity study with curcumin, 
turmeric yellow, in Wistar rats. Food and Chemical Toxicology. Vol.45, pp.64-69. 
Garg, S.K. (1974) Effects of Curcuma longa on fertility. Planta medica. Vol.26, pp.225-227. 
Greßler, S., Gazsó, A., Simkó, M., Nentwich, M., Fiedeler, U. (2010). Nanoparticles and 
nanostructured materials in the food industry. Nano Trust Dossiers. No.004en. 
Güngörmüş, C., Klç, A., Akay, M.T. & Kolankaya, D. (2010). The effects of maternal 
exposure to food additive E341 (tricalcium phosphate) on foetal development of 
rats. Environmental Toxicology and Pharmacology. Vol.29, pp.111–116. 
Hazardous Substances Data Bank. (2005). TOXNET: Toxicological Data Network. Available: 
http://www.toxnet.net.nlm.nih.gov 
Hoffmann-La, R. (1990). Canthaxanthin. Unpublished report submitted to WHO by F. 
Hoffmann - La Roche & Co., Basle, Switzerland (as referred to by JECFA). 
Hossaini, A., Larsen, J.J. & Larsen, J.C. (2000) Lack of oestrogenic effects of food 
preservatives (parabens) in uterotrophic assays. Food and Chemical Toxicology. 
Vol.38, pp.319–23. 
Hsieh, Y.H.P. & Ofori, J.A. (2007). Innovation in food technology for health. Asia Pacific 
Journal of Clinical Nutrition. Vol.16, No.Supplemental1, pp.65-73. 
Institute of Food Science & Technology (IFST). (2006) Nanotechnology Information 
Statement.  
IPCS/JECFA. (1987) Environmental Health Criteria 70: Principles for the Safety Assessment 
of Food Additives and Contaminants in Food. World Health Organization, Geneva. 
International Research & Development Corporation (IRCD). (1981). Longt-term dietary 
toxicity/carcinogenicity study in rats. Unpublished report. 
Ishiwatari, S., Suzuki, T., Hitomi, T., Yoshino, T., Matsukuma, S. and Tsuji, T. (2007) Effects 
of methyl paraben on skin keratinocytes. Journal of Applied Toxicology. Vol.27, pp.1–
9. 
JECFA. (2001). http://www.inchem.org/documents/jecfa/jeceval/jec 2306.htm. 
Joint FAO/WHO Expert Committee. (2000). Guidelines for the preparation of toxicological 
working papers on food additives. Geneva. 
Khera, K.S., Przybylski, W. & McKilnley, W.P. (1974). Implantation and embryonic survival 
in rats treated with Amaranth during gestation. Food and Cosmetics Toxicology. 
Vol.12, pp.507-510. 
Morgareidge, K. (1974a). Teratologic evaluation of FDA 71-82 (caramel, bakers and 
confectioners)in mice, rats and rabbits. Unpublished report No. PB 234-870 from 
 
The Safety Assessment of Food Additives by Reproductive and Developmental Toxicity Studies 
 
47 
Food and Drug Research Laboratories Inc., Waverly, NY; USA (as referred to by 
JECFA, 1987). 
Morgareidge, K., (1974b). Teratologic evaluation of FDA 71-83 (caramel beverage) in mice, 
rats and rabbits. Unpublished report No. PB 234-867 from Food and Drug Research 
Laboratories Inc., Waverly, NY; USA. 
Naciff, J.M., Overmann, G.J., Torontali, S.M., Carr, G.J., Tiesman, J.P. & Richardson, B.D. 
(2003) Gene expression profile induced by 17 alpha-ethynyl estradiol in the 
prepubertal female reproductive system of the rat. Toxicological Sciences Vol.72, 
pp.314–30. 
Oishi, S. (2002) Effects of propyl paraben on the male reproductive system. Food and 
Chemical Toxicology. Vol.40, No.12, pp.1807–1813. 
Okubo, T., Yokoyama, Y., Kano, K. & Kano, I. (2001). ER-dependent estrogenic activity of 
parabens assessed by proliferation of human breast cancer MCF-7 cells and 
expression of ERalpha and PR. Food and Chemical Toxicology. Vol.39, pp.1225–1232. 
Scientific Committee for Food. (1980). Guidelines for the Safety Assessment of Food 
Additives. Reports of the Scientific Committee for Food (Tenth series). Commission 
of the European Communities, Luxembourg EUR 6892. 
Shtenberg, A.I. & Gavrilenko, E.V. (1970). Effects of Amaranth food dye on reproductive 
function and progeny development in experiments with albino rats. Voprosy 
Pitaniia. Vol.29, pp.66. 
Soffritti, M., Belpoggi, F., Degli Esposti, D., Lambertini, L., Tibaldi, E. & Rigano, A. (2006). 
First experimental demonstration of the multipotential carcinogenic effects of 
aspartame administered in the feen to Spraguq-Dawley rats. Environmental Health 
Perspective Vol.114, pp.379-385. 
Soffritti, M., Belpoggi, F., Manservigi, M., Tibaldi, E., Lauriola, M., Falcioni, L. & Bua, L. 
(2010). Aspartame administered in feed, beginning prenatally through life span, 
induces cancers of the live and lung in male swiss mice. American Journal of 
Industrial Medicine. Vol.53, No.12, pp.1197-1206. 
The Government of the Hong Kong Centre for Food Safety Food and Environmental 
Hygiene Department Special Administrative Region. (2010). Nanotechnology and 
Food Safety, Risk Assessment Studies Report No. 41. 
Thuy, T.B., Vo, Y.M.Y., Kyung-Chul, C. & Eui-Bae, J. (2010) Potential estrogenic effect(s) of 
parabens at the prepubertal stage of a postnatal female rat model. Reproductive 
Toxicology. Vol.29, pp.306–316. 
Til, H.P. & Spanjers, M. (1973). Reproduction study in rats with six different Ammonia 
Caramels. Unpublished report No. R 4068 from Centraal Instuut voor 
Voedingsonderzoek (CIVO/TNO), Zeist, The Netherlands. 
Tsuchiya, T., Oguri, I., Yamakoshi, Y.N. & Miyata, N. (1996). Novel harmful effects of 
fullerene on mouse embryos in vitro and in vivo. FEBS Letters Vol.393, No.1, 
pp.139-45. 
U.S. Food and Drug Administration. (2007). Toxicological Principles for the Safety 
Assessment of Food Ingredients, Redbook 2000. 
Vivekanandhi, J., Devi, C.P.A., Jayaraman, K. & Raghavan, L. (2006). Effect of Erythrosine 





FFHPVC. (2002). The terpene consortium test plan for terpenoid tertiary alcohols and 
related esters. In: Report Submitted to the EPA Under the HPV Challenge Program, 
The Flavor and Fragrance High Production Volume Consortia, Washington, DC. 
Food and Drug Administration (FDA). (1996). Food additives permitted for direct addition 
to food for human consumption: Aspartame. Federal Regulations. Vol.61, pp.33654-
33656. 
Food Safety Authority of Ireland. (2011) Guidance on Food Additives, Revision 1.  
Fucikova, A., Valenta, J., Pelant, I., Kusova, K. & Brezina, V. (2011). Nanocrystalline silicon 
in biological studies. Physica Status Solidi. Vol.8, No.3, pp.1093–1096. 
Ganiger, S., Malleshappa, H.N., Krishnappa, H., Rajahekhar, G.V., Ramakrishna, R. & 
Sullivan, F. (2007). A two generation reproductive toxicity study with curcumin, 
turmeric yellow, in Wistar rats. Food and Chemical Toxicology. Vol.45, pp.64-69. 
Garg, S.K. (1974) Effects of Curcuma longa on fertility. Planta medica. Vol.26, pp.225-227. 
Greßler, S., Gazsó, A., Simkó, M., Nentwich, M., Fiedeler, U. (2010). Nanoparticles and 
nanostructured materials in the food industry. Nano Trust Dossiers. No.004en. 
Güngörmüş, C., Klç, A., Akay, M.T. & Kolankaya, D. (2010). The effects of maternal 
exposure to food additive E341 (tricalcium phosphate) on foetal development of 
rats. Environmental Toxicology and Pharmacology. Vol.29, pp.111–116. 
Hazardous Substances Data Bank. (2005). TOXNET: Toxicological Data Network. Available: 
http://www.toxnet.net.nlm.nih.gov 
Hoffmann-La, R. (1990). Canthaxanthin. Unpublished report submitted to WHO by F. 
Hoffmann - La Roche & Co., Basle, Switzerland (as referred to by JECFA). 
Hossaini, A., Larsen, J.J. & Larsen, J.C. (2000) Lack of oestrogenic effects of food 
preservatives (parabens) in uterotrophic assays. Food and Chemical Toxicology. 
Vol.38, pp.319–23. 
Hsieh, Y.H.P. & Ofori, J.A. (2007). Innovation in food technology for health. Asia Pacific 
Journal of Clinical Nutrition. Vol.16, No.Supplemental1, pp.65-73. 
Institute of Food Science & Technology (IFST). (2006) Nanotechnology Information 
Statement.  
IPCS/JECFA. (1987) Environmental Health Criteria 70: Principles for the Safety Assessment 
of Food Additives and Contaminants in Food. World Health Organization, Geneva. 
International Research & Development Corporation (IRCD). (1981). Longt-term dietary 
toxicity/carcinogenicity study in rats. Unpublished report. 
Ishiwatari, S., Suzuki, T., Hitomi, T., Yoshino, T., Matsukuma, S. and Tsuji, T. (2007) Effects 
of methyl paraben on skin keratinocytes. Journal of Applied Toxicology. Vol.27, pp.1–
9. 
JECFA. (2001). http://www.inchem.org/documents/jecfa/jeceval/jec 2306.htm. 
Joint FAO/WHO Expert Committee. (2000). Guidelines for the preparation of toxicological 
working papers on food additives. Geneva. 
Khera, K.S., Przybylski, W. & McKilnley, W.P. (1974). Implantation and embryonic survival 
in rats treated with Amaranth during gestation. Food and Cosmetics Toxicology. 
Vol.12, pp.507-510. 
Morgareidge, K. (1974a). Teratologic evaluation of FDA 71-82 (caramel, bakers and 
confectioners)in mice, rats and rabbits. Unpublished report No. PB 234-870 from 
 
The Safety Assessment of Food Additives by Reproductive and Developmental Toxicity Studies 
 
47 
Food and Drug Research Laboratories Inc., Waverly, NY; USA (as referred to by 
JECFA, 1987). 
Morgareidge, K., (1974b). Teratologic evaluation of FDA 71-83 (caramel beverage) in mice, 
rats and rabbits. Unpublished report No. PB 234-867 from Food and Drug Research 
Laboratories Inc., Waverly, NY; USA. 
Naciff, J.M., Overmann, G.J., Torontali, S.M., Carr, G.J., Tiesman, J.P. & Richardson, B.D. 
(2003) Gene expression profile induced by 17 alpha-ethynyl estradiol in the 
prepubertal female reproductive system of the rat. Toxicological Sciences Vol.72, 
pp.314–30. 
Oishi, S. (2002) Effects of propyl paraben on the male reproductive system. Food and 
Chemical Toxicology. Vol.40, No.12, pp.1807–1813. 
Okubo, T., Yokoyama, Y., Kano, K. & Kano, I. (2001). ER-dependent estrogenic activity of 
parabens assessed by proliferation of human breast cancer MCF-7 cells and 
expression of ERalpha and PR. Food and Chemical Toxicology. Vol.39, pp.1225–1232. 
Scientific Committee for Food. (1980). Guidelines for the Safety Assessment of Food 
Additives. Reports of the Scientific Committee for Food (Tenth series). Commission 
of the European Communities, Luxembourg EUR 6892. 
Shtenberg, A.I. & Gavrilenko, E.V. (1970). Effects of Amaranth food dye on reproductive 
function and progeny development in experiments with albino rats. Voprosy 
Pitaniia. Vol.29, pp.66. 
Soffritti, M., Belpoggi, F., Degli Esposti, D., Lambertini, L., Tibaldi, E. & Rigano, A. (2006). 
First experimental demonstration of the multipotential carcinogenic effects of 
aspartame administered in the feen to Spraguq-Dawley rats. Environmental Health 
Perspective Vol.114, pp.379-385. 
Soffritti, M., Belpoggi, F., Manservigi, M., Tibaldi, E., Lauriola, M., Falcioni, L. & Bua, L. 
(2010). Aspartame administered in feed, beginning prenatally through life span, 
induces cancers of the live and lung in male swiss mice. American Journal of 
Industrial Medicine. Vol.53, No.12, pp.1197-1206. 
The Government of the Hong Kong Centre for Food Safety Food and Environmental 
Hygiene Department Special Administrative Region. (2010). Nanotechnology and 
Food Safety, Risk Assessment Studies Report No. 41. 
Thuy, T.B., Vo, Y.M.Y., Kyung-Chul, C. & Eui-Bae, J. (2010) Potential estrogenic effect(s) of 
parabens at the prepubertal stage of a postnatal female rat model. Reproductive 
Toxicology. Vol.29, pp.306–316. 
Til, H.P. & Spanjers, M. (1973). Reproduction study in rats with six different Ammonia 
Caramels. Unpublished report No. R 4068 from Centraal Instuut voor 
Voedingsonderzoek (CIVO/TNO), Zeist, The Netherlands. 
Tsuchiya, T., Oguri, I., Yamakoshi, Y.N. & Miyata, N. (1996). Novel harmful effects of 
fullerene on mouse embryos in vitro and in vivo. FEBS Letters Vol.393, No.1, 
pp.139-45. 
U.S. Food and Drug Administration. (2007). Toxicological Principles for the Safety 
Assessment of Food Ingredients, Redbook 2000. 
Vivekanandhi, J., Devi, C.P.A., Jayaraman, K. & Raghavan, L. (2006). Effect of Erythrosine 





Vollmuth, T.A., Bennett, M.B., Hoberman, A.M. & Christian, M.S. (1990). An evaluation of 
food flavoring ingredients using an in vivo reproductive and developmental 
toxicity screening test. Teratology. Vol.41, pp.597–598. 
Walton, K., Walker, R., Van de Sandt, J.J.M., Castell, J.V., Knapp, A.G.A.A., Kozianowski, G., 
Roberfroid, M. & Schilter, B. (1999). The application of in vitro data in the 
derivation of the acceptable daily intake of food additives. Food and Chemical 
Toxicology. Vol.37, pp.1175-1197. 
3 
Production and Functional  
Properties of Dairy Products  
Containing Lactophorin and Lactadherin 
Mizuho Inagaki1, Xijier2, Yoshitaka Nakamura3,  
Takeshi Takahashi3, Tomio Yabe1,2, Toyoko Nakagomi4,  
Osamu Nakagomi4 and Yoshihiro Kanamaru1,2 
1Department of Applied Life Science, Gifu University 
2United Graduate School of Agricultural science, Gifu University 
3Food Science Institute, Division of Research and Development, Meiji Co., Ltd. 
4Department of Molecular Microbiology and Immunology,  




In this chapter, we introduce the possible protective utilization of cow milk proteins, 
lactophorin (LP) and lactadherin (also known as periodic acid Schiff 6/7 (PAS6/7)), against 
human rotavirus (HRV) gastroenteritis. 
Milk is the natural food of the newborn mammal, and it is endowed with protective 
components against pathogens, such as antibodies. Our previous studies have demonstrated 
that the 2 proteins, LP and lactadherin, exhibit potent inhibitory activity against HRV. HRV 
is the single most important etiologic agent of severe gastroenteritis in infants and young 
children. To determine whether cow’s milk could serve as a protective food additive 
effective against HRV infection, this chapter discusses the potential utilizations of LP and 
lactadherin from normal cow’s milk to protect against HRV gastroenteritis, focusing in 
particular on sweet whey, a byproduct of industrial-scale cheese manufacturing.  
2. Rotavirus gastroenteritis 
Infectious gastroenteritis is distinguished between bacterial and viral origin, depending on 
pathogenesis. Rotavirus, adenovirus, and norovirus are well-known infectious gastroenteritis 
pathogens of viral origin.  
HRV was first discovered by Ruth Bishop et al. in 1973, and was recognized as a major cause 
of childhood diarrheal morbidity and mortality worldwide (Bishop et al., 1973; Bishop, 2009). 
The virus is transmitted by the fecal-oral route. It infects the enterocytes of the villi of the small 
intestine and causes gastroenteritis. The incubation period of rotavirus infection is 2-4 days, 
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years, nearly every child in the world has been infected with rotavirus at least once (Velázquez 
et al., 1996). The estimated annual incidence of rotavirus gastroenteritis is approximately 114 
million episodes requiring home care and 600,000 deaths in children worldwide (Dennehy, 
2008). More than 85% of these deaths occur in developing countries, South Asia, and sub-
Saharan Africa (Naghipour et al., 2008; Centers for Disease Control and Prevention, 2011). In 
the absence of vaccination, rotavirus gastroenteritis has been estimated to cause 87,000 
hospitalizations in Europe (Soriano-Gabarro et al., 2006), 55,000–70,000 hospitalizations in the 
USA (Parashar et al., 2006), and 78,000 hospitalizations in Japan (Nakagomi et al., 2005) among 
children below 5 years of age. Thus, rotavirus gastroenteritis causes large human costs in 
developing countries and large public medical burdens in developed countries. 
In general, vaccination is the most effective method for protection against viral diseases. To 
reduce the aforementioned global burden posed by rotavirus gastroenteritis, the 2 oral 
rotavirus vaccines Rotarix® (GlaxoSmithKline Biologicals, Rixensart, Belgium) and RotaTeq® 
(Merck and Co., Whitehouse station, NJ) have been licensed for use in more than 100 countries 
worldwide (Tate et al., 2010). Large-scale trials in Europe and North and Latin America 
demonstrated that these vaccines are safe and effictive (Ciarlet & Schödel, 2009; O'Ryan & 
Linhares, 2009). Clinical studies are ongoing in Asia and Africa to assess the safety and efficacy 
of the vaccines in these populations (Zaman et al., 2010; Armah et al., 2010). However, to 
reduce the risk of intussusceptions, the first doses of both vaccines are strictly limited between 
the age of 6-15 weeks, and full doses of vaccines need to be completed by ages 6-8 months 
(Cortese et al., 2009). Therefore, prophylactic options against HRV infection are needed. 
Young mammals depend on passive immunity obtained via breast-feeding for resistance 
against infectious diseases, because their immature immune systems cannot produce 
antibodies immediately after birth. The mother is able to produce antibodies against 
infectious agents, and they are passively transmitted to the offspring via milk. 
It has been proposed that passive protection against HRV infection could be achieved by 
using immunoglobulin G (IgG) from the colostrum of cows hyper-immunized with 
rotavirus (Ebina et al., 1992; Sarker et al., 1998). Unfortunately, the clinical use of bovine 
colostrum from hyper-immunized cows has been limited because of difficulties in large-
scale production. Recently, skimmed and concentrated bovine late colostrum (SCBLC) 
obtained from normal cows at 6-7 days after parturition exhibited high potency in inhibiting 
human rotaviral replication in vitro and in vivo (Inagaki et al., 2010a), indicating that SCBLC 
is likely to play an alternative role to colostrum of cows hyper-immunized with rotavirus.  
Furthermore, studies of milk components exhibiting inhibitory activity against rotavirus 
have also been reported. For example, supplemental dietary whey protein concentrate 
(WPC) (Wolber et al., 2005; Pérez-Cano et al., 2008) and macromolecular bovine whey 
protein fraction (MMWP) (Kvistgaard et al., 2004; Bojsen et al., 2007) exhibited protective 
efficacy against simian rotavirus and murine rotavirus infection in vivo. The inhibitory 
mechanism of WPC remains to be elucidated, whereas Bojsen et al. found that mucin 1 and 
immunoglobulins were the major rotavirus inhibitors in MMWP (2007).  
3. Inhibitory activity of LP and lactadherin against HRV infection 
Recently, we identified LP16 (16 kDa LP fragment) and bovine lactadherin (PAS6/7) as 
human rotavirus inhibitors in bovine milk (Inagaki et al., 2010b). In this section, we will 
describe the anti-viral properties of these components. 
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3.1 Anti-HRV activity of LP 
LP was initially found to be a glycoprotein in the heat- and acid-stable proteose peptone 
(PP) fraction and was referred to as PP component 3 (Girardet et al., 1996). LP is found in 
bovine, cameline (Girardet et al., 2000), caprine (Sørensen et al., 1997), and ovine milk 
(Sørensen et al., 1997), but not in human milk (Sørensen et al., 1997).  
LP is present at an average concentration of 0.3 g/l in normal bovine milk (Koletzko et al., 
2005). LP consists of 2 major glycopeptides; 28 kDa (LP28) and 18 kDa (LP18) (Girardet et 
al., 1996). LP28 contains 5 partial phosphorylation sites (Ser29, Ser34, Ser38, Ser40, and Ser46), 
3 O-glycosylation sites (Thr16, Thr60, (Kjeldsen et al., 2003), and Thr86), and 1 N-
glycosylation site (Asn77) (Girardet & Linden, 1996). It exists in various molecular forms 
formed via posttranslational modification (Kanno, 1989a, 1989b). LP18 has an amino acid 
sequence corresponding to the 54-135 C-terminal portion of LP28, and this sequence is 
thought to occur as a proteolytic degradation product of LP28 (Girardet & Linden, 1996). 
Thus far, emulsification and inhibition of lipolytic activity have been reported as the 
characters and functions of LP (Kanno, 1989a; Girardet et al., 1993). Recently, LP has been 
found to stimulate immunoglobulin production in human hybridoma cells and human 
peripheral blood lymphocytes (Sugahara et al., 2005). However, its biological function 
remains unclear.  
The inhibitory activity of LP against HRV infection was identified as follows. Previously, 
Kanamaru et al. (1999) reported that high-Mr glycoprotein fraction (F1) from cow milk whey 
potently inhibited HRV infection in vitro. They reported that F1 formed a complex with 
various proteins but failed to identify the inhibitory entity in F1. Ten years later, LP was 
identified as one of the inhibitory components of HRV replication in F1 (Inagaki et al., 
2010b). In brief, F1 was initially heated at 95°C for 30 min, rendering milk antibodies inert, 
and then subjected to ammonium sulfate fractionation. The component with a molecular 
size of 16 kDa, found in a certain fraction from ammonium sulfate fractionation, exhibited 
inhibitory activity against HRV replication. Sequencing analysis of this substance resulted in 
the first 7 N-terminal amino acid residues of ILKEKHL, which is consistent with the 
sequence of residues 69-75 of bovine LP. Thus, LP16 exhibited a strong inhibitory activity 
against HRV replication.  
Furthermore, a preliminary experiment revealed that LP28 and LP18 potently inhibited 
HRV infection, suggesting that the consensus structure of LP28 and LP18 (i.e., sequence of 
residues 54-135 C-terminal portion of LP) was involved in their inhibitory activities (Inagaki 
et al., unpublished observation). Further studies are in progress for detailed elucidation of 
the HRV inhibitory mechanism of LP. 
3.2 Anti-HRV activity of lactadherin 
Lactadherin is a major milk fat globule membrane component in milk. Lactadherin in bovine 
milk is also known as PAS6/7.  
Lactadherin consists of 2 N-terminal epidermal growth facter (EGF)-like domains followed 
by 2 repeated C domains with homology to the C1 and C2 domains of blood clotting factors 
V and VIII (Mather, 2000). Interestingly, lactadherin has first EGF-like domain containing 
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Lactadherin consists of 2 N-terminal epidermal growth facter (EGF)-like domains followed 
by 2 repeated C domains with homology to the C1 and C2 domains of blood clotting factors 
V and VIII (Mather, 2000). Interestingly, lactadherin has first EGF-like domain containing 





Lactadherin binds to integrins αvβ3 (Taylor et al., 1997; Andersen et al., 2000; Hanayama et 
al., 2002) and αvβ5 (Andersen et al., 2000), which are expressed by endothelial cells. 
However, the physiological function of lactadherin in milk is little known. 
The inhibitory activity against HRV infection of human lactadherin was first identified by 
Yolken et al. (1992). Furthermore, a previous clinical study indicated a correlation between 
human lactadherin in breast milk and morbidity due to rotavirus gastroenteritis in young 
children (Newburg et al., 1998). These reports led us to investigate non-immunoglobulin 
component(s) of rotavirus inhibitor in bovine milk. 
One report indicated that bovine lactadherin did not have anti-HRV activity (Kvistgaard et al., 
2004). The study was performed using the human Wa strain rotavirus infected to Caco-2 cells 
and a short-term (1 h) incubation of cells with lactadherin. On the contrary, the inhibitory 
activity of bovine lactadherin against HRV infection was reported by Inagaki et al. (2010b). The 
study was performed using the human MO strain rotavirus infected to MA104 cells and 
demonstrated that long-term (22 h) incubation of cells with lactadherin resulted in significant 
antiviral effects. The reasons for the inconsistent results are unclear because of distinct 
experimental conditions. However, it has been reported that lactadherin binds to MA104 cells 
via integrin αvβ3 (Taylor et al., 1997; Andersen et al., 2000; Hanayama et al., 2002), which is 
known as one of the cell receptors for rotavirus (Guerrero et al., 2000). Therefore, the 
interaction between lactadherin and cell surface components is likely important for its antiviral 
activity. Thus, the inhibitory mechanisms of lactadherin remain controversial.  
4. Utilization of sweet whey proteins against HRV gastroenteritis 
Sweet whey is manufactured as a byproduct of cheese production. Thus, its production 
increases as the consumption of cheese expands. However, its routine disposal will become 
a significant problem in the dairy industry. Therefore, the extended utilization of sweet 
whey should be pursued. Based on the above findings that LP and lactadherin exhibit 
inhibitory activities against HRV infection, we attemped to investigate the potential 
utilization of sweet whey as a protective food additive against HRV gastroenteritis. 
4.1 Microfiltration retentate fraction (MFRF) from sweet whey 
To concentrate LP and lactadherin, we attempted to examine the presence of both inhibitory 
components in sweet whey, which was produced during cheese manufacturing. As shown 
in Fig. 1, the concentrate was collected as the MFRF. Then, it was pasteurized by a high-
temperature short-time method sterilization (HTST) method consisting of heating at 72°C 
for 15 s, followed by spray drying (referred to as Dried MFRF).  
Fig. 2A shows the result of two-dimensional electrophoresis of Dried MFRF stained with 
Coomassie Brilliant Blue. Dried MFRF contains α-lactalbumin (α-LA, Mw: 14,100 Da) and  
β-lactoglobulin (β-LG, Mw: 18,200 Da) as the major protein components. The existence of LP 
and lactadherin could be observed, although not as obviously as the major components, 
indicating that the inhibitory components appeared to be contained in Dried MFRF. When 
immunochemical detection using the specific monoclonal antiserum for each protein (Aoki 
et al., 1994) was performed, as shown in Fig. 2B and 2C, LP and lactadherin could certainly 
be detected in Dried MFRF. 
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Fig. 2. Dried MFRF contains LP and Lactadherin. A. Two-dimensional protein profile of Dried 
MFRF. The horizontal dimension was isoelectric focusing (pI, 3.0-10.0), and the second 
dimension was 15% polyacrylamide gel electrophoresis (PAGE). The gel was stained with 
Coomassie Brilliant Blue. The molecular weights of the standards (broad range, Bio-Rad) are 
indicated in kDa on the left. B. Immunochemical detection of LP. Two-dimensional PAGE was 
performed as in panel A, and then samples were transferred onto a polyvinylidene difluoride 
(PVDF) membrane and immunostained for LP using the monoclonal anti-LP 1C10 primary 
antibody (Aoki et al., 1994), followed by horse-radish peroxidase (HRP)-conjugated goat anti-
mouse IgG secondary antibody. The molecular weights of the standards (broad range, Bio-
Rad) are indicated in kDa on the left. C. Immunochemical detection of lactadherin. Two-
dimensional PAGE and western blotting were performed as in panel B. Samples were 
immunostained for lactadherin with the monoclonal anti-lactadherin 3F12 primary antibody 
(Aoki et al., 1994), followed by HRP-conjugated goat anti-mouse IgG secondary antibody. The 
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4.2 Inhibitory activity of Dried MFRF against HRV infection 
Next, we investigated the inhibitory activity of Dried MFRF against HRV infection. A 
replication inhibition (neutralization) assay for HRV was performed using MA104 cells 
(African rhesus monkey kidney cell line) following a procedure described previously 
(Inagaki et al., 2010b) with slight modifications. Our previously published focus reduction 
assay for rotaviral infection was performed using a suspension of MA104 cells, and a 
preincubated virus/milk sample mixture was incubated further for 22 h with the cells before 
fixation. In this study, a confluence monolayer of MA104 cells was established in wells of a 
glass slide, and a virus/milk sample mixture was inoculated for 1 h and removed from the 
monolayer before further advancing the viral infection to exclude the influence of the milk 
sample on MA104 cells by prolonged incubation. 
As shown in Fig. 3, MFRF was found to potently inhibit the replication of HRV MO strain 
(serotype G3P[8]) with an MIC of 3.1 μg/ml. Furthermore, even after pasteurization by 
HTST method, the neutralizing activity of Dried MFRF remained, with an MIC of 4.7 μg/ml. 
This activity might also be attributed largely to the heat-resistant character of LP. The 
colostrums whey from the hyper-immunization of pregnant cows with human rotavirus 
(rotawhey) was used as a positive control. Rotawhey contains a high level of specific anti-
human rotavirus antibodies, and it exhibited a robust inhibitory activity, with an MIC of 
0.012 μg/ml (Fig. 3). Bovine lactoferrin also exhibited an inhibitory activity, although weak, 
with an MIC of 180 μg/ml (Fig. 3). The MIC value of Dried MFRF indicated that it has great 




















Fig. 3. MFRF exhibits inhibitory activity after pasteurization treatment 
MA104 cells were plated into the wells of a 24-well heavy Teflon (HT)-coated slide (AR 
Brown, Tokyo) and grown to full confluence. A suspension containing infectious virus at a 
titer of 1 × 105 - 1 × 106 fluorescent cell focus-forming units (FCFU)/ml was treated with 20 
μg/ml trypsin (Sigma-Aldrich, St. Louis, MO) for 30 min at 37°C. After appropriate dilution 
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with Eagle’s minimum essential medium (E-MEM) containing 2% fetal calf serum to give a 
titer of approximately 103 FCFU per 100 μl, aliquots were mixed with equal volumes (100 μl) 
of one-half serially diluted samples in microtubes for 1 h at 37ºC. The diluted mixtures (20 
μl/well) were added to the confluent monolayer of MA104 cells. The control produced 
approximately 100 infected foci per well without the test samples of milk. The cells were 
further cultured for 1 h at 37°C in an atmosphere of 5% CO2. After removal of the 
inoculums, the cells were washed once with E-MEM to remove unbound virus, followed by 
incubation at 37°C in an atmosphere of 5% CO2. After 17 h of incubation, the cells were fixed 
with cold methanol for 10 min. Infected cells were detected by an indirect 
immunofluorescence assay using the PO-13 monoclonal anti-pigeon rotavirus antibody 
(Minamoto et al., 1993) and fluorescein isothiocyanate-conjugated goat anti-mouse IgG 
serum. The foci numbers of infected cells were measured by observation of fluorescence 
microscopy. Neutralizing activity was expressed as the percentage reduction in the foci 
numbers of infected cells as compared with infected cells without milk sample. The 
minimum inhibitory concentration (MIC), the minimum concentration inducing a 50% 
reduction in infected cells, was calculated for each sample from a logarithmic regression of 
the concentration-dependent percentage focus reduction. The inhibitory activity of each 
sample is expressed as a percentage of infected cells as compared to control cells (100%). The 
experiments were performed in triplicate at least 3 times, and representative results for each 
sample are given as the mean (SD).     
4.3 Analysis of the protective components in Dried MFRF 
To verify and further characterize the effective components of Dried MFRF regarding 
protection against HRV infection, we attempted to fractionate Dried MFRF by size exclusion 
chromatography on Sephacryl S-500 HR. As shown in Fig. 4, 3 fractions were collected 
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The column (60 × 5.0 cm, GE Healthcare UK Ltd., Little Chalfont, UK) was equilibrated with 
50 mM Tris-HCl buffer (pH 8.0) containing 0.15 M NaCl, 2 mM EDTA, and 0.02% NaN3. 
Dried MFRF was dissolved in elution buffer at a concentration of 5 mg/ml, and 30 ml were 
added to a Sephacryl S-500 HR column. The flow rate was 10 ml/min. Eluted fractions were 
freeze-dried after dialysis against distilled water. 
Next, to investigate the protein components in the fractions, we attempted to resolve the 
fractions by two-dimensional PAGE. The results are shown in Fig. 5. We confirmed by 
immunoblot analysis that only F1 contained lactadherin (result not shown). LP was mainly 
detected in F2 and slightly present in F1. Although 2 major whey proteins, α-LA and β-LG, 
were detected in each of the three fractions, the vast majority of them detected in F3. 
Lactadherin and LP28 were present as minor components in F1 and F2, respectively. α-LA 
and β-LG were present as major components in F3.  
 
























Fig. 5. Protein profiles of size exclusion chromatography fractions. Two-dimensional PAGE 
profiles of each fractions. The horizontal dimension was isoelectric focusing (pI, 3.0-10.0), 
and the second dimension was 15% PAGE. The gel was stained with Coomassie Brilliant 
Blue. The molecular weights of the standard (broad standard, Bio-Rad) are indicated in kDa 
on the left 
As mentioned above, IgG was identified as a rotavirus inhibitor in bovine milk (Ebina et al., 
1992; Sarker et al., 1998). Accordingly, to address the contribution of IgG to the anti-HRV 
activity of Dried MFRF, we attempted to separate IgG in each fraction from other 
components by using affinity chromatography on a HiTrap Protein G HP column (5 ml, GE 
Healthcare UK Ltd.). A typical elution pattern of F3 is shown in Fig. 6. The bound fraction 
was IgG, and the unbound fractions from each fraction were collected as F1′, F2′, and F3′. 
We found that IgG was removed from F2 and F3, although a small portion remained, as 
shown in Fig. 6. Conversely, we did not observe the elution of IgG from F1 (results not 
shown). These results indicated that IgG might represent a minor component in Dried 
MFRF. In this manner, we obtained 4 fractions: F1′ (fraction containing lactadherin), F2′ 
(fraction containing LP28), F3′ (fraction containing α-LA and β-LG as major components) 
and IgG collected from F3.  
F3 was dissolved in 20 mM sodium phosphate buffer (pH 7.0) at a concentration of 1 
mg/ml. The column was equilibrated with the same buffer, and the column was connected 
with and controlled by the ÄKTA prime system (GE Healthcare UK Ltd.). The flow rate was 
2 ml/min. Proteins were monitored at 280 nm (solid line). The unbound fraction was 
collected as F3′. The bound fraction, IgG, eluted with a step 100% elution buffer (0.1 M 
glycine-HCl, pH 2.7) (dotted line). The eluted IgG fractions were neutralized with 1 M Tris-
HCl (pH 9.0). Each fraction was freeze-dried after dialysis against distilled water.  
 


































Fig. 6. Fractionation of F3 by Affinity Chromatography on HiTrap Protein G HP column 
In the following focus reduction assay, IgG exhibited inhibitory activity against HRV MO 
infection, with an MIC of 0.27 μg/ml (Fig. 7). F2′ exhibited similar inhibitory activity level as 
IgG, with an MIC of 0.32 μg/ml (Fig. 7). F1′ exhibited slightly weaker inhibitory activity 
than did F2′, with an MIC of 1.2 μg/ml (Fig. 7). Although F3, before proteinG affinity 
chromatography, exhibited a strong inhibitory activity (result not shown), F3′ lost this 
activity after chromatography, resulting in an MIC of 20,000 μg/ml (Fig. 7). Taken together, 
the inhibitory components in Dried MFRF should include at least lactadherin, LP, and IgG. 
These components exhibited very similar activity, although the former 2 could not be  




















Fig. 7. The Fractions Obtained by Protein G Affinity Chromatography and Their in Vitro 
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purified from Dried MFRF in this study. Our previous study demonstrated that the MICs of 
lactadherin and LP16 in pure form were 0.016 and 1.8 μg/ml, respectively (Inagaki et al., 
2010b). As the precise content of these active components in Dried MFRF is at present not 
clear, we conclude that their contribution to the inhibitory efficacy against HRV infection of 
Dried MFRF is likely to be comparable. 
Inhibitory activity was determined as described in the legend to Fig. 3. The inhibitory 
activity of each sample was expressed as the percent decrease in foci numbers of infected 
cells as compared to the foci numbers of control cells, which were treated with PBS in place 
of the milk sample (100%). The experiments were performed in triplicate at least 3 times, 
and representative results for each sample are given as the mean (SD).  
4.4 Inhibitory activity of Dried MFRF against various types of HRV 
Furthermore, we investigated the protective efficacy of Dried MFRF against other types of 
HRV besides the MO strain. Rotavirus has two independent serotypes (G and P types), and 
they are defined by VP7 and VP4, respectively. Epidemiological studies on rotavirus 
showed that strains with G-types of G1, G2, G3, and G4 and those with P-types of P[4] and 
P[8] are the most prevalent causes of rotavirus gastroenteritis in humans (Gentsch et al., 
2005; Santos and Hoshino, 2005; McDonald et al., 2009). Furthermore, the rotavirus G/P-
type distribution varies from year-to-year (O'Ryan, 2009). As shown in Fig. 8, Dried MFRF 
also exhibited inhibitory activity against the Wa strain (serotype G1P[8]) and the Hochi 
strain (serotype G4P[8]), with MICs of 2.8 and 3.2 μg/ml, respectively. Therefore, Dried 
MFRF can be concluded to have potential as a protective food additive against several 
serotypes of HRV. 
 
Fig. 8. Dried MFRF Exhibits Inhibitory Activities against Various Types of HRV 
Inhibitory activity was determined as described in the legend to Fig. 3. The inhibitory 
activity of each sample was expressed as the percent decrease in foci numbers of infected 
cells as compared to the foci numbers of control cells, which were treated with PBS in place 
of the milk sample (100%). The experiments were performed in triplicate at least 3 times, 
and representative results for each sample are given as the mean (SD).  
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4.5 Protective efficacy of Dried MFRF against HRV-induced diarrhea in suckling mice 
Finally, we investigated whether a single administration of Dried MFRF exhibits prophylactic 
efficacy against HRV-induced diarrhea in vivo. As shown in Fig. 9, in the PBS group, 10 of 
the 11 mice developed diarrhea 48 h post inoculation (hpi), and all mice recovered from 
diarrhea by 96 hpi. In the Dried MFRF (2.5 mg) group, only 2 of 16 mice developed diarrhea 
at 48 hpi, and all mice recovered from symptoms by 72 hpi. In the Dried MFRF (1.0 mg) 
group, 4 of 11 mice developed diarrhea at 48 hpi, and all mice recovered by 72 hpi. This 
result clearly indicated that Dried MFRF is a promising candidate for a prophylactic food 
additive against HRV infection. 
 
Fig. 9. Dried MFRF Exhibits Preventive Efficacy against HRV-Induced Diarrhea in Suckling 
Mice 
Pregnant BALB/c mice were purchased from Japan SLC (Hamamatsu, Japan). Litters of 5-
day-old mice were orally administered with PBS (n = 11), 1.0 mg of Dried MFRF (n = 11), or 
2.5 mg of Dried MFRF (n = 16) for 60 min before inoculation with 2.5 ×105 FCFU of the HRV 
MO strain. Stools were examined daily to assess diarrhea for 4 days after viral inoculation. 
Liquid-like mucous yellow stool was considered diarrhea. 
5. Summary 
Milk contains essential components for child growth. In this chapter, we introduced the 
inhibitory activity of LP and lactadherin against HRV infection, and examined the 
possibility of MFRF, which is obtained as a byproduct of cheese manufacturing, as an 
alternative therapeutic option against HRV gastroenteritis.  
Dried MFRF exhibited inhibitory activity against several types of HRV in vitro. Furthermore, 
we demonstrated that prophylactic oral administration of Dried MFRF once before 
inoculation of HRV prevented the development of diarrhea in suckling mice in vivo. Finally, 
we concluded that Dried MFRF contained LP, lactadherin, and IgG as rotavirus inhibitors. 
As the anti-HRV activity of LP was not affected by heating at 95°C for 30 min (Inagaki et al., 





purified from Dried MFRF in this study. Our previous study demonstrated that the MICs of 
lactadherin and LP16 in pure form were 0.016 and 1.8 μg/ml, respectively (Inagaki et al., 
2010b). As the precise content of these active components in Dried MFRF is at present not 
clear, we conclude that their contribution to the inhibitory efficacy against HRV infection of 
Dried MFRF is likely to be comparable. 
Inhibitory activity was determined as described in the legend to Fig. 3. The inhibitory 
activity of each sample was expressed as the percent decrease in foci numbers of infected 
cells as compared to the foci numbers of control cells, which were treated with PBS in place 
of the milk sample (100%). The experiments were performed in triplicate at least 3 times, 
and representative results for each sample are given as the mean (SD).  
4.4 Inhibitory activity of Dried MFRF against various types of HRV 
Furthermore, we investigated the protective efficacy of Dried MFRF against other types of 
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they are defined by VP7 and VP4, respectively. Epidemiological studies on rotavirus 
showed that strains with G-types of G1, G2, G3, and G4 and those with P-types of P[4] and 
P[8] are the most prevalent causes of rotavirus gastroenteritis in humans (Gentsch et al., 
2005; Santos and Hoshino, 2005; McDonald et al., 2009). Furthermore, the rotavirus G/P-
type distribution varies from year-to-year (O'Ryan, 2009). As shown in Fig. 8, Dried MFRF 
also exhibited inhibitory activity against the Wa strain (serotype G1P[8]) and the Hochi 
strain (serotype G4P[8]), with MICs of 2.8 and 3.2 μg/ml, respectively. Therefore, Dried 
MFRF can be concluded to have potential as a protective food additive against several 
serotypes of HRV. 
 
Fig. 8. Dried MFRF Exhibits Inhibitory Activities against Various Types of HRV 
Inhibitory activity was determined as described in the legend to Fig. 3. The inhibitory 
activity of each sample was expressed as the percent decrease in foci numbers of infected 
cells as compared to the foci numbers of control cells, which were treated with PBS in place 
of the milk sample (100%). The experiments were performed in triplicate at least 3 times, 
and representative results for each sample are given as the mean (SD).  
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4.5 Protective efficacy of Dried MFRF against HRV-induced diarrhea in suckling mice 
Finally, we investigated whether a single administration of Dried MFRF exhibits prophylactic 
efficacy against HRV-induced diarrhea in vivo. As shown in Fig. 9, in the PBS group, 10 of 
the 11 mice developed diarrhea 48 h post inoculation (hpi), and all mice recovered from 
diarrhea by 96 hpi. In the Dried MFRF (2.5 mg) group, only 2 of 16 mice developed diarrhea 
at 48 hpi, and all mice recovered from symptoms by 72 hpi. In the Dried MFRF (1.0 mg) 
group, 4 of 11 mice developed diarrhea at 48 hpi, and all mice recovered by 72 hpi. This 
result clearly indicated that Dried MFRF is a promising candidate for a prophylactic food 
additive against HRV infection. 
 
Fig. 9. Dried MFRF Exhibits Preventive Efficacy against HRV-Induced Diarrhea in Suckling 
Mice 
Pregnant BALB/c mice were purchased from Japan SLC (Hamamatsu, Japan). Litters of 5-
day-old mice were orally administered with PBS (n = 11), 1.0 mg of Dried MFRF (n = 11), or 
2.5 mg of Dried MFRF (n = 16) for 60 min before inoculation with 2.5 ×105 FCFU of the HRV 
MO strain. Stools were examined daily to assess diarrhea for 4 days after viral inoculation. 
Liquid-like mucous yellow stool was considered diarrhea. 
5. Summary 
Milk contains essential components for child growth. In this chapter, we introduced the 
inhibitory activity of LP and lactadherin against HRV infection, and examined the 
possibility of MFRF, which is obtained as a byproduct of cheese manufacturing, as an 
alternative therapeutic option against HRV gastroenteritis.  
Dried MFRF exhibited inhibitory activity against several types of HRV in vitro. Furthermore, 
we demonstrated that prophylactic oral administration of Dried MFRF once before 
inoculation of HRV prevented the development of diarrhea in suckling mice in vivo. Finally, 
we concluded that Dried MFRF contained LP, lactadherin, and IgG as rotavirus inhibitors. 
As the anti-HRV activity of LP was not affected by heating at 95°C for 30 min (Inagaki et al., 





Recently, it was reported that one-third of all pediatric rotavirus gastroenteritis patients are 
children between 3 and 6 years of age, an age group outside the primary target of rotavirus 
vaccine in Japan (Ito et al., 2011; Nakanishi et al., 2009). Thus, these epidemiological studies 
indicated the need for not only vaccination but also alternative preventive procedures 
against HRV infection. In conclusion, Dried MFRF, in which the non-immunoglobulin 
components including LP and lactadherin are concentrated, is a promising candidate 
prophylactic food additive against HRV infection. Dried MFRF was also found to be a 
potent inhibitor of several types of bovine rotavirus derived from field breeds (Inagaki et al., 
results not shown). Rotavirus gastroenteritis is an important issue in livestock animals as 
well. Taken together, Dried MFRF is very useful as a protective food additive against 
rotaviral infection. 
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1. Introduction 
This chapter provide a review of traditional and non-traditional food preservation 
approaches including physical methods (non-thermal pasteurization), chemical methods 
(natural food preservatives) and their combinations for extension of the shelf life of fruit 
juices and beverages.  
Traditionally, the shelf-life stability of juices has been achieved by thermal processing. Low 
temperature long time (LTLT) and high temperature short time (HTST) treatments are the 
most commonly used techniques for juice pasteurization. However, thermal pasteurization 
tends to reduce the product quality and freshness. Therefore, some non-thermal 
pasteurization methods have been proposed during the last couple of decades, including 
high hydrostatic pressure (HHP), high pressure homogenization (HPH), pulsed electric field 
(PEF), and ultrasound (US). These emerging techniques seem to have the potential to 
provide “fresh-like” and safe fruit juices with prolonged shelf-life. Some of these techniques 
have already been commercialized. Some are still in the research or pilot scale. The first part 
of the chapter will give an update of these emerging non-thermal techniques. 
Apart from thermal pasteurization, some chemical preservatives are also widely used for 
the extension of the shelf-life of fruit juices and beverages. Two of the most commonly used 
preservatives are potassium sorbate and sodium benzoate. However, consumer demand for 
natural origin, safe and environmental friendly food preservatives has been increasing since 
1990s. Natural antimicrobials such as bacteriocins, organic acids, essential oils and phenolic 
compounds have shown considerable promise for use in some food products. The second 
part of the chapter will comprise of applications of these natural antimicrobials in fruit juice 
preservation.   
From scientific literature, it is apparent that some individual non-thermal methods as well 
as natural antimicrobials are effective to inactivate microorganisms or reduce the log colony 
forming units (CFU) while not adversely affecting the sensory and nutritional quality. 
Moreover, the combination of these techniques could also provide synergistic effects on 
prolonging the shelf-life of fruit juices and beverages and potentially could become 
replacements for traditional pasteurization methods. The third part of the chapter will 
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2. Traditional thermal pasteurization 
Thermal processing is the most widely used technology for pasteurization of fruit juices and 
beverages. Juice pasteurization is based on a 5-log reduction of the most resistant 
microorganisms of public health significance (USFDA 2001). The process could be 
accomplished by different time-temperature combinations.  
2.1 Low temperature long time (LTLT) 
Fruit juice has been traditionally pasteurized by batch heating at 63-65°C for relatively long 
time (D'Amico et al. 2006). This method has been replaced by high temperature short time 
treatment due to the undesirable quality changes during this process. 
2.2 High temperature short time (HTST) 
HTST treatment could minimise those undesirable quality changes made by batch heating 
due to the much less duration of heat treatment. Currently, HTST pasteurization is the most 
commonly used method for heat treatment of fruit juice. For example, orange juice is 
processed by HTST at 90 to 95°C for 15 to 30 s (Braddock 1999). And apple juice is treated by 
HTST at 77 to 88°C for 25 to 30 s (Moyer & Aitken 1980). 
3. Non-traditional method 
Thermal processing has been proven to be effective for preservation of fruit juice and 
beverages.  However, thermal treatment tends to reduce the product quality and freshness. 
Nowadays, consumer demand for natural, healthy and convenient food products is fast 
growing, which leads to the innovation of novel food preservation technologies. Based on 
the literature, these novel technologies can be generally divided into physical methods 
(mostly non-thermal methods) and chemical approaches.  
3.1 Physical methods (Non-thermal pasteurization) 
Some non-thermal pasteurization methods have been proposed during the last couple of 
decades, including high hydrostatic pressure (HHP), high pressure homogenization (HPH), 
pulsed electric field (PEF), and ultrasound (US). These emerging techniques seem to have 
the potential to provide “fresh-like” and safe fruit juices with prolonged shelf-life.  
3.1.1 High hydrostatic pressure (HHP) 
High hydrostatic pressure (HHP) processing uses pressures up to 1000 MPa, with or 
without heat, to inactivate harmful microorganisms in food products (Ramaswamy et al. 
2005). High hydrostatic pressure has traditionally been used in non-food areas such as 
ceramic and steel production. The application of HHP in food area started from 1900s when 
Hite and other researchers applied HHP on the preservation of milk, fruits and vegetables. 
However, it takes a long time for the commercial products to emerge in the market. In 1990, 
the first HHP processed fruit jams were sold in the Japanese market. Subsequently, HHP 
processed commercial products including fruit juices and beverages, vegetable products, 
among others, have been produced in North America, Europe, Australia, and Asia 
(Balasubramaniam et al. 2008). 
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Generally, there are two principles that govern the behaviour of foods under pressure: the 
Le Chatelier-Braun principle and the Isostatic principle. The Le Chatelier-Braun principle 
indicates that any phenomenon (such as phase transition, change in molecular 
configuration, chemical reaction, etc.) accompanied by a decrease in volume is enhanced by 
the increase in applied pressure. The isostatic principle means that the distribution of 
pressure into the sample is uniform and instantaneous. Thus, the process time is 
independent of sample size and shape (Ramaswamy et al. 2005). 
HPP is proven to meet the FDA requirement of a 5-log reduction of microorganisms in fruit 
juices and beverages without sacrificing the sensory and nutritional attributes of fresh fruits 
(San Martín et al. 2002). Compared with thermal processing, HHP has many advantages. It 
can provide safe product with reduced processing time. It can maintain maximum fresh-like 
flavor and taste in the product due to the lower processing temperatures. Moreover, it is 
environmentally friendly since it requires only electrical energy and no waste by-products 
generated (Ramaswamy et al. 2005, Toepfl et al. 2006). Due to these advantages, HHP has 
been widely used in food product preservation including fruit and beverages in the areas of 
microbial inactivation (Table 1) and shelf-life extension (Table 2).  
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3.1.2 Pulsed electric field (PEF) 
Pulsed electric field processing (PEF) applies short bursts of high voltage electricity for 
microbial inactivation and causes no or minimum effect on food quality attributes. Briefly, 
the foods being treated by PEF are placed between two electrodes, usually at room 
temperature. The applied high voltage results in an electric field that causes microbial 
inactivation. The applied high voltage is usually in the order of 20-80 kV for microseconds. 
The common types of electrical field waveform applied include exponentially decaying and 
square wave (Knorr et al. 1994, Zhang et al. 1995, Barbosa-Cánovas et al. 1999).  
The principles of PEF processing have been explained by several theories including the 
trans-membrane potential theory, electromechanical compression theory and the osmotic 
imbalance theory. One of the most accepted theories is associated with the electroporation of 
cell membranes. It is generally believed that electric fields induce structural changes in the 
membranes of microbial cells based on generation of pores of the cell membrane, leading 
consequently to microbial destruction and inactivation (Tsong 1991, Barbosa-Cánovas et al. 
1999). 
Compared with thermal processing, PEF processing has many advantages. It can preserve 
the original sensory and nutritional characteristics of foods due to the very short processing 
time and low processing temperatures. Energy savings for PEF processing are also 
important compared with conventional thermal processing. Moreover, it is environmentally 
friendly with no waste generated (Toepfl et al. 2006). Due to these advantages, PEF 
processing has been widely used in food product preservation including fruit and beverages 
in the areas of microbial inactivation (Table 3) and shelf-life extension (Table 4).  
Foods Microorganism Treatment  
parameters 
Log reduction Sources 
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Escherichia coli O157: H7
30kV/cm,  
172µs, <35ºC
5 Evrendilek  
et al., 1999 
Cranberry 
juice 








Listeria  innocua 30kV/cm,  
12µs, 54ºC 
6.0 McDonald  
et al. 2000 
Apple  
cider 




5.9 Iu et al. 2001 
Orange  
juice 
Salmonella typhimurium 90kV/cm,  
100µs, 55ºC 
5.9 Liang  
et al., 2002 
Apple  
juice  
Escherichia coli 34kV/cm,  
7.68µs, 55ºC 
6.2 Heinz  
et al. 2003 
Grape  
juice  
Escherichia coli 34kV/cm,  
7.68µs, 55ºC 
6.4 Heinz  
et al. 2003 
Cherry  
juice,  
Penicillum expansum 34kV/cm,  
163µs, 21ºC 
100% inaction of spore 
germination 
Evrendilek  
et al. 2008 
Peach  
nectar 
Penicillum expansum 34kV/cm,  
163µs, 21ºC 
100% inaction of spore 
germination 
Evrendilek  
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nectar  
Penicillum expansum 34kV/cm,  
163µs, 21ºC 
100% inaction of spore 
germination 
Evrendilek  
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total acidity, phenolics 
content, and volatile compounds 
than HTST 
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were obtained  
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The principle of ultrasonic processing could be explained as follows: Firstly, the ultrasonic 
transducers convert electrical energy to sound energy. Secondly, when the ultrasonic waves 
propagate in liquid, small bubbles will be formed and collapsed thousands of times per 
second. This rapid collapse of the bubbles (cavitation) results in high localized temperatures 
and pressure, causing breakdown of cell walls, disruption of cell membranes and damage of 
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3.1.3 Ultrasound (US) 
Power ultrasound (US) has emerged as a potential non-thermal technique for preservation 
of food products over the last decade. Compared with diagnostic ultrasound, power US uses 
a lower frequency range of 20 to 100 kHz and a higher sound intensity of 10 to 1000 W/cm2 
(Baumann et al. 2005).  
The principle of ultrasonic processing could be explained as follows: Firstly, the ultrasonic 
transducers convert electrical energy to sound energy. Secondly, when the ultrasonic waves 
propagate in liquid, small bubbles will be formed and collapsed thousands of times per 
second. This rapid collapse of the bubbles (cavitation) results in high localized temperatures 
and pressure, causing breakdown of cell walls, disruption of cell membranes and damage of 





The application of high power ultrasound in the food industry has been widely 
investigated. To meet the FDA requirement of a 5-log reduction of microorganisms, a 
combination of sonication with mild heat treatment and /or pressure is essential 
(Baumann et al. 2005, D’Amico et al. 2006, Ugarte-Romero et al. 2006, Salleh-Mack  
and Roberts 2007, Tiwari et al. 2009). Several works have been done to examine the  
Foods Microorganism Treatment parameters Log 
reduction 
Sources 
Carrot juice E. coli K12 19.3 kHz, 700-800 W,  
1 min, 60ºC 
2.5 Zenker  
et al. 2003 
Apple cider Listeria 
monocytogenes 
48 kHz, 600 W, 3 min, 
25ºC 
1-2 Rodgers & 
Ryser 2004 
Apple cider Escherichia coli 
O157: H7 
48 kHz, 600 W, 5 min, 
25ºC 
1-2 Rodgers & 
Ryser 2004 
Apple cider Listeria 
monocytogenes 
20 kHz, 750 W, 5 min, 
0.46 W/mL, 60ºC 
5 Baumann et 
al. 2005 
Apple cider Escherichia coli 
O157: H7 
20 kHz, 150 W, 18 
min, 118 W/cm2, 57ºC 
6 D’ Amico  
et al. 2006 
Orange juice Total mesophilic 
aerobes 
500 kHz, 240 W, 15 
min, 60ºC 
3.4 Valero 





24 kHz, 300 W,  
60 min 
80% Yuan  
et al. 2009 
Orange juice Aerobic mesophilic 
count (AMC) 




Orange juice Yeast and mold 
counts (YMC) 
20 kHz, 500 W, 8 min, 
89.25 µm, 10ºC 
0.56 Gomez- 
Lopez 2010 






Quality changes Sources 
Carrot 
juice 
19.3 kHz, 700-800 
W, 1 min, 60ºC 
4ºC for  
35 days 
Improvement in surface color 
stability and L-ascorbic acid 
retention  
Zenker  
et al. 2003 
Apple 
cider 
20 kHz, 750 W, 4 





Titratable acidity, pH, and °Brix of 




et al. 2006 
Orange 
juice 
500 kHz, 240 W, 15 
min, 60ºC 
5ºC for  
14 days 
No detrimental effects on limonin 
content, brown pigments and colour 
Valero 
et al. 2007 
Orange 
juice 
20 kHz, 1500 W, 10 
min, 32-38ºC  
10C for  
30 days 
No significant changes in °Brix and 
titratable acidity. Significant changes 
in juice pH, colour, non-enzymatic 
browning, cloud value and ascorbic 
acid 
Tiwari  
et al. 2009 
Orange 
juice 
20 kHz, 500 W, 8 
min, 89.25µm, 10ºC
4ºC for  
10 days 
Color and ascorbic acid content were 
affected during storage  
Gomez-
Lopez 2010 
Table 6. Examples of US effect on quality attributes of fruit products  
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effectiveness of ultrasound on inactivation of microorganisms in fruit juices (Table 5). A 
few studies have been conducted to examine the effect of ultrasound on quality of US-
treated fruit juices (Table 6). 
Except HHP, PEF and power US, other non-thermal techniques including high pressure 
homogenization (HPH), membrane filtration and UV-light, among others, are also being 
investigated.  
3.1.4 Ultraviolet light 
Ultraviolet light (UV-light) technology utilizes radiation with the electro-magnetic spectrum 
in the range of 100 to 400 nanometers, between visible light and x-rays. It could be further 
divided into UV-A (320–400 nm), UV-B (280–320 nm) and UV-C (200–280 nm). UV-C is 
known to have biocidal effects and destroys microorganisms by degrading their cell walls 
and DNA (Ngadi et al. 2003). Therefore, UV-C could be used for the inactivation of 
microorganisms such as bacteria, yeasts, moulds, among others (Bintsis, Litopoulou-
Tzanetaki, & Robinson, 2000). The amount of cell damage depends on the type of medium, 
microorganisms and the applied UV dose (Ngadi et al. 2003). For fruit juice and beverage 
processing, the wavelength of 254 nm is widely used (Guerrero-Beltrán & Barbosa-Cánovas, 
2004).  
As a non-thermal preservation method, UV-C treatment takes the advantages of no toxic or 
significant non-toxic by-products being formed during the treatment, very little energy 
being required when compared to thermal pasteurization processes, and maximum aroma 
and color of the treated fruits being maintained (Tran & Farid, 2004). 
UV-C treatment has been successfully applied to reduce the microbial load in different fruit 
juices and nectars. Under suitable treatment conditions, more than 5-log reduction of some 
pathogenic microorganism, such as E. coli, in fruit juices could be achieved (Guerrero-
Beltrán and Barbosa-Cánovas 2004, Keyser et al. 2008). The minimum treatment condition 
for clear apple juice was under UV dosage of 230 J L−1, whereas higher UV dosage levels 
would be needed for cloudy juices such as orange juice and tropical juices (Keyser et al. 
2008). 
3.1.5 High pressure homogenization (HPH) 
High pressure homogenization (HPH) is considered to be one of the most promising non-
thermal technologies proposed for preservation of fruit juice and beverages. The primary 
mechanisms of HPH has been identified as a combination of spatial pressure and velocity 
gradients, turbulence, impingement, cavitation and viscous shear, which leads to the 
microbial cell disruption and food constituent modification during the HPH process. HPH 
has shown its ability to increase the safety and shelf-life of fruit juices including orange juice 
(Lacroix et al. 2005; Tahiri et al. 2006; Welti-Chanes et al. 2009), apple juice (Kumar et al. 
2009; Pathanibul et al. 2009) and apricot juice (Patrignani et al. 2009). The effectiveness of the 
treatment depends on many parameters including processing factors such as pressure, 
temperature, number of passes and medium factors such as type of juice and 
microorganisms. For example, up to 350 MPa processing pressure was required to achieve 
an equivalent 5-log inactivation of L. Innocua; however, less pressure is required for E. coli  
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processing, the wavelength of 254 nm is widely used (Guerrero-Beltrán & Barbosa-Cánovas, 
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As a non-thermal preservation method, UV-C treatment takes the advantages of no toxic or 
significant non-toxic by-products being formed during the treatment, very little energy 
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for clear apple juice was under UV dosage of 230 J L−1, whereas higher UV dosage levels 
would be needed for cloudy juices such as orange juice and tropical juices (Keyser et al. 
2008). 
3.1.5 High pressure homogenization (HPH) 
High pressure homogenization (HPH) is considered to be one of the most promising non-
thermal technologies proposed for preservation of fruit juice and beverages. The primary 
mechanisms of HPH has been identified as a combination of spatial pressure and velocity 
gradients, turbulence, impingement, cavitation and viscous shear, which leads to the 
microbial cell disruption and food constituent modification during the HPH process. HPH 
has shown its ability to increase the safety and shelf-life of fruit juices including orange juice 
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2009; Pathanibul et al. 2009) and apricot juice (Patrignani et al. 2009). The effectiveness of the 
treatment depends on many parameters including processing factors such as pressure, 
temperature, number of passes and medium factors such as type of juice and 
microorganisms. For example, up to 350 MPa processing pressure was required to achieve 
an equivalent 5-log inactivation of L. Innocua; however, less pressure is required for E. coli  





reduction of Saccharomyces cerevisiae 635 was observed in carrot juice (5-log reduction) than 
in apricot juice. (3-log reduction) with a pressure level of 100 MPa for up to 8 passes 
(Patrignani et al. 2009).  
3.1.6 Membrane filtration 
Ultrafiltration (UF) and microfiltration (MF) are the most commonly used membrane 
filtration techniques for fruit juice processing. They have been used commercially for the 
clarification of fruit juices. Through this processing, a “pasteurized” product could be 
produced with flavours better than thermally treated products (Tallarico et al. 1998; Ortega-
Rivas et al. 1998; Cassano et al. 2003). The effectiveness of the treatment depends on many 
parameters including processing factors such as types of membrane, pore size, 
transmembrane pressure and medium factors such as type of juice and microorganism. For 
example, an ultrafiltration (UF) unit, with polysulphone membranes of 10 kDa and 50 kDa 
pore sizes and trans-membrane pressures of up to 155 kPa, were used to treat apple juices. 
Results indicated that pH, acid content, and soluble solids did not change but presented less 
variability for the smaller pore membrane treatment. Relative colour changes were observed 
for both membranes, which was more detectable for the larger pore membrane treatment  
(Zarate-Rodriguez et al. 2001). Another application example was to use an ultrafiltration 
membrane of 15 kDa pore size to filter carrot and citrus juices. Then the clarified juices could 
be further processed by reverse osmosis and osmotic distillation (Cassano et al. 2003). 
3.2 Chemical methods (natural antimicrobials) 
Apart from physical methods, some chemical preservatives are widely used for the shelf-life 
extension of fruit juices and beverages. The most commonly used preservatives are 
potassium sorbate and sodium benzoate. However, consumer demand for natural origin, 
safe and environmental friendly food preservatives is increasing. Natural antimicrobials 
such as bacteriocins, lactoperoxidase, herb leaves and oils, spices, chitozan and organic acids 
have shown feasibility for use in some food products (Gould 2001, Corbo et al. 2009). Some 
of them have been considered as Generally Recognized As Safe (GRAS) additives in foods. 
Table 7 lists some natural antimicrobials and their status for GRAS. 
3.2.1 Bacteriocins  
Bacteriocins are series of antimicrobial peptides which are readily degraded by proteolytic 
enzymes in the human body. Among them, nisin is the most commonly used food 
preservative and the GRAS additives permitted by the Food Additive Status List (USFDA, 
2006). Apart from dairy, it has been used to preserve fruit and vegetable juices (Yuste & 
Fung 2004, Settanni & Corsetti, 2008). 
3.2.2 Lactoperoxidase  
Lactoperoxidase is an enzyme that is widely distributed in colostrum, raw milk and other 
body liquid. It is an oxidoreductase and catalyses the oxidation of thiocyanate with the 
consumption of H2O2, to produce intermediate products with antibacterial properties 
(Corbo et al. 2009).  These products have been indicated to be bactericidal for some spoilage 
and pathogenic microorganisms and yeasts (Gould 2001). Not much information had been 
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found on the application of lactoperoxidase in fruit juices. Until recently, it was used for the 
preservation of tomato juice and mongo fruits (Touch et al. 2004, Le Nguyen et al. 2005).  
3.2.3 Herb, spice and flavor oils  
Some herbs and spices contain essential oils, which are natural antimicrobials. The main 
elements of these antimicrobials are phenolic compounds, including caffeic, cinnamic, 
ferulic and gallic acids, oleuropein, thymol and eugenol (Gould 2001).  
Name Origin GRAS status 
Bay leaves Plant Yes 
Chitozan Animal No 
Cinamon Plant Yes 
Clove Plant Yes 
Coriander Plant No 
Garlic Plant Yes 
Lactoperoxidase Animal No 
Lemon (peel, balm, grass) Plant Yes 
Lime Plant Yes 
Nisin Microorganism Yes 
Onion Plant Yes 
Rosemary Plant Yes 
Sage Plant Yes 
Thyme Plant Yes 
* Revised from USFDA (2006): Food Additive Status List 
Table 7. Selected natural antimicrobials and their status for GRAS additives* 
Among them, sage (Salvia officinalis), rosemary (Rosemarinus officinalis), clove (Eugenia 
aromatica), coriander (Coriandrum sativum), garlic (Allium sativum) and onion (Allium cepa)) 
were listed as potential antimicrobials for food use (Deans and Ritchie 1987). The oils of bay 
leaves, cinnamon, clove and thyme were also proven to be highly effective for food 
pathogenic microorganisms including Campylobacter jejuni, Salmonella enteritidis, Escherichia 
coli, Staphylococcus aureus and Listeria monocytogenes (Smith-Palmer et al. 1998). It is believed 
that Gram-positive bacteria were more sensitive to inhibition by plant essential oils than the 
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Thyme Plant Yes 
* Revised from USFDA (2006): Food Additive Status List 
Table 7. Selected natural antimicrobials and their status for GRAS additives* 
Among them, sage (Salvia officinalis), rosemary (Rosemarinus officinalis), clove (Eugenia 
aromatica), coriander (Coriandrum sativum), garlic (Allium sativum) and onion (Allium cepa)) 
were listed as potential antimicrobials for food use (Deans and Ritchie 1987). The oils of bay 
leaves, cinnamon, clove and thyme were also proven to be highly effective for food 
pathogenic microorganisms including Campylobacter jejuni, Salmonella enteritidis, Escherichia 
coli, Staphylococcus aureus and Listeria monocytogenes (Smith-Palmer et al. 1998). It is believed 
that Gram-positive bacteria were more sensitive to inhibition by plant essential oils than the 





Cinnamon as an antimicrobial agent has been used in apple juice (Yuste and Fung 2004; 
Friedman et al. 2004), apple cider (Ceylan et al. 2004) and fresh-cut apple slices 
(Muthuswamy et al. 2008). Ground cinnamon (0.3%) could inhibit the growth of 
Staphylococcus aureus, Y. enterocolitica and Salmonella typhimurium in apple juice (Yuste and 
Fung 2004), whereas oils of cinnamon leaf or bark inactivated Salmonella enterica and E. coli 
O157:H7 in apple juice (Friedman et al.2004). Ethanol extract of cinnamon bark (1% to 2% 
w/v) and cinnamic aldehyde (2 mM) could reduce E. coli O157:H7 and L. innocua in vitro. 
Ethanol extract of cinnamon bark (1% w/v) reduced significantly the aerobic growth of 
bacteria inoculated in fresh-cut apples during storage at 6ºC up to 12 days. It was also found 
that cinnamic aldehyde has greater antimicrobial activity than potassium sorbate 
(Muthuswamy et al. 2008). 
Citrus fruits extracts have also been applied successfully to fruits and vegetables (Fisher & 
Phillips, 2008). For example, lemon extract was applied for the inhibition of some spoilage 
microorganisms, such as Bacillus licheniformis, Lactobacillus spp., Pichia subpelliculosa, 
Saccharomyces cerevisiae and Candida lusitaniae, the minimum inhibition concentration is 100 
to 150 ppm (Conte et al. 2007). The growth of pathogenic bacteria, Escherichia coli O157:H7, 
Listeria innocua and the food spoilage fungus, Penicillium chrysogenum were suppressed by 
three phenolic compounds (catechin, chlorogenic acid and phloridzin) at 25 mM but the 
growth of food spoilage yeast Saccharomyces cerevisiae was inhibited only by chlorogenic acid 
and phloridzin (Muthuswamy and Rupasinghe, 2007). Vanillin, the predominant phenolic 
compound present in vanilla beans, has shown a concentration dependent response and the 
minimal inhibitory concentration (MIC) of 6 to 18 mM for pathogenic and spoilage 
microorganisms (Rupasinghe et al., 2006). 
3.2.4 Chitozan 
Chitosan is a modified, natural carbohydrate polymer derived by deacetylation of chitin 
[poly-β-(1 → 4)-N-acetyl-D-glucosamine] (No & Meyers, 1995). It is widely produced from 
crab, shrimp and crawfish, with different deacetylation grades and molecular weights which 
contribute to different functionalities (No et al., 2007).  
Chitosan has attracted attention as a potential food preservative of natural origin due to its 
antimicrobial activity against a wide range of microorganisms (Sagoo and others 2002). The 
principles of the antimicrobial activity of chitosan could be explained by several hypotheses. 
One hypothesis is that the positively charged chitosan molecules could interact with the 
negatively charged microbial cell membranes, which would affect the cell permeability and 
lead to the leakage of intracellular compounds (Fang et al., 1994). Another hypothesis is that 
the interaction of diffused hydrolysis substances with microbial DNA could lead to the 
inhibition of the mRNA and protein synthesis of the microorganisms (Sudarshan et al., 
1992).   
A limited works have been done to assess the antimicrobial properties of chitosan in fruit 
juices (Roller and Covill 1999; Rhoades and Roller 2000). Chitosan glutamate was reported 
to be an effective preservative against spoilage yeasts in apple juice. Chitosan glutamate in 
apple juice from 0.1 to 5 g/L inhibited the growth of all spoilage yeasts at 25°C. The most 
sensitive strain, Z. bailii, was completely inactivated by chitosan at 0.1 and 0.4 g/L for  
32-day of storage at 25°C. The most resistant strain, S. ludwigii, required 5 g/L of chitosan 
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for complete inactivation and for maintaining yeast-free conditions in apple juice for 14 days 
at 25°C (Roller and Covill 1999). Another study by Rhoades and Roller (2000) showed that  
0.3 g/L of Chitosan eliminated all the yeasts in pasteurized apple-elderflower juice during a 
13-day of storage at 7°C. However, the total bacterial counts and the lactic acid bacterial 
counts increased slower than the control (Rhoades and Roller 2000). 
 
Foods Microorganism Method used Log 
reduction 
Sources 
Apple cider Escherichia coli 
O157:H7 
PEF (90 kV/cm, 20 µs, 
42ºC) with nisin or 
cinamon 
6-8 Iu  
et al. 2001 
Orange juice Natural 
microflora 
PEF (80 kV/cm, 44ºC) 
with Nisin (100 U/ml) 
6 Hodgins  
et al. 2002 
Orange juice Escherichia coli 
O157:H7 
PEF (90 kV/cm, 100 µs, 
55ºC) with nisin and/or 
lysozyme 
> 7 Liang  
et al. 2002 
Apple cider Listeria 
monocytogenes 
US (48 kHz, 600 W, 5 min, 
25ºC) with copper, 
sodium hypochlorite 
5 Rodgers and 
Ryser 2004  
Apple cider Escherichia coli 
O157: H7 
US (20 kHz, 150 W, 18 
min, 118 W/cm2) with 
heat (57ºC) 
> 7 D’ Amico  
et al. 2006 
Carrot juice Listeria innocua HPH (350 MPa) with nisin 
(10 IU/ml) 
> 5 Pathanibul 




O157: H7 and 
Salmonella 
Enteritidis 
PEF (35 KV/cm, 4 µs, 
<40ºC) with 0.05% 




et al. 2008 
Apple juice Escherichia coli 
O157: H7 and 
Salmonella 
Enteritidis 
PEF (35 KV/cm, 4 µs, 
<40ºC) with 0.1% 




et al. 2008 
Pear Juice Escherichia coli 
O157: H7 and 
Salmonella 
Enteritidis 
PEF (35 KV/cm, 4 µs, 
<40ºC) with 0.1% 
cinnamon bark oil or 1.5% 
citric acid 
>5 Mosqueda-





O157: H7 and 
Salmonella 
Enteritidis 
PEF (18.6 KV/cm, 150 µs, 
55ºC) with 750 ppm 
sodium benzoate and 350 
ppm potassium sorbate  
5.11 Gurtler  








PEF (18.6 KV/cm, 150 µs, 
55ºC) with 750 ppm 
sodium benzoate, 350 
ppm potassium sorbate 
and 2.7% citric acid 
6.95 Gurtler  
et al. 2011 
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Chitosan has been approved as a food additive in Japan in 1983 and in Korea in 1995. 
However, it is so far not a GRAS approved food additive by the FDA. As long as receiving 
the FDA approval for GRAS status, Chitosan as a food additive and its applications in food 
systems will certainly have a brighter future. 
3.3 Combination of physical and chemical methods 
It is proved that some individual non-thermal methods as well as natural antimicrobials are 
effective in inactivating microorganisms and at the same time do not adversely affect the 
sensory and nutritional quality of the fruit juice and other products. Moreover, the 
combination of these techniques could provide synergistic effects on prolonging the fruit 
juice shelf-life and potentially as replacement for traditional pasteurization methods. Table 8 
and Table 9 list some examples of recent progresses in these combined techniques for the 
microbial inactivation (Table 8) and shelf-life extension (Table 9) of fruit juices and 
beverages. 
 
Foods Method used Storage 
conditions 
Quality changes Sources 
Apple 
cider 
US (20 kHz, 750W, 
4 min, 0.46W/mL) 




Titratable acidity, pH, and 




et al. 2006 
Apple 
juice 
UV (5.3 J/cm2) 
with PEF (34 
kV/cm, 98 µs) or 
with US (20 kHz, 




No significant impact on 
non-enzymatic browning, 
total phenolics, antioxidant 
activity, flavor, color and 
odor of the juices. 
Caminiti  




UV (5.3 J/cm2) 
with PEF (34 
kV/cm, 98 µs) or 
with US (20 kHz, 




No significant impact on 
non-enzymatic browning, 
total phenolics, antioxidant 
activity, flavor, color and 
odor of the juices. 
Caminiti  
et al. 2011 
Table 9. Examples of combined preservation methods on quality attributes of fruit products  
4. Conclusions 
Non-thermal processing is a promising and useful approach for fruit juice and beverage 
preservation. The products based on these techniques show many advantages such as the 
retention of sensorial qualities and nutritional values over traditional thermal processing. 
However, among these non-thermal techniques, only high pressure processing has been 
adopted by the food industry so far. Additional pilot-scale testing may require for these 
non-thermal preservation methods to become a real alternative for thermal processing. 
Similarly, the application of natural antimicrobial compounds in fruit juice and beverages is 
in the laboratory scale. But the potential benefits of these compounds would lead to a fast 
growth of scale-up and commercial application in food industry.   
More practically, the combination of non-thermal techniques and natural antimicrobial 
compounds would be the future trends for fruit juice and beverages preservation, due to the 
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proven records for effective inhibition of microorganisms and shelf-life extension of fruit 
juices and beverages.  
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properties of dairy products. When they are added to food, polysaccharides show functions 
as thickeners, stabilizers, emulsifiers, gelling agents, and water binding agents (Kimmel et 
al., 1998). They also contribute to preservation, and enhance the organoleptic characteristics 
of milk and dairy products such as flavour and aroma (Macedo et al., 2002). More recently, 
these bio-molecules have been regarded as health promoters due to their role as prebiotics 
and/or the immunomodulatory properties linked to their structure. As a result, a number of 
studies are in progress in order to characterize the unmapped diversity of the EPS produced 
by LAB, since they are considered food-grade organisms. 
In this chapter, we shall review the current knowledge pertaining to the EPS synthesized by 
LAB, from biogenesis to application, detailing their nature and structure. Moreover, the 
methods most frequently used for the production and purification of these biopolymers will 
be presented. 
2. Composition, structure and classification of EPS 
The EPS synthesized by LAB vary greatly in their chemical composition, structure and 
molecular weight. According to their chemical composition, EPS are classified into 
heteropolysaccharides (HePS) and homopolysaccharides (HoPS). 
HePS are constructed of a backbone of repeated subunits that are linear or branched, with 
variable molecular masses (up to 106 Da). Each one of these subunits can contain between 
three and eight different monosaccharides and frequently has a range of different linkage 
patterns. The monosaccharides are present as the α- or β-anomer in the pyranose or 
furanose form and D-glucose, D-galactose and L-rhamnose are the most frequently 
encountered. In few cases, N-acetylglucosamine, manose, fucose, glucuronic acid and non-
carbohydrate substituents (phosphate, acetyl and glycerol) are also present (de Vuyst & 
Degeest, 1999; de Vuyst et al., 2001). 
Different strains of LAB isolated from dairy products, cereals and alcoholic beverages 
synthesize HePS. These belong to the genera Lactococcus (L. lactis subsp. cremoris, L. lactis 
subsp. lactis), Lactobacillus (Lb. acidophilus, Lb. delbrueckii subsp. bulgaricus, Lb. casei, Lb. sakei, 
Lb. rhamnosus, Lb. helveticus), Streptococcus (S. thermophilus, S. macedonicus) and Leuconostoc 
(Lc. mesenteroides) (Montersino et al., 2008; Mozzi et al., 2006; Van der Meulen et al., 2007). 
HoPS are composed of repeated units that contain only one type of monosaccharide: D-
glucopyranose (glucans) or D-fructopyranose (fructans). These polysaccharides usually 
display high molecular masses (up to 107 Da), and have different degrees and types of 
branching, linking sites and chain length. Based on their structure, the fructans can be 
divided into two groups: (i) inulins (linked  β-2,1) and (ii) levans (linked β-2,6), both are 
synthesized by different species of the genera Leuconostoc, Lactobacillus, Streptococcus and 
Weissella.  
Glucans can be classified into α- and β-D-glucans. The former are more widely found in 
LAB and they are produced by strains belonging to the genera Lactobacillus, Leuconostoc and 
Streptococcus. According to the linkages in the main chain, the α-glucans are subdivided into 
dextrans (α-1,6), mutans (α-1,3), glucans (α-1,2), reuterans (α-1,4) and alternans (α-1,3 and 
α-1,6) (Figure 1). These polymers may have side-chain branches that involve others α-
linkages different from the main chain. For example, the dextrans produced by various LAB 
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such as Leuconostoc mesenteriodes and Lactobacilli, may have branches with α-1,2, α-1,3 or  
α-1,4 linkages. The dextran most widely used by the industry is a polysaccharide containing 
95% α-1,6 and 5% α-1,3 linkages synthesized by Lc. mesenteroides NRRL B-512F (Korakli & 
Vogel, 2006; Monsan et al., 2001; van Hijum et al., 2006).  
 
Fig. 1. Schematic representation of the repeating units of: dextran, mutan, alternan, glucan 
and reuteran (Korakli & Vogel, 2006) 
(1,3) β-glucans are found in bacteria and eukaryotic organisms. These polysaccharides 
include the linear glucans and 6-substituted (1,3) β-glucans that have branch-on-branch or 
cyclic structures. Concerning prokaryotes, several bacteria including Agrobacterium and 
Rhyzobium species can produce these polymers. One such structure, curdlan, has been 
approved as a food additive by the Food and Drug Administration (FDA), and essentially is 
a linear (1,3) β-D-glucan which may have a few inter- or intra- chain (1,6) linkages (McIntosh 
et al., 2005). 
β-glucan production is rarely found in LAB. It has only been reported to be synthesized and 
secreted by a small number of strains isolated from alcoholic beverages, namely: Pediococcus 
parvulus IOEB8801 and Oenococcus oeni IOEB0205 from wine and P. parvulus 2.6R, CUPV1, 
CUPV22, Lb. diolivorans G77 and O. oeni I4 from cider (Dueñas-Chasco et al., 1997, 1998; 
Garai-Ibabe et al., 2010; Ibarburu et al., 2007; Llauberes et al., 1990). 
In all cases, these β-D-glucans have a common structure comprising a main chain of (1,3)-
linked β-D-glucopyranosyl units along with more or less frequent side chains of β-D-
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Fig. 2. Schematic representation of the repeating unit of  β-(1,3-1,2)-D-glucan of P. parvulus 
2.6 (Dueñas-Chasco et al., 1997) 
In addition, a similar polymer constitutes the capsule of S. pneumoniae serotype 37 and the 
EPS secreted by Propionibacterium freundenreichii subsp. shermanii TL34 (Adeyeye et al., 1988; 
Nordmark et al., 2005).  
3. Biosynthesis of EPS 
3.1 Genetic determinants and mechanisms of production and secretion 
The genes involved in the biogenesis of the HePS are usually organized in clusters that can 
be located either in the chromosome of the thermophilic LAB (e. g. S. thermophilus Sfi6) or in 
plasmids of mesophilic bacteria (e.g. L. lactis subsp. cremoris NIZO B40) (Laws et al., 2001). 
This structural organization is highly conserved among LAB and is very similar to that 
observed for the operons and clusters involved in the synthesis of: (i) O-antigen 
lipopolysaccharides in enterobacteria, (ii) capsules (CPS) of pathogens, such as S. pneumoniae 
or Staphylococcus aureus and (iii) the EPS from Sinorhizobium meliloti (García et al., 2000; 
Glucksmann et al., 1993; Lin et al., 1994). 
The clusters from LAB have been reported for S. thermophilus, Lb. helveticus, L. lactis, Lb. 
delbrueckii subsp. bulgaricus, Lb. rhamnosus and the Lb. casei group (Ruas-Madiedo et al, 2008). 
The genes are oriented in a single direction and transcribed as a single mRNA. The genes 
are grouped into four regions within the cluster: The first contains genes whose products are 
regulatory proteins; the second includes genes encoding proteins involved in 
polymerization/chain length determination; the third contains genes encoding enzymes 
required for the biosynthesis of the HePS repeating units, and the genes of the last region 
encode proteins implicated in transport and polymerization (Figure 3) (Jolly & Stingele, 
2001). 
Additionally, these clusters may occasionally include genes involved in biosynthesis of 
nucleotide sugars from which the repeating units are constructed. Thus, in Lb. rhamnosus, 
they are associated to the EPS operon and they can be transcribed either from their own 
promoter or together with the EPS operon genes (Péant et al., 2005). There is a great 
variability in the genes involved in the synthesis of the repeating units. This region is 
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responsible for the production of a specific EPS type; whereas the genes of polymerization 
and transport are more conserved. 
 
Fig. 3. Organization of the eps gene clusters of (A) S. thermophilus Sfi6, (B) L. lactis subsp. 
cremoris NIZO B40 and (C) Lb. bulgaricus Lfi5 (Lamothe et al., 2002; Laws et al., 2001). The 
proposed function of the different gene products is indicated 
HePS are made by the polymerization of repeating unit precursors formed in the cytoplasm. 
They are assembled at the membrane by the sequential addition of nucleotide sugars (e.g., 
UDP-glucose, UDP-galactose and dTDP-rhamnose) or nucleoside diphosphate sugars to the 
growing repeated units through the action of the specific glycosyltransferases. This unit is 
most probably anchored to a lipid carrier molecule located in the plasma membrane and the 
first monosaccharide is linked by the action of a type of glycosyltransferase called priming-
glycosyltransferase. It has been proposed that this lipid carrier might be an isoprenoid 
derivative such as undecaprenyl-phosphate (C55-P) by analogy with the synthesis of other 
EPS of gram-negative bacteria, as well as in the assembly of peptidoglycan, lipoteichoic 
acids and O-antigen lipopolysaccharides (Ruas-Madiedo et al., 2009). However some studies 
based in the resistance to bacitracin (a compound that blocks the transformation of the C55-
PP to C55-P), suggested that HePS biosynthesis in S. thermophilus Sfi6 uses a lipid carrier 
different from undecaprenyl carrier (Stingele et al., 1999).  
The mechanisms of polymerization, chain length determination and export still remain 
poorly understood. However, the similarity of gene products involved in these processes to 
those participating in the polymerization and export of O-antigens from Escherichia coli and 
the EPS of S. meliloti, suggests that probably LAB utilize similar mechanisms for 
polymerization and export of EPS. Thus, an enzyme of the flipase family could transfer the 
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Using the same line of argument, a polymerase could catalyze the linking of the repeating 
units and an enzyme could uncouple the lipid-bound polymer and control chain length 
(Laws et al., 2001). 
The regulatory mechanisms involved in expression of the HePS genes remain unclear. 
However, a transcriptional regulatory role has been proposed for a group of gene products 
in different LAB genera, due to their similarity with a family of transcriptional regulators 
whose prototype is LytR, the regulator of the autolysin operon of Bacillus subtilis (Ruas-
Madiedo et al., 2009). 
Finally, a variety of nucleotide sugars is needed for the synthesis of a range of 
polysaccharides which is not specific to EPS biosynthesis. The production of these 
precursors occurs in the cytoplasm, mainly from glucose 1-P which is synthesized from 
glucose 6-P. These two forms of phosphorylated glucose are part of the central metabolism 
of the bacterium, which begins with the transport of sugar to the interior of the cell (de 
Vuyst et al., 2001). 
Concerning to HoPS, most of them ( α-glucans and fructans) are synthesized from sucrose 
through the action of extracellular enzymes commonly named glycansucrases. Enzymes 
synthesizing α-glucan polymers are limited to LAB, while enzymes synthesizing fructans, 
are present in other gram-positive and gram-negative bacteria. A large number of these 
glycansucrase encoding genes have been identified in the chromosomes of Streptococcus, 
Leuconostoc and Lactobacillus strains and they usually form part of a monocistronic 
transcriptional unit. Some of these genes are expressed constitutively whilst other are 
sucrose-inducible (Gänzle & Schwab, 2009; van Hijum et al., 2006).  
Only one gene, named gtf, is required for the β-glucan biosynthesis in LAB. This gene is 
located in a 35 kb plasmid of P. parvulus 2.6 or in a 5.5 kb plasmid of P. parvulus IOEB8801, 
CUPV1, CUPV22, Lb. diolivorans G77 and Lb. suebicus CUPV221, while gtf is located in the 
chromosome of Oenococcus oeni I4 and IOEB0205 (Dols-Lafargue et al., 2008; Garai-Ibabe et 
al., 2010; Walling et al., 2001;  Werning et al., 2006). All of these bacteria produced the same 
2-substituted (1,3)-β-D-glucan and their gtf genes show high level of homology (at least 
97%). 
The gtf gene encodes a β-glycosyltransferase (GTF). It is a membrane protein whose 
topological prediction indicates that β-glucan or, at least its repeating unit precursors, are 
synthesized in the cytosol (Werning et al., 2006). In agreement, in vitro experiments indicate 
that the β-glucan polymer is synthesized by GTF directly from UDP-glucose (Werning et al., 
2008) which, as mentioned above, is part of the central metabolism of the bacterium and is 
available within the cell. The translocation through the membrane is performed by a 
mechanism that is not yet known. The fact that heterologous expression of GTF in other 
LAB leads to the synthesis and secretion of β-glucan in the recipient bacteria, strongly 
suggests that this polymer does not require specific transporters to be released into the 
extracellular space (Stack et al., 2010; Werning et al., 2008). Supporting this hypothesis, the 
capsular 2-substituted (1,3)-β-glucan of S. pneumoniae serotype 37, is synthesized by a single 
β-glycosyltransferase called Tts (which shares a 33% identity with GTF), and its 
heterologous expression in other gram-positive bacteria, also result in the capsular EPS 
formation (Llull et al., 2001).  
Biosynthesis, Purification and Biotechnological Use of  
Exopolysaccharides Produced by Lactic Acid Bacteria 
 
89 
The presence of four potential transmembrane regions at the C-terminal region of GTF 
glycosyltransferase and two more at its N-terminus suggest the formation of a membrane 
pore by the enzyme to facilitate the extrusion of the polymer (Werning et al., 2006). In this 
regard, there is experimental evidence (Heldermon et al., 2001; Tlapak-Simons et al., 1998, 
1999) suggesting that in the HAS glycosyltransferase from S. pyogenes only four 
transmembrane domains and two membrane-associated regions are sufficient to interact 
with the membrane phospholipids and to create a pore-like structure through which a 
nascent hyaluronan chain can be extruded to the exocellular environment. A similar 
mechanism could happen in the translocation of curdlan through the Agrobacterium 
membrane, for which it has been proposed that a pore could be formed by interaction of the 
CrdS synthase with phosphatidylethanolamine (Karnezis et al., 2003). Thus, the association 
of several GTF monomers could form a pore for extrusion of the EPS and, that might 
promote the processive catalysis of GTF carried out by this enzyme. However other 
alternative mechanisms might allow the translocation or secretion of β-glucan across LAB 
membranes. This includes the use of an ABC-like transporter, since this class of transporter 
can export various bacterial polysaccharides (Silver et al., 2001). 
Finally, it should be noted that the presence of mobile genetic elements is a common feature 
in the genetic organization of the DNA region involved in HePS or HoPS synthesis 
(Bourgoin et al., 1999; Dabour & LaPointe, 2005; Peant et al., 2005; Tieking et al., 2005; van 
Hijum et al., 2004). It is well known that these elements allow horizontal transfer between 
different genera. In this regard, its presence could explain the instability of the HePS-
producer phenotype of some strains (Ruas-Madiedo et al., 2009) as well as the loss of 
expression of some glycansucrases or the presence of chimeras in different HoPS-producing 
strains (Gänzle & Schwab, 2009). The gtf genes of LAB are flanked by genes which could be 
involved in functions of conjugation and recombination, respectively (Werning et al., 2006; 
Dols-Lafargue et al., 2008). Thus, horizontal transfer mediated by plasmids or transposition 
events, might explain the wide distribution and high degree of gtf gene preservation in β-
glucan-producing strains belonging to different genera. 
3.2 Enzymes for production 
HePS and β-glucans are produced by glycosyltransferases which use nucleotide sugars as 
substrate. On the other hand,  α-glucans and fructans are synthesized by glycansucrases 
which are able to use the energy of the glycosidic bond of sucrose to ligate glucose or 
fructose to the growing polysaccharide chain. In addition, these enzymes can synthesize 
hetero-oligosaccharides, when the acceptors are maltose and isomaltose (Monsan et al., 
2001). 
Enzymes synthesizing α-glucan polymers are called glucansucrases (GS) and those 
synthesizing fructans are named fructansucrases (FS). Unlike the glycosyltransferases 
(discussed below), GS and FS are transglycosidases evolutionarily, structurally, and 
mechanistically related to the glycosyl-hydrolases (GH). Therefore, according to the 
classification of the GH into families (which is based on the amino acid sequences) GS and 
FS can be respectively placed within the GH70 and the GH68 families (Henrissat & Bairoch, 
1996). In addition, according to the Nomenclature Committee of the International Union of 
Biochemistry and Molecular Biology (UIBMB), GS enzymes are classified (according to the 





Using the same line of argument, a polymerase could catalyze the linking of the repeating 
units and an enzyme could uncouple the lipid-bound polymer and control chain length 
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CUPV1, CUPV22, Lb. diolivorans G77 and Lb. suebicus CUPV221, while gtf is located in the 
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97%). 
The gtf gene encodes a β-glycosyltransferase (GTF). It is a membrane protein whose 
topological prediction indicates that β-glucan or, at least its repeating unit precursors, are 
synthesized in the cytosol (Werning et al., 2006). In agreement, in vitro experiments indicate 
that the β-glucan polymer is synthesized by GTF directly from UDP-glucose (Werning et al., 
2008) which, as mentioned above, is part of the central metabolism of the bacterium and is 
available within the cell. The translocation through the membrane is performed by a 
mechanism that is not yet known. The fact that heterologous expression of GTF in other 
LAB leads to the synthesis and secretion of β-glucan in the recipient bacteria, strongly 
suggests that this polymer does not require specific transporters to be released into the 
extracellular space (Stack et al., 2010; Werning et al., 2008). Supporting this hypothesis, the 
capsular 2-substituted (1,3)-β-glucan of S. pneumoniae serotype 37, is synthesized by a single 
β-glycosyltransferase called Tts (which shares a 33% identity with GTF), and its 
heterologous expression in other gram-positive bacteria, also result in the capsular EPS 
formation (Llull et al., 2001).  
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The presence of four potential transmembrane regions at the C-terminal region of GTF 
glycosyltransferase and two more at its N-terminus suggest the formation of a membrane 
pore by the enzyme to facilitate the extrusion of the polymer (Werning et al., 2006). In this 
regard, there is experimental evidence (Heldermon et al., 2001; Tlapak-Simons et al., 1998, 
1999) suggesting that in the HAS glycosyltransferase from S. pyogenes only four 
transmembrane domains and two membrane-associated regions are sufficient to interact 
with the membrane phospholipids and to create a pore-like structure through which a 
nascent hyaluronan chain can be extruded to the exocellular environment. A similar 
mechanism could happen in the translocation of curdlan through the Agrobacterium 
membrane, for which it has been proposed that a pore could be formed by interaction of the 
CrdS synthase with phosphatidylethanolamine (Karnezis et al., 2003). Thus, the association 
of several GTF monomers could form a pore for extrusion of the EPS and, that might 
promote the processive catalysis of GTF carried out by this enzyme. However other 
alternative mechanisms might allow the translocation or secretion of β-glucan across LAB 
membranes. This includes the use of an ABC-like transporter, since this class of transporter 
can export various bacterial polysaccharides (Silver et al., 2001). 
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(Bourgoin et al., 1999; Dabour & LaPointe, 2005; Peant et al., 2005; Tieking et al., 2005; van 
Hijum et al., 2004). It is well known that these elements allow horizontal transfer between 
different genera. In this regard, its presence could explain the instability of the HePS-
producer phenotype of some strains (Ruas-Madiedo et al., 2009) as well as the loss of 
expression of some glycansucrases or the presence of chimeras in different HoPS-producing 
strains (Gänzle & Schwab, 2009). The gtf genes of LAB are flanked by genes which could be 
involved in functions of conjugation and recombination, respectively (Werning et al., 2006; 
Dols-Lafargue et al., 2008). Thus, horizontal transfer mediated by plasmids or transposition 
events, might explain the wide distribution and high degree of gtf gene preservation in β-
glucan-producing strains belonging to different genera. 
3.2 Enzymes for production 
HePS and β-glucans are produced by glycosyltransferases which use nucleotide sugars as 
substrate. On the other hand,  α-glucans and fructans are synthesized by glycansucrases 
which are able to use the energy of the glycosidic bond of sucrose to ligate glucose or 
fructose to the growing polysaccharide chain. In addition, these enzymes can synthesize 
hetero-oligosaccharides, when the acceptors are maltose and isomaltose (Monsan et al., 
2001). 
Enzymes synthesizing α-glucan polymers are called glucansucrases (GS) and those 
synthesizing fructans are named fructansucrases (FS). Unlike the glycosyltransferases 
(discussed below), GS and FS are transglycosidases evolutionarily, structurally, and 
mechanistically related to the glycosyl-hydrolases (GH). Therefore, according to the 
classification of the GH into families (which is based on the amino acid sequences) GS and 
FS can be respectively placed within the GH70 and the GH68 families (Henrissat & Bairoch, 
1996). In addition, according to the Nomenclature Committee of the International Union of 
Biochemistry and Molecular Biology (UIBMB), GS enzymes are classified (according to the 





alternansucrases (E.C.2.4.1.140). The mutansucrases and reuteransucrases are classified 
together with the dextransucrase enzymes. Also, FS enzymes can be classified, based on the 
different products synthesized, into: (i) inulosucrases (E.C.2.4.1.9) and ( ii) levansucrases 
(E.C.2.4.1.10) (van Hijum et al., 2006). 
Although GS and FS enzymes perform very similar reactions on the same substrate, they do 
not show great similarities in their amino acid sequence and strongly differ in their protein 
structures. Regarding the amino acid sequence, these enzymes are composed of 4 structural 
domains from the N to the C terminus: (i) a signal peptide involved in the secretion of the 
enzyme; (ii) a variable N-terminal domain of unknown function; (iii) a conserved catalytic 
domain comprising sucrose-binding and sucrose-cleaving domain and in FS also a calcium 
ion binding site and (iv) a C-terminal domain, that is composed of a series of tandem repeats 
which is thought to be involved in the control of product size as well as in α-glucan binding 
(GS), or in cell wall anchoring (FS) (Korakli & Vogel, 2006). 
The mechanism of action of GS is still not fully understood. The key step in the transfer of 
D-glucosyl units is the formation of a covalent glucosyl-enzyme intermediate, in which an 
amino acid triad, composed of two aspartate and one glutamate residues, is involved. From 
this intermediate, the glucosyl unit is transferred to the acceptor (the polymer in growth) by 
a processive catalytic mechanism. The overall synthesis can be described as three steps: 
initiation, elongation and termination. The last corresponds to the dissociation of the α-
glucan-enzyme complex. Regarding the elongation, this can proceed by two alternative 
mechanisms, one acts at the reducing end and the other at the non-reducing end of the 
growing α-glucan chain (Monchois et al., 1999; Monsan et al., 2001). 
So far little is known about the mechanism of action of the FS enzymes. Fructan biosynthesis 
could be carried out by a multiple elongation mechanism, where the fructose residues are 
added to the growing fructan chain. The catalytic mechanism proposed for the 
transfructosylation reaction occurs in two steps, involving both a nucleophilic and an 
acidophilic site, through the formation of a covalently linked intermediary fructosyl-enzyme 
( Monsan et al., 2001; Sinnott, 1991). 
The glycosyltransferases are ubiquitous enzymes in prokaryotes and eukaryotes. They are 
involved in the biosynthesis of oligosaccharides, polysaccharides and glyconjugates (e.g. 
lipopolysaccharides and glycoproteins). These enzymes are responsible for the biosynthesis 
of glycosidic bonds by the transfer of a sugar residue from activated donor molecules to 
specific acceptor molecules. Donor sugar substrates are mostly nucleotide sugars; however 
they can also be nucleoside monophosphate sugars, lipid phosphate sugars and sugar 1-
phosphate. Frequently the acceptors are other sugars but they can be lipids, nucleic acids, 
antibiotics, etc. Additionally, two stereochemical outcomes are possible for reactions that 
result in the formation of a new glycosidic bond: the anomeric configuration of the product 
can be retained (α-glycosyltransferases) or inverted (β-glycosyltransferases) with respect to 
the donor substrate (Lairson et al., 2008).  
The HePS biosynthesis in LAB involves several enzymes for production of repeating units: a 
priming-glycosyltransferase that transfers the first sugar from sugar 1-phosphate onto a 
phosphorylated carrier lipid and one or more α- or β-glycosyltransferases that sequentially 
add new sugars from nucleotide sugars to the growing repeating unit. Some already 
characterized examples of these enzymes are: EpsE, a phospho-galactosyltransferase from S. 
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thermophilus Sfi6 and EpsD a phospho-glucosyltransferase from L. lactis subsp. cremoris B40, 
which are priming-glycosyltransferases. Examples of other glycosyltransferases are:  
EpsG, an N-acetyl-glucosaminetransferase from S. thermophilus Sfi6, which transfers  
N-acetylglucosamine to a β-galactose precursor anchored to a carrier lipid or EpsG, that 
catalyzes the linkage of galactose to a cellobiose precursor anchored to a carrier lipid from  
L. lactis subsp. cremoris (Ruas-Madiedo et al., 2009). 
As mentioned above, the 2-substituted (1,3)-β-D-glucan biosynthesis of P. parvulus 2.6 is 
carried out by the GTF glucosyltransferase. GTF was overproduced in L. lactis NZ9000 and 
purified as a membrane-associated enzyme (Werning et al., 2008). These membrane 
preparations used UDP-glucose as donor substrate to catalyze the biosynthesis of a high 
molecular weight polysaccharide that corresponds to the 2-substituted (1,3)-β-D-glucan 
(Werning et al., 2008 and unpublished results). The acceptor is so far unknown, but it could 
be the growing β-glucan polymer or any lipid molecule present in the cellular membranes.  
Traditionally, glycosyltransferases have been classified on the basis of their donor, acceptor 
and product specificity according to the recommendations of the IUBMB. However, this 
system requires full characterization before an Enzyme Commission (EC) number can be 
assigned. To overcome this limitation, these enzymes have been classified into families on 
the basis of amino acid sequence similarities as in the case of GH. At present there are 
already 91 families (referred to as GTx), available at URL: 
http://www.cazy.org/fam/acc_GT.html. This classification is periodically reviewed and 
updated (Coutinho et al., 2003). 
According to protein sequence similarity, enzymes that produce HePS can be grouped into 
various families. With regard to HoPS, the dextransucrases have been included in the family 
of glycosyl hydrolases GH70. In addition, GTF belongs to the GT-2 family that includes 
other glycosyltransferases such as cellulose synthases, β-1,3 glucan synthases, 
chitinsynthases, HAS and β-glucosyltransferases. All of these enzymes have in common that 
they use a nucleotide sugar as substrate for the synthesis of a polymer, with inversion of 
anomeric configuration of the donor substrate. 
Two general three-dimensional (3D) folding models, called GT-A and GT-B have been 
observed for all the structures of nucleotide-sugar-dependent glycosyltransferases solved to 
date, and two mechanisms for retaining or inverting enzymes can be proposed within both 
classes. The GT-A fold may be considered as two tightly associated and abutting β/α/β 
Rossmann domains that tend to form a continuous central sheet of at least eight β-strands. 
The GT-B fold consists of two β/α/β Rossmann domains that face each other and are linked 
flexibly. These domains correspond to the donor substrate and acceptor binding sites 
(Breton et al., 2006; Lairson et al., 2008). 
So far, no 3D-structure has been resolved for any glycosyltransferase involved in EPS 
synthesis from LAB, which would be essential for a better understanding of the mode of 
action of these enzymes. However, using the GT classification system proposed by Coutinho 
et al (2003) (in which families can be classified into clans on the basis of their folding and 
stereochemical outcome of the reaction that they catalyze) it is possible to predict that the 
glycosyltransferases can adopt one of two possible foldings. Thus, GTF from P. parvulus 2.6 
belongs to the inverting-clan I of GT-A glycosyltransferases. A 3D-dimensional model based 
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experimentally resolved structures of SpsA synthase from Bacillus subtilis (PDB code 1qgq) 
and of a putative glycosyltransferase from Bacteroides fragilis (PDB code 3bcv). The model 
proposed for GTF corresponds to a GT-A fold, which consists of an open twisted β-sheet 
surrounded by α-helices on both sides, where the N- and C-terminus domains are 
respectively the donor substrate and the acceptor binding sites (Figure 4). 
 
                                               (A)                                                                                    (B) 
Fig. 4. Three-dimensional model for the putative active site of GTF constructed using resolved 
structures of SpsA from B. subtilis (A) and a putative glycosyltransferase from Bc. fragilis (B). 
The conserved N-terminal nucleotide-binding domain is shown in green and the C-terminal 
acceptor domain in red. The ball-and-stick representations show putative residues involved 
in the catalytic center: D143, D198 and D200 at the N-terminal domain and D306 at the C-
terminal domain (in blue) as well as D295 (in violet), which is an alternative residue to D306, 
whose putative functions are discussed in the text 
Based on structural data and on site directed mutagenesis experiments, it has been proposed 
that only four aspartic or carboxylate groups are required to form a single catalytic center of 
GT-A inverting enzymes (Charnock et al., 2001; Garinot-Schneider et al., 2000; Keenleyside 
et al., 2001; Tarbouriech et al., 2001). Three Asp located at the N-terminus domain are 
involved in nucleoside diphosphate (NDP) coordination. The first Asp residue is implicated 
in the recognition of uracil or thymine base. The other two, commonly referred to as DXD 
motif, bind to hydroxyl groups on the ribose moiety and the divalent metal ion (Mg2+ or 
Mn2+), which in turn coordinate the phosphate groups from NDP, facilitating the release of 
the NDP from the donor substrate. A fourth residue, Asp or Glu, in the acceptor domain (C-
terminus) acts at the catalytic site by activating the acceptor hydroxyl group, which would 
subsequently perform a nucleophilic attack on the C1 of the donor substrate (Lairson et al., 
2008). 
Candidate aspartate residues exist in GTF and it is possible to predict their location in the 
active site of this protein based on the 3D-structural model shown in Figure 4. Three 
aspartates (D143, D198 and D200) are coincident with those conserved and proposed in 
other glycosyltransferases from the GT-2 family, including glycosyltransferase SpsA of B. 
subtilis. The fourth aspartate (D306) is not a good candidate to be part of the active site 
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according to the current models and one alternative could be that at D295, though this 
should be evaluated by substrate docking experiments and site directed mutagenesis.  
4. Production, purification and analysis of EPS 
4.1 Methods of production 
Most LAB species show low yields of polysaccharide production which is the main reason 
for their lack of commercial exploitation. Generally (with a few exceptions) the yield of 
production is under 1 g L-1 for HoPS, when culture conditions are not optimized, and even 
less for the majority of the HePS. Van der Meulen et al. (2007) reported the EPS production 
by 10 LAB strains isolated from dairy and cereal products. Nine out of ten produced glucans 
in amounts from 0.8 to 1.7 g L-1. The only HePS producer was Lb. curvatus, which 
synthesized the EPS to levels of 22 mg L-1. Mozzi et al. (2006) reported that 31 HePS 
producers screened from 201 LAB strains (including thermophilic and mesophilic species) 
synthesized from 10 to 166 mg L-1. Only seven of them produced > 100 mg L-1.  
Efforts have been made to improve yields of EPS production by LAB resulting in a variety of 
methods well detailed in the literature. All of them focus on parameters that have a strong 
influence on the production of HoPS and HePS. As a general rule the amount and 
composition of the EPS produced by LAB is strongly influenced by the culture and 
fermentation conditions such as pH, temperature and medium composition (Dueñas et al., 
2003). 
The production of α-glucans by LAB can be obtained in the presence of sucrose, after 
optimization of sucrose concentration in the growth medium and the time of incubation. 
The depletion of the sucrose source would cause the arrest of the enzymatic reaction of 
the dextransucrases. It has been reported that high producers of dextran are primarily 
Leuconostoc, but many other strains of LAB are able to produce this bacterial 
polysaccharide (Sarwat et al., 2008). The importance of improving its production is related 
to the industrial applications in the food, pharmaceutical and chemical industries as 
adjuvant, emulsifier, carrier or stabilizer (Goulas et al., 2004). Lc. mesenteroides CMG713 
produces the highest concentration of dextran after 20 hours of incubation at 30°C in the 
presence of 15% sucrose at pH 7.0, with an EPS yield of 6 g L-1 (Sarwat et al., 2008). 
Recently, Capek et al. (2011) reported an exceptionally high production of this HoPS (50 g 
L-1) by Lc. garlicum PR. 
On the contrary, β-glucan production is very tedious, because of the low yield obtained. 
Therefore, it demands new strategies to improve synthesis apart from the optimization of 
growth parameters. For production of the 2-substituted (1,3) β-glucan heterologous gene 
expression has been tested. A plasmid, pNGTF, was constructed in order to express the  
P. parvulus gtf in L. lactis NZ9000. This plasmid allows inducible expression of the gtf gene 
from the nisA gene promoter by the addition of nisin to the growth medium (Werning et al., 
2008). The EPS released to the medium by NZ9000[pNGTF] was quantified and purified. 
The expression of GTF glycosyltransferase by NZ9000[pNGTF] yielded levels of purified 
EPS of 300 mg L-1 , when the bacteria was grown in batch conditions (Werning et al., 2008). 
The structural characterization of the purified EPS confirmed that the recombinant strain 
synthesizes and secretes the same 2-substituted (1,3)-β-D-glucan as P. parvulus 2.6 (Werning 
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according to the current models and one alternative could be that at D295, though this 
should be evaluated by substrate docking experiments and site directed mutagenesis.  
4. Production, purification and analysis of EPS 
4.1 Methods of production 
Most LAB species show low yields of polysaccharide production which is the main reason 
for their lack of commercial exploitation. Generally (with a few exceptions) the yield of 
production is under 1 g L-1 for HoPS, when culture conditions are not optimized, and even 
less for the majority of the HePS. Van der Meulen et al. (2007) reported the EPS production 
by 10 LAB strains isolated from dairy and cereal products. Nine out of ten produced glucans 
in amounts from 0.8 to 1.7 g L-1. The only HePS producer was Lb. curvatus, which 
synthesized the EPS to levels of 22 mg L-1. Mozzi et al. (2006) reported that 31 HePS 
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synthesized from 10 to 166 mg L-1. Only seven of them produced > 100 mg L-1.  
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The expression of GTF glycosyltransferase by NZ9000[pNGTF] yielded levels of purified 
EPS of 300 mg L-1 , when the bacteria was grown in batch conditions (Werning et al., 2008). 
The structural characterization of the purified EPS confirmed that the recombinant strain 
synthesizes and secretes the same 2-substituted (1,3)-β-D-glucan as P. parvulus 2.6 (Werning 





improved by optimizing growth conditions of the producing recombinant strain in 
continuous culture in a chemostat at controlled pH. 
With regard to HePS, their production has been improved in the native isolates by 
optimizing growth conditions and media composition. As an example, Vijayendra and Babu 
(2008) optimized the EPS production by Leuconostoc sp. CFR-2181, a strain isolated from 
dahi, an Indian traditional fermented dairy product, in a simple, low cost semisynthetic 
medium. Maximum biomass and HePS production was observed when sucrose was used as 
carbon source and a yield of 30 g L-1 of the biopolymer was obtained, although the 
concentration was estimated by dry weight and purity of the HePS was not assayed. As an 
alternative, to improve production of HePS, the eps clusters of various LAB have been 
overexpressed, mainly in L. lactis, by construction of recombinant strains carrying the genes 
in multicopy plasmids (e.g. the HePS of S. thermophilus Sfi39). In addition, metabolic 
engineering of L. lactis has been used to redirect carbon distribution between glycolysis and 
nucleotide sugar biosynthesis, with the aim of increasing intracellular levels of UDP-
glucose, UDP-galactose and UDP-rhamnose, the substrates of the glycosyltransferases 
encoded by plasmid pNZ4000 and involved in HePS biosynthesis in the NIZO B40 strain 
(Boels et al., 2002). 
The importance that EPS has gained in the food industries has been responsible for the 
development of other strategies to improve the total amount produced. Some good 
examples are their in situ production in food matrices and their in vitro production by the 
use of immobilized enzymes. 
LAB can produce a large variety EPS during elaboration of dairy products. Since the use of 
LAB is historically considered safe (GRAS microorganisms), production in situ of novel 
functional EPS means that toxicological testing will be reduced, or not required, and the 
products can be quickly brought to the market (De Vuyst et al., 1999). 
Yogurt is a well-known dairy product derived from milk fermentation by cultures 
producing EPS (e.g. Lb. delbrueckii ssp. bulgaricus and S. thermophilus produce, respectively, 
60-150 mg L-1 and 30-890 mg L-1 of HePS) (Marshall and Rawson, 1999). The use of EPS-
producing starter cultures for yogurt elaboration is increasing, because these biopolymers 
improve water retention and texture and confer thickness without altering the organoleptic 
characteristics of the final product. Thus, there is no need to add stabilizers, many of which 
are prohibited in a wide range of countries. Although the role of pure EPS has not been 
studied, authors agree that the key points of improving the texture are the conformation of 
the EPS and their interactions with casein (Badel et al., 2011).  
In the cheese making process strains such as Lb. delbrueckii ssp. bulgaricus, Lb. helveticus and 
Lb. casei, produce HePS. These polysaccharides, as occurs in yogurt, help to improve the 
rheological properties of the cheese. Their role in cheese elaboration depends on associations 
with other strains and also on the presence or absence of charges in the EPS produced (Badel 
et al., 2011). 
Furthermore, there are other examples of in situ EPS production, such as kefir. This is a very 
important beverage in Eastern European countries. It is a fermented milk product produced 
by a population of different species of bacteria and yeasts. Several functional properties of 
kefir, such as is ability to modulate immune responses, to diminish allergic reactions and to 
inhibit tumour growth have been postulated for this beverage (Liu et al., 2002). LAB 
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produce lactic acid and yeast synthesize ethanol, which is used by Lb. kefiranofaciens to 
produce kefiran, a polysaccharide resistant to enzymatic degradation. Kefiran is a natural 
biopolymer that could be used as a thickener in fermented products. 
Finally, the use of enzymes for the in vitro synthesis of polysaccharides is showing promise. 
Immobilized enzymes are preferred as this allows the recovery and reuse of the enzyme, 
and may improve the properties of the enzyme such as stability, activity, specificity and 
selectivity (Mateo et al., 2007). The technique is used for production of 
isomaltooligosaccharides by immobilized dextransucrase. Isomaltooligosaccharides are 
oligosaccharides with prebiotic activity that can be produced either by acceptor reactions of 
dextransucrase or hydrolysis of dextran by dextranase. In the case of dextransucrase, it can 
also produce leucrose (a disaccharide used as sweetener). Other uses are also currently 
being developed e.g. immobilization of  β-galactosidase to produce galactooligosaccharides. 
Concerning immobilization technology, the alginate encapsulation method has the best 
performance, rendering yields of up to 90% (Tanriseven & Dogan, 2002). Dextranase has 
been immobilized on various supports including glutaraldehyde-activated chitosan, porous 
glass, bentonite and the commercially available matrix, Eupergit C, with high yield (90%) 
(Aslan & Tanriseven, 2007). Dextransucrase and dextranase share the optimum pH (pH 5.4) 
which facilitates their combined use. However, few studies using co-immobilization of 
dextransucrase and dextranase are yet available (Erhardt et al., 2008; Olcer & Tanriseven, 
2010).  
4.2 Methods of purification and characterization of EPS 
Purification is the physical separation of a chemical substance of interest from 
contaminating substances. In the case of EPS, purification from bacterial culture 
supernatants means elimination of producer microorganisms and their secreted metabolites 
as well as components of the growth media. Ruas-Madiedo et al. (2005) extensively 
reviewed this subject, thus we shall present here only an overview of the more usual 
procedures, with a more detailed description of methods related to the determination of EPS 
structure. 
The first step of purification of EPS depends on the bacterial growth medium utilized for its 
production. In complex media or in food matrix, such as milk, the first requirement is the 
elimination of proteins. For their removal a precipitation with TCA as well as treatment with 
proteases are the most commonly used methods. Then, the supernatant as well as the 
supernatant of bacterial cultures grown in defined media are usually subjected to one or 
more cycles of precipitation with either ethanol or acetone. The biopolymers present in the 
supernatants, if they are soluble, are dissolved in water, and then dialysed to remove the 
low molecular weight contaminants, in general a membrane with a cut-off of MWCO 12-
14.000 Da is used.  
After lyophilisation of the samples, the EPS is often further purified using a 
chromatographic technique. The parameters involved in the choice of the appropriate 
chromatography are: charge, solubility and molecular weight of the EPS. Size-exclusion 
chromatography (SEC) is a chromatographic method in which molecules in solution are 
separated by their size, not by molecular weight. It is usually applied to large molecules or 
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allows the separation of ions and polar molecules based on their charge. In general the 
procedure involves passing a mixture dissolved in a mobile phase through a stationary 
phase. For high molecular weight polysaccharides, such as the 2-substituted (1,3)-β-glucan, 
SEC is the most suitable method, because the charge of the EPS is zero. In this case, dried 
EPS are dissolved in 0.3 M NaOH (to eliminate extra contaminants and to improve the 
solubility of the EPS) and centrifuged to eliminate insoluble material. The supernatant is 
loaded into a column of Sepharose CL-6B equilibrated with NaOH, which is also used as 
eluent. Fractions are collected, and monitored for carbohydrate content by the phenol-
sulphuric method (Dubois et al., 1956).  
Polysaccharides are polydisperse polymers, and consequently only an apparent average 
molecular weight (Mw) can be determined. To this end, the average Mw can be estimated 
after SEC fractionation. A calibration curve is performed by fractionation of standards 
(Dextran Blue, T70, T10, and vitamin B12) and used for the determination of the Mw. As an 
alternative, high-performance size-exclusion chromatography (HPSEC) equipped with 
multi-angle laser-light scattering (MALLS) and refractive index (RI) detectors can be used to 
determine (Mw) and z-average radius of gyration (Rz) of the EPS. 
To determine the monosaccharide composition of the EPS, the analysis of neutral sugars is 
performed by polysaccharide hydrolysis with 3M TFA. The resulting monosaccharides are 
converted into their corresponding alditol acetates by reduction with NaBH4 and 
subsequent acetylation (Laine et al., 1972). Identification and quantification is performed by 
gas-liquid chromatography (GLC) using a HP5 fused silica column, with a temperature 
program and a flame ionization detector. With this technique the chromatogram shows only 
one peak per each monosaccharide, leading to an easy identification of the monosaccharide 
composition. However, if the polysaccharide contains uronic acid(s) it must be subjected to 
methanolysis after the hydrolysis. An O-methyl glycoside is formed, the acid function is 
transformed into an ester group and the sugar derivative can then be acetylated and 
analyzed by GLC. 
To determine the type of bond between each residue present in the EPS molecule a 
methylation analysis is usually performed. The polysaccharides are methylated according to 
the method of Ciucanu and Kerek (1984). The partially methylated polysaccharides are 
hydrolyzed with 3M TFA and the products are reduced with NaBD4, acetylated and 
analyzed by gas chromatography/mass spectroscopy (GC-MS) (Leal et al., 2008). Each peak 
of the chromatogram is identified by the retention time and mass spectra parameters. The 
quantification is associated to the peaks area.  
To resolve the 3D-structure of an EPS molecule, both the ring size (pyranose/furanose) of 
the monosaccharide residues and the relative orientations of the adjacent monosaccharides 
have to be determined. Nuclear magnetic resonance (NMR) is the technique most often used 
to study the conformation of the polysaccharides and allows elucidation of the type of 
glycosidic linkages and the structure of the repeating units that constitute the EPS molecules 
(review by Duus et al., 2000). Before NMR analysis, the purified EPS is dissolved in D2O so 
that exchangeable protons are replaced by deuterium (deuteration). This procedure is 
repeated several times and may involve intermediate lyophylisation steps. A 1H NMR 
spectrum of the EPS gives information about the number of monosaccharides present in the 
repeating unit by counting the resonances in the anomeric region (4.4-5.5 ppm). The 
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common hexoses are detected as well in 13C NMR spectra (95-110 ppm). If there are 
resonances just downfield of 1 ppm in the 1H NMR spectrum it is a sign of CH3-groups of 
e.g. a fucose or a rhamnose residue. Resonances close to 2 ppm reveal N-acetyl and/or O-
acetyl functionalities. From the splitting of the anomeric peaks in 1H spectra (JH1,H2) the 
anomeric configuration can be established; a J-coupling of ~4 Hz indicates the α-
configuration and a value of ~8 Hz indicates the β-form for common monosaccharides like 
D-glucopyranose and D-galactopyranose. The corresponding values of JC1,H1 are ~170-175 
Hz for the α-form and ~160-165 Hz for the β-form obtained from a coupled 13C NMR 






Fig. 5. NMR analysis of the purified the 2-substituted (1,3)-β-D-glucan. 1H-NMR (A) and 
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(δH 3.1-4.4), 2D-NMR techniques are often applied. The proton chemical shifts are linked to 
their respective carbon by a 1H,13C-HSQC NMR analysis or, when the resonances in the 13C 
dimension overlap too much, a 13C,1H-HETCOR NMR analysis is performed. To distinguish 
methylene protons (CH2) from methyl (CH3) and methine (CH), a multiplicity-edited 1H,13C-
HSQC analysis can be used. The protons in each spin system can be assigned using 1H,1H-
TOCSY and/or 1H,1H-DQF-COSY analysis, both techniques allow the magnetization to 
travel over bonds with the help of J-couplings and thereby connecting the protons. EPS 
contain protons and carbons, but sometimes also nitrogen and even phosphorus. Their 
respective chemicals shifts can be assigned and correlated to 1H using e.g. 1H,15N-HSQC and 
1H,31PTOCSY analysis. The exchangeable amide protons, measured in a H2O-D2O mixture, 
have J-couplings to the ring protons and can be assigned correctly in the ring by a 1H,1H-
TOCSY with water suppression. As an example, the uni- and bi-dimensional NMR analysis 
of the 2-substituted (1,3)-β-D-glucan is depicted in Figure 5. The 1D-NMR spectrum (Fig. 
5A) revealed several peaks in the region between 3.2 and 4.1 ppm and 2 peaks in the 
anomeric region characteristics of this type of polysaccharide. 2D-COSY analysis (Fig. 5B) 
showed couplings between anomeric protons and C2 protons (H1C/H2C, H1B/H2B y 
H1A/H2A) characteristic of the 2-substituted (1,3)-β-D-glucan. 
Finally, to determine the supramolecular structure and conformation of an EPS, atomic force 
microscopy (AFM) is currently used. It has been successfully applied to visualize a range of 
polysaccharides including curdlan (Ikeda & Shishido, 2005), and oat β-glucan (Wu et al., 
2006). The (1,3)-β-D-glucan helixes dissociate into random coils when the strength of the 
bonds keeping the helix together are decreased below a critical limit. The helix-coil 
transition is referred to as denaturation (Sletmoen & Stokke, 2008). Denaturation of (1,3)-β-
D-glucan triplexes occurs in alkaline solutions or in dimethyl sulfoxide. In alkaline solutions 
due to the ionization of the hydroxyl groups and the subsequent electrostatic repulsion 
between chains, a previous dissociation of the aggregates takes places and then, as the 
alkalinity increases, the helix structure is believed to denature to yield individual disordered 
single chains (Sletmoen & Stokke, 2008). 
5. Biotechnological applications of EPS from LAB 
5.1 Current applications of the EPS in the food industry 
High molecular weight polysaccharides are used as additives in the manufacture of a wide 
variety of food products, because they act as thickeners, stabilisers, viscosifiers, emulsifiers 
or gelling agents. Most of these polysaccharides are derived from plants (e.g. pectin, 
cellulose) and seaweeds (e.g. alginate, carrageenan) (Kleerebezem et al., 1999). In terms of 
applications in the food industry, microbial extracellular polysaccharides including HePS 
such as xanthan from the phytopathogenic bacterium Xanthomanas campestris and gellan 
from Sphingomonas paucimobilis, are also alternative sources of biothickners approved by the 
FDA for use as foods additives (Laws et al., 2001). Although these are prepared in reliable 
quantities, their physical properties might not suit all applications, given that there is also a 
demand for novel materials that can improve rheological characteristics and health 
promoting properties. On the other hand, the use of bacterial polysaccharides as food 
additives requires their production by non-pathogenic bacteria. In this sense, LAB have QPS 
(qualified presumption of safety) status and EPS produced by these bacteria can be 
considered as food-grade additives (Ruas-Madiedo et al., 2008). 
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LAB are routinely used in food preparations, not only due to their metabolic activities, but 
also due to their preservative effects such as: (i) acidification or production of hydrogen 
peroxide and (ii) the production of bacteriocins (e.g. nisin), which restrict microbial 
contamination (Kuipers et al., 1998; Wood, 1997). In addition, EPS production by LAB has 
received considerable attention, since they provide thickening properties and contribute to 
improve the texture and mouth-feel of the resulting fermented milks or other dairy 
products. Moreover, certain EPS produced by LAB, have beneficial effects on human health 
such as cholesterol-lowering, immunomodulation and prebiotic effect, features that are 
discussed later. It is therefore considered an advantage to use these polymers as food 
additives rather than the gram-negative polymers, for which no health promoting abilities 
have been proposed (Ruas-Madiedo et al., 2008). 
EPS may act both as a texturizer, improving the rheology (viscosity and elasticity) of a final 
product, and as physical stabilizers by binding hydration water and interacting with other 
milk constituents (ions and proteins) thus limiting syneresis. These physical and rheological 
properties depend on features such as chemical composition, molecular size, charge, 
presence of side chains, rigidity of the molecules and 3D-structures of the EPS polymers. In 
addition to physical characteristics, the interactions between EPS and various components in 
food products contribute to the development of the final product. Nevertheless, many 
studies have shown that rheological properties of fermented milk products do not correlated 
well with the amount of EPS content (de Vuyst et al., 2001; Duboc & Mollet, 2001; 
Folkenberg et al., 2006). 
Despite the above, EPS from LAB have not yet been exploited industrially as food additives 
and one of the main drawbacks to use these polymers for such purpose is the low 
production level compared with xanthan (de Vuyst & Degeest, 1999). Furthermore, low cost 
culture media and easy isolation procedures, both rendering high yields are essential for the 
application of EPS as food grade additives. For this reason, production in situ by LAB can be 
an alternative to the use of biopolymers from plants or non-GRAS bacteria. In particular, 
HePS producing LAB are used in the dairy industry, mostly belonging to the genera 
Streptococcus, Lactobacillus and Lactococcus to improve the texture and organoleptic 
properties of the product. Some examples of these are the production of fermented milks 
such as viili and langmjolk in Nordic countries as well as the production of kefir, yogurt and 
low fat cheese type mozzarella and Cheddar cheese (de Vuyst et al., 2001; Ricciardi & 
Clementi, 2000; Ruas-Madiedo et al., 2008). Another application in development for the 
bakery industry is the in situ production of glucans or fructans by the use of Lactobacillus or 
Weissella strains in sour dough manufacture (Tieking et al., 2003). 
The use of cereal-base substrates is considered as a promising alternative to fermented dairy 
products due to their high nutritional value and the presence of both soluble and insoluble 
dietary fiber (Angelov et al., 2005; Martensson et al., 2005). In this sense, regarding the 
development of new functional foods, and their particular ability to produce 2-substituted 
(1,3)- β-glucans, P. parvulus 2.6 and Lb. diolivorans G77 have been studied as starter cultures 
in the preparation of oat-based fermented foods. It has been found that these bacteria can 
grow and produce the EPS in the oat-base substrate, improving the viscosity and texture of 
the fermented product (Martensson et al., 2003). In addition, analysis of the rheological 
properties of the β-glucan synthesized by P. parvulus 2.6 showed that it has potential utility 
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viscosity of two cultures of different strains of Pediococus parvulus were not attributable to 
differences in the primary structure or molecular mass of the β-glucan produced (Garai-
Ibabe et al., 2010). Other factors such as EPS conformation or interactions between EPS and 
growth media microstructure could also affect the rheological features. Thus, presumably in 
the near future, 2-substituted (1,3)- β-glucan-producing LAB will be used for elaboration of 
non-dairy fermented food. Moreover, the β-glucan could be used as a food additive, due to 
its gelling properties. 
5.2 Potential applications of EPS for production of functional food 
5.2.1 Prebiotics 
The concept of prebiotic was originally defined as “non-digestible food ingredient that 
beneficially affects the host by selectively stimulating the growth and/or activity of one or a 
limited number of bacteria in the colon, and thus improves host health” (Gibson & 
Roberfroid, 1995). Nine years later, this definition was revised by Gibson et al. (2004) and 
redefined the concept of prebiotic as “a selectively fermented ingredient that allows specific 
changes, both in the composition and/or activity in the gastrointestinal microbiota that 
confers benefits upon host wellbeing and health”.  
The non-digestible oligosaccharides (NDO) are the prototypes of prebiotic saccharides. The 
oligosaccharides are compounds with lower molecular weight due to a lower degree of 
polymerization (DP). Although the IUB-IUPAC defined oligosaccharides as saccharides 
composed of 3 to 10 monosaccharide units, other sources define them as compounds with 3 
to 20 monosaccharide units. Since, there is not a standard definition, the use of “short-chain 
carbohydrates” as a term to include oligosaccharides and smaller polysaccharides seems to 
be more appropriate. The NDO are oligosaccharides with monosaccharide units, having a 
configuration that makes their osidic bonds non-digestible by the hydrolytic activity of the 
human digestive enzymes (Roberfroid & Slavin, 2000). They have a low calorific value, non-
cariogenicity, are associated with a lower risk of infections and diarrhoea, promote the 
growth of beneficial bacteria in the colon and an improvement of the immune system 
response (Mussatto & Mancilha, 2007). The ability of the gut microbiota to ferment 
oligosaccharides depends on a variety of factors including the degree of polymerization, 
type of sugar, the glycosidic linkage and the degree of branching, as well as the synergy 
between bacteria during fermentation, the relationship between substrate bacteria and 
fermentation products, the nature of the fermentations and the saccharolytic capacity of the 
bacteria (Voragen, 1998).  
The production of oligosaccharides in food started to be investigated in Japan, between 
1970-1975, and since then a number of these biopolymers have been identified (Table 1). The 
USA and Europe have recently become leaders in fructan, fructo-oligosaccharide (FOS) and 
inulin production. The reason is linked to their low cost production as well as the 
reproducibility of prebiotic effects in humans. Galacto-oligosaccharides (GOS) are also 
commercialized in these countries but not yet as widely used as fructans. (Rastall & Maitin, 
2002). 
The oligosaccharides have been widely used in foods, beverages and confectionery due to 
their properties as hygroscopicity, stabilization of active substances (involved in e.g. flavour 
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and colour), water activity, sweetness and bitterness. They can be obtained by three 
different ways: (i) extraction with hot water from roots (e.g. inulin) or seeds (e.g. soybean 
oligosaccharides), (ii) enzymatic synthesis from one or a mixture of disaccharides using 
osyl-transferases (e.g. fructooligosaccharides) or (iii) partial enzymatic hydrolysis of 
oligosaccharides (e.g. oligofructose) or polysaccharides (e.g. xylooligosaccharides) (Roberfroid 
& Slavin, 2000). 
Compound Molecular structure* Raw material Process 
Cyclodextrins (Glu)n Starch transglycosylation 
Fructooligosaccharides (Fru)n-Glu Sucrose transglycosylation 
Galactooligosaccharides (Gal)n-Glu Lactose transglycosylation 
Gentiooligosaccharides (Glu)n Starch 
transglycosylation 
/hydrolysis 
Glycosylsucrose (Glu)n-Fru Sucrose transglycosylation 
Isomaltooligosaccharides (Glu)n Starch 
transglycosylation 
/hydrolysis 
Isomaltulose (palatinose) (Glu-Fru)n Sucrose transglycosylation 
Lactosucrose Gal-Glu-Fru Lactose/Sucrose transglycosylation 
Lactulose Gal-Fru Lactose isomerization 
Maltooligosaccharides (Glu)n Starch hydrolysis 
Raffinose Gal-Glu-Fru Sucrose extraction 
Stachyose Gal-Gal-Glu-Fru Sucrose extraction 
Soybean 
oligosaccharides (Gal)n-Glu-Fru Starch extraction 
Xylooligosaccharides (Xyl)n Xylan hydrolysis 
Table 1. Non-digestible oligosaccharides. * Glu, glucose; Fru, fructose; Gal, galactose; Xyl, 
xylose 
Polysaccharides are often the main source of bioactive oligosaccharides and therefore new 
sources of them are continuously investigated. In this context, LAB have become a 
promising target due to its GRAS/QPS status. Currently, bioactive commercialized 
oligosaccharides are extracted from plants but not yet from LAB. However, the high 
diversity of LAB and their EPS offer new possibilities for detection and production of 
bioactive oligosaccharides. To obtain oligosaccharides, the post-synthetic engineering 
strategies consist in enzymatic or chemical actions involving two types of enzymes, 
glycosyl-hydrolases (EC 3.2.1.y) and polysaccharide lyases (EC 4.2.2.y). A strategy to make 
the action of the enzyme specific is to grow the EPS-producing bacteria on plates with their 
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the action of the enzyme specific is to grow the EPS-producing bacteria on plates with their 





EPS degrading enzymes. After detection and purification, a specific enzyme for catalysis of 
the polysaccharide is obtained (Badel et al., 2011). 
5.2.2 Immunomodulators 
An immunomodulator is a substance which has an effect on the immune system. This 
system can be regulated in different ways by the use of immunosuppressors or 
immunostimulants to inhibit or to induce the immune response. In particular, their use, 
included as additives in food, could be useful to combat infections, to prevent digestive tract 
cancers or to treat sicknesses due to immunodeficiency, such as inflammatory bowel 
diseases (Crohn's disease and ulcerative colitis). One strategy to modulate the immune 
system is the modulation of cytokine expression through the use of herbal medicines. The 
immunomodulators alter the activity of immune function through the dynamic regulation of 
informational molecules such as cytokines (Spelman et al., 2006). 
The mechanism involved in the immunomodulation can be explained by the interaction of 
the immunomodulators to their receptor in the membrane of an immune system cell. This 
interaction activates an internal cascade of phosphotranfer of proteins mediated by kinases 
and related to a specific pathway. As a consequence, a change of binding affinity of 
transcriptional regulators for their operators takes place, which results in activation or 
repression of gene expression (Figure 6). 
Immunomodulators
Agents that alter the immune response,






Fig. 6. Stimulation and/or inhibition mediated by immunomodulators 
Neither HoPS nor HePS produced by LAB have been used to elaborate functional food, nor 
directly tested as immunomodulators. However, most of the LAB used as probiotics 
(according to FAO/WHO, "live microorganisms which when administered in adequate 
amounts confer a health benefit on the host") for elaboration of functional food, have 
immunomodulatory properties (Foligne et al., 2007), and produce EPS. However, their 
ability to immunomodulate is strain specific and can not yet be directly connected to the 
EPS. In addition, current knowledge (see below) indicates that the nature and structure of 
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some of these biopolymers synthesized by LAB have the potential to be used as 
immunomodulating food additives.  
β-glucans are known as “biological response modifiers" (Wasser, 2011), due to their ability 
to activate the immune system. β-glucans are integral cell wall components of a variety of 
fungi, plants and bacteria. In the early 40’s Pillemer and Ecker (1941) described the effect of 
a crude yeast cell wall, called Zymosan, and described that this extract was able to activate 
the non-specific innate immunity. Only in the 80’s Czop and Austen (1985) described the 
action of Zymosan that involved its binding to a β-1-3-glucan specific receptor, latter on 
identified and named Dectin-1 (Brown et al., 2001), found in the cell membrane of 
macrophages, which activates an internal cascade of events. 
The immunomodulating function of the β-glucans is related to their structure; in fact 
different polysaccharides are able to interact with specific receptors, due to their 3D-
structure. It has been recently demonstrated that β-glucans with a linear backbone 
containing 1-3 linkage (e. g. Zymosan) have the ability to activate several receptors: Dectin-
1, complement receptor 3 (CR3), scavenger receptors class A and class B, and Toll-like 
receptors (TLRs) 2 and 6 (Chlubnova et al., 2011). The interaction with these receptors 
triggers a cascade of internal effects, including production of cytokines (TNF-α, IL-6 and IL-
10). 
Also branched 6-substituted (1,3)- β-glucans isolated from mushroom, Candida albicans and 
Pneumocystis carinii, show high affinity for Dectin-1 (Palma et al., 2006) and for TLR-2 and 
TLR-4 receptors in elicitation of immune response (Chlubnova et al., 2011). Mushroom, 
especially Basidiomycetes, are a source of β-glucans with a high biological activity. They 
mostly have a 1-3 linkage in the main chain, and sometimes an additional 1-6 branch point. 
This branching point increase their antitumoral and immunomodulating effects (Barreto-
Bergter & Gorin, 1983). It is well established that the structural composition offers a higher 
capacity for carrying biological information, because they have a greater potential for 
structural variability, specially related to the triple-helical tertiary conformation (Yanaki et 
al., 1983). A good example of a preventive effect is given by a Japanese study on their 
popular edible and medicinal mushroom Hypsizygus marmoreus (Ikekawa, 2001). In this 
study mice were divided into two groups: untreated and treated with a diet containing 5% 
of the dried fruiting body of H. marmoreus. All mice were injected with a strong carcinogen, 
methyl-cholanthrene, and carcinogenesis was investigated. The results obtained allowed to 
the authors to conclude that the mechanism of prevention and inhibition of carcinogenesis 
was due to immunopotentiation (Ikekawa, 2001). Therefore, (1,3) β-glucan produced by LAB 
and their producing strains have potential as immunomodulators. 
In this line, it has been shown that 2-substituted (1,3) β-glucan producer LAB belonging to 
the Lactobacillus and Pediococcus genera are able to immunomodulate macrophages in vitro 
(Fernández de Palencia et al., 2009; Garai-Ibabe et al., 2010). Moreover, treatment of the 
macrophages with the purified biopolymer resulted in an increase of secretion of the anti-
inflammatory IL-10 cytokine (Fernández de Palencia et al., unpublished results). In 
addition, four β-glucan-producing LAB strains have been tested for their survival under 
gastrointestinal stress (Fernández de Palencia et al., 2009; Garai-Ibabe et al., 2010) using an 
in vitro model that simulates the human gut conditions (Fernández de Palencia et al., 
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Fig. 6. Stimulation and/or inhibition mediated by immunomodulators 
Neither HoPS nor HePS produced by LAB have been used to elaborate functional food, nor 
directly tested as immunomodulators. However, most of the LAB used as probiotics 
(according to FAO/WHO, "live microorganisms which when administered in adequate 
amounts confer a health benefit on the host") for elaboration of functional food, have 
immunomodulatory properties (Foligne et al., 2007), and produce EPS. However, their 
ability to immunomodulate is strain specific and can not yet be directly connected to the 
EPS. In addition, current knowledge (see below) indicates that the nature and structure of 
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some of these biopolymers synthesized by LAB have the potential to be used as 
immunomodulating food additives.  
β-glucans are known as “biological response modifiers" (Wasser, 2011), due to their ability 
to activate the immune system. β-glucans are integral cell wall components of a variety of 
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receptors (TLRs) 2 and 6 (Chlubnova et al., 2011). The interaction with these receptors 
triggers a cascade of internal effects, including production of cytokines (TNF-α, IL-6 and IL-
10). 
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Pneumocystis carinii, show high affinity for Dectin-1 (Palma et al., 2006) and for TLR-2 and 
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This branching point increase their antitumoral and immunomodulating effects (Barreto-
Bergter & Gorin, 1983). It is well established that the structural composition offers a higher 
capacity for carrying biological information, because they have a greater potential for 
structural variability, specially related to the triple-helical tertiary conformation (Yanaki et 
al., 1983). A good example of a preventive effect is given by a Japanese study on their 
popular edible and medicinal mushroom Hypsizygus marmoreus (Ikekawa, 2001). In this 
study mice were divided into two groups: untreated and treated with a diet containing 5% 
of the dried fruiting body of H. marmoreus. All mice were injected with a strong carcinogen, 
methyl-cholanthrene, and carcinogenesis was investigated. The results obtained allowed to 
the authors to conclude that the mechanism of prevention and inhibition of carcinogenesis 
was due to immunopotentiation (Ikekawa, 2001). Therefore, (1,3) β-glucan produced by LAB 
and their producing strains have potential as immunomodulators. 
In this line, it has been shown that 2-substituted (1,3) β-glucan producer LAB belonging to 
the Lactobacillus and Pediococcus genera are able to immunomodulate macrophages in vitro 
(Fernández de Palencia et al., 2009; Garai-Ibabe et al., 2010). Moreover, treatment of the 
macrophages with the purified biopolymer resulted in an increase of secretion of the anti-
inflammatory IL-10 cytokine (Fernández de Palencia et al., unpublished results). In 
addition, four β-glucan-producing LAB strains have been tested for their survival under 
gastrointestinal stress (Fernández de Palencia et al., 2009; Garai-Ibabe et al., 2010) using an 
in vitro model that simulates the human gut conditions (Fernández de Palencia et al., 





resistance to digestive tract gut conditions. Furthermore, the presence of the EPS 
conferred to the producing strains increased capability to adhere to Caco-2 human 
epithelial intestinal cells (Garai-Ibabe et al., 2010; Fernández de Palencia et al., 2009). 
Thus, the use of the 2-substituted (1,3) β-glucan as an additive, or produced in situ, in 
fermented food or in the gut has potential as an immunomodulator to alleviate 
inflammatory bowel diseases. In addition, human consumption of oat-based food 
prepared with P. parvulus 2.6 resulted in a decrease of serum cholesterol levels, boosting 
the effect previously demonstrated for (1,3)-β-D-glucans in oat (Martensson et al., 2005). 
Finally, the production of yogurt and various beverages with 2-substituted β-D-glucan-
producer LAB indicate advantageous techno-functional properties of these strains 
(Elizaquível et al., 2011). Therefore, LAB producing this EPS have potential as probiotic 
strains useful for the manufacture of functional foods. 
Dextrans have been also investigated as immunomodulators. Previous studies on dextran-70 
justified its beneficial effect in the prevention of acute respiratory distress syndrome after 
trauma and sepsis as well as pancreatitis (Modig, 1988). Recently, it was reported that 
dextran-70 reduced the leukocyte-endothelium interaction. In a clinical trial forty patients 
who were undergoing coronary bypass surgery were divided into 2 groups of 20. In group 
A a dextran-70 infusion was administrated at a concentration of 7.5 ml kg-1 before the 
surgery, and 12.5 ml kg-1 after the cardiopulmonary bypass. Group B was the control and 
received a gelatin infusion at the same concentration. Several parameters were measured 
including determination of IL 8, IL 10 and troponin-I levels. The conclusion was that this α-
glucan was able to reduce the systemic inflammatory response and the release of the cardiac 
troponin-I after cardiac operation (Gombocz et al., 2007). 
Another α-glucan from the edible mushroom Tricholoma matsutake has been investigated, 
and reported to have excellent biological activities; exerting modulating effects on the 
immune competence of mice and rats. In this study, a sodium hydroxide extract of the 
mushroom was defatted followed by fractionation with a combination of ion exchange 
chromatography and gel filtration to identify the active component. A single-peak fraction 
(MPG-1) was obtained after reverse-phase chromatography. MPG-1 was a glycoprotein with 
molecular mass of 360 kDa, and contained about 90% glucose. NMR and methylation 
analysis revealed that the α-1,4-linkage was the predominant glucan linkage with α-1,6- and 
α-1,2-branching in the minority. It was demonstrated that the mycelium preparation is 
effective in improving immunological functions in stressed individuals. In an in vitro model 
the compound formed a complex with the active form of TGF-β1. These results indicate that 
the mycelium contains a novel α-glucan-protein complex with immunomodulatory effect 
(Hoshi et al., 2005). 
Therefore, the high production of α-glucans by LAB and the immunomodulatory properties 
of these bio-molecules as described above, predict that in the near future studies will be 
performed to evaluate the beneficial properties of these EPS, with the aim to use them as 
food additives. 
Finally, the low yield of HePS produced by LAB and their complex biosynthetic pathway, 
suggests that in the short term they are not very good candidates as food additives, 
although it is expected that the immunomodulatory properties of the producing strains will 
be further investigated. 
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Currently it is clear that diversification of functional foods, which have been scientifically 
validated as having beneficial properties, will increase in the near future, and the EPS 
synthesized by LAB could have a place in the market as an ingredient of this type of food. 
To this end, EPS can be synthesized in situ by their producing strains or can be used in 
isolated form as a food additive. Their chances of reaching the Market place will be 
improved by the discovery and utilization of new EPS-producing strains isolated from 
sources other than dairy products. The discovery and characterization of new EPS-
producers isolated from food (e.g. processed meat products) and beverages (e.g. wine and 
cider) will increase the variety of EPS and the use of their producing strains for the 
elaboration of novel solid and liquid functional food. For example, Lc. mesenteroides Lb. 
plantarum and Lb. sakei strains have been isolated from Spanish sausages. They produce 
highly homogeneous, α-glucan HoPS synthesised by a dextransucrase, and are able to 
immunomodulate macrophages (Nácher-Vázquez et al., unpublished results). Microorganisms 
that are native to the human gut and produce EPS (or could be engineered to produce EPS) 
would also be of great interest as their chances of survival in the gut environment would be 
much higher than other microbes. It has been shown that microorganisms that produce 2-
substituted-(1,3)-β-glucan are able to adhere to human gut epithelial cells. Such organisms 
would presumable be able to colonise the gut and compete effectively with pathogens, at the 
same time as producing a beneficial immunomodulation. 
However, the use of EPS producing LAB strains will require a thorough scientific evaluation 
both in vitro and in vivo. It has to be stated that currently most of the general claims for 
components of functional food (though this does not apply to oat β-glucans and their blood 
LDL-cholesterol lowering properties) have not been approved for use after evaluation by the 
European Food Safety Authority (EFSA, http://www.efsa.europa.eu). The main reason for 
rejection of probiotic bacteria has been the lack of enough characterization of the bacteria 
(determination of the nucleotide sequence of their entire genome is advisable), and/or 
insufficient scientific evidence to correlate the use of the bacteria with health benefits (Lb. 
delbrueckii subsp. bulgaricus AY/CSL and S. thermophilus 9Y/CSL and beneficial modulation 
of the gut microbiota). Therefore, each particular strain has to be subjected to evaluation, 
although its EPS has been already experimentally validated. The evaluation should be 
performed, first in vitro, then in animal models and finally in human trails. In addition, due 
to the rules of the EFSA the use of genetically modified organisms (GMO) is restricted 
(although they are not totally forbidden). Moreover, the opinion of consumers in Europe 
and USA regarding the use of GMO in food is not favourable. Consequently, well-
characterized (preferably GRAS) EPS-producers from natural ecological environments are 
the best candidates for use in functional food. 
However, if the EPS are going to be used as food additives, after purification, then there is 
no restriction concerning the use of a GMO producing strain. The use of GMO able to 
produce high levels of EPS or newly designed biopolymers is still very limited, and the 
production levels of most EPS are not very high. Therefore, provided that enzymes, and 
hence the genes, involved in their biosynthetic pathways are known, the future 
improvement of EPS production, will be by DNA recombinant technology and metabolic 
engineering to generate GMO EPS-producing LAB, that will be used for production of the 
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substrate specificity of the EPS biosynthetic enzymes to generate new polysaccharides and 
oligosaccharides with improved prebiotic properties. In the case of the glycosyltransferases, 
which synthesize HoPS this strategy could result in the synthesis of not only new HoPS, but 
also new HePS. Finally, the requirement of only one protein for the synthesis opens the 
window for production of new biopolymers by immobilized enzymes. 
Overall, there should be a rapid expansion in the development of novel LAB probiotic 
organisms and their prebiotic EPS products. However, their ultimate success in the market 
place will require a rigorous scientific evaluation. 
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1. Introduction 
Various surface active agents are used as food additives in food processing when a decrease 
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agitation (1). 
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determine the mode of adsorption at the interface (3). Flexible disordered proteins like beta-
casein can undergo rapid conformational changes at the interface, being excellent foaming 
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foam products to endure rupture and collapse due to heat expansion of air. Thus the gelling 
properties in addition to foaming properties are also required for this purpose (1). 
Proteins from egg white and milk are widely used for many processed foods and foam-type 
products. Egg white contains various globular proteins with enough flexibility to make 
strong cohesive interactions, being a prime foam stabilizer for a variety of baked foam 
products. In fact, egg white appears to be only protein suited to producing baked foam 
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white has a serious drawback, strong allergenicity. Egg white contains ovomucoid and 
ovalbumin, which make it the major food allergen (4). 
Recently we isolated an albumin fraction with high foaming ability and foam stabilizing 
ability from guar meal, and designated guar foaming albumin (GFA) (5). The foaming 
activity of GFA was 10 times higher than that of egg white at low protein concentrations. 
GFA mainly composed of a simple protein with the molecular mass of 13 kDa. As a plant 
protein, GFA has a rather high nutritional value, and would be best suited to allergic 
patients against animal proteins. These features of GFA make it a promising candidate as a 
foaming agent in lieu of egg white. Guar meal is a byproduct during extraction of a guar 
gum, a galactomannnan gum, widely used as stabilizer in various processed food (6). 
Although proteins isolated from guar meal are characterized in some extent (7-10), GFA was 
first identified as a protein responsible for their foaming property. 
With the particular attention to the high foaming ability and foam stabilizing ability of GFA, 
in this chapter we would like to investigate its foaming functionality, especially from the 
perspective of its application for baked food products. We focused on possible application of 
GFA to substitute egg white, a major food allergen. 
2. Materials and methods 
All chemicals were of analytical grade and were used as supplied. Commercial guar meals 
imported from Pakistan were provided by Taiyokagaku Co. Ltd. (Yokka-ich, Japan) 
Materials. GFA was prepared according the method we reported elsewhere (5). The GFA 
solution was dialyzed against 0.1 M phosphate buffer (pH 6.8) for assessing foaming 
properties. To examine the effect of added sucrose and NaCl, sample is dialyzed against 
5 mM phosphate buffer (pH 6.8), and diluted with using the same buffer if necessary. For a 
control experiment, thin albumen (EW), obtained from fresh egg white strained through fine 
gauze, was diluted with an appropriate buffer. 
Foaming Studies. The sample (8 g each) diluted to 5～70 mg/ml of protein concentration 
was placed in a bowl (14.5 cm in diameter and 9.5 cm in depth), and whipped with a two-
blade hand mixer (model HF-230, Hitachi Appliance, Inc.) for 2 min at the lowest speed 
setting of 1, followed for 2.5 min at speed 5 and finally for 0.5 min at speed 1. To determine 
the effect of sucrose and NaCl, samples were whipped for 2 min at speed 1 followed for 7.5 
min at speed 5 and for 0.5 min at a speed setting of 1. The concentration of sucrose was 
adjusted by adding an appropriate amount of saturated sucrose solution to sample solutions 
in order to achieve a mild and complete mixing. The addition of sucrose and NaCl was 
carried out before whipping. To measure the specific volume, the foam prepared was 
transferred to a glass container (2.7 cm in diameter and 2.0 cm in depth) by using a plastic 
spatula and the overflowed foam was removed by sliding the spatula along the edge of the 
container without pressing foam. The precise volume of the container was previously 
obtained by measuring the weight of the container filled with water. The specific volume of 
foam was obtained by dividing the foam volume by the foam weight.  
For baking, the foam in a bowl were transferred to a plastic tube (2.5 cm in diameter and 2.0 
cm in height) which was placed on cooking paper by using a spatula without squeezing 
foam. After removing the tube off by carefully lifting it up (no foam left attached to the 
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tube), the shaped foam samples were baked in an electric oven (model EMO-VA4, Sanyo 
Appliance, Inc.) for 20 min at 100ºC. To measure the volume of a baked foam sample, a 
plastic tube big enough to cover the whole sample without touching it was placed 
surrounding the sample. Then a clump of rapeseed was carefully introduced into the tube 
without damaging the sample just to fulfill the tube, and the weight of the rapeseed was 
measured. The volume of the baked foam was calculated by subtracting the displaced 
rapeseed volume from the total tube volume. Control experiments were carried out in the 
same manner using EW as samples. All determinations in the foam volumes were 
performed in triplicate samples of at least two independent experiments. 
Bubble size measurement. A portion of the foam sample, usually around 0.5 cm3, was 
carefully placed on a microscope slide and observed through an inverted microscope 
equipped with a digital camera (Olympus, C5060). The protein concentrations of samples 
were 5 and 40 mg/ml in 0.1 M phosphate buffer (pH 6.8). All pictures were taken within 3 
min after the formation of foam. The image analysis to measure the size distribution of foam 
was carried out by using ImageJ (version 1.43b, NIH) program and statistical analysis by 
Excel program (Microsoft). 
Enzyme-linked immunosorbent assay. An enzyme-linked immunosorbent sassy kit to 
determine the peanut protein content was purchased from Morinaga (Tokyo, Japan). The kit 
is manufactured according to the guideline for detecting food allergens, approved by 
Ministry of Health, Labour and Welfare in Japan. The antibody used in the kit was elicited 
by using a mixture of peanut proteins containing Ara h2, which is one of major peanut 
allergenic proteins. 
Other Analytical Procedures. Protein concentrations were determined according to the 
Bradford method (11) with bovine serum albumin as a standard. 
3. Results and discussion 
Protein concentration dependence. When the concentration dependence of the foam 
volumes were examined, the specific foam volumes of GFA increased as the protein 
concentration increased to 20 mg/ml and plateaued thereafter (Figure 1 A). The specific 
volumes of GFA were 1.2-1.9 times higher than those of egg white when compared at the 
same protein concentrations. It should be mentioned that in the previous study (5) we 
showed 10 times higher foaming ability of GFA than that of EW where the foamability was 
assessed at much lower protein concentrations, less than 0.1 mg/ml. In the present study the 
foaming ability as well as stability were assessed at much higher protein concentrations. 
Interestingly, the foam volumes of the 1:1 mixture of GFA:EW were close to those of EW at 
lower than 20 mg/ml, but they became close to those of GFA as the protein concentration 
increased. At high protein concentrations (> 40 mg/ml), the foam volumes of the 1:1 mixture 
much exceeded those of GFA, indicating a synergistic effect of GFA on the foaming activity 
at high protein concentrations. It should be noted that the protein concentration here 
represents that of the total protein, i.e., the protein concentration of GFA and EW is 30 
mg/ml each for the 1:1 mixture sample at 60 mg/ml. 
It is known that basic proteins such as lysozyme and clupeine improve the foaming 
properties of acidic proteins such as bovine serum albumin and β-lactoglobulin due to 





white has a serious drawback, strong allergenicity. Egg white contains ovomucoid and 
ovalbumin, which make it the major food allergen (4). 
Recently we isolated an albumin fraction with high foaming ability and foam stabilizing 
ability from guar meal, and designated guar foaming albumin (GFA) (5). The foaming 
activity of GFA was 10 times higher than that of egg white at low protein concentrations. 
GFA mainly composed of a simple protein with the molecular mass of 13 kDa. As a plant 
protein, GFA has a rather high nutritional value, and would be best suited to allergic 
patients against animal proteins. These features of GFA make it a promising candidate as a 
foaming agent in lieu of egg white. Guar meal is a byproduct during extraction of a guar 
gum, a galactomannnan gum, widely used as stabilizer in various processed food (6). 
Although proteins isolated from guar meal are characterized in some extent (7-10), GFA was 
first identified as a protein responsible for their foaming property. 
With the particular attention to the high foaming ability and foam stabilizing ability of GFA, 
in this chapter we would like to investigate its foaming functionality, especially from the 
perspective of its application for baked food products. We focused on possible application of 
GFA to substitute egg white, a major food allergen. 
2. Materials and methods 
All chemicals were of analytical grade and were used as supplied. Commercial guar meals 
imported from Pakistan were provided by Taiyokagaku Co. Ltd. (Yokka-ich, Japan) 
Materials. GFA was prepared according the method we reported elsewhere (5). The GFA 
solution was dialyzed against 0.1 M phosphate buffer (pH 6.8) for assessing foaming 
properties. To examine the effect of added sucrose and NaCl, sample is dialyzed against 
5 mM phosphate buffer (pH 6.8), and diluted with using the same buffer if necessary. For a 
control experiment, thin albumen (EW), obtained from fresh egg white strained through fine 
gauze, was diluted with an appropriate buffer. 
Foaming Studies. The sample (8 g each) diluted to 5～70 mg/ml of protein concentration 
was placed in a bowl (14.5 cm in diameter and 9.5 cm in depth), and whipped with a two-
blade hand mixer (model HF-230, Hitachi Appliance, Inc.) for 2 min at the lowest speed 
setting of 1, followed for 2.5 min at speed 5 and finally for 0.5 min at speed 1. To determine 
the effect of sucrose and NaCl, samples were whipped for 2 min at speed 1 followed for 7.5 
min at speed 5 and for 0.5 min at a speed setting of 1. The concentration of sucrose was 
adjusted by adding an appropriate amount of saturated sucrose solution to sample solutions 
in order to achieve a mild and complete mixing. The addition of sucrose and NaCl was 
carried out before whipping. To measure the specific volume, the foam prepared was 
transferred to a glass container (2.7 cm in diameter and 2.0 cm in depth) by using a plastic 
spatula and the overflowed foam was removed by sliding the spatula along the edge of the 
container without pressing foam. The precise volume of the container was previously 
obtained by measuring the weight of the container filled with water. The specific volume of 
foam was obtained by dividing the foam volume by the foam weight.  
For baking, the foam in a bowl were transferred to a plastic tube (2.5 cm in diameter and 2.0 
cm in height) which was placed on cooking paper by using a spatula without squeezing 
foam. After removing the tube off by carefully lifting it up (no foam left attached to the 
 
Guar Foaming Albumin – A Foam Stabilizer 
 
117 
tube), the shaped foam samples were baked in an electric oven (model EMO-VA4, Sanyo 
Appliance, Inc.) for 20 min at 100ºC. To measure the volume of a baked foam sample, a 
plastic tube big enough to cover the whole sample without touching it was placed 
surrounding the sample. Then a clump of rapeseed was carefully introduced into the tube 
without damaging the sample just to fulfill the tube, and the weight of the rapeseed was 
measured. The volume of the baked foam was calculated by subtracting the displaced 
rapeseed volume from the total tube volume. Control experiments were carried out in the 
same manner using EW as samples. All determinations in the foam volumes were 
performed in triplicate samples of at least two independent experiments. 
Bubble size measurement. A portion of the foam sample, usually around 0.5 cm3, was 
carefully placed on a microscope slide and observed through an inverted microscope 
equipped with a digital camera (Olympus, C5060). The protein concentrations of samples 
were 5 and 40 mg/ml in 0.1 M phosphate buffer (pH 6.8). All pictures were taken within 3 
min after the formation of foam. The image analysis to measure the size distribution of foam 
was carried out by using ImageJ (version 1.43b, NIH) program and statistical analysis by 
Excel program (Microsoft). 
Enzyme-linked immunosorbent assay. An enzyme-linked immunosorbent sassy kit to 
determine the peanut protein content was purchased from Morinaga (Tokyo, Japan). The kit 
is manufactured according to the guideline for detecting food allergens, approved by 
Ministry of Health, Labour and Welfare in Japan. The antibody used in the kit was elicited 
by using a mixture of peanut proteins containing Ara h2, which is one of major peanut 
allergenic proteins. 
Other Analytical Procedures. Protein concentrations were determined according to the 
Bradford method (11) with bovine serum albumin as a standard. 
3. Results and discussion 
Protein concentration dependence. When the concentration dependence of the foam 
volumes were examined, the specific foam volumes of GFA increased as the protein 
concentration increased to 20 mg/ml and plateaued thereafter (Figure 1 A). The specific 
volumes of GFA were 1.2-1.9 times higher than those of egg white when compared at the 
same protein concentrations. It should be mentioned that in the previous study (5) we 
showed 10 times higher foaming ability of GFA than that of EW where the foamability was 
assessed at much lower protein concentrations, less than 0.1 mg/ml. In the present study the 
foaming ability as well as stability were assessed at much higher protein concentrations. 
Interestingly, the foam volumes of the 1:1 mixture of GFA:EW were close to those of EW at 
lower than 20 mg/ml, but they became close to those of GFA as the protein concentration 
increased. At high protein concentrations (> 40 mg/ml), the foam volumes of the 1:1 mixture 
much exceeded those of GFA, indicating a synergistic effect of GFA on the foaming activity 
at high protein concentrations. It should be noted that the protein concentration here 
represents that of the total protein, i.e., the protein concentration of GFA and EW is 30 
mg/ml each for the 1:1 mixture sample at 60 mg/ml. 
It is known that basic proteins such as lysozyme and clupeine improve the foaming 
properties of acidic proteins such as bovine serum albumin and β-lactoglobulin due to 
















































Protein concentration   (mg/mL)  
                                              (A)                                                                                        (B) 
                                  GFA                                                     EW                                                     1:1 mixture 
     
(C) 
Fig. 1. (A) Changes in the specific volume at various protein concentrations of GFA, EW and 
the 1:1 mixed sample. Samples were dialyzed against 0.1 M phosphate buffer (pH 6.8), and 
GFA, EW and the 1:1 mixed sample were whipped by a hand mixer for 5 min. The specific 
foam volumes calculated were plotted against protein concentrations. GFA (• ), EW (○) and 
the 1:1 mixed sample (▲). Bars indicate the standard deviation. (B) Change in the foam 
volumes before and after baking of GFA, EW and the 1:1 mixed sample. The samples 
prepared in Figure 1A were baked for 20 min at 100 ºC using an electric oven. The volumes 
of baked foams were always smaller than the foams before baking. GFA (• ), EW (○) and the 
1:1 mixed sample (▲). Bars indicate the standard deviation. (C) Appearance of the baked 
foam produced by GFA, EW and the 1:1 mixture. The protein concentration used was 50 
mg/ml each 
isoelectric points (pI) between the acidic and basic proteins must be sufficiently large so that 
at intermediate pHs, interactions are strong enough to yield good foaming properties. GFA 
is prepared by the acid precipitation at its pI of 4 and most proteins of egg white have their 
pIs at the acidic region. Therefore, the synergistic effect observed here may not be explained 
merely by a simple electrostatic interaction between oppositely charged proteins. It is also 
interesting to mention that mixtures of two dissimilar proteins exhibit thermodynamic 
incompatibility upon mixing resulting in phase separation at the air-water interface (13). 
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The phase separation occurred at high protein concentrations (10-20% w/v) then brings 
about the instability of the film since the high interfacial energy between the phase-
separated regions may act as zones of instability. Considering the increased foaming ability 
observed in the 1:1 mixtures at high protein concentrations, GFA must be a protein that is 
compatible to most of proteins present in EW. Any intermolecular disulfide interactions 
between proteins, if any, existed in the 1:1 mixture appears not to be involved in the 
synergistic effect observed here since a similar augmented foam formation was also 
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(C) 
Fig. 2. (A) The effect of sucrose on the specific  volumes of GFA, EW and the 1:1 mixed 
sample. The protein concentration used was 32 mg/ml each. Samples were prepared as 
described in Figure 1 A, except sucrose was added to each solution before foaming by a 
hand mixer for 10 min. GFA (• ), EW (○) and the 1:1 mixed sample (▲). Bars indicate the 
standard deviation. (B) The effect of sucrose on the volume changes before and after baking. 
The protein concentration used was 32 mg/ml each. Samples were baked as described in 
Figure 1 B. GFA (• ), EW (○) and the 1:1 mixed sample (▲). Bars indicate the standard 
deviation. (C) Appearance of the baked foam produced in the presence of 5% sugar by GFA, 
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of the synergistic effect remains to be investigated, some specific, weak interaction operative 
only at high protein concentrations might be involved. 
The ability of proteins to stabilize foams is mainly determined by the rheological properties 
of protein adsorption layers: viscoelastic behaviour, irreversible structures and rheological 
changes under compression and expansion (14). An extreme expansion of foams may occur 
upon heating, for example, during baking meringue. Since GFA was shown to possess better 
foam stability than EW (5), changes in foam volume upon baking were examined. In all 
samples of GFA, EW and the 1:1 mixture, the foam volumes after baking reduced to 15% to 
65% of the original volumes depending on the protein concentrations and the protein 
concentration dependence of the volume reduction were similar among the samples (Figure 
1 B). Therefore, the stability of the GFA adsorbed film upon baking is comparable to that of 
the EW film. It should be noted, however, that the actual foam volume after baking in the 
present experiment was maximum in the 1:1 mixture at 60 mg/ml (Figure 1 C). The fact that 
the strength of the GFA adsorbed film remained even after baking is in contrast to that of β-
casein, for example, whose foams are easily ruptured upon baking. 
Effect of sucrose addition.  The addition of sucrose up to 13% to EW did not significantly 
affect its foaming ability (Figure 2 A). The addition of 2-3% sucrose to GFA slightly 
enhanced the foam specific volume but decreased at higher sucrose concentrations. In the 
1:1 mixture, the positive effect of sucrose was observed between 2-6%, but at higher 
concentrations sucrose affected adversely. In fact sucrose appears to damage the foaming 
ability of GFA more severely than that of EW as the foam volume of GFA reduced 
considerably in the presence of 45% sucrose in contrast to EW, which did not show an 
appreciable reduction (data not shown). 
In general, addition of sugars to protein solutions often impairs foamability due to enhanced 
stability of protein structure, but improves foam stability due to increased viscosity (2). 
When the foams prepared with various sucrose concentrations were baked, stabilizing effect 
of sucrose is pronounced (Figure 2 B, C). Both GFA and EW foams were similarly stabilized 
and the maximum stability was observed at around 5% sucrose. The stabilizing effect of 
sucrose in the 1:1 mixture was similar but more conspicuous, suggesting that the synergistic 
interaction between GFA and EW was effectively augmented by the presence of small 
amount of sucrose. The increase in viscosity by the addition of sucrose may not contribute 
significantly to the observed stability. 
Effect of NaCl addition. The addition of NaCl to EW decreased the foam specific volume 
only slightly (Figure 3 A). In contrast, the foaming ability of GFA as well as the 1:1 mixture 
were slightly enhanced by the NaCl addition. The synergistic interaction between GFA and 
EW appears not to be influenced by charge neutralization upon addition of salt ions. Upon 
baking, however, the addition of NaCl notably influenced the foam stability (Figure 3 B, C). 
EW reduced its foam volume upon heating as increased the NaCl concentration. On the 
contrary, in both GFA and the 1:1 mixture, the foam volume reduction upon heating was 
restrained by the addition of NaCl. Especially, the foams produced by the 1:1 mixture were 
greatly stabilized by NaCl, as was the case by sucrose, implying that both electrostatic 
interactions and hydrogen bondings between proteins in the film may contribute to 
exhibiting the synergistic effect.  
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Fig. 3. (A) The effect of NaCl on the specific volumes of GFA, EW and the 1:1 mixed sample. 
The protein concentration used was 25 mg/ml each. Samples were prepared as described in 
Figure 1 A, except NaCl was added to each solution before foaming and samples were 
dialyzed against 5 mM phosphate buffer (pH 6.8).  GFA (• ), EW (○) and the 1:1 mixed 
sample (▲). Bars indicate the standard deviation. (B) The effect of NaCl on volume changes 
before and after baking. The protein concentration used was 25 mg/ml each. Samples were 
baked as described in Figure 1 B. GFA (• ), EW (○) and the 1:1 mixed sample (▲). Bars 
indicate the standard deviation. (C) Appearance of the baked foam produced in the presence 
of 0.3 M NaCl by GFA, EW and the 1:1 mixture. The protein concentration used was 50 
mg/ml each 
Bubble size distribution. Since the foam produced by GFA seemed much smoother in 
appearance than that by EW (5), the size distribution of the GFA bubbles was examined 
through microscopic observation (Figure 4). GFA can produce smaller and more uniform 
bubbles than EW; the average bubble size of GFA is half of that of EW with a much 
narrower size distribution (Table 1). The average bubble size obtained with the 1:1 mixture 
was between those with GFA and EW. A similar difference in size distribution was also 
observed at lower protein concentration (5 mg/ml); the average bubble areas with GFA and 





of the synergistic effect remains to be investigated, some specific, weak interaction operative 
only at high protein concentrations might be involved. 
The ability of proteins to stabilize foams is mainly determined by the rheological properties 
of protein adsorption layers: viscoelastic behaviour, irreversible structures and rheological 
changes under compression and expansion (14). An extreme expansion of foams may occur 
upon heating, for example, during baking meringue. Since GFA was shown to possess better 
foam stability than EW (5), changes in foam volume upon baking were examined. In all 
samples of GFA, EW and the 1:1 mixture, the foam volumes after baking reduced to 15% to 
65% of the original volumes depending on the protein concentrations and the protein 
concentration dependence of the volume reduction were similar among the samples (Figure 
1 B). Therefore, the stability of the GFA adsorbed film upon baking is comparable to that of 
the EW film. It should be noted, however, that the actual foam volume after baking in the 
present experiment was maximum in the 1:1 mixture at 60 mg/ml (Figure 1 C). The fact that 
the strength of the GFA adsorbed film remained even after baking is in contrast to that of β-
casein, for example, whose foams are easily ruptured upon baking. 
Effect of sucrose addition.  The addition of sucrose up to 13% to EW did not significantly 
affect its foaming ability (Figure 2 A). The addition of 2-3% sucrose to GFA slightly 
enhanced the foam specific volume but decreased at higher sucrose concentrations. In the 
1:1 mixture, the positive effect of sucrose was observed between 2-6%, but at higher 
concentrations sucrose affected adversely. In fact sucrose appears to damage the foaming 
ability of GFA more severely than that of EW as the foam volume of GFA reduced 
considerably in the presence of 45% sucrose in contrast to EW, which did not show an 
appreciable reduction (data not shown). 
In general, addition of sugars to protein solutions often impairs foamability due to enhanced 
stability of protein structure, but improves foam stability due to increased viscosity (2). 
When the foams prepared with various sucrose concentrations were baked, stabilizing effect 
of sucrose is pronounced (Figure 2 B, C). Both GFA and EW foams were similarly stabilized 
and the maximum stability was observed at around 5% sucrose. The stabilizing effect of 
sucrose in the 1:1 mixture was similar but more conspicuous, suggesting that the synergistic 
interaction between GFA and EW was effectively augmented by the presence of small 
amount of sucrose. The increase in viscosity by the addition of sucrose may not contribute 
significantly to the observed stability. 
Effect of NaCl addition. The addition of NaCl to EW decreased the foam specific volume 
only slightly (Figure 3 A). In contrast, the foaming ability of GFA as well as the 1:1 mixture 
were slightly enhanced by the NaCl addition. The synergistic interaction between GFA and 
EW appears not to be influenced by charge neutralization upon addition of salt ions. Upon 
baking, however, the addition of NaCl notably influenced the foam stability (Figure 3 B, C). 
EW reduced its foam volume upon heating as increased the NaCl concentration. On the 
contrary, in both GFA and the 1:1 mixture, the foam volume reduction upon heating was 
restrained by the addition of NaCl. Especially, the foams produced by the 1:1 mixture were 
greatly stabilized by NaCl, as was the case by sucrose, implying that both electrostatic 
interactions and hydrogen bondings between proteins in the film may contribute to 
exhibiting the synergistic effect.  
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Fig. 4. Bubble size distribution of foams made by GFA (solid), EW (oblique) and the 1:1 
mixture (shaded). The protein concentration in all samples was 40 mg/ml 
 GFA EW 1:1 mixture 
Bubble area, 
Mean x 10-3 (mm2) ± SD 
12.5 ± 9.31 23.3 ± 26.4 19.4 ± 16.2 
Bubble area,  
Median x 10-3 (mm2) 
10.3 13.1 14.2 
Number of Bubbles (mm-2) 
 
43.4 23.7 32.3 
Table 1. Summary of the bubble size distribution in foams obtained with GFA, EW and the 
1:1 mixture 
According to the Laplace principle, the internal pressure of a bubble is greater than the 
external pressure, and the pressure difference is inversely proportional to radius of the foam 
bubble (1). Therefore, smaller foam bubbles can withstand heavier load than larger bubbles; 
the smaller the bubble sizes, the stiffer and stronger the foams become. The observed small 
bubble sizes of GFA substantiate the stability of GFA foams. However, the fact that the 
average foam size of the 1:1 mixture is larger than that of GFA did not appear to be in line 
with the synergistic effect observed in the mixture (Figure 1 A). The mechanism for the 
synergistic effect should be further investigated in many respects.  
Immunological analysis. Previously no apparent immunoreactivity of GFA was observed 
against the antisera obtained from the allergic patients to egg, wheat and soybean (5). 
Since GFA was obtained from guar (Cyamopsis tetragonolobus) which belongs to the pea 
family (Fabaceae), the possible immunological relation to peanut proteins (Arachis 
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hypogaea) was investigated by using an enzyme-linked immunosorbent assay kit, which is 
manufactured according to the guideline for detecting food allergens approved by 
Ministry of Health, Labour and Welfare in Japan. In Table 2 were listed the amount of 
protein in various nuts detected by the antibody against peanut proteins. The content of 
the protein in guar beans reactive to the anti-peanut antibody were less than 10-5 fold 
compared with that found in peanut. In the protein isolate of GFA, the amount of protein 
detected by the present method was 10-5 μg/g, which could be negligible when GFA was 
used in processed food as foam enhancer. It should be pointed out that an allergic 
warning against peanuts such as “contains peanuts” should be labelled properly on the 
surface of processed food products according to Japanese Food Sanitation Act if food 
contains the peanut protein more than 10 ppm. 
Sources Reactive Protein (μg/g)* 
Peanut (Arachis hypogaea)  62880 
Guar (Cyamopsis tetragonolobus)  5.9 
Makadamia nut (Macadamia integrifolia) 0.9 
Soybean (Glycine max) 0.5 
Common bean (Phaseolus vulgaris) 0.5 
Azuki bean (Vigna angularis) 0.3 
Pistachio (Pistacia vera) 0.2 
GFA 10.0 
*The amount of the protein reactive to the anti-peanut antibody is calculated on the basis of mass of nut 
(bean), except for GFA which is based on the total protein content measured by the Bradford method 
(11). 
Table 2. The amount of protein detected by ELISA using the antibody against peanut 
proteins 
Abbreviations Used: EW, egg white (thin albumen); GFA, guar forming albumin; pI, 
isoelectric point  
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1. Introduction 
The majority of phosphorous in plant seed, especially cereal grains and legumes, is myo-
inositol hexaphosphate (phytate or IP6) (Rosa et al., 1999). Structure of IP6 is shown in Figure 
1. Figure 2 shows distribution of IP6 in some plant foods. Unrefined cereals and soybean 
products contain high levels of IP6. Rice bran contains IP6 more than 6,000 mg/100 g of dry 
matter. IP6 has a strong capability to chelate multivalent metal ions, particularly zinc, 
calcium, and iron ions, which results in the formation of highly insoluble salts (Nolan et al., 
1987; Hotz et al., 2001). The IP6 can be hydrolyzed by enzyme (phytase) and converted to 
lower myo-inositol phosphates; from inositol pentaphosphate (IP5) to inositol 
monophosphate (IP1) and myo-inositol. It has been demonstrated that the metal complexes 
with IP1−IP4 are more soluble than those with IP5 and IP6 (Sandberg et al., 1989). Animal 
experiments have demonstrated that the ingestion of the meal that contains more than 1% 
IP6 decreases intestinal absorption of metal ions and induces the metal ion deficiency 
(Hirabayashi et al., 1998; Grases et al., 2001). In some communities, unrefined cereals are still 
main ingredients for the diet. In addition, the unrefined grains of rice, wheat, rye, etc., are 
richer in various minerals, dietary fiber, vitamins, and other bioactive components than 
refined ones. Therefore, these unrefined cereals are used as food ingredients for bread,   
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with IP1−IP4 are more soluble than those with IP5 and IP6 (Sandberg et al., 1989). Animal 
experiments have demonstrated that the ingestion of the meal that contains more than 1% 
IP6 decreases intestinal absorption of metal ions and induces the metal ion deficiency 
(Hirabayashi et al., 1998; Grases et al., 2001). In some communities, unrefined cereals are still 
main ingredients for the diet. In addition, the unrefined grains of rice, wheat, rye, etc., are 
richer in various minerals, dietary fiber, vitamins, and other bioactive components than 
refined ones. Therefore, these unrefined cereals are used as food ingredients for bread,   
 





breakfast cereals and so on due to their high health-promoting activities (Fukui et al., 1997; 
Haros et al., 2001; Lopez et al., 2001; Porres et al., 2001). In addition to the unrefined cereals, 
legumes, especially soybean have long history as food ingredient. Recently, soy flour, soy 
protein isolate, its protease digest, etc. have been formulated and used as protein source for 
infant formulae, sports drinks, enteral nutrients and also diets for animal, poultry, and fish. 
However, as mentioned above, these products are also rich in IP6. Then, nutritional 
disturbances in the absorption of iron and zinc may occur by ingestion of IP6–rich foods 
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refined    oats bread*  raw brown     30%          soybean          SPI          soybean        natto      salted natto
wheat flour                       rice flour  brown-rice     flour*                                curd
bread
 
* Data from Rosa et al. 1999. Natto; steamed soybean fermented with Baccillus subtillis. Salted natto; 
steamed soybean fermented with Aspergillus oryzae and further fermented with wild yeast and lactic 
acid bacteria in the presence of salt (more than 5%). 
Fig. 2. Phytate contents of some cereals and soybean products 
It has been demonstrated that the IP6 in foods can be degraded by phytase, which would 
improve mineral absorption in humans (Sandberg et al., 1996; 2002). On the basis of these 
facts, some phytase preparations have been formulated and used to reduce IP6 and IP5 levels 
of some plant-based foods (Haros et al., 2001; Saito et al., 2001; Porres et al., 2001: Matsuo et 
al., 2005; 2010) and also animal and fish diets (Pallauf & Rimbach, 1997; Sajjadi & Carter, 
2003).  
In this chapter, the recent application of fungal phytase preparation as food additive and its 
problem are reviewed. In addition, recent studies for control of the contamination of other 
enzymes in the phytase preparation are focused. 
2. Source of phytase 
It has been demonstrated that fermentation using lactic acid bacteria and fungus can reduce 
IP6 levels in soybean flour and bran-enriched bread (Hirabayashi et al., 1995; Harose et al., 
2001; Andlid et al., 2004; Leenhardt et al., 2005; Matsuo et al., 2005; Reale et al., 2004; 2007; 
Palacious et al., 2007; Li et al., 2008; Jorquera et al., 2008; Sanz-Penella et al., 2009). These 
facts indicate microorganisms involved in the fermentation process can produce phytase. 
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Indeed, some bacteria, yeasts, and fungi have been demonstrated to produce phytases. As 
mentioned above, the enzymatic hydrolysis of the IP6 in unrefined cereals and legumes 
improves mineral absorption in humans (Sandberg et al., 1996; 2002). These facts can lead an 
idea that microbial phytase can be used as food additive to reduce IP6 level in the plant-
based foods. So far to now, phytase preparations have been prepared from Asperigillus niger,  
recombinant Aspergillus oryzae, Pichia pastoris etc. in an industrial scale and used as food 
additive (Greiner & Konietzny, 2006). However, these microbial also produce protease, 
amylase and etc. As demonstrated in the following sections, a food additive-grade 
Asperigillus niger phytase preparation has significant protease and amylase activities 
(Matsuo et al., 2010). In some cases, occurrences of protease and amylase in the food 
additive-grade phytase preparation exerts adverse effects on texture and appearance of the 
final products.  
In the following sections, application of a food additive-grade Aspergillus niger phytase 
preparation on some plant-based foods are introduced. Effect of the phytase treatment not 
only on IP6 content but also on the other properties will be discussed. 
3. Application for improvement of nutritional value of animal, poultry, and 
fish diets 
Plant seeds and grains have been used for animal, poultry, and fish diets. As shown in 
Figure 2, the unfermented soy and cereal products contain high levels of IP6. The occurrence 
of IP6 in diet may interfere mineral absorption (Sandberg, 2002). In some cases, it may 
induce serious nutritional problem. Indeed, feeding IP6-containing soy protein isolate 
retarded growth of fish larvae. To solve these problems, Aspergillus niger and Pichia pastoris 
phytase preparation was used to decrease IP6 in the plant-based diet. This treatment 
significantly improve feeding efficacy. Now, formulated Aspergillus niger and Pichia pastoris 
phytases for improvement of feeding efficacy for fish, chicken, animals are commercially 
available (Pallauf & Rimbach, 1997; Sajjadi & Carter, 2003).  
4. Application of phytase to isolate conglycinin and glycinin from soy protein 
isolate 
Phytase treatment of soy protein isolate can be carried out in aqueous solution. During the 
Asperigillus niger phytase treatment, protein precipitation occurred (Saito et al., 2001). As 
well known, major soluble proteins in soybean are glycinin and β-conglycinin, which are 
classified as globulin. Both proteins are precipitated in acidic condition at approximately pH 
4.5. However, predicted isoelectric point of glycinin based on the protein sequence is neutral 
pH. The glycinin forms complex with IP6 and then it has apparent acidic isoelectric point, 
which makes glycinin precipitate in acidic condition. The phytase treatment degrades the 
glycinin-bound IP6 and shifts isoelectric point to neutral pH. Then selective precipitation of 
glycinin occurs at neutral pH after the phytase treatment of soy protein isolate. This 
technique is successfully applied to sepration of glycinin and β-conglycinin for food 
ingredient. It has been demonstrated that β-conglycinin can reduce blood neutral lipid level 
of animal and human by ingestion (Fukui et al., 2004; Moriyama et al., 2004; Kohno et al., 
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facts indicate microorganisms involved in the fermentation process can produce phytase. 
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Indeed, some bacteria, yeasts, and fungi have been demonstrated to produce phytases. As 
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final products.  
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significantly improve feeding efficacy. Now, formulated Aspergillus niger and Pichia pastoris 
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technique is successfully applied to sepration of glycinin and β-conglycinin for food 
ingredient. It has been demonstrated that β-conglycinin can reduce blood neutral lipid level 
of animal and human by ingestion (Fukui et al., 2004; Moriyama et al., 2004; Kohno et al., 





and following selective precipitation technique. The β-conglycinin fraction is approved to 
present health claim on lipid metabolism in “Food for the Specific Health Use” in Japan. 
5. Application for unrefined cereal flour-containing bread making.  
Whole grains of wheat, rice, rye, etc., are richer than refined grains in various minerals, 
dietary fiber, and vitamins. Besides minerals, vitamins, and dietary fiber, the unrefined 
grains are rich in bioactive components that have health-promoting activities; for example, 
γ-aminobutyric acid (GABA), γ-oryzanol, polyphenols, and feruric acid. These components 
show antihypertensive (GABA), antioxidant, and anti-hypercholesterolemic (γ-oryzanol and 
feruric acid) activities (Sugano et al., 1997; Xu et al., 2001; Hayakawa et al., 2002). However, 
the consumption of the unrefined whole grains as the steamed and fried forms, are not very 
prevalent due to the poor swelling and textural properties of the unrefined whole grains. 
Then, the unrefined whole grains are usually processed to flour and used as bread 
ingredient, which has been gaining popularity worldwide (Fukui et al., 1997; Haros et al., 
2001; Lopez et al., 2001; Porres et al., 2001). As shown in Figure 3, IP6 in the dough mix 
containing 30% brown rice flour decreases during processing by the action of yeast phytase. 
However, the relatively higher levels of IP6 remains in the bread containing brown rice flour. 
As shown in Figure 3, addition of food additive-grade Aspergillus niger phytase preparation 

































0                50              100             150             200             250
                                          time (min)
 
Fig. 3. Changes in phytate contents during bread making process. 0-195 min; mixing and 
fermentation, 240-min; baking. (□); 30% brown rice flour-containing dough without addition 
of yeast and phytase, (◊); added with yeast only, (○); added with yeast and 600 U of the 
Asparagillus niger phytase preparation, ( ); added with yeast and 3000 U of the phytase 
preparation. Values are means ±SD, n=3. From Matsuo et al., 2005 
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been also used to decrease IP6 level in the whole wheat fours (Haros et al., 2001). At early 
attempt, the flour was pretreated with phytase in water suspension system. It has been, 
however, demonstrated that direct addition of the phytase preparation into dough mix can 
reduce IP6 content, which is the easier approach to decrease IP6 level in the unrefined grain 
flour-containing bread (Haros et al., 2001; Matsuo et al., 2005; 2010). However, addition of 
high dose of the phytase preparation (3000 U) induced collapse of whole bread crust and 
deteriorates texture and taste of the final product as shown in Figure 4 E (Matsuo et al., 
2005). 
 
Fig. 4. Effect of addition of brown rice flour and phytase on the loaf volume. (A); wheat 
bread, (B); 30% brown rice flour bread, (C); 50% brown rice flour bread, (D); 30% brown rice 
bread flour bread added with 600 U of the phytase preparation; (E) 30% brown rice flour 
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Fig. 5. Separation of phytase from amylase and protease in the crude phytase preparation by 
anion-exchange chromatography. Fraction indicated by the bar was collected and used as 
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Fig. 5. Separation of phytase from amylase and protease in the crude phytase preparation by 
anion-exchange chromatography. Fraction indicated by the bar was collected and used as 





Two grams of the crude phytase preparation was dissolved in 50 mL of 0.02 M sodium 
acetate buffer, pH 6.0 and loaded on a column (15 cm × 10 mm i.d.) packed with TSK gel 
Super Q-Toyopearl 650S (Tosoh Co., Tokyo, Japan) that had been pre-equilibrated with the 
same buffer. The absorbed proteins were eluted using 200 mL of a linear gradient of 0-0.5 M 
NaCl in the same buffer at 1.5 mL/min. Fractions were collected every 1 min. From Matsuo 
et al., 2010. 
Figure 5 shows that the food additive-grade phytase preparation contains significant 
activities of protease and amylase, which can be separated from the phytase activity by 
anion-exchange column chromatography (Matsuo et al., 2010). Addition of the purified 
phytase fraction free from protease and amylase activities into the dough mix decreased IP6 
level without affecting bread volume (Figure 6). These facts imply that amylase and/or 
protease are responsible for the collapse of the bread crust by addition of high dose of the 
commercial phytase preparation. However, it has been difficult to isolate phytase, protease, 
and amylase activities in enough amounts for the additive purpose by conventional 
chromatography technique due to high cost of preparative LC system. Then it is difficult to 
control protease and amylase activities in the phytase preparation, which has limited the use 
of the fungal phytase preparation as food additive. To solve this problem, a large-scale 
isolation method for food additive-grade enzyme is necessary. This method should be 
inexpensive, biocompatible, easy to scale-up. The following section introduces recent 
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Fig. 6. Effect of crude and purified phytase (3,000 U) on phytate contents and swelling 
property of 30% brown rice bread. A; 30% brown rice bread, B; added with the crude 
phytase, C; added with the purified phytase. From Matsuo et al., 2010 
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6. Control of protease and amylase activities in phytase preparation by 
autofocusing 
As mentioned in the previous section, it has been demanded to develop a method for large-
scale fractionation of enzymes in crude extract and fermentation broth in order to control 
contamination of other enzymes in phytase preparation. For fractionation of peptides in the 
crude digests of food proteins, a preparative ampholyte-free isoelectric focusing has been 
developed (Hashimoto et al., 2005), which has a potential for purification of enzymes. This 
technique depends on amphoteric nature of the sample compounds. The crude enzymatic 
digest of food protein, crude extract, fermentation broth, etc. contain numerous compounds 
with different isoelectric points. Then these compounds can act as ampholine for isoelectric 
focusing. This phenomenon is referred to autofocusing (Yata et al., 1996; Akahosi et al., 2000; 
Hashimoto et al., 2005). This technique does not require harmful reagents and solvents just 
requires water and agarose gel in sample compartments and diluted phosphoric acid and 
sodium hydroxide in the electrode compartments. All of them can be used for food 
processing. Assembly of the apparatus is illustrated in Figure 7. A plastic plate with window 
is covered with nylon screen and the screen is wetted with hot agarose solution. After 
standing for few minutes, thin agarose gel layer is formed on the screen. The plates with 
agarose gel layer are inserted into the slots of the tank as shown in Figure 7. Then the tank 
can be separated into 12 compartments. Both ends of the compartments are used as 
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Fig. 7. Schematic drawing for assembly of Autofocusing apparatus. The tank is divided into 
12 compartments separated with thin agarose gel layer. Volume of compartment can be 
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Fig. 7. Schematic drawing for assembly of Autofocusing apparatus. The tank is divided into 
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Water-solution of sample is applied into the sample compartments. 0.1 N phosphoric acid 
and sodium hydroxide are loaded into cathode and anode, respectively. By loading direct 
electric current into the electrode compartments at constant voltage mode at 500 – 1000 V, 
the compounds in sample start to migrate to their own isoelectric points. This technique has 
been successfully used for peptide fractionation (Hashimoto et al., 2005; Higaki-Sato et al., 
2006; Park et al., 2008; Murota et al., 2010; Elbarbary et al., 2010).  
The food additive-grade phtase preparation also contain many compounds. Then 
autofocusing was used to purify phytase in the commercial preparation. As shown in Figure 
8, pH gradient approximately from 2 to 11 was formed by autofocusing of food additive-
grade Aspergillus niger phytase preparation. The protease activity was migrated to acidic 
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Fig. 8. Fractionation of phytase, amylase, and protease in a food additive-grade Aspergillus 
niger phytase preparation. pH gradient (upper) was formed by autofocusing for 24 hours. 
Fraction No. 7 and 9 were free from protease activity and used as high amylase and low 
amylase fractions, respectively 
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highest phytase and amylase activities. In the Fr. 9, the amylase activity dropped to 15% of 
the maximum activity, whereas relatively high level of the phytase activity (more than half 
of the activity in Fr. 7) was recovered in the Fr. 9. Then, Fr. 7 and 9 were collected and used 
as high amylase and low amylase fractions, respectively. These fractions were free from 
protease activity. The crude phyase preparation, which contains significant protease activity 
and two protease free autofocusing fractions were added to the 30% brown rice flour-added 
bread dough mix. Phytate content decreased by addition of all fractions. As shown in Figure 9, 
addition of the low amylase fraction did not significantly affect the loaf volume and did not 
induce collapse of crust up to 3000 U of phytase activity. Addition of the high amylase fraction 
showed positive effect on loaf volume up to 514 U of amylase activity. However, addition of 
amylase, more than 1029 U, decrease of loaf volume and partial collapse of crust (arrow) 
were observed. Addition of the crude preparation at 791 U of protease activity induced 
partial collapse of crust even amylase activity was less than 500 U. Addition of protease 
more than 1582 U resulted in extensive collapse of whole crust and deteriorated texture 
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Fig. 9. Effects of addition of crude phytase preparation and high amylase (Fr. No. 7) and low 
amylase (Fr. No. 9) fractions on appearance and swelling properties of the 30% brown rice 
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On the basis of these results, it can be concluded that IP6 content in the unrefined grain 
flour-containing bread can be reduced by direct addition of the fungal phytase. However, 
presence of high protease activity in the phytase preparation can deteriorate swelling and 
textural properties and collapse the crust. On the other hand, amylase can improve the 
swelling property at relatively low activity (<500 U), while it deteriorates the swelling 
property at high activity (> 1000 U). These phenomena can be explained as follows. 
Protease in the preparation degrades gluten and deteriorates gluten network. 
Consequently, the dough can not retain the CO2 gas generated by fermentation, which 
decreases loaf volume and finally collapses whole crust. The amylase in the preparation 
may induce oligosaccharides from starch and consequently enhance fermentation by yeast 
at the low amylase activity. On the other hand, the high amylase activity can deteriorate 
starch gel network after cooking process. Indeed, fungal amylase has been used in the 
baking industry to accelerate fermentation. However, addition of excessive amylase and 
protease has been demonstrated to make the dough slack (Fred et al., 1975). These facts 
clearly indicate that the control of protease and amylase activities is crucial for the 
application of the fungal phytase preparation to bread making to reduce IP6 and obtain 
good quality of the product.  
7. Conclusion and future prospects 
It has been demonstrated that fungal phytase can be used to reduce IP6 level of the soybean 
based products and also unrefined grain flour-containing products, especially bread. 
However, fungal phytase may contain protease and amylase, which may affect quality of 
the final products. In some cases, the product may be unacceptable due to excessive 
degradation of protein, which induces unfavorable effects on texture and appearance. Then 
it is crucial to control the contaminated enzyme activity in the phytase preparation. In the 
present chapter, ion exchange column chromatography and autofocusing can at least 
partially control contamination of protease and amylase activities. In regardless of the high 
resolution, column chromatography requires relatively expensive apparatus and high 
running cost. In addition, it may require salts, buffer, solvents etc, which should be removed 
from the final product. It also increases preparation cost. On the other hand, autofocusing 
does not require organic solvents and salts for fractionation and has inherited potential for 
scale-up. Recently, continuous type autofocusing apparatus has been developed (Hashimoto 
et al., 2006). Then this technique would be useful to control protease and amylase activities 
in the phytase preparation. By using this technique, a food additive phytase optimized for 
bread making and other applications could be produced.  
IP6 also suppresses divalent ions-induced Fenton’s reaction; producing hydroxyl radical 
from hydrogen peroxide. Then IP6 has been used to suppress oxidation of food (Graf and 
Eaton, 1990). However, little is known for the suppressive effect of IP1-IP5 against Fenton’s 
reaction. If degradation products of IP6 by phytase also suppress Fenton’s reaction without 
reducing mineral bio-availability, phytase can be used for production of anti-oxidant food 
ingredient with excellent nutritional value. In addition, functional food based on 
suppression of Fenton’s reaction without disturbing nutritional could be also produced by 
the limited digestion of IP6 by phytase. For these purposes, further studies on control of 
hydrolysis of IP2-6 by phytase are necessary. 
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On the basis of these results, it can be concluded that IP6 content in the unrefined grain 
flour-containing bread can be reduced by direct addition of the fungal phytase. However, 
presence of high protease activity in the phytase preparation can deteriorate swelling and 
textural properties and collapse the crust. On the other hand, amylase can improve the 
swelling property at relatively low activity (<500 U), while it deteriorates the swelling 
property at high activity (> 1000 U). These phenomena can be explained as follows. 
Protease in the preparation degrades gluten and deteriorates gluten network. 
Consequently, the dough can not retain the CO2 gas generated by fermentation, which 
decreases loaf volume and finally collapses whole crust. The amylase in the preparation 
may induce oligosaccharides from starch and consequently enhance fermentation by yeast 
at the low amylase activity. On the other hand, the high amylase activity can deteriorate 
starch gel network after cooking process. Indeed, fungal amylase has been used in the 
baking industry to accelerate fermentation. However, addition of excessive amylase and 
protease has been demonstrated to make the dough slack (Fred et al., 1975). These facts 
clearly indicate that the control of protease and amylase activities is crucial for the 
application of the fungal phytase preparation to bread making to reduce IP6 and obtain 
good quality of the product.  
7. Conclusion and future prospects 
It has been demonstrated that fungal phytase can be used to reduce IP6 level of the soybean 
based products and also unrefined grain flour-containing products, especially bread. 
However, fungal phytase may contain protease and amylase, which may affect quality of 
the final products. In some cases, the product may be unacceptable due to excessive 
degradation of protein, which induces unfavorable effects on texture and appearance. Then 
it is crucial to control the contaminated enzyme activity in the phytase preparation. In the 
present chapter, ion exchange column chromatography and autofocusing can at least 
partially control contamination of protease and amylase activities. In regardless of the high 
resolution, column chromatography requires relatively expensive apparatus and high 
running cost. In addition, it may require salts, buffer, solvents etc, which should be removed 
from the final product. It also increases preparation cost. On the other hand, autofocusing 
does not require organic solvents and salts for fractionation and has inherited potential for 
scale-up. Recently, continuous type autofocusing apparatus has been developed (Hashimoto 
et al., 2006). Then this technique would be useful to control protease and amylase activities 
in the phytase preparation. By using this technique, a food additive phytase optimized for 
bread making and other applications could be produced.  
IP6 also suppresses divalent ions-induced Fenton’s reaction; producing hydroxyl radical 
from hydrogen peroxide. Then IP6 has been used to suppress oxidation of food (Graf and 
Eaton, 1990). However, little is known for the suppressive effect of IP1-IP5 against Fenton’s 
reaction. If degradation products of IP6 by phytase also suppress Fenton’s reaction without 
reducing mineral bio-availability, phytase can be used for production of anti-oxidant food 
ingredient with excellent nutritional value. In addition, functional food based on 
suppression of Fenton’s reaction without disturbing nutritional could be also produced by 
the limited digestion of IP6 by phytase. For these purposes, further studies on control of 
hydrolysis of IP2-6 by phytase are necessary. 
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Xylitol is a polyalcohol of five carbon atoms which is widely used in the food and chemical 
industry. Its interest is due to the sweetening power similar to that of sucrose. However, it 
has been shown that the use of xylitol as a sweetener is better due to its anticariogenecity, 
tooth rehardening and remineralization properties. It is suitable as sugar substitute for 
diabetics, and it limits the tendency to obesity when is continuously supplied in diet 
(Salgado et al., 2010a). Table 1 shows the properties of the food additives that are used as 
sweeteners and are permitted in the European Union (EU). 
Xylitol can be found naturally in various fruits and vegetables such as strawberries, 
raspberries, yellow plum, lettuce and cauliflower (Prakasham et al., 2009). The extraction of 
xylitol from these products is low, for this reason is not a good source. It is produced mainly 
by chemical processes. This process is the hydrogenation of the five-carbon sugar D-xylose 
in the presence of nickel catalyst at elevated temperature and pressure (Prakasham et al., 
2009). The chemical process has some drawbacks such as high cost of purification processes. 
To avoid aggressive stages of the chemical processes, biotechnological processes were 
studied for xylitol production. This alternative production is bioconversion of D-xylose to 
xylitol by microorganisms. To reduce costs and environmental problems renewable biomass 
from agro-industrial waste can be used as source of D-xylose. 
The food, agricultural and forestry industries produce large volumes of wastes annually 
worldwide, causing a serious disposal problem (Rodríguez-Couto, 2008). In the EU waste 
hierarchy and legislation, prevention and minimization of waste is given the highest priority 
(Staniskis & Stasiskiene, 2005). The List of Wastes (formerly the European Waste Catalogue), 
is a catalogue of all waste types generated in the EU. This list of wastes is periodically 
reviewed on the basis of new knowledge and, in particular, of research results, and if 
necessary revised in accordance with Article 18 of Waste Framework Directive (75/442/EEC). 
The list of wastes has been published in the Spanish Official Gazette of 19th February 2002 by 
Order MAM/304/2002 in conformity with the Commission Decision 2000/532/EC of 3 May 
2000, replacing Decision 94/3/EC establishing a list of wastes pursuant to Article 1(a) of 
Council Directive 75/442/EEC on waste and Council Decision 94/904/EC establishing a list 
of hazardous waste pursuant to Article 1(4) of Council Directive 91/689/EEC on hazardous 
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of hazardous waste pursuant to Article 1(4) of Council Directive 91/689/EEC on hazardous 





2001/119/EU and 2001/573/EU. The different types of waste in the List are fully defined by 
a six-digit code, with two digits each for chapter, sub-chapter and waste type. The List is 
used to categorize items and substances when they become waste, but does not itself define 
items and substances as waste. 
 














Sorbitol E 420 60 3.5 <10 Acceptable Directive 
94/35/EC 
Mannitol E 421 50 2.4 0 Acceptable Directive 
94/35/EC 
Acesulfame K E 950 200 0 0 0 - 15 Directive 
94/35/EC 
Aspartame E 951 160 - 220 4 0 0 - 40 Directive 
94/35/EC 
Cyclamic acids and 
its Na and Ca salts 
E 952 30 0 <10 0 - 7 Directive 
94/35/EC 
Isomalt E 953 40 2.4 <10 Acceptable Directive 
94/35/EC 
Saccharin and its Na, 
K and Ca salts 
E 954 300 0 0 0 - 15 Directive 
94/35/EC 
Sucralose E 955 500 0 0 0 - 5 Directive 
2003/115/EC 
Thaumatin E 957 1400 - 2200 4 0 Acceptable Directive 
94/35/EC 
Neohesperidine DC E 959 1500 4 0 0 - 5 Directive 
94/35/EC 




E 962  4 0 0 - 40 Directive 
2003/115/EC 
Maltitol E 965 90 2.4 36 Acceptable Directive 
94/35/EC 
Lactitol E 966 30 - 40 2.4 <10 Acceptable Directive 
94/35/EC 
Xylitol E 967 100 2.4 <10 Acceptable Directive 
94/35/EC 
Erythritol E 968 60 - 70 0.2 0 Acceptable Directive 
2006/52/EC 
SP: Sweetener power respect to sucrose (100) 
ADI: Acceptable daily intake established by the Scientific Committee on Food (SCF) 
Table 1. Sweeteners permitted for food use in the European Union 
The wastes studied in the current work, listed in Table 2, are included in paragraph 2 and 20 
of the European List of Waste “Wastes from agricultural, horticultural, hunting, fishing and 
aquacultural primary production, food preparation and processing” and “Municipal wastes 
and similar commercial, industrial and institutional wastes including separately collected 
fractions”, respectively. Their reutilization, as well as other wastes, is of great interest since,  
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due to legislation and environmental reasons, the industry is increasingly being forced to 
find an alternative use for its residual matter, at the same time that the use of these wastes 
considerably reduces the production costs (Rodríguez-Couto, 2008). 
Lignocelluloses in nature derive from wood, grass, agricultural residues, forestry wastes 
and municipal solid wastes (Pérez et al., 2002). They constitute a renewable resource from 
which many useful biological and chemical products can be derived. Accumulation of 
lignocellulose in large quantities in places where agricultural residues present a disposal 
problem results not only in deterioration of the environment but also in loss of potentially 
valuable material that can be used in paper manufacture, biomass fuel production, 
composting, human and animal feed among others (Sánchez, 2009). These lignocellulosic 
materials are renewable sources of energy where approximately 90 % of the dry weight of 
most plant materials is stored in the form of cellulose, hemicelluloses, lignin, and pectin 
(Kumar et al., 2009). Some authors have reported their fractionation to obtain a variety of 
marketable chemicals from the polymeric fractions of the raw materials (Moldes et al., 2007), 
including the xylitol production by Debaryomyces hansenii.  
 
2. Wastes from agricultural, horticultural, hunting, fishing and aquacultural primary 
production, food preparation and processing 
Code Origin Type of waste Characterized waste 
02 01 03 Primary production 
wastes 
Plant tissue waste Leaf fruit 
Vine leaf 
02 03 04 Wastes from fruit, 
vegetables, cereals, edible 
oils, cocoa, coffee and 



















Wheat bran leaves 
02 07 02 Waste from spirits 
distillation 
Distilled bagasse 






White and red grape stems 
20. Municipal wastes and similar commercial, industrial and institutional wastes including 
separately collected fractions. 
Code Origen Type of waste Characterized waste 
20 02 01 Garden and park wastes 
(including cemetery 
waste) 
Compostable waste Grass 
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This chapter deals with the study of different agroindustrial wastes through their 
characterization, fractionation by acid pre-hydrolysis and further analysis of the 
hemicellulosic fraction. The pre-hydrolysis of pistachio hulls was optimized; and finally, the 
liquors obtained under the optimal conditions, after supplementation, where assayed to 
carry out the xylose to xylitol bioconversion by D. hansenii. 
2. Materials and methods 
2.1 Quantitative acid hydrolysis 
Aliquots from the homogenized lot were submitted to moisture determination and to 
quantitative hydrolysis in a two-stage acid treatment (the first stage with 72 wt % sulfuric 
acid at 30 ºC for 1 h, the second stage after dilution of the media to 4 wt % sulfuric acid at 
121 ºC for 1 h) (Bustos et al., 2004). The solid residue after hydrolysis was considered as 
Klason lignin meanwhile hydrolyzates were analyzed by HPLC as described bellow. 
2.2 Acid hydrolysis 
Hydrolyzates were obtained in autoclave at 130 °C with 3 % H2SO4 solutions during 30 min, 
using a liquid/solid ratio of 8 g g-1 (Portilla-Rivera et al., 2007). The liquid phase from the 
acid hydrolysis was neutralized with CaCO3 to a final pH of 5.8-6.0, and the CaSO4 
precipitated was separated from the supernatant by filtration. 
2.3 Charcoal adsorption 
Powdered charcoal (Probus, Madrid, Spain) was activated with hot water and dried at room 
temperature. Charcoal detoxification of hydrolyzates was carried out by contacting 
hydrolyzates and charcoal (mass ratio: 10 g g-1) at room temperature under stirring for one 
hour (Rivas et al., 2002). The liquid phase was recovered by filtration and used for making 
culture media. 
2.4 Experimental design and statistical analysis of the pistachio shells prehydrolysis 
Pistachio shells were treated with solutions containing 1-3 % H2SO4 during 15–45 min. at  
130 ºC, according to a statistical experimental design (Design Expert version 5.0, Stat-Ease 
Inc., Minneapolis, USA), to optimize the prehydrolysis stage, and evaluated by the Response 
Surface Methodology using Statistica version 5.0 (Statsoft, USA) software considering the SS 
residual to evaluate the significance of the effects and the model. The influence of two 
operational variables (concentration of catalyser and reaction time) was tested on three 
levels in a 3**(2-0) full factorial design. All experiments were carried out in duplicate in 
randomized run order. Liquors were separated from the solid fraction by vacuum filtration 
through common laboratory paper filters and analyzed the concentration of xylose, glucose, 
arabinose, acetic acid, formic acid and furfural, which were the dependent variables.  
This design allowed the estimation of the significance of the parameters and their interaction 
using Student’s t-test. The interrelationship between dependent and operational variables 
was established by Eq.1, a model including linear, interaction and quadratic terms:  
 y = b0 + b1·x1 + b11·x12 + b2·x2 + b22·x22 + b12·x1·x2 (1) 
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where y represents the dependent variables, b denotes the regression coefficients (calculated 
from experimental data by multiple regression using the least-squares method), and x 
denotes the independent variables. 
2.5 Microorganism and culture conditions 
Debaryomyces hansenii NRRL Y-7426 was kindly provided by the National Center for 
Agricultural Utilization Research (Peoria, Illinois, USA). Freeze-dried cells were grown on a 
basal medium containing 30 g L-1 commercial xylose, 3 g L-1 yeast extract, 3 g L-1 malt 
extract, and 5 g L-1 peptone. The microorganism was maintained in agar slant tubes 
containing a medium formulated with the same components and concentrations as the 
previous one plus 20 g L-1 agar. Inocula were prepared by solubilization of cells with sterile 
water and underwent growth during 24 hours in the previous medium without agar. 
Biomass in inocula was measured by optical density at 600 nm and adjusted by dilution 
with water, and added to fermentation broth to reach a final concentration in the vicinity of 
0.04 g L-1. 
Shake flask fermentation experiments were carried out under microaerophilic conditions in 
250 mL Erlenmeyer flasks containing 100 mL of culture media (sterilized in autoclave at 100 
ºC during 60 min) prepared with 85 mL hydrolyzates and 10 mL of the nutrients indicated 
in Table 3. 
  
Fermentation Hydrolyzate Nutrients 
1 Liquid vinasses + stream B (conc.) 
2 Corn steep liquor (30 g/L) 




5 Detoxified YE (3 g/L), ME (3 g/L), Peptone (5 g/L) 
YE: Yeast Extract; ME: Malt Extract. 
Table 3. Nutrients employed in fermentations 
Fermentation 1 contains the optimal amount of economic nutrients described by Salgado et 
al. (2010b) consisting in 50 mL liquid vinasses and 25 mL stream B but concentrated 7.5 
times in rotavapor at 50 ºC to reach a final volume of 10 mL. Fermentation 2 contains 
another economic nutrient, corn steep liquor. Fermentation 4 was carry out using non 
supplemented hydrolyzates, meanwhile Fermentations 3 and 5 contains commercial 
nutrients using raw or dextoxified hyrolyzates. 
After inoculation (5 mL), fermentations were carried out in orbital shakers (New Brunswick, 
Edison, NJ, USA) at 100 rpm and 31 ºC for 96 hours. Samples (2 mL) were taken at given 
fermentation times and centrifuged at 6,000 rpm for 3 min. The supernatants were stored for 
analyses. 
2.6 Analytical methods 
Glucose, xylose, arabinose, xylitol, glycerol, acetic acid, ethanol, furfural, and 
hydroxymethylfurfural (HMF) were measured by a high-performance liquid 
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index detector and an Aminex HPX-87H ion exclusion column (Bio Rad) eluted with 0.003 
M sulfuric acid at a flow rate of  0.6 mL min-1 at 50 ºC. Biomass concentration in experiments 
was measured by centrifugation, washing of the cells, and oven-drying to constant weight at 
100 ºC. 
3. Results and discussion 
3.1 Characterization of different agro-industrial wastes 
Lignocellulosic materials consists of three types of polymers – cellulose, hemicelluloses, and 
lignin – that are strongly intermeshed and chemically bonded by non-covalent forces and by 
covalent cross-linkages. Cellulose and hemicelluloses are macromolecules from different 
sugars; whereas lignin is an aromatic polymer synthesized from phenylpropanoid 
precursors (Pérez et al., 2002). They also contain smaller amounts of proteins, pectin, acids, 
salts, minerals, ashes and extractives, including soluble non-structural sugars, nitrogenous 
material, chlorophyll, and waxes.  
Cellulose is a linear polymer of D-glucose subunits linked to each other by β-(1,4)-glucosidic 
bonds with fibrous structure with a degree of polymerization of up to 10,000 or higher 
(Jørgensen et al., 2007). The long-chain cellulose polymers are linked together by hydrogen 
and van der Waals bonds, which cause the cellulose to be packed into microfibrils. 
Hemicelluloses and lignin cover the microfibrils (Kumar et al., 2009). Cellulose can appear 
in crystalline form (crystalline cellulose) and, in smaller percentage, in non-organized 
cellulose chains (amorphous cellulose) (Pérez et al., 2002). 
Hemicelluloses is a complex carbohydrate polymer consisting of short highly branched 
chains of different five-carbon sugars (xylose, rhamnose and arabinose) and six-carbon 
sugars (glucose, galactose and mannose) and smaller amounts of non-sugars, mainly acetyl 
groups, but also uronic acids such as 4-o-methylglucuronic, D-glucuronic, and  
D-galactouronic acids. The backbone of hemicelluloses is either a homopolymer or a 
heteropolymer with short branches linked by β-(1,4)-glycosidic bonds and occasionally  
β-(1,3)-glycosidic bonds, and also can have some degree of acetylation. These polymers do 
not aggregate, even when they cocrystallize with cellulose chains (Kumar et al., 2009). 
Glucuronoxylan is the principal component of hardwood hemicelluloses whereas 
glucomannan is predominant in softwood (Pérez et al., 2002). The degree of polymerization 
is below 200 (Jørgensen et al., 2007). 
Finally, lignin is a complex network formed by polymerization of phenyl propane units and 
constitutes the most abundant non-polysaccharide fraction in lignocellulose (Jørgensen et 
al., 2007). Lignin is an amorphous heteropolymer complex. The large molecular structure 
contains cross-linked polymers of phenolic monomers linked by alkyl-aryl, alkyl-alkyl, and 
aryl-aryl ether bonds (Kumar et al., 2009). Lignin encrusts the cell walls and cements the 
cells together (Hamelinck et al., 2005), conferring structural support, impermeability, and 
resistance against microbial attack and oxidative stress (Pérez et al., 2002). 
Table 4 summarizes the quantitative acid hydrolysis of different agroindustrial wastes. 
Cellulose changes widely from only 10.1 % in vine leaf up to 80-95 % in cotton seed hairs, 
and 85-99 % in papers, which is an almost exclusively cellulosic material. Furthermore, the 
composition varies no only among species but also within a single plant depending on  
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Hemicelluloses  Cellulose 
Total Xylan Arabinan Acetyl 
groups 
Lignin Extractives Reference 
50.7 28.9    20.4 2.5 Demirbas, 2003 Almond shell 
26.8 32.5 26.1 2.4 04.0 27.4 5.0 Nabarlatz et al., 
2005 
Apple fiber 20.8 10.0-28.4    12.1  Claye et al., 1996 
Barley bran 
husks 
23.0 34.3 26.6 6.1 1.6 21.4  Cruz et al., 2000 
Chestnut shells 21.1 13.9 10.5 1.4 2.0 46.5 18.6 * 
Coastal 
Bermuda grass 
25.0 35.7    6.4  Kumar et al., 2009 
31.7 38.1 30.9 3.8 3.4 20.3  Cruz et al., 2000 
52.0 32.0    15.1  Demirbas, 2003 
41.2 36.0    6.1  Domínguez et al., 
1997 
Corncob 
45 35    15  Kumar et al., 2009 
Corn fiber 14.3 16.8    8.4  Mosier et al., 2005 
Corn leaves 37.6 37.7 30.3 4.2 3.2 12.6  Cruz et al., 2000 
51.2 30.7    14.4  Demirbas, 2003 Corn stover 




80-95 5-20    0  Kumar et al., 2009 
Distilled grape 
marc 
10.8 11.2 7.5 2.2 1.6 50.9 14.7 Portilla-Rivera et 
al., 2008 
Flax 34.9 23.6    22.3  Fan et al. 1987 
Grasses 25-40 35-50    10-30  Kumar et al., 2009 
Hardwood 
stems 
40-55 24-40    18-25  Kumar et al., 2009 
Hazelnut 
kernel shells 
29.6 15.7    53.0  Demirbas, 2003 
25.9 29.9    42.5 3.3 Demirbas, 2003 Hazelnut shell 
23.7 24.4 19.6 0.7 4.1 40.8 11.1 Portilla-Rivera et 
al., 2008 
Leaf fruit 11.1 14.7 9.2 1.2 4.3 20.5 53.8 * 
Leaves 15-20 80-85    0  Kumar et al., 2009 
61.3 9.8    12.0  Kim & Moon, 2003 Newspaper 
40-55 25-40    18-30  Kumar et al., 2009 
Nut shells 25-30 25-30    30-40  Kumar et al., 2009 
Oats 26.6 30.2    21.4  Claye et al., 1996 
Oat fiber 26.6 17.0-21.3    21.4  Claye et al., 1996 
Oat straw 39.4 27.1    17.5  Fan et al., 1987 
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husks 
23.0 34.3 26.6 6.1 1.6 21.4  Cruz et al., 2000 
Chestnut shells 21.1 13.9 10.5 1.4 2.0 46.5 18.6 * 
Coastal 
Bermuda grass 
25.0 35.7    6.4  Kumar et al., 2009 
31.7 38.1 30.9 3.8 3.4 20.3  Cruz et al., 2000 
52.0 32.0    15.1  Demirbas, 2003 
41.2 36.0    6.1  Domínguez et al., 
1997 
Corncob 
45 35    15  Kumar et al., 2009 
Corn fiber 14.3 16.8    8.4  Mosier et al., 2005 
Corn leaves 37.6 37.7 30.3 4.2 3.2 12.6  Cruz et al., 2000 
51.2 30.7    14.4  Demirbas, 2003 Corn stover 




80-95 5-20    0  Kumar et al., 2009 
Distilled grape 
marc 
10.8 11.2 7.5 2.2 1.6 50.9 14.7 Portilla-Rivera et 
al., 2008 
Flax 34.9 23.6    22.3  Fan et al. 1987 
Grasses 25-40 35-50    10-30  Kumar et al., 2009 
Hardwood 
stems 
40-55 24-40    18-25  Kumar et al., 2009 
Hazelnut 
kernel shells 
29.6 15.7    53.0  Demirbas, 2003 
25.9 29.9    42.5 3.3 Demirbas, 2003 Hazelnut shell 
23.7 24.4 19.6 0.7 4.1 40.8 11.1 Portilla-Rivera et 
al., 2008 
Leaf fruit 11.1 14.7 9.2 1.2 4.3 20.5 53.8 * 
Leaves 15-20 80-85    0  Kumar et al., 2009 
61.3 9.8    12.0  Kim & Moon, 2003 Newspaper 
40-55 25-40    18-30  Kumar et al., 2009 
Nut shells 25-30 25-30    30-40  Kumar et al., 2009 
Oats 26.6 30.2    21.4  Claye et al., 1996 
Oat fiber 26.6 17.0-21.3    21.4  Claye et al., 1996 
Oat straw 39.4 27.1    17.5  Fan et al., 1987 





Office paper 68.6 12.4    11.3  Mosier et al., 2005 
Olive husk 24.0 23.6    48.4  Demirbas, 2003 
Paper 85-99 0    0-15  Kumar et al., 2009 
Pistachio shells 15.2 38.5 33.1 0.0 5.4 29.4 17.0 * 
Red grape stem 13.3 8.47 6.7 0.77 1.0 35.9 42.4 * 
Rice bran 24.4 7.6-24.0    18.4  Claye et al., 1996 
Rice hulls 35.6 11.96    15.4  Saha et al., 2005 
Softwood 
stems 
45-50 25-35    25-35  Kumar et al., 2009 
Solid cattle 
manure 
1.6-4.7 1.4-3.3    2.7-5.7  Kumar et al., 2009 
Sorted refuse 60.0 20    20  Kumar et al., 2009 
Soybean stems 34.5 24.8    19.8  Fan et al., 1987 
Sugarcane 
bagasse 
35.0 35.8    16.1  Sasaki et al., 2003 
Sunflower shell 48.4 34.6    17.0 2.7 Demirbas, 2003 
Swine waste 6.0 28    -  Kumar et al., 2009 
32.0 25.2 21.1 2.8  18.1 17.5 Hamelinck et al., 
2005 
45.0 31.4    12  Kumar et al., 2009 
31.0 20.4    17.6  Mosier et al., 2005 
Switchgrass 
 
22.2 13.9 10.4 3.5 0.0 18.0 46.0 * 
Thistle 
 
31.1 12.2    22.1  Jiménez & López, 
1993 
Tomato fiber 19.7 13.2-23.3    13.8  Claye et al., 1996 
Vine leaf 10.1 8.37 5.9 1.8 0.67 44.4 37.1 * 
Vineshoots 34.1 19.0 12.8 0.90 5.3 27.1 7.1 Bustos et al. 2004 
25.6 22.1    52.3 3.3 Demirbas, 2003 Walnut shell 





60-70 10-20    5-10  Kumar et al., 2009 
Wheat bran 32.2 16-28    5.2  Claye et al., 1996 
Wheat bran 
leaves 
26.2 24.3 15.8 8.5 0.0 7.9 41.5 * 
28.8 39.1    18.6  Demirbas, 2003 
30.0 50    15  Kumar et al., 2009 
38.2 21.2    23.4  Mosier et al., 2005 
Wheat straw 
48.6 27.7      Saha et al., 2005 
White grape 
stem 
20.7 11.37 10.4 0.00 0.97 31.3 36.7  
*Current work. 
Table 4. (continued) Quantitative acid hydrolysis (in %) of agro-industrial wastes 
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several factors such as age, location or stage of growth. For instance, we obtained a 
percentage of 22.2 % in switchgrass, but Kumar et al. (2009) reported a percentage of 45 %. 
Meanwhile, hemicelluloses are in general in smaller amounts, although in some particular 
cases such as leaves can account for values as high as 80-85 % (Kumar et al., 2009), being 
xylan the main constituent in all the cases indicated. Regarding lignin, Demirbas (2003) 
reported the highest percentage of lignin (53.0 %) in hazelnut kernel shells, although this 
percentage varies widely depending on the material. Papers and herbaceous plants show in 
general the lowest contents; meanwhile softwoods and nuts have the highest contents (see 
Table 4). 
3.2 Prehydrolysis of lignocellulosic materials 
Due to the robust structure of lignocellulosic biomass, pretreatment is a prerequisite for 
hydrolysis into fermentable sugars to be completed within an industrially acceptable time 
frame (Jørgensen et al., 2007). Although fermentable D-glucose could be produced from 
cellulose through the action of either acid or enzymes breaking the β-(1,4)- glycosidic 
linkages (Kumar et al., 2009), the structure of cellulose along with the intermolecular 
hydrogen bonds gives cellulose high tensile strength, makes it insoluble in most solvents 
and is partly responsible for the resistance of cellulose against microbial degradation (Ward 
& Moo-Young 1989). On the contrary, hemicelluloses, because of their branched, amorphous 
nature, are relatively easy to hydrolyze (Hamelinck et al., 2005), particularly, in contrast to 
cellulose, the polymers present in hemicelluloses are easily hydrolyzable (Kumar et al., 
2009). 
Over the years a number of different technologies have been successfully developed for 
pretreatment of lignocellulose (Jørgensen et al., 2007), including concentrated or dilute-acid 
hydrolysis. Concentrated acids such as H2SO4 and HCl have been used to treat 
lignocellulosic materials. Nevertheless, although they are powerful agents for cellulose 
hydrolysis, concentrated acids are toxic, corrosive, hazardous, and thus require reactors that 
are resistant to corrosion, which makes the pretreatment process very expensive. In 
addition, the concentrated acid must be recovered after hydrolysis to make the process 
economically feasible (Kumar et al., 2009). 
Among the chemichal hydrolysis methods, dilute-acid hydrolysis is probably the most 
commonly applied (Taherzadeh & Karimi, 2007). Therefore, dilute-acid hydrolysis 
(prehydrolysis) where a mineral acid is added to the reaction media to break down 
polymers, can be a possible first processing step for an integral use of biomass, since 
hemicelluloses can be almost completely solubilized, whereas little alteration is caused in 
both lignin and cellulose, which are recovered in the solid phase (Moldes et al., 2007). 
Among them, sulfuric acid has been of the most interest in such studies as it is inexpensive 
and effective (Kumar et al., 2009). 
The lignocellulosic materials were subjected to prehydrolysis treatments under the same 
conditions (3 % H2SO4, 130 ºC, 30 min., liquid to solid ratio = 8 g/g) previously reported by 
other authors (Portilla-Rivera et al., 2007). Table 5 reports the sugars content and other 
compounds solubilized during the treatment. Xylose was the sugar released in highest 
concentration, reaching a maximal xylose content of 41.8 g L-1 in pistachio shells. 
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Vineshoots 34.1 19.0 12.8 0.90 5.3 27.1 7.1 Bustos et al. 2004 
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26.2 24.3 15.8 8.5 0.0 7.9 41.5 * 
28.8 39.1    18.6  Demirbas, 2003 
30.0 50    15  Kumar et al., 2009 
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20.7 11.37 10.4 0.00 0.97 31.3 36.7  
*Current work. 
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several factors such as age, location or stage of growth. For instance, we obtained a 
percentage of 22.2 % in switchgrass, but Kumar et al. (2009) reported a percentage of 45 %. 
Meanwhile, hemicelluloses are in general in smaller amounts, although in some particular 
cases such as leaves can account for values as high as 80-85 % (Kumar et al., 2009), being 
xylan the main constituent in all the cases indicated. Regarding lignin, Demirbas (2003) 
reported the highest percentage of lignin (53.0 %) in hazelnut kernel shells, although this 
percentage varies widely depending on the material. Papers and herbaceous plants show in 
general the lowest contents; meanwhile softwoods and nuts have the highest contents (see 
Table 4). 
3.2 Prehydrolysis of lignocellulosic materials 
Due to the robust structure of lignocellulosic biomass, pretreatment is a prerequisite for 
hydrolysis into fermentable sugars to be completed within an industrially acceptable time 
frame (Jørgensen et al., 2007). Although fermentable D-glucose could be produced from 
cellulose through the action of either acid or enzymes breaking the β-(1,4)- glycosidic 
linkages (Kumar et al., 2009), the structure of cellulose along with the intermolecular 
hydrogen bonds gives cellulose high tensile strength, makes it insoluble in most solvents 
and is partly responsible for the resistance of cellulose against microbial degradation (Ward 
& Moo-Young 1989). On the contrary, hemicelluloses, because of their branched, amorphous 
nature, are relatively easy to hydrolyze (Hamelinck et al., 2005), particularly, in contrast to 
cellulose, the polymers present in hemicelluloses are easily hydrolyzable (Kumar et al., 
2009). 
Over the years a number of different technologies have been successfully developed for 
pretreatment of lignocellulose (Jørgensen et al., 2007), including concentrated or dilute-acid 
hydrolysis. Concentrated acids such as H2SO4 and HCl have been used to treat 
lignocellulosic materials. Nevertheless, although they are powerful agents for cellulose 
hydrolysis, concentrated acids are toxic, corrosive, hazardous, and thus require reactors that 
are resistant to corrosion, which makes the pretreatment process very expensive. In 
addition, the concentrated acid must be recovered after hydrolysis to make the process 
economically feasible (Kumar et al., 2009). 
Among the chemichal hydrolysis methods, dilute-acid hydrolysis is probably the most 
commonly applied (Taherzadeh & Karimi, 2007). Therefore, dilute-acid hydrolysis 
(prehydrolysis) where a mineral acid is added to the reaction media to break down 
polymers, can be a possible first processing step for an integral use of biomass, since 
hemicelluloses can be almost completely solubilized, whereas little alteration is caused in 
both lignin and cellulose, which are recovered in the solid phase (Moldes et al., 2007). 
Among them, sulfuric acid has been of the most interest in such studies as it is inexpensive 
and effective (Kumar et al., 2009). 
The lignocellulosic materials were subjected to prehydrolysis treatments under the same 
conditions (3 % H2SO4, 130 ºC, 30 min., liquid to solid ratio = 8 g/g) previously reported by 
other authors (Portilla-Rivera et al., 2007). Table 5 reports the sugars content and other 
compounds solubilized during the treatment. Xylose was the sugar released in highest 
concentration, reaching a maximal xylose content of 41.8 g L-1 in pistachio shells. 





respectively, showing a xylose to glucose ratio of 47.6. Nevertheless, some possible toxins of 
further fermentable broths were generated, including acetate from the deacetylation of xylan 
and furan dehydration products (furfural from xylose and hydroxymethylfurfural from 
glucose). Using pistachio shells, 8.0 g L-1 of acetic acid and 1.7 g L-1 of furfural were released, 
meanwhile the highest amount of HMF, 1.2 g L-1, was observed after the acid hydrolysis of 
white grape stems. Other compounds were also present in hydrolyzates, including citric, 
tartaric and lactic acids, and glycerol. Tartaric acid concentrations were relatively elevated in 
viticulture wastes (white and red grape stems and vine leafs) with concentrations up to 9.8 g 















Chestnut shells 0.0 6.9 2.6 13.3 5.0 3.2 0.0 0.0 2.8 0.0 0.0 
Grass 1.7 1.0 8.4 12.4 1.5 3.4 0.0 0.0 1.5 0.51 0.51 
Leaf fruit 0.0 1.4 5.8 9.1 1.6 5.5 0.0 0.0 2.2 0.47 0.0 
Pistachio shells 0.0 1.5 0.88 41.8 47.6 0.67 0.0 0.0 8.0 0.0 1.7 
Red grape stem 0.79 9.8 5.3 12.6 2.4 2.1 0.0 1.1 2.7 0.0 0.0 
Vine leaf 0.0 9.4 4.4 6.8 1.6 3.7 0.0 0.0 1.6 0.0 0.0 
Wheat bran leaves 0.0 0.0 23.8 22.5 0.95 9.9 0.0 0.0 0.71 0.69 0.88 
White grape stem 1.2 8.2 12.1 13.5 1.1 2.0 0.98 3.5 2.6 1.2 0.0 
Table 5. Composition (g/L) of hydrolyzates after prehydrolysis at 130 °C with 3 % H2SO4 
during 30 min. using a liquid/solid ratio = 8 g g-1 
3.3 Optimization of the prehydrolysis of pistachio shells 
Considering that pistachio shells provides the highest amount of xylose, the acid hydrolysis 
of this material was optimized using a 3**(2-0) full factorial design, to produce the highest 
level of hemicelluloses hydrolysis with the lowest level of degradation of the cellulosic 
fraction. The use of experimental designs to optimize the hydrolysis conditions is a 
technology widely used in bibliography (Bustos et al., 2005). In the present work, the 
independent variables considered and their variation ranges were: H2SO4 concentration (1-3 
%) and duration of treatments (15-45 min). The standardized (coded) adimensional variables 
employed, having variations limits (-1,1), were defined as x1 (coded H2SO4 concentration) 
and x2 (coded time). The correspondence between coded and uncoded variables was 
established by linear equations deduced from their respective variation limits: 
 x1 = ([H2SO4] - 2) (2) 
 x2 = (t – 30)/15 (3) 
The composition of liquors was measured by dependent variables: y1 (glucose, g L-1), y2 
(xylose, g L-1), y3 (arabinose, g L-1), y4 (acetic acid, g L-1), y5 (formic acid, g L-1) and y6 
(furfural, g L-1). Table 6 shows the set of experimental conditions assayed expressed in terms 
of coded variables, as well as the experimental data obtained for variables y1 to y6. The 
sequence for the experimental work was randomly established to limit the influence of 
systematic errors on the interpretation of results. 
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 Operational conditions Experimental results 
Experiment x1 x2 y1 y2 y3 y4 y5 y6 
1 -1 -1 0.44 34.4 0.62 7.2 0.79 0.21 
2 -1 0 0.66 37.9 0.83 7.5 0.75 1.3 
3 -1 1 0.62 37.8 0.92 7.9 0.82 1.6 
4 0 -1 0.56 39.0 0.60 8.1 0.90 0.65 
5 0 0 0.74 41.1 0.64 8.1 0.84 1.3 
6 0 1 0.88 38.8 0.65 8.3 1.1 1.9 
7 1 -1 0.67 40.6 0.65 8.1 1.2 1.1 
8 1 0 0.98 41.8 0.64 8.1 1.1 2.2 
9 1 1 1.1 38.0 0.67 8.5 1.3 3.0 
Table 6. Operational conditions considered in this study (expressed in terms of the coded 
independent variables dimensionless H2SO4 concentration x1 and dimensionless time x2 and 
experimental results achieved for the dependent variables y1 (glucose concentration, g/L);  
y2 (xylose concentration, g/L); y3 (arabinose concentration, g/L); y4 (acetic acid concentration, 
g/L); y5 (formic acid concentration, g/L) and y6 (furfural concentration, g/L). Results are the 
average of two independent experiments. Standard deviations were in the range of 1-3 % of 
the mean 
Table 7 lists the regression coefficients and their statistical significance (based on a t-test) as 
well as the statistical parameters (R2, R2 adjusted, F and the significance level based on the F 
test) measuring the correlation and the statistical significance of the models, respectively. It 
can be noted that all the models showed good statistical parameters for correlation and 
significance allowing a close reproduction of experimental data. In relation with the 
influence of independent variables, H2SO4 concentration (x1) caused the strongest effect on 
the variation of dependent variables considered, as it can be seen from the absolute value of 
the corresponding coefficients. 
Fig. 1 shows a three dimensional representation of the response surface for the predicted 
dependence of the xylose concentration of samples (y2) on the sulfuric acid concentration 
and reaction time as well as a two-dimensional contour plot generated by the model. The 
response surface shows a slight continuous increase in y2 with catalyze and an optimum 
value at intermediate reaction times. 
From the coefficients of Table 7, Eq. 4 was deduced for y2 (xylose concentration): 
 y2 = 41.06889 + 1.72 * x1 - 1.21333 * (x1)2 - 2.16333 * (x2)2 - 1.4975 *x1 * x2 (4) 
Using the “solver” application of Microsoft Excell the maximum xylose concentration 
predicted for the model (y1 = 41.8 g L-1) was achieved when x1 = 0.90 (2.9 %) and x2 = -0.31 
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tartaric and lactic acids, and glycerol. Tartaric acid concentrations were relatively elevated in 
viticulture wastes (white and red grape stems and vine leafs) with concentrations up to 9.8 g 















Chestnut shells 0.0 6.9 2.6 13.3 5.0 3.2 0.0 0.0 2.8 0.0 0.0 
Grass 1.7 1.0 8.4 12.4 1.5 3.4 0.0 0.0 1.5 0.51 0.51 
Leaf fruit 0.0 1.4 5.8 9.1 1.6 5.5 0.0 0.0 2.2 0.47 0.0 
Pistachio shells 0.0 1.5 0.88 41.8 47.6 0.67 0.0 0.0 8.0 0.0 1.7 
Red grape stem 0.79 9.8 5.3 12.6 2.4 2.1 0.0 1.1 2.7 0.0 0.0 
Vine leaf 0.0 9.4 4.4 6.8 1.6 3.7 0.0 0.0 1.6 0.0 0.0 
Wheat bran leaves 0.0 0.0 23.8 22.5 0.95 9.9 0.0 0.0 0.71 0.69 0.88 
White grape stem 1.2 8.2 12.1 13.5 1.1 2.0 0.98 3.5 2.6 1.2 0.0 
Table 5. Composition (g/L) of hydrolyzates after prehydrolysis at 130 °C with 3 % H2SO4 
during 30 min. using a liquid/solid ratio = 8 g g-1 
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of this material was optimized using a 3**(2-0) full factorial design, to produce the highest 
level of hemicelluloses hydrolysis with the lowest level of degradation of the cellulosic 
fraction. The use of experimental designs to optimize the hydrolysis conditions is a 
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independent variables considered and their variation ranges were: H2SO4 concentration (1-3 
%) and duration of treatments (15-45 min). The standardized (coded) adimensional variables 
employed, having variations limits (-1,1), were defined as x1 (coded H2SO4 concentration) 
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established by linear equations deduced from their respective variation limits: 
 x1 = ([H2SO4] - 2) (2) 
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sequence for the experimental work was randomly established to limit the influence of 
systematic errors on the interpretation of results. 
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Table 7 lists the regression coefficients and their statistical significance (based on a t-test) as 
well as the statistical parameters (R2, R2 adjusted, F and the significance level based on the F 
test) measuring the correlation and the statistical significance of the models, respectively. It 
can be noted that all the models showed good statistical parameters for correlation and 
significance allowing a close reproduction of experimental data. In relation with the 
influence of independent variables, H2SO4 concentration (x1) caused the strongest effect on 
the variation of dependent variables considered, as it can be seen from the absolute value of 
the corresponding coefficients. 
Fig. 1 shows a three dimensional representation of the response surface for the predicted 
dependence of the xylose concentration of samples (y2) on the sulfuric acid concentration 
and reaction time as well as a two-dimensional contour plot generated by the model. The 
response surface shows a slight continuous increase in y2 with catalyze and an optimum 
value at intermediate reaction times. 
From the coefficients of Table 7, Eq. 4 was deduced for y2 (xylose concentration): 
 y2 = 41.06889 + 1.72 * x1 - 1.21333 * (x1)2 - 2.16333 * (x2)2 - 1.4975 *x1 * x2 (4) 
Using the “solver” application of Microsoft Excell the maximum xylose concentration 
predicted for the model (y1 = 41.8 g L-1) was achieved when x1 = 0.90 (2.9 %) and x2 = -0.31 






a) Regression coefficients and significance level for the dependent variables. 
Coeficientes y1 y2 y3 y4 y5 y6 
b0 0.7822* 41.06889* 0.6422* 8.1289* 0.86* 1.4* 
b1 0.17* 1.72* -0.06833** 0.3533* 0.1883* 0.5317* 
b11 0.01667 -1.21333* 0.091667*** -0.2933*** 0.045 0.285 
b2 0.1533* 0.08 0.061667** 0.2483** 0.045*** 0.75* 
b22 -0.08333*** -2.16333* -0.018333 0.08167 0.105** -0.2 
b12 0.06*** -1.4975* -0.07*** -0.0775 0.015 0.1425 
b) Statistical parameters (R2 and F) measuring the correlation and significance of the 
models. 
Variable R2 corrected R2 Fexp. significance level 
(based on the F test) 
y1 0.98722 0.96592 540.715 96.69 
y2 0.99356 0.98283 1080.1478 97.66 
y3 0.93434 0.82491 99.6115 92.30 
y4 0.95926 0.89137 164.8324 94.01 
y5 0.97965 0.94574 337.0255 95.81 
y6 0.98035 0.94761 349.3056 95.88 
* Significant coefficients at the 90 % confidence level. 
** Significant coefficients at the 95 % confidence level. 
*** Significant coefficients at the 99 % confidence level. 
Table 7. Regression coefficients, significance level for dependent variables and statistical 
parameters measuring the correlation and significance of the models 
 
Fig. 1. Response surface and contour plot for the dependence of xylose concentration (y2) on 
H2SO4 conc. (x1) and reaction time (x2) 
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3.4 Fermentation under the optimal hydrolysis conditions of pistachio shells 
Diluted acids were used under the optimal conditions predicted by the solver application to 
obtain hydrolyzates with high content of xylose. Fig. 2 and Table 8 show the effect of 
nutrient supplementation on xylitol production by D. hansenii. Under all the conditions 
assayed, a 24h lag phase was observed. Xylose started to be consumed after glucose was 
firstly depleted within 24h. Conversely to other works with the same yeast (Carvalheiro et 










































































































Fig. 2. Course with time for the xylose to xylitol bioconversion by Debaryomyces hansenii 
during fermentations carried out using the nutrients described in Table 3. (O) xylose, ( ) 
glucose, ( ) acetic acid, ( ) xylitol, ( ) ethanol, ( ) biomass. (F1) raw hydrolyzate, liquid 
vinasses and stream B (conc.); (F2) raw hydrolyzate, corn steep liquor (30 g/L); (F3) raw 
hydrolyzate, yeast extract (3 g/L), malt extract (3 g/L), peptone (5 g/L); (F4) raw 
hydrolyzate, without nutrients; (F5) detoxified hydrolyzate, yeast extract (3 g/L), malt 





a) Regression coefficients and significance level for the dependent variables. 
Coeficientes y1 y2 y3 y4 y5 y6 
b0 0.7822* 41.06889* 0.6422* 8.1289* 0.86* 1.4* 
b1 0.17* 1.72* -0.06833** 0.3533* 0.1883* 0.5317* 
b11 0.01667 -1.21333* 0.091667*** -0.2933*** 0.045 0.285 
b2 0.1533* 0.08 0.061667** 0.2483** 0.045*** 0.75* 
b22 -0.08333*** -2.16333* -0.018333 0.08167 0.105** -0.2 
b12 0.06*** -1.4975* -0.07*** -0.0775 0.015 0.1425 
b) Statistical parameters (R2 and F) measuring the correlation and significance of the 
models. 
Variable R2 corrected R2 Fexp. significance level 
(based on the F test) 
y1 0.98722 0.96592 540.715 96.69 
y2 0.99356 0.98283 1080.1478 97.66 
y3 0.93434 0.82491 99.6115 92.30 
y4 0.95926 0.89137 164.8324 94.01 
y5 0.97965 0.94574 337.0255 95.81 
y6 0.98035 0.94761 349.3056 95.88 
* Significant coefficients at the 90 % confidence level. 
** Significant coefficients at the 95 % confidence level. 
*** Significant coefficients at the 99 % confidence level. 
Table 7. Regression coefficients, significance level for dependent variables and statistical 
parameters measuring the correlation and significance of the models 
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SC = total sugars consumed; QS = volumetric rate of substrates (xylose, glucose and arabinose) 
consumption; QXylitol = global volumetric productivity of xylitol; YXylitol/SC = xylitol yield (xylitol 
produced/total sugars consumed); QX = biomass volumetric productivity; YX/SC =  biomass yield 
Table 8. Stoichiometric parameters, productivities and yields after 74h for hemicellulosic 
pistachio shells hydrolyzates bioconversion in assays carried out by D. hansenii. Results are 
the average of two independent experiments. Standard deviations were in the range of 2-4 
% of the mean 
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mixture of glucose and xylose. A similar pattern was observed for Candida guilliermondii 
(Canilha et al., 2005), and Candida tropicalis (Walther et al., 2001). Arabinose and acetic acid 
were scarcely consumed (see Table 8). Thus, meanwhile no arabinose was consumed in 
fermentation 4 (raw hydrolyzates without supplementation), the consumption in 
fermentation 5 (detoxified hydrolyzates supplemented with commercial nutrients) only 
reached 37 %; whereas acetic acid consumption ranged 39.1-58.8 % regardless of 
supplementation or detoxification treatment. Supplementation with economic nutrients 
(vinasses or corn steep liquor) led to an increase in the overall sugars consumption rate in 
comparison with the use of commercial nutrients. 
Xylitol was the main product for all media except for fermentation 4 where no production 
was observed, meaning that these hydrolyzates require to be supplemented with additional 
nutrients to stimulate the xylitol production. The necessity to supplement hydrolyzates with 
nutrients seems to depend on the raw material (Carvalheiro et al., 2007), and while the 
supplementation was shown to be beneficial for Candida guilliermondii during the xylose-to-
xylitol bioconversion in Eucalyptus hydrolyzates (Canettieri et al., 2001), no addition of 
nutrients was necessary in rice straw hydrolyzates for the same yeast (Silva & Roberto, 
1999). The highest concentration, 19.3 g L-1 after 74 hours, was obtained in hydrolyzates 
supplemented with economic wastes (vinasses and stream B), corresponding to 
fermentation 2 (QP = 0.260 g L-1 h-1; YP/S = 0.63 g g-1), followed by the use of another 
economic nutrient in fermentation 3, corn steep liquor, where xylitol reached up to 18.0 g L-1 
(QP = 0.244 g L-1 h-1; YP/S = 0.56 g g-1). In fermentations supplemented with commercial 
nutrients (fermentations 1 and 5), conversely to the expected, the higher xylitol value, 16.2 g 
L-1, was observed in fermentation without detoxification. Ethanol and glycerol were also 
produced although in small amounts. 
Finally, it is important to mention the amount of biomass generated in all fermentations 
with the exception of fermentation 4 where only 2.3 g L-1 was achieved. Usually, the growth 
begins with a lag phase in which the microorganism adapts to the enzymatic systems in 
order to metabolize the new substrate, but without growing (Sánchez et al., 2008), however, 
the previous adaptation of D. hansenii to hydrolyzates minimize this phase, showing a linear 
growth during the total period of fermentation, producing up to 9.5 g L-1 after 96 hours in 
fermentation 3 (QX = 0.099 g L-1 h-1; YX/S = 0.29 g g-1). 
4. Conclusions 
In this study, the following conclusions can be drawn related to agro industrial wastes 
evaluation: 
1. Based on the characterization and further diluted acid hydrolysis carried out to the agro 
industrial wastes evaluated, it can be concluded their great potential as feedstocks for 
the production of industrially relevant food additives. 
2. In particular, pistachio shells show the higher xylan content. Optimizing the conditions 
of hydrolysis by an experimental design reaches 90% of the theorical xylose present in 
raw material. 
3. Hydrolyzate medium obtained with nutrients supplementation can be effectively 
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1. Introduction 
The oxidation of lipids in food, cosmetic and pharmaceutical products, together with the 
growth of undesirable microorganisms results in the development of spoilage, off-flavor, 
rancidity and deterioration of such products turning them unacceptable for human 
consumption. In consequence, the addition of exogenous antioxidants such as butylated 
hydroxytoluene and butylated hydroxyanisole is frequently required to improve the 
stability of these products. As synthetic butylated derivatives may have toxic effects there is 
an increasing interest in the use of natural antioxidants, such as phenols isolated from plants 
to avoid undesired food borne diseases (Shylaja & Peter, 2004). 
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Which natural source is to be used? Which is a good candidate to be used as nutraceutical?. 
Rosemary (Rosmarinus officinalis L., Lamiaceae) is considered one of the most important 
sources for the extraction of phenolic compounds with strong antioxidant activity. This 
specie grows worldwide and has been cultivated since long ago, in ancient Egypt, 
Mesopotamia, China and India (Bradley, 2006). Rosemary extracts, enriched in phenolic 
compounds are effective antioxidants due to their phenolic hydroxyl groups but they also 
possess plenty of other beneficial effects like antimicrobial, antiviral, anti-inflammatory, 
anticarcinogenic activities and is also known to be an effective chemopreventive agent (al-
Sereiti et al., 1999; Aherne et al., 2007).  
Therefore, this specie contains bioactive ingredients which provide a complementary value 
other than the nutritional one, to be applied in the food industry. However, particular 
bioactives of rosemary responsible for some biological activities, as antimicrobial, have not 
been deeply characterized. A lesser amount of information exists about their mechanism of 
action. The present chapter focuses on the most significant rosemary biological properties, 
reviewing the free radical scavenging and antibacterial actions of non-volatile constituents 
and essential oils, the antibacterial activity of main rosemary bioactives in combination 
with antibiotics, as well as possible antibacterial mechanism of action is proposed, among 
other topics. In addition, a toxicity assay using the nematode Caenorhabditis elegans is 
covered.  
2. Rosemary the best natural antioxidant 
2.1 Antioxidant action of different fraction of rosemary 
Rosemary plants have many phytochemicals which constitute potential sources of natural 
compounds as phenolic diterpenes, flavonoids phenolic acids and essential oils. About 90% 
of the antioxidant activity is attributed mainly to a high content of non-volatile components 
as carnosic acid and carnosol (phenolic diterpenes) and rosmarinic acid (Bradley, 2006). It 
is clear that R. officinalis constituents have antioxidant activity according to traditional use 
and scientific evidence, although little information is available on the relationship between 
chemical composition and antioxidant activity of the essential oils and non-volatile 
extracts.  
We investigated the antioxidant activity of volatile and non-volatile fractions isolated from 
two leaf phenotypes of rosemary plants growing in the same farm in Argentina. Plants 
showing a wide (W) and a narrow (N) leaves phenotypes were collected from Jardín 
Botánico Arturo E. Ragonese from National Institute of Agricultural Technology-INTA 
Castelar, Argentina, January 2008. The essential oils were obtained by hydrodistillation of 
dried leaves using a Clevenger-type apparatus and samples were analyzed by high 
resolution gas chromatography coupled with mass spectrometry. Ethanol extracts were 
prepared according to the method previously reported (Moreno et al., 2006) and stored at -
20 °C. To determine the dry weight of each extract, 1 ml of the sample was dried in an oven 
to constant weight. The extracts were centrifuged using a 5804 Eppendorf centrifuge at 5000 
rpm for 15 min at room temperature before HPLC analysis. Quantification of phenolic 
compounds and identification was performed on an HPLC (LKB Bromma) equipped with a 
diode array detector, using a 250 mm × 4 mm C18 Luna analytical column (Phenomenex, 
USA), as previously described (Moreno et al., 2006).  
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The antioxidant activity was tested using a stable radical 2,2-diphenyl-1-picrylhydrazyl 
(DPPH) as described by Brand-Williams et al., 1995. The percentage of DPPH radical was 
calculated measuring the change in absorbance at 517 nm and EC50 (extract concentration 
necessary to decolorate DPPH radical in a 50%) was determined for each fraction.  
Results showed that different amounts of key bioactive compounds were present in the 
essential oils of both phenotypes. The main constituents of W phenotype essential oil were 
α-pinene and 1,8-cineole, while the N phenotype contained a comparable amount of 1,8 
cineole and high contents of myrcene (Table 1). Therefore, the first is referred as an α-pinene 
chemotype and the other one as a myrcene chemotype. The essential oil of the myrcene 
chemotype exhibited approximately a double fold antioxidant activity than the α-pinene 
phenotype. Recently, other authors reported that pure myrcene showed antioxidant activity 
and eliminated oxidative stress in rats in a time-dependent manner (Ciftci et al., 2011). 
Essential oil EC50  (μl/ml) Main constituents (%) 
W Phenotype  25.0 ± 1.0 α-Pinene  
1,8 -Cineole  
31.2 ± 2.5 
21.6 ± 1.6 
 N Phenotype  10.0 ± 0.4 Myrcene  
1,8-Cineole  
31.1 ± 2.3 
18.7 ± 1.4 
Table 1. Antioxidant activity and main constituents of essential oils isolated from two 
phenotypes of rosemary plants. Values ± SD 
Chemical analysis of ethanol rosemary extracts indicated that W phenotype contained about 
36.8% of diterpenes (carnosic acid plus carnosol) and 8.4% of rosmarinic acid, while the 
other phenotype contained a higher amount of diterpenes and lesser amounts of rosmarinic 
acid (Table 2). The ethanol extract isolated from the N phenotype, containing a high amount 
of diterpenes, exhibited approximately double fold antioxidant activity than plants of W 
phenotype. 
Our results showed that the volatile and non-volatile fractions isolated from the same 
phenotype had similar antioxidant activity. 
Ethanol extract  EC50 (μg/ml) Main constituents (%) 
W Phenotype  20.0 ± 0.8 Carnosic acid + carnosol  
Rosmarinic acid 
 36.8 ± 2.7 
   8.4 ± 0.5 
N Phenotype  10.8 ± 0.4 Carnosic acid + carnosol  
Rosmarinic acid  
 50.0 ± 4.5 
   2.9 ± 2.5 
Table 2. Antioxidant activity and main constituents of ethanol extracts isolated from two 
phenotypes of rosemary plants. Values ± SD 
2.2 Rosemary as protective agent against oxidative protein damage  
A large number of reports have shown rosemary constituents to be an efficient antioxidant 
against lipid peroxidation and DNA damage induced by radical oxygen species in rat liver 
mitochondria and microsomes at concentrations of 3 - 30 µM, demonstrating their ability to 
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well-known that several antioxidants exhibited pro-oxidant effect producing protein 
damage under certain conditions as in the presence of transition metals such as Fe and Cu. 
In order to study the protection of rosemary compounds against protein damage in 
comparison with ascorbate and 6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid 
(Trolox), hydroxyl radical-mediated oxidation experiments, were carried out using a metal-
catalyzed reaction. Bovine serum albumin (4 µg) was incubated with or without Cu+ (100 
µM) and H2O2 (1 mM) in the absence or presence of ascorbate, Trolox or the methanol 
rosemary extract (obtained as described in Moreno et al., 2006). Reactions were performed in 
opened tubes at 37°C, mixed with loading buffer and loaded in 12.5% dodecyl sulfate-
polyacrylamide gel electrophoresis as reported by Mayo et al., 2003. Figure 1 shows that 20 
µg of the plant extract used containing a concentration of 18 µM diterpenes, reduced 
significantly protein damage compared with 20 µM of ascorbate (compare the intensity of 
the protein’s monomer in lane 8 vs. lane 6). Figure 1 also shows that Trolox and ascorbate 
only protected protein modifications when they were present at lower concentrations, and 
no protection of the protein was observed at higher concentrations. Ascorbate reveals a 
higher pro-oxidant action than Trolox.  
Control H2O2+
Cu (100μM)+
Trolox (μM)  Ascorbate (μM)            RE (μg/ml)
2000    20        2000      20         40         20        10
 
Fig. 1. Gel electrophoresis of bovine serum albumin protein after treatment with H2O2 + 
CuSO4 in the presence of Trolox, ascorbate and methanol rosemary extract (RE) at the 
concentrations indicated. Control was performed with the addition of ethanol 0.2%. Arrow 
indicates the bovine serum albumin monomer 
3. Antibiotics and antioxidants of rosemary working together  
Due to the recent trend in green consumers, there is an increasing interest in the 
antimicrobial properties of rosemary compounds. Essential oils and organic or aqueous 
extracts of isolated from this specie not only have antioxidant activity but also present 
antibiotic effects, therefore they have gained acceptance in industry to replace existing 
synthetic preservatives in foods (Davidson, Sofos, & Branen, 2005).  
In the area of health, the near-term interest of plant products as antimicrobial agents is 
related to the development of new strategies/therapies for infections caused by bacterial 
species (Cowan, 1999; Lewis and Ausubel, 2006). Recently, it was reported that natural plant 
products can potentiate the activity of antibiotics in combination (Coutinho et al., 2009). 
Moreover, the use of bacterial resistance modifiers derived from natural sources, mainly 
from plants, such as efflux pump inhibitors, was suggested to be useful to suppress the 
emergence of multidrug resistant strains (Stavri et al., 2007).  
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To determine the validity of rosemary compounds as nutraceuticals, a rigorous analysis of 
the biological activities of their bioactives is required as well as the further study of their 
antibacterial mechanism of action. 
3.1 Antibiotic action of different fractions of rosemary 
We previously reported the effective antimicrobial action of non-volatile rosemary extracts 
containing 33 – 46% of diterpenes (carnosic acid plus carnosol) against common food 
pathogenic Gram positive bacteria as Staphylococcus aureus and Enterococcus faecalis as well as 
the Gram negative bacteria Escherichia coli (Moreno et al., 2006). These microorganisms cause 
severe problems in human health (NNIS, 2004). According to a 2011 research study, S. 
aureus was found in ~50% of beef, pork, and poultry products throughout the United States, 
96% of these isolates were resistant to at least 1 antibacterial agent relevant in human 
medicine and 52% were resistant to three or more types (Waters et al., 2011). 
Here, we show the antibacterial performance of a methanol rosemary extract (obtained as 
described in Moreno et al., 2006) in comparison with common food preservatives. The 
results are expressed in percent of inhibition of bacterial growth (see Equation 1)  
 595 595
595
(A Control - A Sample)% Inhibition of bacterial growth 100
A Sample
= ×   (1) 
Where, A595 Control is the absorbance of the bacterial culture without compounds.  
Rosemary extracts presented a higher antimicrobial efficacy than benzoic acid, butylated 
hydroxytoluene (BHT) and butylated hydroxyanisole (BHA) to inhibit S. aureus growth (Fig. 
2A), while a similar action than BHT and benzoic acid and a minor antimicrobial activity in 
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Fig. 2. Effect of the methanol rosemary extract (RE) on the S. aureus growth (A) or on the 
growth of E. coli (B), in comparison with BHA, BHT and benzoic acid. Values are shown as 
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The performance of rosemary oils and ethanol extracts isolated from the W phenotype and 
N phenotype plants against the human pathogen E. faecalis, was also compared (Table 3). 
Results showed that the essential oil from the α-pinene chemotype (W phenotype) exhibited 
a higher antibacterial activity than the essential oil isolated from N phenotype. By contrast, 
the ethanol extract isolated from the N phenotype containing higher amounts of carnosic 
acid and carnosol exhibited the highest antimicrobial action (Table 4).  
Phenotype Essential oil Inhibition of E. faecalis growth (%) 
W 26 μl/ml 100 
N 26 μl/ml 45.5 ± 3 
Table 3. Antibiotic activity of essentials oils isolated from two phenotypes of rosemary 
plants. Values are shown as the mean of three independent experiments ± SD 
Phenotype Ethanol extract Inhibition of E. faecalis growth (%) 
 
W  0.25 mg/ml  50.0 ± 6 
N  0.25 mg/ml 100 
Table 4. Antibiotic activity of ethanol extracts isolated from two phenotypes of rosemary 
plants. Values are shown as the mean of three independent experiments ± SD 
All findings suggested that carnosic acid and α-pinene are key ingredients responsible that 
confer the antibacterial properties in the non-volatile and volatile fractions isolated from 
rosemary plants, respectively. 
The essential oils isolated from N phenotype exhibited minor antibacterial activity than the 
other one, although it presented a higher performance as antioxidant.  
We are investigating the antibacterial action against several Gram positive and negative 
microorganisms. Others authors demonstrated antibacterial activity of volatile compounds 
against Listeria monocytogenes, Salmonella typhimurium, Escherichia coli, Shigella dysenteria, 
Bacillus cereus (For review see Burt, 2004).  
3.2 Antibiotic potentiation by rosemary bioactives 
The use of combined antioxidants has gained acceptance in industry and has been applied 
to different aspects of food preservation (Davidson, Sofos & Branen, 2005). Although, up to 
date, a rational basis for the use of phytochemicals enhancing and/or broadening the 
biological antioxidant and antimicrobial activities against food-borne pathogens, is still 
poorly explored (Wei & Shibamoto, 2007). In the health’s area, natural compounds are 
usefull strategies for the development of therapies against infections caused by bacterial 
species, and they are used in combination with common antibiotics potentiating their 
activity (Coutinho et al., 2009).  
We previously reported a synergistic antioxidant effect between the methanol rosemary 
extract and BHT and a synergistic interaction with BHA to inhibit E. coli and S. aureus 
growth (Romano et al., 2009). Here, we reported the in vitro antibiotic interaction of 
rosemary extracts with common antibiotics using the broth microdilution method against S. 
aureus and E. faecalis. 
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Figure 3A shows the dose-response curve, in which the addition of 6.25 μg/ml of the plant 
extract clearly displaced the curve to the left, meaning that an increment in the antimicrobial 
action against S. aureus took place in the binary mixture at all gentamicin concentrations 
tested. It can be extrapolated from the curve that 0.035 μg/ml of pure gentamicin is needed 
to achieve 50% of  inhibition, while the same effect can be achieved with 0.015 μg/ml of the 
aminoglycoside in the presence of rosemary extract.  
Then, to study the type of interactions binary mixtures with different concentrations of 
rosemary extract and pure carnosic acid with gentamicin were analyzed by isobolograms 



































Concentration (μg/ml)                                         FIC RE                                             FIC CA
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Fig. 3. Rosemary extract (RE) and carnosic acid (CA) acts synergistically with gentamicin 
against S. aureus. Dose-response curve (A), isobologram of gentamicin in combination 
with RE (B) or pure carnosic acid (C). Inhibition of S. aureus 25923 growth was determined 
after 24 h of incubation. FIC, fractional inhibitory concentration, normalized to the unit of 
RE, gentamicin or pure carnosic acid, corresponds to the MIC50 = 12 µg/ml, 0.035 µg/ml 
and 8 µg/ml, respectively. Values are shown as the mean of three independent 
experiments ± SD 
Compounds concentrations lower than their MIC50 values were prepared for every 
combination tested as described previously (Romano et al., 2009) and isobolograms were 
performed. When compounds in combination are more effective than what might be 
expected from their dose-response curves (synergy), smaller amounts will be needed to 
produce the effect under consideration, and a concave-up isobole results (Tallarida, 2001).  
The Fractional inhibitory concentration (FIC index) was determined (see Equation 2). 
 FIC index = FICA + FICB = [A]/MICA + [B]/MICB (2) 
FICA, FICB: Fractional inhibitory concentration of drug A & B respectively. MICA, MICB: 
Minimum inhibitory concentration of drug A & B respectively. [A], [B]: Concentration of 
drug A & B respectively.  
FIC index obtained by checkerboard method is interpreted as follows: ≤ 0.5- synergy; > 0.5 
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Fig. 3. Rosemary extract (RE) and carnosic acid (CA) acts synergistically with gentamicin 
against S. aureus. Dose-response curve (A), isobologram of gentamicin in combination 
with RE (B) or pure carnosic acid (C). Inhibition of S. aureus 25923 growth was determined 
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and 8 µg/ml, respectively. Values are shown as the mean of three independent 
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Figure 3B shows that different combinations of rosemary extracts corresponding to FIC 0.01 
to 0.25 with gentamicin (FIC of 0.2 to 0.4) resulted in fixed-ratio points below the additive 
line and exhibited values of FIC index ≤ 0.5, verifying synergistic antimicrobial effects of the 
plant extract with gentamicin.  
As carnosic acid was shown to be the main antimicrobial compound of non-volatile 
rosemary extracts against S. aureus (Moreno et al., 2006), this compound was assayed in 
combination with gentamicin at concentrations equivalent to those found in the extract (1 to 
10 μg/ml). The minimal inhibition concentration (MIC) of carnosic acid against the bacteria 
was 16 µg/ml and was referred as a FIC of 1. Values of FIC index ≤ 0.5 (FIC 0.3 of carnosic 
acid in combination with FIC 0.2 to 0.3 of gentamicin) were observed (Fig. 3C).  
On the other hand, rosmarinic acid exhibited a minor antibacterial effectiveness than 
carnosic acid and exhibited additive antibacterial actions with gentamicin (Data not shown). 
Therefore, data showed that the addition of both the extract and carnosic acid allows a 
reduction of the gentamicin amount in approximately 3 - 4 folds to obtain the same 
antibiotic action. The bactericidal action of rosemary extracts and pure carnosic acid were 
confirmed by time-kill curves. 
Table 5 shows that carnosic acid plus tetracycline, tobramycin, kanamycin, ciprofloxacin and 
gentamicin exhibits significant synergistic antibiotic activity against S. aureus. 
Antibiotics MIC values of antibiotic in combination  
with MIC of carnosic acida (µg/ml) 
FIC 
Index 
 0 1/8 1/4 1/2  
Tetracycline 0.50 0.06 0.06 0.06 0.25 
Tobramycin 0.50 0.12 0.12 0.06 0.37 
Kanamycin 2.00 1.00 0.50 0.25 0.50 
Vancomycin 2.00 1.00 1.00 0.50 0.62 
Ciprofloxacin 0.50 0.06 0.12 0.12 0.25 
Penicillin 0.06 - 0.03 0.03 0.75 
Gentamicin 0.50 0.06 0.06 0.06 0.25 
Table 5. Antibiotic activity of carnosic acid in combination with several antibiotics against  
S. aureus ATCC 25923. aUnderlined values: combinations of minimum FIC used to calculate 
the FIC index. Values are the mean of three independent experiments 
In order to confirm the role of carnosic acid as the main bioactive compound of rosemary 
extracts involved in the synergistic effect with gentamicin, additional experiments were 
carried out, examining carnosic acid in combination with gentamicin against E. faecalis  
(Fig. 4). Results showed that 30 μg/ml of the diterpene in combination with 0.25 μg/ml of 
gentamicin resulted in an strong antibiotic synergistic effect as the expected value for the 
sum corresponding to individual effects was 42% of inhibition, whereas experimental data 
showed a100 % of inhibition on bacteria growth for the combination mixture. 
 
Rosemary Compounds as Nutraceutical Health Products 
 
165 
30               45              0.10              0.25              30                45
CA                            Gentamicin                       CA+


























Fig. 4. Antibiotic activity of carnosic acid in combination with gentamicin against E. faecalis 
ATCC 29212. Dark grey bars represent the expected results if an additive interaction took 
place and light grey bars show the experimental data 
3.3 Mechanism of antibacterial action of rosemary bioactives 
R. officinalis plants exhibited antibiotic activity although less is known regarding the 
mechanisms of action of the particular bioactives. Polyphenols still constitute a promising 
source of new drugs and there is a high interest in understanding their mechanisms of 
action (Scalbert, 2005). We carried out studies to determine the antibacterial effect of the 
carnosic acid. This liphophilic diterpene has been found associated with chloroplasts 
membranes (Perez-Fons et al., 2006). Herein the cell membrane permeabilization effect by 
carnosic acid using the membrane potential sensitive cyanine dye DiS-C3-(5). This 
fluorescent probe is a caged cation, which distributes between cells and medium depending 
on the cytoplasmic membrane potential. Once it is inside the cells, it becomes concentrated 
and self-quenches its own fluorescence. The fluorescence monitored with an excitation 
wavelength of 610 nm and an emission wavelength of 670 nm. A blank with only cells and 
the dye was used to subtract the background and compounds as the proton motive force 
inhibitor carbonyl cyanide-m-chlorophenylhydrazone (CCCP) and Polimycyn B were used 
as controls for their ability to decreased or increase the membrane potential, respectively.  
S aureus suspension was incubated with 1.6 µM DiS-C3-(5) until a stable reduction in 
fluorescence and 100 mM KCl was added to equilibrate the cytoplasmic and external K+ 
concentration. Figure 5 shows time decreases of the fluorescence intensities upon addition of 
32 µg/ml of carnosic acid to S. aureus cells in a similar way than the inhibitor CCCP, while 
the cationic antimicrobial peptides Polimyxyn B produced an increment on the fluorescence. 
CCCP is a small amphipathic molecule which dissolves in phospholipid bilayers, providing 
a polar environment for the ion and an hydrophobic face to the outside world, it is an 
uncoupling agent that specifically increases the proton permeability, and disconnects the 
electron transport chain from the formation of ATP, discharging the pH gradient, and 





Figure 3B shows that different combinations of rosemary extracts corresponding to FIC 0.01 
to 0.25 with gentamicin (FIC of 0.2 to 0.4) resulted in fixed-ratio points below the additive 
line and exhibited values of FIC index ≤ 0.5, verifying synergistic antimicrobial effects of the 
plant extract with gentamicin.  
As carnosic acid was shown to be the main antimicrobial compound of non-volatile 
rosemary extracts against S. aureus (Moreno et al., 2006), this compound was assayed in 
combination with gentamicin at concentrations equivalent to those found in the extract (1 to 
10 μg/ml). The minimal inhibition concentration (MIC) of carnosic acid against the bacteria 
was 16 µg/ml and was referred as a FIC of 1. Values of FIC index ≤ 0.5 (FIC 0.3 of carnosic 
acid in combination with FIC 0.2 to 0.3 of gentamicin) were observed (Fig. 3C).  
On the other hand, rosmarinic acid exhibited a minor antibacterial effectiveness than 
carnosic acid and exhibited additive antibacterial actions with gentamicin (Data not shown). 
Therefore, data showed that the addition of both the extract and carnosic acid allows a 
reduction of the gentamicin amount in approximately 3 - 4 folds to obtain the same 
antibiotic action. The bactericidal action of rosemary extracts and pure carnosic acid were 
confirmed by time-kill curves. 
Table 5 shows that carnosic acid plus tetracycline, tobramycin, kanamycin, ciprofloxacin and 
gentamicin exhibits significant synergistic antibiotic activity against S. aureus. 
Antibiotics MIC values of antibiotic in combination  
with MIC of carnosic acida (µg/ml) 
FIC 
Index 
 0 1/8 1/4 1/2  
Tetracycline 0.50 0.06 0.06 0.06 0.25 
Tobramycin 0.50 0.12 0.12 0.06 0.37 
Kanamycin 2.00 1.00 0.50 0.25 0.50 
Vancomycin 2.00 1.00 1.00 0.50 0.62 
Ciprofloxacin 0.50 0.06 0.12 0.12 0.25 
Penicillin 0.06 - 0.03 0.03 0.75 
Gentamicin 0.50 0.06 0.06 0.06 0.25 
Table 5. Antibiotic activity of carnosic acid in combination with several antibiotics against  
S. aureus ATCC 25923. aUnderlined values: combinations of minimum FIC used to calculate 
the FIC index. Values are the mean of three independent experiments 
In order to confirm the role of carnosic acid as the main bioactive compound of rosemary 
extracts involved in the synergistic effect with gentamicin, additional experiments were 
carried out, examining carnosic acid in combination with gentamicin against E. faecalis  
(Fig. 4). Results showed that 30 μg/ml of the diterpene in combination with 0.25 μg/ml of 
gentamicin resulted in an strong antibiotic synergistic effect as the expected value for the 
sum corresponding to individual effects was 42% of inhibition, whereas experimental data 
showed a100 % of inhibition on bacteria growth for the combination mixture. 
 
Rosemary Compounds as Nutraceutical Health Products 
 
165 
30               45              0.10              0.25              30                45
CA                            Gentamicin                       CA+


























Fig. 4. Antibiotic activity of carnosic acid in combination with gentamicin against E. faecalis 
ATCC 29212. Dark grey bars represent the expected results if an additive interaction took 
place and light grey bars show the experimental data 
3.3 Mechanism of antibacterial action of rosemary bioactives 
R. officinalis plants exhibited antibiotic activity although less is known regarding the 
mechanisms of action of the particular bioactives. Polyphenols still constitute a promising 
source of new drugs and there is a high interest in understanding their mechanisms of 
action (Scalbert, 2005). We carried out studies to determine the antibacterial effect of the 
carnosic acid. This liphophilic diterpene has been found associated with chloroplasts 
membranes (Perez-Fons et al., 2006). Herein the cell membrane permeabilization effect by 
carnosic acid using the membrane potential sensitive cyanine dye DiS-C3-(5). This 
fluorescent probe is a caged cation, which distributes between cells and medium depending 
on the cytoplasmic membrane potential. Once it is inside the cells, it becomes concentrated 
and self-quenches its own fluorescence. The fluorescence monitored with an excitation 
wavelength of 610 nm and an emission wavelength of 670 nm. A blank with only cells and 
the dye was used to subtract the background and compounds as the proton motive force 
inhibitor carbonyl cyanide-m-chlorophenylhydrazone (CCCP) and Polimycyn B were used 
as controls for their ability to decreased or increase the membrane potential, respectively.  
S aureus suspension was incubated with 1.6 µM DiS-C3-(5) until a stable reduction in 
fluorescence and 100 mM KCl was added to equilibrate the cytoplasmic and external K+ 
concentration. Figure 5 shows time decreases of the fluorescence intensities upon addition of 
32 µg/ml of carnosic acid to S. aureus cells in a similar way than the inhibitor CCCP, while 
the cationic antimicrobial peptides Polimyxyn B produced an increment on the fluorescence. 
CCCP is a small amphipathic molecule which dissolves in phospholipid bilayers, providing 
a polar environment for the ion and an hydrophobic face to the outside world, it is an 
uncoupling agent that specifically increases the proton permeability, and disconnects the 
electron transport chain from the formation of ATP, discharging the pH gradient, and 





0                 30                60                90              120
















Fig. 5. Time changes of the fluorescence intensities of DiS-C3-(5) upon addition of carnosic 
acid to S. aureus cells: 32 µg/ml ( ), 16 µg/ml ( ), cells treated with CCCP ( ), cells 
treated with Polimyxyn B ( ) and untreated cells ( ). Representative records from two 
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Fig. 6. Effect of carnosic acid on EtBr efflux in S. aureus cells. Control corresponds to the 
initial intracellular fluorescence of EtBr at time 0. Representative efflux records from two 
similar independent experiments are shown 
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As it can be seen above, carnosic acid at 1/4 - 1/8 MIC value (2 to 4 μg/ml) showed a 
selective synergistic interaction with tetracycline and aminoglycosides (Table 5) that may be 
explained by selective modulation of the antibiotics accumulation possibly by inhibition of 
their efflux in S. aureus. To assess whether this compound may have an efflux pump 
inhibitor activity in S. aureus, the efflux substrate ethidium bromide (EtBr) was used. EtBr 
shows a characteristic fluorescence when it enters the cell and binds to DNA and its uptake 
was determined by monitoring the fluorescence using a multiwell plate reader (DTX 880 
Multimode detector, Beckman Coulter) at 29ºC every 10 sec intervals for 3 min with 
excitation and emission wavelengths of 535 nm and 485 nm, respectively. Figure 6 shows 
that carnosic acid rapidly increased EtBr uptake and this effect was dose dependent 
indicating a positive effect on the intracellular accumulation of the fluorescent molecule.  
Whether carnosic acid is a general disruptor of the transmembrane electrochemical 
potential, it should display a synergistic effect with chloramphenicol which is effluxed out 
of the cell by secondary transport relying in the membrane potential. Additionally, an 
antagonist effect with ampicillin and penicillin G, which enter inside cells by a proton 
symport mechanism, should be displayed however, none of these effects were observed 
(Table 5).  
Other studies from our laboratory on the antibiotic action of carnosic acid against E. faecalis 
showed similar results. In time-kill studied, carnosic acid displayed a bacteriostatic effect at 
its MIC value (64 μg/ml), whereas a bactericidal effect was achieved at 2 x MIC (128 μg/ml) 
increasing the permeability of cell membrane effects. At sub MIC values, the diterpene 
inhibited the drug efflux pumps of secondary transporters (Repetto, 2009). Other authors 
reported the antibacterial and resistance modifying activity of R. officinalis and suggested 
that the carnosic acid has the capacity to modify the resistance pattern of strains of S. aureus 
expressing multidrug efflux pumps (Oluwatuyi et al., 2004). Regarding this feature, we 
decided to investigate several bioactive compounds of R. officinalis with antimicrobial 
activity per se, or as modulators of bacterial resistance, against multidrug-resistant clinical 
strains of S. aureus isolated from pediatric patients (Ojeda Sana et al., 2011). 
Our findings, together with results from other authors, suggest that this diterpene is a 
potential antibacterial agent to be used in combinational therapy (at least with 
aminoglycosides, tetracyclin and fluoroquinolones) against sensitive as well as multidrug 
resistant, vancomicyn and/or methicillin resistant Gram-positive cocci. Moreover, as an 
antibacterial compound, carnosic acid can not only target membrane permeability and 
enhance drug uptake, but also this compound, at sub MIC values inhibited the drug efflux 
transport probable by altering the cell membrane potential. We proposed a model for the 
antibacterial action of carnosic acid (Fig. 7). 
3.4 Rosemary bioactives kill inthaphagocytic S. aureus cells 
We examined the intracellular antibacterial activity of carnosic acid against S. aureus. A 
model of S. aureus infected RAW 654.7 mouse macrophages has been monitored for long-
term (24 h) experiments. This bacterium adheres to phagocytes and easily invades them and 
tends to restrict the phagolysosomal compartment, where it largely escapes destruction and 
survives in a semiquiescent state for prolonged periods (Maurin et al., 2001). These 
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staphylococcal infections as well as for the many failures of apparently appropriate 
antibiotic treatments.  
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Fig. 7. Proposed model for the antibacterial action of carnosic acid. NMGs, aminoglycosides; 
TETs, Tetracyclins and FGs, fluoroquinolones 
Confocal microscopy was used to ascertain the localization of the bacteria inside RAW 264.7 
macrophages observed 24 h after phagocytosis of opsonized S. aureus. As shown in Fig. 8 A 
and B S. aureus clearly appeared intracellular. Pericellular membrane, located mostly on the 
inner face was labeled with FITC- phalloidin (green signal), and bacteria were labeled with 
DAPI (Blue signal).  Later, macrophages were incubated for 24 h with carnosic acid from the 
MIC (16 µg/ml, determined in broth at pH 7.3). Carnosic acid caused a marked reduction in 
CFU, diminishing 3-4 log the bacterial growth at a concentration of 1 ½ MIC (24 µg/ml) (Fig. 
8C). This effect was comparable to the control cells incubated with 0.5 µg/ml ciprofloxacin, 
a fluoroquinolone antibiotic that has excellent antibacterial activity against gram positive 
bacteria and intracellular penetration. 
Earlier we demonstrated the in vivo antibacterial efficacy of a rosemary extract containing 
high amounts of carnosic acid against S. aureus in two skin infection models in mice (Barni 
et al, 2009). 
Clinically effective antimicrobial agents exhibit selective toxicity towards the bacterium 
rather than the host. It is this characteristic that distinguishes antibiotics from disinfectants. 
The basis for selectivity will vary depending on the particular antibiotic. Carnosic acid at the 
concentrations that kill S. aureus has a high selectivity to bacteria and is not toxic to 
macrophages. 
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Fig. 8. Intraphagocitic killing of  S. aureus by carnosic acid. Confocal microscopy of 
uninfected RAW 264.7 macrophages (A) or after phagocytosis of S. aureus (B). Arrowheads 
indicate intraphagocytic bacteria. (C) variations in the number of CFU per mg of protein  
(± SD; n= 2) after 24 h of incubation with carnosic acid or with 0.5 µg/ml of ciprofloxacin 
(Cipro). (D) Effect of carnosic acid following a 24-h exposure using a standard MTS cell 
viability assay 
4. Safety of rosemary: Toxicity evaluation 
Due to the potential use in human nutrition and health in foods of carnosic acid, it is 
important to determine its toxicological effects in a living organism.  
In this study, we used Caenorhabditis elegans as a model system to examine the toxic effects of 
rosemary bioactives. This nematode, present in soil and found in temperate regions of the 
world, has emerged as an important animal model in various fields including toxicological 
research and rapid toxicity assessment for new chemicals (Moy T et al., 2006). C. elegans is 
easily cultured on agar medium plates with Escherichia coli OP50 as a food source. The ease 
of laboratory cultivation, its small size, large brood size, short development time (the entire 
complete life cycle from egg to egg producing hermaphrodite occurs over 3 days at 20°C 
under normal laboratory conditions) and the well-studied biology, makes the C.elegans an 
ideal model organism for biological studies. The transparency of this nematode allows for 
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how carnosic acid affects C. elegans survival by exposing them to various concentrations of 
this compound. The C. elegans life cycle is comprised of an embryonic stage, four larval 
stages designated L1-L4 and adulthood. As it had been previously described that some 
nematode killing observed in this assays was a consequence of eggs being retained in the 
uterus and hatching internally, we substituted wild type worms by the glp-4 temperature-
sensitive sterile mutants to prevent internal hatching of progeny. glp-4 does not make a 
germline at the restrictive temperature and survive without a bacterial food source, whereas 
WT C. elegans die by internal hatching of progeny when transferred to bacteria-free media. 
Worms were synchronized by isolating eggs from gravid adults, hatching the eggs 
overnight in M9 buffer, and plating L1-stage worms onto lawns of OP50 E. coli on nematode 
growth medium (NGM) agar media. Worms were grown to sterile, young adults by 
incubation at 25°C for 48 – 52 h, washed off the plates with M9 buffer. Approximately 40 
worms were transferred to 24 well plates containing 500 microliters of M9 medium and the 
compounds to be tested. Each compound was tested in individual wells, and the screen was 
performed by using triplicate 24-well plates. To score for survival, the plates were shaken by 
hand, worms were considered to be dead if they did not move or exhibit muscle tone when 
viewed using a stereo microscope at 20X magnification. Worms were observed every two 
days and scored for survival analysis at day 8 after transfer. As carnosic acid was dissolved 
in ethanol, we first tested if the 1.6% final ethanol concentration found in the vehicle of this 
assay had any effect over the survival of worms. We didn’t find significative differences 
between the survival of ethanol treated and untreated worms. Our results demonstrated 
that up to 250 µg/ml of carnosic acid tested the compound does not adversely affect the 
normal physiology of the nematodes, while the highest concentration tested (500 µg/ml) of 
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Fig. 9. Effect of carnosic acid over C.elegans survival. (Inset) typical morphology of living 
nematodes maintaining a sinusoidal shape (left) and dead ones appearing as straight, rigid 
rods (right) (at ×20 magnification). Values are shown as the mean of three independent 
experiments ± SD 
 




The present chapter summarizes the most significant rosemary biological properties, 
reviewing its free radical scavenging, antibacterial actions of essential oils and non-volatile 
pure constituents and in combination with antibiotics. 
Both volatile and non-volatile secondary metabolites isolated from rosemary plants growing 
in the same place exhibited comparable antioxidant activities. Non-volatile constituents 
exhibited at least a minor pro-oxidant property than ascorbic acid and Trolox, at the 
concentration assayed.  The non-volatile fractions containing high content of carnosic acid as 
well as the volatile oils rich in α-pinene exhibited the highest antibiotic activity. 
Rosmarinus officinalis extract as well pure carnosic acid, showed synergistic effect in 
combination with aminoglycosides and ciprofloxacin against S. aureus. We proposed a 
model for the antibacterial action of carnosic acid which may be useful for future 
applications. 
Unexpectedly, carnosic acid showed a clear antistaphylococcal action towards extracellular 
and intraphagocytic forms of Staphylococcus aureus, pointing out a potential use of this 
compound in the treatment of S. aureus infections, without significant effect on the 
macrophage viability. Moreover, carnosic acid at bactericide concentrations did not show 
adverse effects on the viability of a living organism as the nematode C. elegans. 
6. Rosemary in human nutrition and health: Future and prospect 
All together, the available evidence indicates that rosemary compounds might be of 
therapeutic benefit in bacterial infections and be an ideal candidate for nutraceutical health 
products. Non-volatile extracts of rosemary containing approximately an amount of 20 
μg/ml (18 μM) of carnosic acid as the key compound, killed several bacteria and represent a 
therapeutic alternative against extracellular-intracellular S. aureus infections. This compound 
did not show pro-oxidant effects and its use is safe at least until a concentration of 250 
μg/ml (750 μM). The in vivo antibacterial efficacy of an ethanol extract of Rosmarinus 
officinalis L. containing high amounts of carnosic acid against the pathogenic bacteria S. 
aureus has been demonstrated previously in mouse (Barni et al, 2009). Even though, 
prospective controlled clinical studies are still lacking. 
Rosemary is the only spice commercially available for use as an antioxidant in Europe and 
the United States. This specie has the advantage to contain different antioxidant molecules 
(lipophilic monoterpenes and diterpenes, as well as hydrophilic derivatives of caffeic acid as 
rosmarinic acid) that could be effective in both, aqueous fluids as well as in lipophilic parts 
of the body as a very effective antioxidant to scavenge free radicals. In addition, non-volatile 
extracts of rosemary can also be used to decrease 4.4 - to 17-fold the amounts of the synthetic 
butyl derivatives used as food or cosmetic preservatives (Romano et al., 2009).  
Although not discussed in this chapter, due to the associated bioactivities of carnosic acid 
(anti-inflammatory-and anticarcinogenic  effects), rosemary polyphenols can be considered 
as a potential source of promising new nutraceuticals formulations (Mengoni et al., 2011). 
Improvements in the processes of regulation of rosemary bioactives are needed, and the 
general tendency is to perpetuate the German Commission E experience, which combines 
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There is still work to be done regarding how to use rosemary derivatives inside the human 
diet. Particular attention needs to be given to stability studies and interactions of rosemary 
constituents with other food constituents. Further investigations will be directed towards 
the application of phenolic compounds in various food matrices. The use of functional foods 
enriched with rosemary compounds need technologies for incorporating health-promoting 
ingredients into food without reducing their bioavailability or functionality. In this sense, 
we are also working on the addition of rosemary bioactives into edible films (Proyect 
CYTED, 309AC0382 action: Getting additive materials from plant by-products of the region 
and its application in the development of biodegradable packaging food processing and 
nutraceutical use). Finally, the production and biotechnological studies and genetic 
improvement of rosemary plants will offer great advantages, since it will be possible to 
obtain uniform and high quality raw materials which will ensure the efficacy and safety of 
rosemary products. 
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1. Introduction 
The increasing consumer awareness that diet and health are linked is stimulating innovative 
development of novel products by the food industry. Lactic acid bacteria (LAB) have 
received much attention over recent decades due to the health-promoting properties of 
certain strains, called probiotics. The concept probiotics has been redefined over time. Fuller 
defined it as “A live microbial feed which beneficially affects the host animal by improving 
intestinal microbial balance” (Fuller, 1989). The probiotic products traditionally incorporate 
intestinal species of Lactobacillus because of their long history of safe use in the dairy 
industry and their natural presence in the human intestinal tract, which is known to contain 
a myriad of microbes, collectively called the microbiota. Intestinal LAB in humans are 
intimately associated with the host’s health because they are an important biodefense factor 
in preventing colonization and subsequent proliferation of pathogenic bacteria in the 
intestine. In fact, probiotics have been used for as long as people have eaten fermented 
foods. However, it was Metchnikoff at the turn of the 20th century who first suggested that 
ingested bacteria could have a positive influence on the normal microbial flora of the 
intestinal tract (Metchnikoff, 1907). He hypothesized that lactobacilli were important for 
human health, longevity, and promoted yogurt and other fermented foods as healthy. Food 
derived from plants, animals, or their products often contain many types of microbes. These 
microbes from natural and external sources colonize food by contact, which can occur 
anytime between production and consumption. Microbial contamination of food (i.e. the 
colonization by unwanted microorganisms) can have many undesirable consequences 
ranging from spoilage to food borne illness. However, some microbes possess properties 
that are beneficial for food production or conversion or storage. These food grade 
microorganisms are used to produce a variety of fermented foods (with improved storage 
capability) from raw animal and plant material. Having natural preservatives in mind, LAB 
and their metabolites are good alternatives. The increasing consumer awareness of the risks 
derived not only from food-borne pathogens, but also from the artificial chemical 
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microorganisms are used to produce a variety of fermented foods (with improved storage 
capability) from raw animal and plant material. Having natural preservatives in mind, LAB 
and their metabolites are good alternatives. The increasing consumer awareness of the risks 
derived not only from food-borne pathogens, but also from the artificial chemical 
preservatives used to control them (Abee et al., 1995), has led to renewed interest in so-called 
“green technologies” including novel approaches for a minimal processing and exploitation 





the link between fermentation and preservation, and refers to extension of the shelf-life and 
improvement of the safety of food using microorganisms and/or their metabolites (Kao & 
Frazier, 1966; Klaenhammer, 1988; Holzapfel et al., 1995). Furthermore, the use of LAB and 
or their metabolites for food preservation is generally accepted by consumers as something 
“natural” and “health-promoting” (Montville & Winkowski, 1997). Among LAB, addition of 
Lactobacillus culture to food is an approach to food preservation, it also contributes to taste, 
texture and also inhibits food spoilage bacteria by producing growth inhibiting substances 
like bacteriocins, lactic acid etc. Strategies utilized to study incorporation of biopreservatives 
into food include: direct use of LAB-strains with proven antimicrobial activity as starter 
cultures or food additives, use of biopreservatives preparation in the form of previously 
fermented product, or use of partially-purified, purified or chemically synthesized 
bacteriocins (De Vuyst & Vandamme, 1994).  
2. Food-associated Lactic acid bacteria 
The first essential step in food fermentation is the catabolism of carbohydrates by the LAB. 
LAB as a group exhibit an enormous capacity to degrade different carbohydrates and 
related compounds. LAB are Gram-positive, non-spore forming cocci, coccobacilli or rods 
and most genera have a DNA base composition of less than 50% G+C, lack catalase, grow 
under microaerophilic or anaerobic conditions, and typically ferment glucose mainly to 
lactic acid (homo-fermentative), but can also have lactic acid, CO2, and ethanol/acetic acid 
as end products (hetero-fermentative). In nature, species of the LAB are found in gastro-
intestinal tract (GIT) of mammals and also in fermented food products (dairy, meat, 
vegetables, fruits and beverages). LAB associated with foods are generally restricted to the 
genera Lactobacillus, Lactococcus, Leuconostoc, Pediococcus and Streptococcus. Orla-Jensen (1919) 
proposed a classification of lactic acid bacteria, which was based on morphology, 
temperature range of growth, nutritional characteristics, carbon sources utilization and 
agglutination effects. Orla-Jensen (1919) differentiated three major groups. The first group 
contained Thermobacterium, Streptobacterium and Streptococcus which were all catalase 
negative and produce mainly lactic acid besides traces of other by-products. The second 
group contained Betabacterium and Betacoccus, which also lack catalase but as a rule formed 
detectable amounts of gas and other by-products, besides lactic acid. The third group 
consisting of Microbacterium and Tetracoccus show a positive catalase reaction. In 1960, Van 
den Hammer showed that representative of Betabacterium did not possess fructose-1,6-
bisphosphate aldolase, in contrast to Thermobacterium and Streptobacterium. These findings 
supported the discrimination of the three physiological groups: (i) the obligately  
homo-fermentative lactobacilli, lacking both glucose-6-phosphate dehydrogenase and 6-
phosphogluconate dehydrogenase (Thermobacterium), (ii) the facultatively homo-fermentative 
lactobacilli having both dehydrogenases but degrading glucose preferably via the Embden-
Meyerhof-Parnas pathway (Streptobacterium) and (iii) the obligately hetero-fermentative 
lactobacilli lacking fructose 1,6-bisphosphatealdolase (Betabacterium). Thermobacterium, 
Streptobacterium and Betabacterium were considered to be the three subgenera within the 
genus Lactobacillus.  
The genus Lactobacillus belongs to the large group of lactic acid bacteria. The genus 
Lactobacillus belongs phylogenetically to the phylum Firmicutes (Garrity et al., 2004). The 
family Lactobacillaceae comprises the main family in the order Lactobacillales which itself 
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belongs to the class Bacilli. Lactobacilli can be found in a variety of ecological niches, such as 
plants (fruits, vegetables, cereal grains) or plant-derived materials, silage, fermented foods 
(yogurt, cheese, olives, pickles, salami, etc.), as well as in the oral cavities, GIT, and vaginas 
of human and animals. The bacteria that occupy a niche in the GIT are true residents or 
autochthonous (i.e., found where they are formed). Other bacteria are just “get a lift” 
through the gut and are allochthonous (i.e., formed in another place). Autochthonous strains 
have a long-term association with a particular host, and they form stable populations of a 
characteristic size in a particular region of the gut. It is often difficult to determine whether 
or not a particular microorganism is truly autochthonous to a particular host (Tannock, 
2004). 
3. The role of lactic acid bacteria in the functional food concept 
3.1 The functional food concept 
Functional food is food that promotes human health above the provision of basic nutrition. 
The term “functional food” was first proposed in Japan two decades ago and legally 
approved there as Food for Specified Health Use (FOSHU). A relatively recently proposed 
working definition describes functional food as “food that can be satisfactorily 
demonstrated to affect beneficially one or more target functions in the body, beyond 
adequate nutritional effects, in a way relevant to an improved state of health and well-being 
and/or reduced risk of diseases” (Contor, 2001). Functional foods are also known as 
designer foods, medicinal foods, nutraceuticals, therapeutic foods, super foods, 
foodiceuticals, and medifoods (Shah, 2001). Functional food has a significant and growing 
global market, of which the largest segment in Europe, Japan and Australia comprises food 
containing probiotics, prebiotics and synbiotics (Stanton et al., 2005). 
3.2 Probiotics 
The idea that LAB prevents intestinal disorders and diseases is nearly as old as the science 
of microbiology (Molin, 2001). Therefore, in the development of probiotic food intended for 
human consumption, strains of LAB have most commonly been used. The term “probiotic” 
(Greek: for life) was first used by Lilly and Stillwell (1965). “Probiotic” was later more 
widely used and defined by Parker (1974), and further improved by Fuller (1989) with the 
following definition: “A live microbial food supplement which beneficially affects the host 
animal by improving its intestinal microbial balance”. This definition has later been slightly 
revised (Schaafsma, 1996; Schrezenmeir & de Vrese, 2001) to “Foods containing live and 
defined bacteria, which when given in sufficient numbers, exert beneficial effects by altering 
the microflora in the host” or as expressed by Salminen et al., (1998) “Viable preparation in 
food or dietary supplements to improve the health of humans and animals”. According to 
these definitions, an impressive number of microbial species and genera can be considered 
as probiotics. However, only strains classified as LAB are (due to their traditional use in 
food) currently considered of importance in regard to food and nutrition. 
3.3 Prebiotics 
Since the viability of the live bacteria in food products and during transit through the GIT 
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“non-digestible food ingredient that beneficially affects the host by selectively stimulating 
the growth and/or activity of one or a limited number of bacteria in the colon that can 
improve the host health” (Gibson & Ruberfroid, 1995). Thus, selective growth of certain 
indigenous gut bacteria is improved by the administration of the prebiotic and thereby any 
viability problems of orally administered bacteria in the upper GIT can be overcome. Some 
oligosaccharides, due to their chemical structure, are resistant to digestive enzymes and 
therefore pass into the large intestine where they become available for fermentation by 
saccharolytic bacteria. Compounds that are either partially degraded or not degraded by the 
host and are preferentially utilized by probiotic bacteria as a carbon and/or energy source. 
The criteria which allow classification of a food ingredient as a prebiotic, are defined by 
Fooks and Gibson (2002), and include the following statements, ex. fructo-oligosaccharides, 
xylo-oligosaccharides, lactose derivatives such as lactulose, lactitol, galacto-oligosaccharides 
and soyabean oligosaccharides. 
i. It must be neither hydrolysed, nor absorbed in the upper part of the GIT. 
ii. It should be selectively fermented by one or a limited number of potentially beneficial 
bacteria in the colon. 
iii. Its presence should alter the colonic microbiota towards a healthier composition. 
iv. It should induce effects which are beneficial to the host’s health. 
3.4 Synbiotics 
A further possibility in microflora management procedures is the use of synbiotics, i.e., the 
use in combination of probiotics and prebiotics (Gibson & Roberfroid, 1995). The live 
microbial additions may be used in conjunction with a specific substrate for growth and the 
end result should be improved survival of the probiotic, which has a readily available 
substrate for its fermentation, as well as the individual advantages that each may offer 
(Fooks & Gibson, 2002). Many studies suggest that the consumption of synbiotic products 
has higher beneficial effects on the human health than probiotic or prebiotic products 
(Gmeiner et al., 2000), leading to improved survival of probiotic bacteria during the storage 
of the product and during the passage of the intestinal tract. Moreover, the synbiotic 
product may allow an efficient implantation of probiotic bacteria in colonic microbiota, 
because the prebiotic has a stimulating effect on the growth and/or activities of both the 
exogenous and the endogenous bacteria (Champagene & Gardner, 2005). 
3.5 Important aspects for selection of probiotic strains 
When selecting a probiotic strain, a number of aspects should be considered, and the 
theoretical basis for selection should involve safety, functional as well as technological 
aspects (Salminen et al., 1998; Adams, 1999; Saarela et al., 2000). When selecting a preferable 
probiotic strain, several aspects of functionality have to be considered, as specified below: 
i. Strains for human use are preferably of human origin and isolated from a healthy 
human GIT and non-pathogenic 
ii. must survive through upper GIT and arrive alive at its site of action and able to 
function in the gut environment  
iii. adhere to the intestinal epithelium cell lining and colonize the lumen of the intestinal 
tract 
iv. strains should not carry transmissible antibiotic resistance genes 
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v. must be able to survive GI transit (acid and bile salt tolerant) 
vi. must have good technological properties so that it can be manufactured and 
incorporated into food products without loosing viability and functionality or creating 
unpleasant flavors or textures 
vii. functional aspects include viability and genetic stability  
3.5.1 Acid and bile tolerance  
Probiotic lactobacilli encounter various environmental conditions upon ingestion by the 
host and during transit in the GIT. Firstly, they need to survive the harsh conditions of the 
stomach. Humans secrete approximately 2.5 litres of gastric juice each day, generating a 
fasting pH of 1.5, increasing to pH 3 to 5 during food intake and that the food transit time 
through the human stomach is about 90 minutes. The aggregation of cells could possibly be 
explained by an increased hydrophobicity of the cell surface at low pH. The cell envelope of 
gram-positive bacteria consists of an inner plasma membrane and a thick outer layer of 
peptidoglycan. In contrast to gram-negative bacteria, cell walls of gram-positive bacteria 
contain large amounts of negatively charged teichoic acids (polymers of glycerol or ribitol 
joined by phosphate groups). Hence, one can assume that the teichoic acids become 
protonated at low pH, leading to a more hydrophobic surface. Ingested microorganisms 
must endure numerous environmental extremes to survive in the human GIT. Bile tolerance 
is one of the most essential criteria for the selection of a probiotic strain. Bile acids are 
synthesized in the liver from cholesterol and are secreted from the gall-bladder into the 
duodenum, where they play an important role in the digestion of fat. Bile acids are 
conjugated to either glycine or taurine. Bile is a digestive secretion that plays a major role in 
the emulsification of lipids. Bile acids are surface active, amphipathic molecules with potent 
antimicrobial activity and act as detergents, disrupting biological membranes. It has the 
ability to affect the phospholipids, proteins of cell membranes and disrupt cellular 
homeostasis. Therefore, the ability of pathogens and commensals to tolerate bile is likely to 
be important for their survival and subsequent colonization in the GIT (Begley et al., 2005). 
In our study, we have isolated Lactobacillus rhamnosus Fb from healthy human infant feces, is 
a gram-positive, catalase negative, non-motile and non-spore forming rod-shaped organism 
(De Man et al., 1960). Its ability to ferment ribose, rhamnose and growth at 15°C and 45°C 
indicate that it belongs to the group Streptobacterium (Orla-Jensen, 1943). The identity of the 
L. rhamnosus Fb was confirmed by 16S rDNA sequence analysis. The primary requirement 
for potential probiotic organisms is to survive during the passage through the acidic (pH 1-
3) environment of stomach. L. rhamnosus survives at pH 2 for 2 h, 87% of total cells remain 
viable, a sufficiently long time for the cells to pass through the stomach and reach their site 
of action in the intestine. L. rhamnosus show high survival which is satisfactory especially as 
probiotic strains can be buffered by food or other carrier molecules and in fact are not 
directly exposed to such a low pH in the stomach. After passage through acidic condition 
cells were exposed to bile salt (0.1% pancreatin, 0.5% bile salt, pH 8) viability increase after 3 
h of incubation to 95%. Mimicking gastro-intestinal transit, we observed that the bacterial 
stress originated by low pH may be overcome after the subsequent treatment in presence of 
bile (Charteris et al., 1998). A bile concentration of 0.3% is usually used for screening of bile 
tolerant strains, as this is considered as an average intestinal bile concentration of the human 
GIT (Gilliland et al., 1984). L. rhamnosus possesses the ability to grow in the presence of 0.4% 
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a gram-positive, catalase negative, non-motile and non-spore forming rod-shaped organism 
(De Man et al., 1960). Its ability to ferment ribose, rhamnose and growth at 15°C and 45°C 
indicate that it belongs to the group Streptobacterium (Orla-Jensen, 1943). The identity of the 
L. rhamnosus Fb was confirmed by 16S rDNA sequence analysis. The primary requirement 
for potential probiotic organisms is to survive during the passage through the acidic (pH 1-
3) environment of stomach. L. rhamnosus survives at pH 2 for 2 h, 87% of total cells remain 
viable, a sufficiently long time for the cells to pass through the stomach and reach their site 
of action in the intestine. L. rhamnosus show high survival which is satisfactory especially as 
probiotic strains can be buffered by food or other carrier molecules and in fact are not 
directly exposed to such a low pH in the stomach. After passage through acidic condition 
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during putrefaction in the GIT (Khedekar, 1988). L. rhamnosus also possesses the ability to 
grow in the presence of 6% NaCl (Jacobsen et al., 1999). The ability of L. rhamnosus cells to 
survive in the presence of bile, NaCl and phenol can help them to survive, grow, colonize 
and elicit the beneficial effects to the host. 
4. Health benefits of functional probiotic culture 
A number of health benefits are claimed in favour of products containing probiotic 
organisms including antimicrobial activity, gastrointestinal infections, improvement in 
lactose metabolism, antimutagenic properties, anticarcinogenic properties, reduction in 
serum cholesterol, anti-diarrhoeal properties, immune system stimulation, improvement in 
inflammatory bowel disease and suppression of Helicobacter pylori infection (Ambalam et al., 
2009; 2011; Kurmann & Rasic, 1991; Shah, 2007). Some of the health benefits are well 
established, while other benefits have shown promising results in animal models. However, 
additional studies are required in humans to substantiate these claims. Health benefits 
imparted by probiotic bacteria are strain specific, and not species- or genus-specific. It is 
important to note that no strain will provide all proposed benefits, not even strains of the 
same species, and not all strains of the same species will be effective against defined health 
conditions. The strains of Lactobacillus and Bifidobacterium are able to restore the normal 
balance of microbial populations in the intestine and most commonly used as probiotics 
(Shah, 2006). 
4.1 Antimicrobial activity of probiotic Lactobacillus rhamnosus  
Many mechanisms have been postulated by which Lactobacilli could produce antimicrobial 
activity. In addition to their competitive inhibition of the epithelial and mucosal adherence 
of pathogens and inhibition of epithelial invasion by pathogens, lactobacilli and 
bifidobacteria show antimicrobial activity by producing antimicrobial substances and/or 
stimulating mucosal immunity (Servin, 2004). Probiotic bacteria produce organic acids, 
hydrogen peroxide and bacteriocins as antimicrobial substances that suppress the 
multiplication of pathogenic and putrefying bacteria. Lactic and acetic acids account for 
over 90% of the organic acids produced. Lowering of pH due to lactic acid or acetic acid 
produced by these bacteria in the gut has a bacteriocidal or bacteriostatic effect. Lactobacillus 
rhamnosus has shown antimicrobial activity against Escherichia coli, Enterobacter aerogenes, 
Salmonella typhi, Shigella sp., Proteus vulgaris, Pseudomonas aeruginosa, Serratia marcescens, 
Staphylococcus aureus, Bacillus subtilis, Bacillus megaterium, Bacillus cereus, Helicobacter pylori, 
Campylobacter jejuni, and Listeria monocytogenes (Ambalam et al., 2009). L. rhamnosus produces 
other antimicrobial metabolites, as evidenced from the antimicrobial activity of Cell Free 
Culture filtrate (CFC) even when Extracellular Protein Concentrate (EPC) (independently) 
was less active. This evidence suggests the multifactorial nature of the antimicrobial activity 
and possibly a synergistic effect. Roles of other metabolites remain to be identified. 
4.2 Classification of bacteriocins from Lactic acid bacteria 
Bacteriocins of LAB are a heterogeneous group of bacterial antagonists and several 
classification criteria have been used to group them. The bacteriocins have been divided into 
three main categories: Class I Lantibiotics ribosomally synthesized peptides that undergo 
extensive post-translational modifications for ex. Nisin. Class II Non-lantibiotic peptides  
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ribosomally synthesized peptides that undergo minimal post-translational modification. 
They have diverse chemical and genetic characteristics. They have been sub-divided into 
three main groups: (a) single peptides, often with a characteristic YGNGVXC amino acid 
motif near the N-terminus (b) two-peptide bacteriocins (c) In Nes’ classification bacteriocins 
produced by the cell’s general secretory (sec) pathway and in Klaenhammer’s classification, 
thiol-activated peptides. Class III Non-lantibiotic, heat labile proteins. These are relatively 
uncommon among the antibacterial compounds of LAB, Class IV A fourth category of 
complex bacteriocins containing protein and lipid or carbobydrate moieties was included in 
Klaenhammer’s classification (Klaenhammer, 1993) but Nes and coworkers (Nes et al., 1996) 
excluded this category because these compounds have not been purified and evidence for 
them is based on loss of activity following treatment with carbohydrate-or lipid-hydrolysing 
enzymes and Class V bacteriocins with circular, unmodified structure ex. enterocin (Eijsink, 
et al., 1998; Guyonnet et al., 2000). L. acidophilus produces various bacteriocins and 
antibacterial substances such as Lactocidin, Acidolin, Acidophilin, Lactacium-B and 
inhibitory protein (Shah, 1999).  
4.3 Characteristics of antimicrobial protein(s) of Lactobacillus rhamnosus 
Antimicrobial activity of Cell Free Culture filtrates (CFC) against the test organisms increase 
with the culture age of L. rhamnosus Fb and became stable when culture reached the 
stationary phase. A similar antimicrobial spectrum of CFC filtrate was observed against all 
the test organisms (Fig. 1, b & d). The antimicrobial spectrum of Extracellular Protein 
Concentrate (EPC) against the test organisms changed with culture age. Antimicrobial 
activity against E. coli was observed in the initial growth phase, activity increases with 
culture age upto 18 h, it decreases later with increasing culture age (Fig. 1, a & c). 
Antimicrobial activity against Ent. aerogenes, B. subtilis, B. megaterium and Staph. aureus 
appeared after 6 h of growth and increased with culture age became stable in stationary 
phase. Whereas activity against Shigella sp., Ps. aeruginosa and B. cereus was observed after 12 
h of growth and increased with culture age upto 30 h before decreasing marginally. 
Antimicrobial activity against S. typhi and P. vulgaris was observed in stationary phase and 
it did not change much with the increase in culture age. The antimicrobial extracellular 
proteins are produced during exponential and stationary phases. Changes in the 
antimicrobial activity spectrum of the EPC during different growth phases provide evidence 
that the EPC is a mixture of antimicrobial peptides and its composition changes with the 
culture age (Ambalam et al., 2009). Antimicrobial activity spectrum changes with culture 
age, indicates that the antimicrobial activity is attributed to the mixture of antimicrobial 
peptides. Antimicrobial activity of EPC shows activity over broad pH range (2-9) but the 
activity varies with test organisms. At pH 2 to 5 and 8 mode of inhibition was bactericidal 
against E. coli, Ent. aerogenes, S. typhi, Shigella sp., P. vulgaris, Ser. marcescens, Ps. aeruginosa, 
Staph. aureus, B. megaterium, B. cereus and B. subtilis. While at pH 6, 7 and 9 the activity was 
bacteriostatic. Antimicrobial activity of EPC was thermostable (60 min at 100°C), 
thermostability was evidenced from the bactericidal activity of heat treated EPC, heat 
treatment caused complete loss of activity against Ps. aeruginosa and Bacillus spp. Heat 
stability of antimicrobial proteins has been suggested to be the major feature of low 
molecular weight bacteriocins and arises from complex pattern of disulphide intramolecular 
bonds that stabilize secondary structures by reducing the number of possible unfolded 
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Fig. 1. Association of antimicrobial spectrum of EPC produced by L. rhamnosus Fb culture 
during logarithmic and idiophasic growth. (a) & (c) Antimicrobial activity of Extracellular 
Protein Concentrate (EPC) and (b & d) Cell Free Culture Filtrate (CFC) of Lactobacillus 
rhamnosus produced at the different growth phases (6, 12, 18, 24, 30 and 36 h) determined by 
well-diffusion assay against E. coli, Ent. aerogenes, S. typhi, Shigella sp., P. vulgaris, Ps. aeruginosa, 
B. subtilis, B. megaterium, B. cereus and Staph. aureus 
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antimicrobial peptides but the work is in progress to further characterize the structure and 
functions of EPC. Sensitivity of EPC to proteolytic enzymes like Proteinase K, Trypsin and 
Pepsin shows strain specificity, it varies with test organism which also further indicates the 
proteinaceous nature of the active agent. EPC treated with Proteinase K cause reduction in 
antimicrobial activity against B. megaterium (80%), Staph. aureus (79%), B. cereus (71%), P. 
vulgaris (60%), Ser. marcescens (53%), S. typhi (46%), E. coli (41%), Ent. aerogenes, Shigella sp. 
and Ps. aeruginosa marginally (<10%). Proteinase K exhibits broad substrate specificity. 
Proteinase K degrades many proteins in the native state even in the presence of detergent. 
The predominant site of cleavage is the peptide bond adjacent to the carboxyl group of 
aliphatic and aromatic amino acids which block alpha amino group. It is commonly used for 
its broad specificity (Ebeling et al., 1974). Trypsin cleaves peptide chains mainly at the 
carboxyl site of the amino acids lysine or arginine, except when either is followed by 
proline. Antimicrobial activity of EPC treated with trypsin was completely lost against Ps. 
aeruginosa, Staph. aureus and Bacillus spp. indicates the presence of the active site for 
antimicrobial action may be present at the carboxyl site of protein. Pepsin is most efficient in 
cleaving peptide bonds between hydrophobic and preferably aromatic amino acids such as 
phenylalanine, tryptophan, and tyrosine (Dunn, 2001). EPC treated with pepsin results in 
complete loss of antimicrobial activity against S. typhi and Staph. aureus while partially 
reduced against Bacillus spp. Variable sensitivity of antimicrobial activity of EPC against test 
organisms imply the presence of a more than one antimicrobial peptides active against 
different test organisms. Gel permeation chromatography (Sephadex G-25) of EPC provides 
additional evidence of inhibitory protein is low molecular protein. Gel electrophoresis 
(Tricine SDS PAGE) of EPC shows that proteins present in EPC resolved into three bands, 
one diffuse band representing low molecular weight peptides (4 kDa) and the other marking 
the presence of higher molecular weight proteins (Schagger & Von Jagow, 1987). Gel over-
layer confirmed that inhibition of the test organisms was due to the diffuse band of low 
molecular weight protein(s). EPC is a dynamic mixture of antimicrobial peptides, since the 
antimicrobial spectrum of the EPC is intimately associated with the growth phase. The 
following experimental evidences related to heat stability, sensitivity to proteolytic 
enzymes, and gel permeation chromatography further implicate the presence and 
involvement of more than one antimicrobial peptides in the EPC. Purification and 
characterization of antimicrobial peptides of Lactobacillus rhamnosus Fb strain provides novel 
approach as anti-infective drug, as it shows wide spectrum of antimicrobial action against 
human pathogens and food spoilage organisms. It has also potential for food additives, 
treatment of antibiotic resistant organisms. Probiotic formulation derived from this culture 
can be used to treat gastrointestinal problems including various forms of dysbacteriosis. 
However further studies are necessary to investigate the possibility of using this novel 
antimicrobial peptides as an anti-infective agent and in vivo study. 
4.4 Present approaches and future prospects for bacteriocins in food application 
The increasing demand for high-quality ‘safe’ foods that are not extensively processed has 
created a niche for natural food preservatives. The ideal natural food preservative should 
fulfil the following criteria (Hill et al., 2002), acceptably low toxicity, stability to processing 
and storage, efficacy at low concentration, economic viability, no medical use, and no 
deleterious effect on the food. While most bacteriocins fulfil all these criteria, to date nisin is 
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Drug Administration (FDA) approval in the USA in 1988, although it had been in use in 
Europe for some time (the WHO approved the use of nisin in 1969). Its success has 
stimulated further research targeted towards identifying new bacteriocins from LAB which 
potentially could be used in a similar manner. Many bacteriocins have now been 
characterized that exhibit antibacterial activity against a range of pathogenic and food 
spoilage bacteria. It is to be expected that bacteriocins and bacteriocin-producing LAB (used 
as starters or protective cultures) will find many roles in both fermented and nonfermented 
foods as a means of improving food quality, naturalness and safety. Three approaches are 
commonly used in the application of bacteriocins for biopreservation of foods (Schillinger et 
al., 1996). Inoculation of food with LAB that produce bacteriocin in the products. The ability 
of the LAB to grow and produce bacteriocin in the products is crucial for its successful use, 
Addition of purified or partially-purified bacteriocins as food preservatives, use of a 
product previously fermented with a bacteriocin producing strain as an ingredient in food 
processing. 
4.5 Antimutagenic properties 
Humans are continually exposed to a variety of natural and artificial mutagens generated by 
industrial and environmental activities (Vorobjeva et al., 2002). One of the possible ways of 
the lowering of mutation pressure on animals and human is the increasing antimutagens 
levels and of the antimutagenic activity of bacteria, predominantly those inhabiting the 
intestine of mammals being the ingredients of probiotic, used in food processing and 
ensilage. Probiotic organisms are reported to bind mutagens to the cell surface (Orrhage et 
al., 1994). Probiotic L. rhamnosus 231 cells has ability to bind, biotransform and detoxify 
different mutagens like acridine orange (AO), N-methyl-N’-nitro-N-nitrosoguanidine 
(MNNG), 2-amino-3,8-dimethylimidazo-[4,5-f]-quinoxaline (MeIQx) (Ambalam et al., 2011). 
Binding of AO by Lr 231 is due to adsorption, thereby leading to removal of mutagen in 
solution and is instantaneous, pH- and concentration-dependent. Whereas, binding of 
MNNG and MeIQx by Lr 231 results into biotransformation leading to detoxification with 
subsequent loss of mutagenicity as determined by spectral analysis, thin layer 
chromatography and Ames test. Lr 231 exhibits ability to bind and detoxify potent 
mutagens, and this property can be useful in formulating fermented foods for removal of 
potent mutagens. Similar results were also observed by Sreekumar & Hosono (1998) 
instantaneous binding of the mutagen Trp-P-1 by Lactobacillus gasseri. Lankaputhra and 
Shah (1998) studied the antimutagenic activity of organic acids produced by probiotic 
bacteria against several mutagens and promutagens. In their study, butyric acid showed a 
broad-spectrum antimutagenic activity against all mutagens or promutagens studied and 
live bacterial cells showed higher antimutagenicity than killed cells. Probiotic bacteria are 
reported to reduce faecal enzymatic activities including β-glucuronidase, azoreductase, and 
nitroreductase, which are involved in activation of mutagens (Goldin & Gorbach, 1984). 
4.6 Anticarcinogenic properties 
Bacteria and metabolic products such as genotoxic compounds (nitrosamine, heterocyclic 
amines, phenolic compounds, and ammonia) are responsible for colorectal cancer. The 
consumption of cooked red meat, especially barbequed meat, and low consumption of fibre 
are reported to play a major role in causing colorectal cancer. The colonic flora is also 
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reported to cause carcinogenesis mediated by microbial enzymes such as β-glucuronidase, 
azoreductase, and nitroreductase, which convert procarcinogens into carcinogens. Certain 
strains of L. acidophilus and Bifidobacterium spp. are reported to decrease the levels of 
enzymes such as β-glucuronidase, azoreductase, and nitroreductase responsible for 
activation of procarcinogens and consequently decrease the risk of tumour development 
(Yoon et al., 2000). Short chain fatty acids produced by L. acidophilus and Bifidobacterium, L. 
plantarum and L. rhamnosus are reported to inhibit the generation of carcinogenic products 
by reducing enzyme activities (Cenci et al., 2002). The anticarcinogenic effect of probiotic 
bacteria reported is due to the result of removal of sources of procarcinogens (or the 
enzymes that lead to their formation) improvement in the balance of intestinal microflora, 
normalized intestinal permeability (leading to prevention or delaying of toxin absorption), 
strengthening of intestinal barrier mechanisms, and activation of non-specific cellular factors 
(such as macrophages and natural killer cells) via regulation of γ-interferon production. 
Orally administered Bifidobacterium is also reported to play a role in increasing production of 
IgA antibodies and functions of Peyer’s patch cells (Singh et al., 1997).  
4.7 Reduction in serum cholesterol 
The level of serum cholesterol is a major factor for coronary heart disease, and elevated 
levels of serum cholesterol, particularly LDL-cholesterol, have been linked to an increased 
risk (Liong & Shah, 2006). There is a high correlation between dietary saturated fat or 
cholesterol intake and serum cholesterol level. Feeding of fermented milk containing very 
large numbers of probiotic bacteria to hypercholesterolaemic human subjects has resulted in 
lowering cholesterol from 3.0 to 1.5 g/L. Probiotic bacteria are reported to de-conjugate bile 
salts: deconjugated bile acid does not absorb lipid as readily as its conjugated counterpart, 
leading to a reduction in cholesterol level. L. acidophilus is also reported to take up 
cholesterol during growth and this makes it unavailable for absorption into the blood 
stream (Klaver & Meer, 1993). 
5. Conclusions 
Lactobacillus strains play an important role in food fermentation processes. Modern concepts 
or perspectives of the application of Lactobacillus strains include the following selections; the 
best adapted and safe for human application as it is an important biodefense factor in 
human intestinal tract, non-pathogenic, with probiotic effects and/or health-promoting 
effects and food protective activities. From our study we conclude that L. rhamnosus is a 
potential candidate for probiotic product preparation or as food additives as evidenced by 
its ability to acid-bile tolerance, salt, antimicrobial activity against human pathogens and 
food spoilage organisms. The antimicrobial extracellular low molecular weight proteins are 
produced during exponential and stationary phases. Changes in the antimicrobial activity 
spectrum of the EPC during different phases of growth provide evidence that the EPC is a 
mixture of antimicrobial peptides and its composition changes with the culture age. Strain-
specific thermostability and sensitivity to proteolytic enzymes of antimicrobial peptides 
provide further evidence that the antimicrobial activity of EPC is due to mixture of peptides 
that are heat sensitive and/or resistant. Thermostability of antimicrobial peptides confers 
additional advantage which can survive the thermal processing cycle of foods and can also 
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foods as a means of improving food quality, naturalness and safety. Three approaches are 
commonly used in the application of bacteriocins for biopreservation of foods (Schillinger et 
al., 1996). Inoculation of food with LAB that produce bacteriocin in the products. The ability 
of the LAB to grow and produce bacteriocin in the products is crucial for its successful use, 
Addition of purified or partially-purified bacteriocins as food preservatives, use of a 
product previously fermented with a bacteriocin producing strain as an ingredient in food 
processing. 
4.5 Antimutagenic properties 
Humans are continually exposed to a variety of natural and artificial mutagens generated by 
industrial and environmental activities (Vorobjeva et al., 2002). One of the possible ways of 
the lowering of mutation pressure on animals and human is the increasing antimutagens 
levels and of the antimutagenic activity of bacteria, predominantly those inhabiting the 
intestine of mammals being the ingredients of probiotic, used in food processing and 
ensilage. Probiotic organisms are reported to bind mutagens to the cell surface (Orrhage et 
al., 1994). Probiotic L. rhamnosus 231 cells has ability to bind, biotransform and detoxify 
different mutagens like acridine orange (AO), N-methyl-N’-nitro-N-nitrosoguanidine 
(MNNG), 2-amino-3,8-dimethylimidazo-[4,5-f]-quinoxaline (MeIQx) (Ambalam et al., 2011). 
Binding of AO by Lr 231 is due to adsorption, thereby leading to removal of mutagen in 
solution and is instantaneous, pH- and concentration-dependent. Whereas, binding of 
MNNG and MeIQx by Lr 231 results into biotransformation leading to detoxification with 
subsequent loss of mutagenicity as determined by spectral analysis, thin layer 
chromatography and Ames test. Lr 231 exhibits ability to bind and detoxify potent 
mutagens, and this property can be useful in formulating fermented foods for removal of 
potent mutagens. Similar results were also observed by Sreekumar & Hosono (1998) 
instantaneous binding of the mutagen Trp-P-1 by Lactobacillus gasseri. Lankaputhra and 
Shah (1998) studied the antimutagenic activity of organic acids produced by probiotic 
bacteria against several mutagens and promutagens. In their study, butyric acid showed a 
broad-spectrum antimutagenic activity against all mutagens or promutagens studied and 
live bacterial cells showed higher antimutagenicity than killed cells. Probiotic bacteria are 
reported to reduce faecal enzymatic activities including β-glucuronidase, azoreductase, and 
nitroreductase, which are involved in activation of mutagens (Goldin & Gorbach, 1984). 
4.6 Anticarcinogenic properties 
Bacteria and metabolic products such as genotoxic compounds (nitrosamine, heterocyclic 
amines, phenolic compounds, and ammonia) are responsible for colorectal cancer. The 
consumption of cooked red meat, especially barbequed meat, and low consumption of fibre 
are reported to play a major role in causing colorectal cancer. The colonic flora is also 
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reported to cause carcinogenesis mediated by microbial enzymes such as β-glucuronidase, 
azoreductase, and nitroreductase, which convert procarcinogens into carcinogens. Certain 
strains of L. acidophilus and Bifidobacterium spp. are reported to decrease the levels of 
enzymes such as β-glucuronidase, azoreductase, and nitroreductase responsible for 
activation of procarcinogens and consequently decrease the risk of tumour development 
(Yoon et al., 2000). Short chain fatty acids produced by L. acidophilus and Bifidobacterium, L. 
plantarum and L. rhamnosus are reported to inhibit the generation of carcinogenic products 
by reducing enzyme activities (Cenci et al., 2002). The anticarcinogenic effect of probiotic 
bacteria reported is due to the result of removal of sources of procarcinogens (or the 
enzymes that lead to their formation) improvement in the balance of intestinal microflora, 
normalized intestinal permeability (leading to prevention or delaying of toxin absorption), 
strengthening of intestinal barrier mechanisms, and activation of non-specific cellular factors 
(such as macrophages and natural killer cells) via regulation of γ-interferon production. 
Orally administered Bifidobacterium is also reported to play a role in increasing production of 
IgA antibodies and functions of Peyer’s patch cells (Singh et al., 1997).  
4.7 Reduction in serum cholesterol 
The level of serum cholesterol is a major factor for coronary heart disease, and elevated 
levels of serum cholesterol, particularly LDL-cholesterol, have been linked to an increased 
risk (Liong & Shah, 2006). There is a high correlation between dietary saturated fat or 
cholesterol intake and serum cholesterol level. Feeding of fermented milk containing very 
large numbers of probiotic bacteria to hypercholesterolaemic human subjects has resulted in 
lowering cholesterol from 3.0 to 1.5 g/L. Probiotic bacteria are reported to de-conjugate bile 
salts: deconjugated bile acid does not absorb lipid as readily as its conjugated counterpart, 
leading to a reduction in cholesterol level. L. acidophilus is also reported to take up 
cholesterol during growth and this makes it unavailable for absorption into the blood 
stream (Klaver & Meer, 1993). 
5. Conclusions 
Lactobacillus strains play an important role in food fermentation processes. Modern concepts 
or perspectives of the application of Lactobacillus strains include the following selections; the 
best adapted and safe for human application as it is an important biodefense factor in 
human intestinal tract, non-pathogenic, with probiotic effects and/or health-promoting 
effects and food protective activities. From our study we conclude that L. rhamnosus is a 
potential candidate for probiotic product preparation or as food additives as evidenced by 
its ability to acid-bile tolerance, salt, antimicrobial activity against human pathogens and 
food spoilage organisms. The antimicrobial extracellular low molecular weight proteins are 
produced during exponential and stationary phases. Changes in the antimicrobial activity 
spectrum of the EPC during different phases of growth provide evidence that the EPC is a 
mixture of antimicrobial peptides and its composition changes with the culture age. Strain-
specific thermostability and sensitivity to proteolytic enzymes of antimicrobial peptides 
provide further evidence that the antimicrobial activity of EPC is due to mixture of peptides 
that are heat sensitive and/or resistant. Thermostability of antimicrobial peptides confers 
additional advantage which can survive the thermal processing cycle of foods and can also 





broad antimicrobial spectra produced by L. rhamnosus are potentially valuable in topical 
treatment, bio-control, food additives, and other applications that aim at eradicating gram-
positive and gram-negative pathogens or non-pathogenic contaminants in the targeted 
environment. Further work on the purification, characterization of these antimicrobial 
peptides and mode of action is in progress.  
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According to researchers, in the first photosynthetic life forms known on earth 3.6 billion 
years ago, was created by the God. Blue-green algae, cyanobacteria, is the evolutionary 
bridge between bacteria and green plants. It contained within it everything life needed to 
evolve. This immortal plant has renewed itself for billions of years, and has presented itself 
to us in the last 40 years. Spirulina has 3.6 billion years of evolutionary wisdom coded in its 
DNA. Spirulina, or what was most likely Arthrospira, is a photosynthetic, filamentous, spiral-
shaped, multicellular and blue-green microalga that has a long history of use as food. For 
this microorganism contain chlorophyll a, like higher plants, botanists classify it as a 
microalga belonging to Cyanophyceae class; but according to bacteriologists it is a bacterium 
due to its prokaryotic structure (Fig. 1). Spirulina, essentially an exceptional simple extract of 
blue-green algae, has been extensively studied and is now in widespread usage throughout 
the world as a food product and as a dietary supplement (Fox, 1996; Paleaz, 2006). 
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The goals of this paper are: to review the present literature on the historical evolution and 
potential nutritional use of Spirulina and its products; to provide insight into the potential 
implications of the studies reviewed in the context of possible nutritional and therapeutic 
applications in health management, and; to identify areas of interest for future research. 
2. Historical background on the use of Spirulina 
2.1 Evolutionary history 
The cyanobacteria are believed to have evolved 3.5 billion years ago. Fossils discovered in 
the 3.5-Ga-old Apex chert in northwestern Western Australia crude filamentous cyanobacteria 
with strikingly similar morphologies to present-day filamentous cyanobacteria (Oscillatoriacea). 
The occurrence of aerobic respiration and oxygenic photosynthesis, photosynthetic carbon 
dioxide fixation like that of extant cyanobacteria, cell division more similar to the extant 
cyanobacterial and recent rRNA analyses showing that the Oscillatoriacea are among the 
earliest evolved also lend further evidence to the fossil record. Arthrospira belongs to the 
Class Oscillatoriacea and therefore has a very old lineage. Despite their old lineage, the fossil 
cyanobacteria are morphologically very similar to their extant forms, suggesting a slow 
evolutionary process. Spirulina (Arthrospira) is a ubiquitous organism. After the first 
isolation by Turpin in 1827 from a freshwater stream, species of Spirulina have been found in 
a variety of environments: soil, sand, marshes, brackish water, seawater, and freshwater. 
Species of Spirulina have been isolated, for instance, from tropical waters to the North Sea, 
thermal springs, salt pans, warm waters from power plants, fish ponds, etc. Thus, the 
organism appears to be capable of adaptation to very different habitats and colonizes certain 
environments in which life for other microorganisms is, if not impossible, very difficult 
(Ciferri, 1983; Tomaselli, 2003). 
2.2 Use of Spirulina as human food and animal feed 
It is not known with accuracy when human began to use microalgae. The current use of 
these resources has three precedents: tradition, scientific and technological development, 
and the so-called, “green tendency”. There are reports that it was used as food in Mexico 
during the Aztec civilization approximate 400 years ago. Bernal Díaz del Castillo, a member 
of Hernán Cortez´s troops, reported in 1521, that S. maxima was harvested from the Lake 
Texcoco, dried and sold for human consumption in a Tenochtitlán (today Mexico City) 
market (Sánchez, et al., 2003). In 1940, a French phycologist Dangeard published a report on 
the consumption of dihé by the Kanembu people near Lake Chad. Scientist Dangeard, also 
noted these same algae populated a number of lakes in the Rift Valley of East Africa, and 
was the main food for the flamingos living around those lakes. Twenty-five years later 
during 1964-65, a botanist on a Belgian Trans-Saharan expedition, Jean Léonard, reported 
finding a curious greenish, edible cakes being sold in native markets of Fort-Lamy (now 
N’Djamena) in Chad. When locals said these cakes came from areas near Lake Chad, 
Léonard recognized the connection between the algal blooms and dried cakes sold in the 
market (Habib et al., 2008). It is still being used as food by the Kanembu tribe in the Lake 
Chad area of the Republic of Chad where it is sold as dried bread called “dihe” (Fox, 1996; 
Belay, 2002). In 1967 Spirulina was established as a “wonderful future food source” in the 
International Association of Applied Microbiology (Sasson, 1997). This traditional food  
 
Earth Food Spirulina (Arthrospira): Production and Quality Standarts 
 
193 
(Fig. 2), by a European scientific mission, and is now widely cultured throughout the world. 
In its commercial use, the common name, Spirulina, refers to the dried biomass of the 
cyanobacterium, Arthrospira platensis, and is a whole product of biological origin. A. platensis 
and A. maxima, that are commonly used as food, dietary supplement, and feed supplement 
(Wikfors & Ohno, 2001). The re-introduction of Spirulina as a health food for human 
consumption in the late 1970s and the beginning of the 1980s was associated with many 
controversial claims which attribute to Spirulina a role of a ‘magic agent’ that could do 
almost everything, from curing specific cancer to antibiotic and antiviral activity. Since most 
claims were never backed up by detailed scientific and medical research, they will not be 
discussed in this chapter. Nevertheless, one cannot ignore the fact that more than 70 per cent 
of the current Spirulina market is for human consumption, mainly as health food. Primarily 
concern in Spirulina focused mainly on its rich content of protein, essential amino acids, 
minerals, vitamins, and essential fatty acids. Spirulina is 60-70% protein by weight and 
contains a rich source of vitamins, for example vitamin B12 and provitamin A (β-carotene), 
and minerals, especially iron. One of the few sources of dietary γ-linolenic acid (GLA), it also 
contains a host of other phytochemicals that have potential health benefits. This first data 
was enough to launch many research projects for industrial purposes in the 1970s, because 
micro-organisms (Chlorella, Spirulina, yeast, some bacteria and moulds) seemed at that time 
to be the most direct route to inexpensive proteins – the iconic “single cell proteins”. In 
1970’s, a request was received from a company named Sosa-Texcoco Ltd by the “Institut 
français du pétrole” to study a bloom of algae occurring in the evaporation ponds of their 
sodium bicarbonate production facility in a lake near Mexico City. As a result, the first 
systematic and detailed study of the growth requirements and physiology of Spirulina was 
performed. This study, which was a part of Ph.D. thesis by Zarrouk (1966), was the basis for 
establishing the first large-scale production plant of Spirulina (Sasson, 1997). Arthrospira has 
been produced commercially for the last 30 years for food and specialty feeds. Commercial 
algae like Spirulina, are normally produced in large outdoor ponds under controlled 
conditions (Fig. 3). Some companies also produce directly from lakes. Current production of 
Spirulina worldwide is estimated to be about 3,000 metric tons.  
The incidence of toxic episodes in freshwaters due to the presence of toxic cyanobacteria has 
considerably increased over the last few years. There is also increasing evidence that low 
levels of exposure may have chronic effects in humans and therefore strict and reliable 
control of these toxins should be carried out in order to prevent serious public health 
problems. It is known that cyanobacteria have been implicated in a number of episodes of 
human illnesses worldwide (Martinez, 2007; Šejnohová, 2008). For this reason toxicological 
tests obligation done so the Spirulina culture and biomass. There is no report of 
cyanobacterial toxins in Arthrospira species to date. Although inadvertent harvest of these 
toxic species is a risk when harvesting algae from natural bodies of water with mixed 
phytoplankton populations, it is very unlikely to be a problem in properly controlled and 
properly managed monoculture of Arthrospira (Belay, 2008). So, sold widely in health food 
stores and mass-market outlets throughout the world, Spirulina’s safety as food has been 
established through centuries of human use and through numerous and rigorous 
toxicological studies (Belay, 1997; Cevallos, et al., 2008).  
The nutritive value of Arthrospira is amplified in that it has a relatively low percentage of 
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Fig. 2. Harvesting, traditionally drying Spirulina dihé in a sand filter, and selling local 
market (www.AlgaeIndustryMagazine.com, Algae in Historical Legends March 10, 2011, by 
Robert Henrikson) 
 
Fig. 3. Spirulina production ponds under controlled conditions (İzmir-Aydn/Turkey), Photo 
by Edis Koru 
extremely high in vitamin B12, the mucoprotein cell walls are easy to digest, unlike the 
cellulose cell wall found in many other nutritional algae, it is completely non-toxic, and its 
lipids are made up of unsaturated fatty acids that do not form chlesterol. This makes 
Spirulina a potential food item for persons suffering from coronary illness and obesity 
(Richmond, 1992). In addition to being exeptionally high in protein, Arthrospira appears to 
have the highest vitamin B12 content of any unprocessed plant or animal food, representing 
a boon to vegetarian diets. Two or three heaped tablespoons of Spirulina (~20-25 g), provide 
all the daily body requirements of vitamin B12, as well as significant quantities of other  
B-complex vitamins, including 70% of the recommended daily allowance for vitamin B1 
(thiamine), 50% for B2 (riboflavin), and 12% for B3 (niacin). Also, 10 g. of Spirulina contains 
about 25000 international units of vitamin A, representing over 500% of the recommended 
daily allowance. Other nutritional attributes of Spirulina include essential unsaturated fatty 
acids, the most important of which is γ-linolenic acid (6,9,12-octadecatrienoic-acid) of which 
it has a high content (Becker, 1992, Richmond, 1992). Also, researchers have reported the 
therapeutic effects of Spirulina as a growth promoter, probiotic, and booster of the immune 
system in animals including fishes (Venkataraman, 1993; James et al., 2006). 
Some of the best worldwide known Spirulina producing companies are: Earthrise Farms 
(USA), Cyanotech (USA), Hainan DIC Microalgae Co., Ltd (China), Marugappa Chettir 
Research Center (India), Genix (Cuba) and Solarium Biotechnology (Chile) (Belay, 1997). 
 
Earth Food Spirulina (Arthrospira): Production and Quality Standarts 
 
195 
Nowadays, Spirulina has been marketed and consumed as a human food and has been 
approved as a food for human consumption by many governments, health agencies and 
associations of these countries: Argentina, Australia, Austria, Bahrain, Bahamas, Bangladesh, 
Belarus, Belgium, Brazil, Bulgaria, Canada, Chad, Chile, China, Colombia, Costa Rica, 
Croatia, Czech Republic, Denmark, Ecuador, Egypt, Ethiopia, Finland, France, Germany, 
Greece, Guam, Gulf States Haiti, Hungary, India, Iceland, Indonesia, Ireland, Israel, Italy, 
Jamaica, Japan, Kenya, Korea, Kuwait, Liechtenstein, Luxembourg, Macedonia, Malaysia, 
Mexico, Myanmar, Monaco, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, 
Poland, Portugal, Romania, Russia, Saudi Arabia, Serbia, Singapore, Slovenia, South Africa, 
Spain, Sweden, Switzerland, Taiwan, Thailand, Togo, Turkey, Ukraine, United Kingdom, 
United States, Venezuela, Vietnam, Zaire, Zimbabwe. (Becker & Venkataraman, 1984; 
Vonshak, 2002; Koru, 2009, Henrikson, 2010). 
3. Biological properties of Spirulina 
3.1 Morphology and taxonomy 
Spirulina (Arthrospira) is symbiotic, multicellular and filamentous blue-green microalgae 
with symbiotic bacteria that fix nitrogen from air. Spirulina can be rod- or disk-shaped. Their  
 
Fig. 4. Morphology of Spirulina (Arthrospira), Scanning electron micrograph of a trichome of 
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Nowadays, Spirulina has been marketed and consumed as a human food and has been 
approved as a food for human consumption by many governments, health agencies and 
associations of these countries: Argentina, Australia, Austria, Bahrain, Bahamas, Bangladesh, 
Belarus, Belgium, Brazil, Bulgaria, Canada, Chad, Chile, China, Colombia, Costa Rica, 
Croatia, Czech Republic, Denmark, Ecuador, Egypt, Ethiopia, Finland, France, Germany, 
Greece, Guam, Gulf States Haiti, Hungary, India, Iceland, Indonesia, Ireland, Israel, Italy, 
Jamaica, Japan, Kenya, Korea, Kuwait, Liechtenstein, Luxembourg, Macedonia, Malaysia, 
Mexico, Myanmar, Monaco, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, 
Poland, Portugal, Romania, Russia, Saudi Arabia, Serbia, Singapore, Slovenia, South Africa, 
Spain, Sweden, Switzerland, Taiwan, Thailand, Togo, Turkey, Ukraine, United Kingdom, 
United States, Venezuela, Vietnam, Zaire, Zimbabwe. (Becker & Venkataraman, 1984; 
Vonshak, 2002; Koru, 2009, Henrikson, 2010). 
3. Biological properties of Spirulina 
3.1 Morphology and taxonomy 
Spirulina (Arthrospira) is symbiotic, multicellular and filamentous blue-green microalgae 
with symbiotic bacteria that fix nitrogen from air. Spirulina can be rod- or disk-shaped. Their  
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main photosynthetic pigment is phycocyanin, which is blue in colour. These bacteria also 
contain chlorophyll a and carotenoids. Some contain the pigment phycoythrin, giving the 
bacteria a red or pink colour. Spirulina are photosynthetic and therefore autotrophic. 
Spirulina reproduce by binary fission. Arthrospira (Spirulina) species show great plasticity in 
morphology. This is attributed to environmental factors like temperature and other physical 
and chemical factors and possibly also due to genetic change. Transmission Electron 
Microscope observations show for Spirulina prokaryotic organization, capsule, pluri-
stratified cell wall, photosynthetic or thylakoid lamella system, ribosomes and fibrils of 
DNA region and numerous inclusions (Fig. 4,5). The capsule has fibrillar structure and 
covers each filament protecting it. The irregular presence of capsule around the filaments in 
S. platensis is a differentiating morphological characteristic to compare with S. maxima 
(Ciferri, 1983; Fox, 1996; Belay, 1997; Tomaselli, 2002). 
3.2 Spirulina biochemical composition 
Microalgae could be utilized for the production of several chemicals which are either unique 
to the algae or found at relatively high concentrations and command a high market value. In 
this respect, Spirulina is one of the more promising microalgae. It is especially rich, relative 
to other sources, in the polyunsaturated fatty acid γ- linolenic acid (GLA), and in pigments 
such as phycocyanin, myxoxanthophyl and zeaxanthin. The biochemical composition of 
Spirulina has been analyzed since 1970, showing high protein concentration, 60–70% of its 
dry weight, whose nutritive value is related to the quality of amino acid. Spirulina contains 
essential amino acids, including leucine, isoleucine and valine. It also contains a relative 
high concentration of provitamin A, vitamin B12 and β-carotene. Spirulina have 4–7% lipids, 
essential fatty acids as linolenic and γ-linolenic acid, and ω-3 and ω-6 polyunsaturated fatty 
acids (Wu, L.C. et al., 2005) (Table 1,2,3). Cyanobacteria and algae possess a wide range  
of colored compounds, including carotenoids, chlorophyll, and phycobiliproteins.  
C-phycocyanin is the principal phycobiliprotein. A selenium-containing phycocyanin has 
been isolated from S. platensis (Shekharam et al., 1987). A. platensis contains about 13.5% 
carbohydrates, the sugar composition is mainly composed of glucose, along with rhamnose, 
mannose, xylose, galactose, and two unusual sugars: 2-O-mehtyl-l-rhamnose and 3-O-
methyl-l-rhamnose. Nowadays the antiviral activity of Spirulina has been attributed to three 
groups of substances: sulfated polysaccharides, sulfoglycolipids, and a protein-bound 
pigment, the allophycocianin (Barrón et al., 2008). Spirulina contains 2.2%-3.5% of RNA and 
0.6 %-1% of DNA, which represents less than 5% of these acids, based on dry weight. 
Food Type Crude Protein (%) 
Spirulina powder 65 
Chicken Egg 47 
Beer Yeast 45 
Chicken meat 24 
Skimmed Powdered milk 37 
Cheese 36 
Beef meat 22 
Fish 22 
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Vitamins  mg 100/g 
Provitamin A 2.330x103IU/kg 
(β-carotene) 140 
Vitamin E 100 a-tocopherol equiv. 
Thiamin B1 3.5 
Riboflavin B2  4.0 
Niacin B3 14.0 
Vitamin B6 0.8 
Vitamin B12 0.32 
Biotin 0.005 
Folic acid 0.01 
Phantothenic acid 0.1 
Vitamin K 2.2 
Table 2. Vitamins in Spirulina powder (Belay, 1997) 
Composition Quantity (per 100 g dry wt) 
General composition  
Moisture 3.5 g. 
Protein 63.5 g. 
Fat (Lipids) 9.5 g. 
Fibre 3.00 g. 
Ash 6.70 g. 
N-free extract 15 g. 
Colorants  
Phycocyanin 15.6 g. 
Carotenoids 456.00 mg 
Chlorophyll-a 1.30 g 
Vitamins  
Provitamin A 213.00 mg 
Thiamin (V.B1) 1.92 mg 
Riboflavin (V.B2) 3.44 mg 
Vitamin B6 0.49 mg 
Vitamin B12 0.12 mg 
Vitamin E 10.40 mg 
Niacin 11.30 mg 
Folic acid 40 μg 
Panthothenic acid 0.94 mg 
Inositol 76.00 mg 
Minerals  
Phosphorus 916.00 mg 
Iron 53.60 mg 
Calcium 168 mg 
Potassium 1.83 g 
Sodium 1.09 g 
Magnesium 250 mg 
Table 3. A typical analysis of Spirulina product. Based on sample of dried Spirulina powder 
of Turkish Algae Company analyzed by Republic of Turkey Ministry of Agriculture and 
Rural Affairs Izmir Province Control Laboratory and Ege University (Koru et al., 2008) 
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Composition Fatty acids (%) 
(C14) Myristic acid 0.23a 1.6-1.7b 
(C16) Palmitic acid 46.07a 18-38b 
(C16:1)Δ9 Palmitoleic acid 1.26a 5-7b 
(C18:1)Δ9 Oleic acid 5.26a 5-6b 
(C18:2)Δ9,12 Linoleic acid 17.43a 6-15b 
(C18:3)Δ9,12,15 γ-Linolenic acid 8.87a 4-22b 
Others 20.88a 10-68b 
Table 4. Fatty acid composition of Spirulina platensis powder (a Othes and Pire, 2001;  
b Diraman et al., 2009) 
3.3 General quality and safety assurance for Spirulina 
In 1970’s, Spirulina underwent extensive safety studies with animals and fish. Independent 
feeding tests in France, Mexico and Japan showed no undesirable results and no toxic side 
effects on humans, rats, pigs, chickens, fish and oysters. Many independent rat feeding trials 
were conducted in Japan and no negative effects at all were found for acute or chronic 
toxicity or reproduction. The re-introduction of Spirulina as a health food for human 
consumption in the late 1970s and the beginning of the 1980s was associated with many 
controversial claims which attribute to Spirulina a role of a ‘magic agent’ that could do 
almost everything, from curing specific cancer to antibiotic and antiviral activity. Since most  
Spirulina food standards: 
 quality requirements of France, Sweden, Japan and Earthrise Farms (USA) 
Standard Francea Swedenb Japanc USAd 
Protein %55-65 %55-65 ≥%50 %55-65 
Total Carotenoids ♦ ♦ >100 mg % 300 mg/100g 
Chlorophyll-a >500 mg % ♦ >500 mg % 900 mg/100g 
Phycocyanin ♦ ♦ >2000 mg % 8,000 mg/100g 
Moisture ♦ ♦ <7 % <7 % 
Standard Plate Count <100,000/g 1,000,000/g <200,000/g <200,000/g 
Mold ♦ <1000/g ♦ <100/g 
Saccharomyces sp. ♦ ♦ ♦ < 40/g 
Coliform bacteria <10/g <100/g negative negative 
Staphylococcus aureus <100/g <100/g ♦ negative 
Salmonella enteritidis negative negative ♦ negative 
total heavy metals (Lead, Mercury, 
Cadmium, Arsenic) 
♦ ♦ < 20.0 ppm 2.1 ppm 
Insect fragmen 
♦ ♦ ♦ <30 pcs per 10 g 
Rodent hair ♦ ♦ ♦ < 1.5 pcs per 150 g 
a Superior Public Hygiene Council of France, 1984, 1986. 
b Ministry of Health, Sweden. 
c Japan Health Foods Association, auth. by Ministry of Health and Welfare. 
d Earthrise Farms, 1995. 
definitions: < = less than, ≥ more than, ♦ = no set Standard, /g = per gram, parts per million (ppm) 
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claims were never backed up by detailed scientific and medical research, they will not be 
discussed in this chapter. Nevertheless, one cannot ignore the fact that more than 70 per cent 
of the current Spirulina market is for human consumption, mainly as health food. (Vonshak, 
2002, Shimamatsu, 2004, Henrikson, 2010). So, there are established national and 
international quality standards for Spirulina products. Tables 5 show the typical analysis of 
the contents of Spirulina product, the quality standard in Europe, Japan and United States 
Food and Drug Administration’s (FDA) requirement for Spirulina product respectively. 
Recently,cyanobacterial toxins have become a major issue in public health due to the 
increased occurrence of toxic cyanobacterial blooms. These toxic blooms contain algae that 
produce hepatotoxins called microcystins (Carmichael, 1994). Spirulina companies like 
Earthrise Farms have already developed methods for the determination of these toxins and 
actually certify each lot of their product to be toxin free. Spirulina does not normally contain 
microcystins but contamination of outdoor culture by other cyanobacteria is a possibility. 
4. Conclusion and outlook 
A bibliographical review on Spirulina (Arthrospira) identifies this microorganism as 
microalgae or bacteria, by bacteriologist and botanists respectively. This study has revealed 
many research studies done on its properties, some of these are related to human and 
animal food uses. Spirulina is claimed as a non-toxic, nutritious food, with some corrective 
properties against viral attacks, anemia, tumoral growth and low prostaglandins production 
in mammals; and as a source of the yellow coloration of egg yolk when consumed by hens, 
and a growth, sexual maturation and fertility factor, in poultry and bovines. This material 
contains proteins, carbohydrates, essential fatty acids, vitamins, minerals, carotenes, 
chlorophyll a and phycocyanin. Arthrospira may be produced in rather simple pilot plants or 
industrial installations if good conditions and quality controls are assured. Spirulina has 
been used as food for centuries in human history. Moreover, it has been produced 
commercially over the past 30 years and consumed by thousands of people without 
problem. Many research show that it has a good nutritional profile in addition to containing 
some phytonutrients that have potential health benefits. The technology of Spirulina 
production has also advanced in the past 30 years, resulting in higher-quality of product at 
relatively lower cost. Spirulina or Arthrospira has attracted the attention of researchers for 
many years, as shown by the hundreds of publications in its various aspects. There are more 
and more information is being made available about its biology, biotechnological and 
nutrition applications, and health application and even in what seem to be remote 
applications like biofuel production and as a life support system in space studies. This 
interest will no doubt continue. Research along these lines will be rewarding both socially 
and professionally. 
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1. Introduction 
Aluminum (Al) is distributed throughout the environment because of its presence as the 
third most abundant element on earth. Concern about Al toxicity to humans, including from 
food sources, has persisted since the demonstration that it has the potential to be a 
neurotoxicant (Wiley 1928, 1929; Schaeffer et al. 1928; Döllken 1898; Gies 1911; Anon. 1913; 
Yokel and Golub 1997; WHO 1997; Krewski et al. 2007; ATSDR 2008). Exposure of humans 
to Al is mainly from food, water, airborne dust, antiperspirants, immunizations, allergy 
injections and antacids (Table 1). Foods and beverages are the single largest contributor of 
Al intake for the typical human, providing ~ 3.5 to 10 mg/day. Food additives provide a 
significant percentage of the daily intake. Among the food additives, sodium aluminum 
phosphates (SALPs) are the main contributors. Drinking water provides ~ 0.1 mg. Other 
sources for some humans, their daily exposures and intakes, estimated percentage absorbed, 
and amount of Al that enters the blood are summarized in Table 1. The history of the use 
and regulation of Al food additives in the US, approved Al-containing food additives in the 
US and some other countries, primary food types contributing Al to the diet, typical daily 
dietary Al intake, dietary intake in relation to established tolerable intake and minimal risk 
levels, and some discussion of Al absorption, distribution, excretion, and toxicity are 
presented in this chapter.  
Aluminum is present in food naturally, as a food additive, and taken up through contact 
with Al used in food preparation and storage. The Al content of foods is highly variable, 
depending upon the food product, its processing or lack thereof, the site of growth of the 
food stuff, and for grains if they are Al-tolerant varieties. Contamination of food with soil, 
that typically contains 5 to 10% Al, can significantly increase the Al content of the food, 
although the Al may not be in a readily absorbable form. 
2. The history of aluminum-containing food additives in the US 
Smith (1928) reviewed the Report of the Referee Board of Consulting Scientific Experts, 
Created by Executive Order of President Roosevelt in February, 1908, to address the safety 
of the use of Al compounds in food. He also reviewed the published literature and some 
unpublished studies up to 1925 and court cases relevant to the use of Al in baking powders 
and conducted some studies himself. He concluded, in agreement with the Referee Board 
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Water Average ~ 70 μg/l  100 μg 0.3 b 0.004 
Food - total diet  3500-10,000 μg c 0.1 to 0.3 d 0.05-0.4 
Air-office 0.15 μg/m3 e 1 μg 1 to 2 from lungs f 
0.1 to 0.3 from GI tract
0.0002 
0.00003  
Air-outside 0.2 - 1 μg/m3 e,g  4 μg h 1 to 2 from lungs f 
0.1 to 0.3 from GI tract
0.001 
0.0001  
Antiperspirants 5-7.5% i 50,000-75,000 
μg 
up to 0.012 j up to 0.1 
Vaccines, pediatric 
patient 




 up to 5,000,000 
μg  
0.1  80 
Industrial Air 25-2500 μg/m3  250-25,000 μg 
per work day 
1 to 2 from lungs f 
0.1 to 0.3 from GI tract 
0.6-8 
0.008-1 
Allergy immunotherapy 150-850 μg/dose 7-40 μg m 100 eventually l 0.1-0.6 
Dialysis solution If tap water 50 
μg/l 
2400 μg 25 n 9 
Neonatal/pediatric 9-23 μg/kg o  100 9-23 Total Parenteral 
Nutrition Solutions 
Adult  1.5 μg/kg p 100 1.5 
aBased on a 70 kg adult except for vaccines (20 kg child) and total parenteral nutrition solutions. b(Yokel 
et al. 2001a; Zhou, Harris, and Yokel 2008; Stauber et al. 1999; Priest et al. 1998). cBased on reports cited 
in the text. d(Stauber et al. 1999; Yokel and Florence 2006; Yokel, Hicks, and Florence 2008). e(Horemans 
et al. 2008). fBased on Al exposure in an industrial setting: (Sjögren et al. 1997; Gitelman et al. 1995; 
Pierre et al. 1995; Riihimäki et al. 2000; Priest 2004). g(Jones and Bennett 1986). h(Priest 2004). iBased on 
20% Al zirconium glycine complex or 25% Al chlorohydrate in a topical product, which are typical 
concentrations (POISINDEX information system, Micromedex, Inc, Englewood, CO). jBased on (Flarend 
et al. 2001), assuming that the percentage of Al absorbed does not change with repeated exposure. 
kBased on 30 injections in the first 6 years of life, an average weight of 20 kg, 0.75 mg from 
RECOMBIVAX HB®, 1.32 mg from Pentacel®, 0.5 mg from Prevnar®, 0.5 mg from HAVRIX® and none 
from RotaTeq®, Fluzone®, M-M-R® II, or Varivax®, assuming absorption over 6 years. l(Flarend et al. 
1997). mBased on a typical allergen extract treatment schedule and maintenance injections for 3.5 years 
of one allergen extract. n(Kovalchik et al. 1978). o(Speerhas and Seidner 2007; Poole et al. 2010; Bohrer et 
al. 2010). p(Speerhas and Seidner 2007).  
Table 1. Sources of Al exposure, Al concentration in the source, resultant daily Al 
exposure from the source, estimated percentage absorbed from the source, and calculated 
amount of Al absorbed daily, normalized to body weight. Modified from (Yokel and 
McNamara 2001)  
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1899, that baking powder containing sodium aluminum sulfate had not been shown to cause 
functional disorders or disease or impairment of the digestion and general health to 
humans.  
Al salts were used in food prior to 1958. The U.S. Congress amended the Food, Drug and 
Cosmetic Act (FDC Act) in 1958 (Food Additives Amendment) to require pre-market 
approval of any substance intentionally added to food, that becomes a component of food or 
otherwise affects the characteristics of food, unless the use of the substance is generally 
recognized as safe (GRAS) or otherwise excepted from the definition of food additive, e.g., a 
color additive. A temporal summary of the development of food regulation in the US is 
available at:  
(http://www.fda.gov/Food/FoodIngredientsPackaging/GenerallyRecognizedasSafeGRAS
/ucm094040.htm). It legislated exemptions for many substances with a history of safe use as 
food. For substances used in foods prior to 1958, the FDA permits expert opinion to be based 
on a reasoned judgment founded in experience with common food use, taking into account 
reasonably anticipated patterns of consumption, cumulative effects in the diet, and safety 
factors appropriate for the utilization of animal experimentation data. Appropriate 
regulation is also required that is published in the Federal Register and codified in the Code 
of Federal Regulations (CFR). The food additive petition process of the FDA is based on 
Section 409 of the FDC Act. Corresponding regulations are described in CFR Title 21. The 
GRAS substance list appears in 21 CFR Parts 171, 182, 184, and 186. These regulations are 
accessible on the Internet, e.g., 21 CFR 133.169 at: http://frwebgate.access.gpo.gov/cgi-
bin/get-cfr.cgi?TITLE=21&PART=133&SECTION=169&TYPE=TEXT.  
In 1959 the US FDA published a list of substances it considered to be GRAS for use in foods. 
GRAS is defined in CFR 121.1. Legal authority for Al as GRAS is codified in 21 CFR 182.  
The list included Al salts. Food additive approval does not require human clinical testing 
and there is no risk-benefit analysis. GRAS recognition may be based on scientific 
procedures (safety studies) or through experience based on common use in food prior to 
1958. The original determination of GRAS status of Al was based on common use. President 
Nixon in 1969 directed the FDA to undertake a systematic safety review of all GRAS 
substances. The Life Sciences Research Office (LSRO) of the Federation of American 
Societies for Experimental Biology (FASEB) was contracted by the FDA to review and 
evaluate the available information on each GRAS substance, summarize the available 
scientific literature, and to recommend what restrictions, if any, on their use would be 
needed to ensure their safe use in food. A re-review of the GRAS status of Al was conducted 
by a select committee of the FASEB in 1975, Select Committee on GRAS Substances [SCOGS]. 
It was based on the previous review, a review of the published literature from 1920 to 1973 
related to the safety of Al compounds as food ingredients (Tracor-Jitco 1973), and 
unpublished studies contracted by producers of SALP which was fed to rats and dogs. The 
opinion of the select committee was that “There is no evidence in the available literature 
on …acidic sodium aluminum phosphate [and other Al forms] … that demonstrates, or 
suggests reasonable grounds to suspect, a hazard to the public when they are used at levels 
that are now current or that might reasonably be expected in the future” (FASEB 1975) 
(http://www.fda.gov/Food/FoodIngredientsPackaging/GenerallyRecognizedasSafeGRAS
/GRASSubstancesSCOGSDatabase/default.htm). Although noting that care should be taken 
by patients with kidney disease when consuming food containing high levels of Al salts, the 
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controversial role of Al in Alzheimer’s disease. Description of these clinical problems began 
about the same time (Crapper, Krishnan, and Dalton 1973; Alfrey, LeGendre, and Kaehny 
1976). 
In 1982 the FDA issued Toxicological Principles for the “Safety Assessment of Direct Food 
Additives and Color Additives Used in Food” (a.k.a. the Red Book) to provide testing 
guidelines to obtain scientific evidence of safety (Humphreys 1992). In 1992 the FDA was in 
the process of reviewing Al, which was evidently not completed. The FDA Center for Food 
Safety and Applied Nutrition is responsible for monitoring Al in foods, that which is 
naturally occurring, and that which is from food additives (Pennington 1992).  
3. The current approved uses, purposes for use, and regulation of aluminum-
containing food additives 
3.1 In the US 
Aluminum is used as a direct food additive as a firming agent, carrier, coloring agent, 
anticaking agent, buffer, neutralizing agent, dough strengthener, emulsifying agent, 
stabilizer, thickener, leavening agent, curing agent and texturizer. Direct food additives are 
those that have been intentionally added to food for a functional purpose, up to a few %. 
These additives are used in milk, processed cheese, yogurt, preserves, jams and jellies, 
baking soda, sugars, cereals, flours, grains and powdered or crystalline desert products 
(Pennington 1987). Table 2 lists FDA-approved GRAS food additives containing Al and 
Table 3 other FDA-approved Al-containing food additives.  
The most important uses include the addition of acidic SALP to self-rising flour as an 
acidifying and leavening agent; basic SALP to processed cheese, cheese food and cheese 
spread as an emulsifying agent to give them a soft texture and easy melting characteristics 
(Lione 1983); and sodium aluminosilicate as an anticaking agent. Acidic SALP 
NaAl3H14(PO4)8 ·4H2O reacts with NaHCO3 to produce the leavening action by generating 
CO2. Basic SALP (Na8Al2(OH2)((PO)4)4) is one of many “emulsifying salts” added to process 
cheese, cheese food and cheese spread which react with and change the protein of cheese to 
produce a smooth, uniform film around each fat droplet to prevent separation and bleeding 
of fat from the cheese. This produces the desired soft texture of cheese, easy melting 
characteristics, and desirable slicing properties (Ellinger 1972). 
Aluminum is also permitted in lakes (water-soluble artificial colors adsorbed onto alumina), 
which typically have an Al content of 25% (United Kingdom Ministry of Agriculture 
Fisheries and Food 1993). Alumina (Al oxide) is the only substratum approved for 
manufacturing U.S. Food, Drug & Cosmetic approved lakes (Soni et al. 2001). These are 
listed in Table 3. 
Aluminum and some Al compounds are also approved by the FDA as indirect food 
additives (21CFR) Parts 175, 176, 177, and 178. Indirect food additives are substances used in 
food-contact articles, and include adhesives and components of coatings (Part 175), paper 
and paperboard components (Part 176), polymers (Part 177), and adjuvants and production 
aids (Part 178). In general, these are substances that may come into contact with food and 
enter food products in small quantities as a result of growing, processing or packaging 
(http://www.fda.gov/Food/FoodIngredientsPackaging/ucm115333.htm).  
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• Prior-sanctioned food ingredients. Stabilizers (substances that may migrate from 
food-packaging material into food) (21 CFR 181.29)  
• Aluminum mono-, di-, and tristearate 
• GRAS substances (21 CFR 182) 
• Substances migrating to food from paper and paperboard products (182.90) 
- Alum (double sulfate of aluminum, and ammonium, potassium, or sodium) 
- Aluminum hydroxide 
- Aluminum oleate [1975, 43,1] 
- Aluminum palmitate [1975, 43,1] 
- Sodium aluminate, [1975, 43,1] 
- Sodium phosphoaluminate, [1975, 43,1] 
• Multiple purpose GRAS food substances (Subpart B) 
- Aluminum sulfate (182.1125), [1975, 43,1] 
- Aluminum ammonium sulfate (182.1127), [1975, 43,1], buffer and neutralizing 
agent 
- Aluminum potassium sulfate (182.1129 ), [1975, 43,1], buffer and neutralizing 
agent 
- Aluminum sodium sulfate (182.1131), [1975, 43,1], buffer and neutralizing 
agent 
- Sodium aluminum phosphate, acidic (182.1781), [1975, 43,1] a leavening 
agent in cereal foods and related products, self-rising flours & meals  
- Sodium aluminum phosphate, basic (182.1781), [1975, 43,1] an emulsifying 
agent in pasteurized process cheese, cheese food and cheese spread 
• Anticaking Agents (Subpart C) 
- Aluminum calcium silicate, (182.2122), [1979,1], anticaking agent, < 2% by 
weight in table salt; (169.179), vanilla powder 
- Sodium aluminosilicate (sodium silicoaluminate) (182.2727), [1979,61,1], 
anticaking agent, < 2% 
- Sodium calcium aluminosilicate, hydrated (sodium calcium silicoaluminate) 
(182.2729), [1979,61,1], anticaking agent, < 2%  
• Direct food substances affirmed as GRAS (21 CFR 184) 
• Aluminum hydroxide (184.1139) [1975, 43,1] 
• Indirect food substances affirmed as GRAS (21 CFR 186) 
• Clay (kaolin), which consists of hydrated aluminum silicate (186.1256)  
SCOGS conclusion: 
1. There is no evidence in the available information on [substance] that demonstrates, 
or suggests reasonable grounds to suspect, a hazard to the public when they are used 
at levels that are now current or might reasonably be expected in the future. 
Table 2. Generally recognized as safe (GRAS) food additives containing Al. The 21 CFR for 
those substances that have a CFR citation is in parentheses. The year of the SGOGS review 
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• Cheeses and related cheese products 
• To bleach milk for cheese, potassium alum, (133.102, 106, 111, 141, 165, 181, 183, 
and 195), < 0.012% 
• Grated cheeses: Sodium aluminosilicate 
• Pasteurized process cheese: sodium aluminum phosphate, (133.169), < 3% by 
weight 
• Pasteurized process cheese food, sodium aluminum phosphate, (133.173), < 3% 
by weight 
• Pasteurized process cheese spread, sodium aluminum phosphate, (133.179), < 
3% by weight 
• Cereal flours and related products, Subpart B 
• Flour: potassium alum and sodium aluminum sulfate, (137.105) 
• Self-rising flour: sodium aluminum phosphate (137.180) 
• Self-rising white corn meal: sodium aluminum phosphate (137.270)  
• Eggs and egg products 
• Dried whole eggs and egg yolks: sodium silicoaluminate, anticaking agent, 
(160.105), < 2% 
• Food dressings and flavorings 
• Vanilla powder: Aluminum calcium silicate, (169.179), < 2% 
• Food additives permitted for direct addition to food for human consumption, 
Subpart D—Special Dietary and Nutritional Additives 
•  As a source of niacin in foods for special dietary use, aluminum nicotinate, 
dietary supplement, (172.310) 
• Salts of fatty acids: aluminum salts of fatty acids, binder, emulsifier, and 
anticaking agent (172.863)  
• Food starch-modified: aluminum sulfate, [1979,115,3] , (172.892), < 2.0%  
• Defoaming agents: Secondary direct food additives permitted in food for human 
consumption 
• Aluminum stearate - Processing beet sugar & yeast, antifoaming (or defoaming) 
agent, (173.340) 
• Boiler water additives, in steam contacting food 
• Sodium aluminate, (173.310) 
• Aluminum in lakes 
• FD&C Blue #1 aluminum lake 
• FD&C Blue #2 aluminum lake on alumina 
• FD&C Red #40 aluminum lake 
• FD&C Yellow #5 aluminum lake 
• Indirect food additives: adjuvants, production aids, and sanitizers, Subpart B - 
Substances utilized to control the growth of microorganisms, coatings on fresh citrus 
fruit 
• Aluminum 
• Aluminum acetate 
• Aluminum di(2-ethylhexoate) 
Table 3. (continues on next page) Some other FDA-approved sources of Al in food 
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• Aluminum distearate 
• Aluminum, hydroxybis[2,4,8,10-tetrakis(1,1-dimethylethyl)-6-hydroxy12h-
ibenzoid[d,g][1,3,2]dioxaphosphocin 6-oxidato] 
• Aluminum isodecanoate 
• Aluminum linoleate 
• Aluminum monostearate 
• Aluminum naphthenate 
• Aluminum neodecanoate 
• Aluminum oxide 
• Aluminum potassium silicate 
• Aluminum ricinoleate 
• Aluminum silicate 
• Aluminum sodium sulfate, anhydrous 
• Aluminum stearoyl benzoyl hydroxide 
• Bis(benzoate-o)(2-propanolato)aluminum 
• D&C Red no. 7-aluminum lake 
• Dialkyldimethylammonium aluminum silicate 
• Gum rosin, aluminum salt 
• Gum rosin, disproportionated, aluminum salt 
• Rosin, hydrogenated, aluminum salt 
• Rosin, partially dimerized, aluminum salt 
• Sodium aluminum pyrophosphate 
• Soybean oil fatty acids, aluminum salt 
• Tall oil fatty acids, aluminum salt 
• Tall oil rosin, aluminum salt 
• Tall oil rosin, disproportionated, aluminum salt 
• Wood rosin, aluminum salt 
• Wood rosin, disproportionated, aluminum salt 
SCOGS conclusion: 
3. While no evidence in the available information on [substance] demonstrates a hazard 
to the public when it is used at levels that are now current and in the manner now 
practiced, uncertainties exist requiring that additional studies be conducted. 
Table 3. (continued) Some other FDA-approved sources of Al in food 
3.2 Countries other than the US 
Canada permits the use of Al as a food additive, as described in Part B Foods Division 16 of 
the Food and Drug Regulations of the Canadian Food and Drugs Act (http://laws. 
justice.gc.ca/eng/regulations/C.R.C.,_c._870/page-147.html#h-110). These regulations are 
similar to the FDA’s. The fifteen member states of the European Union, as well as Norway 
and Iceland, allow the use of Al as a food additive. European Parliament and Council 
Directive 94/36/EC lays down detailed rules on colors and 95/2/EC, as amended by 
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of all food additives other than colors and sweeteners (http://ec.europa.eu/food/fs/ 
sfp/flav_index_en.html). Approved Al-containing food additives are shown in Table 4. The 
United Kingdom (http://www.legislation.hmso.gov.uk/si/si1995/Uksi_19953187_en_5. 
htm#sdiv3) and Australia and New Zealand (http://www.foodstandards.gov.au/ 
mediareleasespublications/publications/shoppersguide/foodadditivesnumeric1680.cfm) also 
permit Al food additives. Regulations for the former are very similar to the EC’s. The 
approved Al-containing food additives for the latter are shown in Table 5. Japan carries out 
food safety work under the Food Safety Basic Law (enacted in May 2003) and related laws  
94/36/EC (colors): 
• Aluminum metal (E 173) is authorized for the external coating of sugar confectionary 
and for the decoration of cakes and pastries.  
 95/2/EC: 
• E520 Aluminum sulfate, firming agent 
• E521 Aluminum sodium sulfate, firming agent 
• E522 Aluminum potassium sulfate, acidity regulator  
• E523 Aluminum ammonium sulfate, acidity regulator 
(Aluminum sulfates (E 520-523) are permitted to be used in egg white up to 30 mg/kg; 
and candied, crystallized glacé fruit and vegetables, up to 200 mg/kg individually or in 
combination, expressed as aluminum 
• E541 Sodium aluminum phosphate, acidic is permitted to be used in fine bakery 
wares (scones and sponge wares only) up to 1 g/kg expressed as aluminum. 
[Sodium aluminum phosphate, basic is not authorized in the EU as a food additive] 
• E554 Sodium aluminum silicate, anticaking agent  
• E555 Potassium aluminum silicate, anticaking agent  
• E556 Calcium aluminum silicate, anticaking agent  
• E558 Bentonite (hydrated aluminum silicate), carrier in food colors, maximum 5% 
• E559 Aluminum silicate (kaolin, anticaking agent) 
• E554-E559 are permitted to be used in dried powdered foodstuffs (including sugars); 
salt and its substitutes; sliced or grated hard, semi-hard and processed cheese and 
sliced or grated cheese analogues and processed cheese analogues, up to 10 g/kg; 
chewing gum; rice; sausages as a surface treatment only; seasonings up to 30 g/kg; 
confectionery excluding chocolate as a surface treatment only; tin-greasing products 
up to 30 g/kg 
• E1452 Starch aluminum octenylsuccinate, permitted encapsulated in vitamin 
preparations in food supplements in food supplements up to 35 g/kg 
94/36/EC on colors for use in foodstuffs: 
• Aluminum lakes of the permitted colors 
• FD&C Red 40 aluminum lake (E 129)  
Table 4. Allowed Al-containing additives for use in foodstuffs by the European Parliament 
and Council Directives 
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• Permitted flavoring substances, for the purposes of this Standard 
• Flavoring substances which are listed in at least one of the following 
publications: 
- Generally Recognized as Safe (GRAS) lists of flavoring substances published 
by the Flavour and Extract Manufacturers’ Association of the United States 
from 1960 to 2011 (edition 25) 
- Chemically-defined flavoring substances, Council of Europe, November 
2000 
- 21 CFR § 172.515 
• 559 Aluminum silicate 
• 470 Aluminum, calcium, sodium, magnesium, potassium and ammonium salts of 
fatty acids  
• 556 Calcium aluminum silicate 
• 554 Sodium aluminosilicate 
• 470 Aluminum, calcium, sodium, magnesium, potassium and ammonium salts of 
fatty acids  
• 541 Sodium aluminum phosphate, acidic (baking compound), [Basic SALP is not 
permitted as a food additive] 
• 555 Potassium aluminum silicate, dried milk, milk powder, cream powder 
• 555 Potassium aluminum silicate, cheese and cheese products up to 1%  
• 173 Aluminum, confectioneries, spirits and liqueurs 
• 556 Calcium aluminum silicate, salt 
Table 5. Al-containing food additives permitted by the Australia New Zealand Food Standards 
Code - Standard 1.3.1 . Colours and their aluminium and calcium lakes. A reference to a 
color listed in Schedules 1, 3 and 4 of this Standard includes a reference to the aluminum 
and calcium lakes prepared from that color 
• Aluminum ammonium sulfate (ammonium alum), raising agent, processing aid 
• Aluminum potassium sulfate (potassium alum), raising agent, processing aid 
• Food Blue No. 1, aluminum lake, restricted for the purpose of coloring 
• Food Blue No. 2, aluminum lake  
• Food Green No. 3, aluminum lake  
• Food Red No. 2, aluminum lake  
• Food Red No. 3, aluminum lake  
• Food Red No. 40, aluminum lake  
• Food Yellow No. 4, aluminum lake  
• Food Yellow No. 5, aluminum lake  
Table 6. Al-containing designated food additives deemed not injurious to human health, 
related to Articles 12 and 21 of the Food Sanitation Law of Japan (http://www. 
tokio.polemb.net/files/Gospodarka/Handel/food-e.pdf). The conditions of use of all but 
aluminum potassium sulfate are strictly defined or limited. All lakes are restricted for the 





of all food additives other than colors and sweeteners (http://ec.europa.eu/food/fs/ 
sfp/flav_index_en.html). Approved Al-containing food additives are shown in Table 4. The 
United Kingdom (http://www.legislation.hmso.gov.uk/si/si1995/Uksi_19953187_en_5. 
htm#sdiv3) and Australia and New Zealand (http://www.foodstandards.gov.au/ 
mediareleasespublications/publications/shoppersguide/foodadditivesnumeric1680.cfm) also 
permit Al food additives. Regulations for the former are very similar to the EC’s. The 
approved Al-containing food additives for the latter are shown in Table 5. Japan carries out 
food safety work under the Food Safety Basic Law (enacted in May 2003) and related laws  
94/36/EC (colors): 
• Aluminum metal (E 173) is authorized for the external coating of sugar confectionary 
and for the decoration of cakes and pastries.  
 95/2/EC: 
• E520 Aluminum sulfate, firming agent 
• E521 Aluminum sodium sulfate, firming agent 
• E522 Aluminum potassium sulfate, acidity regulator  
• E523 Aluminum ammonium sulfate, acidity regulator 
(Aluminum sulfates (E 520-523) are permitted to be used in egg white up to 30 mg/kg; 
and candied, crystallized glacé fruit and vegetables, up to 200 mg/kg individually or in 
combination, expressed as aluminum 
• E541 Sodium aluminum phosphate, acidic is permitted to be used in fine bakery 
wares (scones and sponge wares only) up to 1 g/kg expressed as aluminum. 
[Sodium aluminum phosphate, basic is not authorized in the EU as a food additive] 
• E554 Sodium aluminum silicate, anticaking agent  
• E555 Potassium aluminum silicate, anticaking agent  
• E556 Calcium aluminum silicate, anticaking agent  
• E558 Bentonite (hydrated aluminum silicate), carrier in food colors, maximum 5% 
• E559 Aluminum silicate (kaolin, anticaking agent) 
• E554-E559 are permitted to be used in dried powdered foodstuffs (including sugars); 
salt and its substitutes; sliced or grated hard, semi-hard and processed cheese and 
sliced or grated cheese analogues and processed cheese analogues, up to 10 g/kg; 
chewing gum; rice; sausages as a surface treatment only; seasonings up to 30 g/kg; 
confectionery excluding chocolate as a surface treatment only; tin-greasing products 
up to 30 g/kg 
• E1452 Starch aluminum octenylsuccinate, permitted encapsulated in vitamin 
preparations in food supplements in food supplements up to 35 g/kg 
94/36/EC on colors for use in foodstuffs: 
• Aluminum lakes of the permitted colors 
• FD&C Red 40 aluminum lake (E 129)  
Table 4. Allowed Al-containing additives for use in foodstuffs by the European Parliament 
and Council Directives 
 
Aluminum in Food – The Nature and Contribution of Food Additives 
 
211 
• Permitted flavoring substances, for the purposes of this Standard 
• Flavoring substances which are listed in at least one of the following 
publications: 
- Generally Recognized as Safe (GRAS) lists of flavoring substances published 
by the Flavour and Extract Manufacturers’ Association of the United States 
from 1960 to 2011 (edition 25) 
- Chemically-defined flavoring substances, Council of Europe, November 
2000 
- 21 CFR § 172.515 
• 559 Aluminum silicate 
• 470 Aluminum, calcium, sodium, magnesium, potassium and ammonium salts of 
fatty acids  
• 556 Calcium aluminum silicate 
• 554 Sodium aluminosilicate 
• 470 Aluminum, calcium, sodium, magnesium, potassium and ammonium salts of 
fatty acids  
• 541 Sodium aluminum phosphate, acidic (baking compound), [Basic SALP is not 
permitted as a food additive] 
• 555 Potassium aluminum silicate, dried milk, milk powder, cream powder 
• 555 Potassium aluminum silicate, cheese and cheese products up to 1%  
• 173 Aluminum, confectioneries, spirits and liqueurs 
• 556 Calcium aluminum silicate, salt 
Table 5. Al-containing food additives permitted by the Australia New Zealand Food Standards 
Code - Standard 1.3.1 . Colours and their aluminium and calcium lakes. A reference to a 
color listed in Schedules 1, 3 and 4 of this Standard includes a reference to the aluminum 
and calcium lakes prepared from that color 
• Aluminum ammonium sulfate (ammonium alum), raising agent, processing aid 
• Aluminum potassium sulfate (potassium alum), raising agent, processing aid 
• Food Blue No. 1, aluminum lake, restricted for the purpose of coloring 
• Food Blue No. 2, aluminum lake  
• Food Green No. 3, aluminum lake  
• Food Red No. 2, aluminum lake  
• Food Red No. 3, aluminum lake  
• Food Red No. 40, aluminum lake  
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Table 6. Al-containing designated food additives deemed not injurious to human health, 
related to Articles 12 and 21 of the Food Sanitation Law of Japan (http://www. 
tokio.polemb.net/files/Gospodarka/Handel/food-e.pdf). The conditions of use of all but 
aluminum potassium sulfate are strictly defined or limited. All lakes are restricted for the 





(including the Food Sanitation Law), under the jurisdiction of the Department of Food 
Safety under the Pharmaceutical and Food Safety Bureau, in the Ministry of Health, Labour 
and Welfare. The Standards and Evaluation Division is responsible for the establishment of 
specifications/standards for food additives. Approved Al-containing food additives are 
shown in Table 6. The National Standard of the People’s Republic of China, Hygiene 
Standard for Use of Food Additives, GB2760-2007, issued by the Ministry of Health and the 
Standardization Administration of China, lists the following as allowed food additives: 
allura, amaranth, brilliant blue, erythrosine, indigo carmine, new red, ponceau 4 r, sunset 
yellow, and tartrazine aluminum lakes as coloring agents; sodium aluminosilicate as an 
anticaking agent up to 5 g/kg; aluminum potassium sulfate and aluminum ammonium 
sulfate as bulking agents and stabilizers with a maximum aluminum residual level of 100 
mg/kg dry weight; and starch aluminum octenylsuccinate as a thickener, anticaking agent, 
and emulsifier (http://www.fas.usda.gov/GainFiles/200803/146294056.pdf). Food additives 
listed by the Bureau of Food Sanitation, Department of Health, Republic of Taiwan, Scope of 
Usage and Measurement Standards for Food Additives as Food quality improvement, 
fermentation and food processing agents include aluminum silicate, aluminum sulfate, 
bentonite, diatomaceous earth, kaolin and sodium silicoaluminate as leavening agents, as 
well as ammonium alum, burnt ammonium alum, potassium alum, burnt potassium alum, 
sodium alum, burnt sodium alum, and acidic SALP (http://www.doh.gov.tw/EN2006 
/DM/DM2.aspx?now_fod_list_no=6005&class_no=386&level_no=2). The Government of 
India Prevention of Food Adulteration Act (PFA) of 1954, enforced by the Food Safety and 
Standards Authority of India, permits acid compounds of Al in baking powder; aluminum 
silicates and aluminum ammonium, calcium, potassium or sodium myristates, palmitates or 
stearates as anticaking agents up to 2%; aluminum sulfate (520) and aluminum sodium 
sulfate (521) as firming agents; aluminum potassium sulfate (522) as an acidity regulator and 
stabilizer; aluminum ammonium sulfate (523) as a stabilizer and firming agent; acidic and 
basic sodium aluminum phosphate (541) as an acidity regulator and emulsifier; sodium (up 
to 0.5% in powdered soft drink concentrate mix/ fruit beverage drinks and up to 10 gm/kg 
in cocoa powder and lozenges), potassium and calcium aluminosilicate and aluminum 
silicate (554, 555, 556 and 559) as anticaking agents; aluminum lake of Sunset Yellow FCF in 
powdered dry beverage mixes; and aluminum lake of Sunset Yellow and aluminum as 
colors. The Government of South Africa, Department of Health, Foodstuffs, Cosmetics and 
Disinfectants Act, 1972, Regulations Relating to Food-Grade Salt, permit calcium, magnesium 
and sodium aluminum and calcium-aluminum silicates as anticaking agents (http://www. 
doh.gov.za/docs/regulations/2006/reg0114.pdf).  
International Numbering System numbers are assigned by the Codex Alimentarius Committee 
to allow each food additive to be uniquely identified. On packaging in the EC, approved 
food additives are written with a prefix of 'E'. Some governments, e.g., Australia and New 
Zealand and India, do not use a prefix letter when listing additives in the ingredients.  
4. Al processing and packaging that comes in contact with food  
The use of Al cookware began around 1890 (Smith 1928). Al is used in cookware due to its 
heat conductivity. The surface of Al oxidizes to form a few nm thick layer of Al oxide, which 
resists corrosion from pH ~ 4.5 to 8.5. Studies on Al mobilization from Al shavings, strips 
and vessels from 1890 to 1925, reviewed by (Smith 1928), showed Al was solubilized by 
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beverages and foods. Many subsequent studies have shown that Al can be mobilized from 
Al cookware, particularly by acidic and alkaline foods. These are pH conditions where Al is 
more soluble than at circumneutral pH (Fimreite, Hansen, and Pettersen 1997; Scancar, 
Stibilj, and Milacic 2003; Neelam, Bamji, and Kaladhar 2000; Gramiccioni et al. 1996). It has 
also been demonstrated that NaCl can increase Al mobilization from Al vessels (Datta 1935; 
Inoue, Ishiwata, and Yoshihara 1988; Takeda, Kawamura, and Yamada 1998; Fukushima 
and Tanimura 1998).  
Most countries of the world, including the EC, do not have specific requirements for light 
metal alloys in contact with food (Severus 1989). The conclusion of a review by Wuhrer 
(1939) was that Al is safe and harmless as a material for cooking and household utensils in 
contact with food. The U.S. FDA came to a similar conclusion (Reilly 1991).  
5. The contribution of aluminum food additives, processing and packaging to 
human aluminum intake 
In the UK it was suggested that SALP, sodium Al silicate, and Al lakes contributed ~ 1.4, 0.9 
and 3 mg Al to daily intake, respectively (United Kingdom Ministry of Agriculture Fisheries 
and Food 1993). In the US the two most quantitatively significant food additives containing 
Al are acidic and basic SALP (Katz et al. 1984; Humphreys and Bolger 1997; Saiyed and 
Yokel 2005). The use of Al as a food additive can increase the low inherent level of Al in 
food, particularly in processed cheese and grain products. The foods highest in Al are those 
with added Al (Delves, Sieniawaska, and Suchak 1993). For example, it was noted that the 
addition of SALPs to cake mixes could result in 5 to 15 mg/serving and its addition to 
processed cheese at the permitted concentrations could result in 50 mg Al/slice (Lione 
1983). Similarly, the use of sodium Al sulfate in household baking powder could result in 5 
mg Al in each serving of a cake made with 1 teaspoon of baking powder (Lione 1983). It has 
been estimated that this practice can increase food Al content by about five-fold 
(Humphreys and Bolger 1997).  
Women who reported frequent or average use of Al utensils and foil averaged higher 
duplicate diet Al intakes than those who reported little or no use (Jorhem and Haegglund 
1992). They estimated cooking utensils contributed 2 mg Al to the diet (Jorhem and 
Haegglund 1992). Daily Al intake in China was estimated to be 9 to 12 mg plus ~ 4 mg from 
Al-ware (Wang, Su, and Wang 1994). It was concluded that food processing and storage are 
generally not major contributors to Al in food (Pennington 1987; Sherlock 1989). Greger and 
Sutherland (1997) concluded that "… under typical cooking conditions, it is doubtful that 
use of Al utensils adds more than 2 mg Al/day to food." However, if daily Al intake is 3.5 to 
10 mg (see Daily consumption of Al in food, below, and Table 1), this would add or 
constitute about 20 to 40% of the daily Al intake.  
6. Estimates of the extent of aluminum-containing food additive use  
Estimated use in the 1970s of Al-containing food additives were ~ 18 million kilograms of 
SALP; 3.6 million kg of sodium Al sulfate in baking powder; and an unknown amount of Na 
Al silicate, Al calcium silicate and Na calcium aluminosilicate as anticaking agents (FASEB 
1975). Based on 200 million people in the U.S. at that time and 10% of SALP as Al, the 
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mg/person/day. The estimate of daily Al consumption at that time was 20 mg/person 
(FASEB 1975). The 1977 Survey of Industry on the Use of Food Additives estimated use of ~ 
9 million pounds (~ 4 million kilograms) of SALP (NAS 1979). The amount of Al in SALP, 
sodium aluminosilicate, sodium aluminate, aluminum sulfate, and aluminum ammonium 
sulfate consumed by the 225 million people in the US produced an estimated daily Al intake 
at that time of ~ 5 mg/person. Al-containing lakes and other sources would increase this 
estimate. In 1982 four million pounds of Al were used as food additives in the US, which 
would average 20 mg/person/day (Committee on Food Additives survey data 1984; Greger 
1985). Although these estimates are not very consistent over time, they consistently estimate 
a large amount of Al intake from FDA-approved food additives in relation to total Al intake 
in the US. More recent estimates of the use of these approved food additives in the US were 
not found. 
Companies in the global phosphates industry that market SALPs include Innophos, which 
acquired Rhodia’s phosphate business in 2004, maker of acidic SALP (Levair®) and basic 
SALP (Kasal®); ICL Performance Products LP which acquired Astaris LLC in 2005, maker of 
Levn-Lite®, Stabil-9® and Pan-O-Lite®; Xuzhou Hengxing Chemical Co., Ltd maker of 
HENGXING®; Amerisweet Co., Ltd. maker of AmeriPhos®; China Chem Source (HK) Co., 
Ltd.; Foodchem International Corporation; and Thermphos International. Rhodia completed 
an expansion in 1998 to its Nashville plant to increase its SALP capacity by 15% (Anon, 
1998) and Astaris expanded its capacity in 2001 to boost production of SALP.  
7. Daily consumption of aluminum in food 
There have been at least 48 reports that measured or estimated daily oral Al consumption 
from the diet since the FDA’s total diet study reported in 1987. They have been conducted 
using many different methods, including duplicate portion studies of composite diets, total 
diet studies, calculations based on the foods in a total diet study times their Al content, and 
market basket surveys. These studies have been conducted in North America (Canada and 
the US), Europe (England and the U.K., France, Germany, Hungary, Italy, Netherlands, 
Portugal, Spain and the Canary Islands, Sweden, and Slovenia), Asia (China, India, Japan, 
and Taiwan), Australia and Brazil. Median daily Al intake for infants, children, teenagers 
and adults was 0.7, 6, 8.6 and 4.8 mg, respectively. Total Al intake generally relates to total 
food intake, which partially explains the greater Al intake in adolescents than adults. 
Another contributor is the selection of foods. Adolescents eat more prepared foods that have 
Al-containing food additives. For adults in the US and Canada, Europe, China and Japan, 
median Al intake by adults was 8.5 (n = 3 reports), 3.6 (n = 18), 9.5 (n = 6), and 9 mg (n = 3), 
respectively. Al food additives are the main source of Al intake in the US (WHO 1997) but of 
much less importance in other countries, which includes much of Europe, where less Al is 
added to cereal grain products as raising agents and basic SALP is not permitted to be used 
in processed cheese (United Kingdom Ministry of Agriculture Fisheries and Food 1993; 
Müller, Anke, and Illing-Günther 1998; Sherlock 1989; Humphreys and Bolger 1997). This is 
reflected in the fewer approved Al food additives and lower minimum permissible levels in 
the EC than the US (Table 4 compared to Tables 2 and 3). For example, the average Swedish 
daily diet was calculated to contain ~ 0.6 mg Al from unprocessed foods whereas 105 
duplicate diets of 15 women living in the Stockholm area were found to provide 1.2 to 99 mg 
Al/day, averaging 13 mg Al/day. The most important difference between these was a cake 
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made from a mix containing Al phosphate (Jorhem and Haegglund 1992), illustrating the 
contribution from food additives. 
8. The aluminum concentration in commercial products that contain 
aluminum food additives 
Among the three sources of Al in food, naturally occurring, additives and from food 
preparation and storage, the major food sources of Al in the daily diet of adults ~ 25 years 
ago were probably grain products with Al additives, processed cheese with Al additives, 
tea, herbs, spices and salt containing an Al additive (Pennington 1987). It was estimated that 
grains and grain products, dairy products, desserts, and beverages contributed about 24 to 
49%, 17 to 36%, 9 to 26% and 5 to 10%, respectively, of dietary Al in the U.S. diet 
(Pennington 1987). Similarly, grains, vegetables and tea were estimated to contribute ~ 60 to 
70, 25 and 5% of daily Al intake to the Chinese diet (Wang, Su, and Wang 1994; Zhong et al. 
1996). The Australian National Nutrition Survey suggested 30, 24, 10 and 8% was from 
cereals, beverages, vegetables, and meats, respectively (Allen and Cumming 1998). Biego et 
al. (1998) estimated 36% from milk and dairy products, 29% from fish and crustaceans, 16% 
from cereals and 8% from vegetables in France. A study from the UK concluded beverages 
contributed 35%, bread 21%, and cereals 16% of the Al in the diet (Ysart et al. 2000). The Al 
content of natural cheese and processed cheese containing added Al has been reasonably 
constant for a few decades. It appears that the use of Al in pancake mixes and prepared 
pancakes in the US has increased in the past few decades. A report of Al in convenience and 
fast foods in Spain noted the increased popularity of these foods and considerable Al in 
them (Lopez et al. 2002). 
9. Comparison of aluminum intake to established tolerable intake and 
minimal risk levels 
The Joint Food and Agriculture Organization of the United Nations/World Health 
Organization Expert Committee on Food Additives (JECFA) withdrew in 2006 its previously 
established acceptable daily intake (ADI) and provisional tolerable weekly intake (PTWI) of 
7 mg/kg body weight to establish a PTWI for Al of 1 mg/kg. It applied to all Al compounds 
in food, including additives (FAO/WHO 2006; FAO/WHO 2007). The Expert Committee 
concluded that Al compounds have the potential to affect the reproductive system and 
developing nervous system at doses lower than those used in establishing the previous 
PTWI. In setting this limit the Committee assumed a “probable lower bioavailability of the 
less soluble Al compounds present in food” and noted that the PTWI was likely to be 
exceeded by some population groups, particularly children, who regularly consume foods 
containing Al additives. At the 74th meeting of the JECFA (June 14 to 23, 2011, Rome) the 
previous PTWI of 1 mg/kg body weight was withdrawn and a PTWI of 2 mg/kg body 
weight was established based on a no-observed-adverse-effect level (NOAEL) of 30 mg/kg 
body weight per day and application of a safety factor of 100. The PTWI applies to all 
aluminum compounds in food, including food additives (ftp://ftp.fao.org/ag/agn/ 
jecfa/JECFA_74_Summary_Report_4July2011.pdf). 
The Panel on Food Additives, Flavourings, Processing Aids and Food Contact Materials 
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(TWI) of 1 mg Al/kg/week. They also noted that this TWI is likely to be exceeded in a 
significant part of the European population by the typical dietary Al intake (Panel on Food 
Additives 2008). Similarly, the Agency for Toxic Substances and Disease Registry (ATSDR) 
derived an intermediate-duration oral exposure (15 to 364 days) minimal risk level (MRL) of 
1 mg Al/kg/day, based on neurodevelopmental effects in the offspring of mice exposed to 
aluminum lactate in the diet on gestation day 1 through lactation day 21 followed by pup 
exposure until postnatal day 35 (Golub and Germann 2001). 
At the 42nd session of the Codex Committee on Food Additives (CCFA) of the Joint 
FAO/WHO Food Standards Programme (March 15-19, 2010, Beijing, China) it was agreed to 
establish an electronic working group (eWG) to review comments and information 
submitted and to revise the maximum use levels for the following Al-containing food 
additives included in the General Standard for Food Additives (GSFA): acidic and basic 
SALP, aluminum ammonium sulfate, sodium aluminum silicate, calcium aluminum silicate, 
and aluminum silicate. The eWG recommended that only numerical maximum levels be set 
for Al-containing food additives and that they be expressed on an Al basis, and that the 
potential exposure to Al from the food additive intake be assessed and compared to the 
PTWI and that proposed levels of Al-containing food additive are not acceptable when the 
contribution of a single portion of the food with its additive reaches the PTWI. Comments to 
the draft and the compilation of proposals from the eWG and comments from governments 
and trade organizations provide further insight into the uses of Al-containing food additives 
(including the results of a Canadian survey of the maximum levels of use of SALP and 
sodium aluminum silicate reported by various Canadian food industry stakeholders), and 
concerns about their safety (www.cclac.org) (http://www.docstoc.com/docs/80793084/ 
Comments_Second_Circular_Aluminium) (ftp://ftp.fao.org/Codex/ccfa43/fa43_10e.pdf). 
The recommendations of the 43rd session of the CCFA (Xiamen, China, March 14 to 18, 2011) 
were presented to the 34th session of the Codex Alimentarius Commission of the Joint 
FAO/WHO Food Standards Programme (Geneva, Switzerland, July 4 to 9, 2011) 
(http://www.cclac.org/documentos/CCFA/2011/1%20Alinorm/REP11_FAe.pdf). The 
report of the 34th session does not appear to mention these recommendations or whether 
action was taken on them (ftp://ftp.fao.org/codex/ Reports_2011/REP11_CACe.pdf). 
10. The fate of aluminum relevant to its intake by the human in food 
10.1 Absorption 
Oral bioavailability (fractional absorption, a.k.a. uptake) is the amount absorbed compared 
to the amount administered. For Al, systemic bioavailability, the fraction that reaches 
systemic circulation (blood) from which it has access to the target organs of its toxicity, is 
most relevant. 
Oral 27Al bioavailability from water from a municipal water treatment facility was estimated 
to be 0.36% in a study of 21 humans (Stauber et al. 1999). Two studies that had only two 
human subjects each estimated oral Al bioavailability to be 0.1 and 0.22% (Hohl et al. 1994; 
Priest et al. 1998). The bioavailability of hydrophilic substances that are not well absorbed 
can be determined by comparing the area under the curve (AUC) × time for the test 
substance given orally and intravenously (Rowland and Tozer 1995). Using a modification 
of this approach the oral Al bioavailability in the rat averaged 0.28% and 0.29% (Yokel et al.  
 
Aluminum in Food – The Nature and Contribution of Food Additives 
 
217 
2001a; Zhou, Harris, and Yokel 2008). These studies indicate oral Al bioavailability from 
water is ∼ 0.1 – 0.3%. 
Oral Al bioavailability from food has been estimated to be ~ 0.1 to 0.15% based on average 
daily urinary Al excretion compared to average daily Al intake from food (Powell and 
Thompson 1993; Priest 1993; Nieboer et al. 1995; Ganrot 1986; Priest 2004). Using the AUC × 
time method, oral Al bioavailability in rats that ate ~ 1 gm of biscuit containing [26Al]-
labeled acidic SALP averaged ~ 0.12% (Yokel and Florence 2006) and 0.1% to 0.3% from 
basic SALP incorporated into cheese (Yokel, Hicks, and Florence 2008). Concurrent 
consumption of citrate, and to a lesser extent other carboxylic acids, can increase oral Al 
absorption, as can increased solubility of the Al, a more acidic environment, uremia, and 
perhaps fluoride (Krewski et al. 2007). Absorption of Al from injected Al in vaccines and 
allergy immunotherapy is probably completely absorbed over time (Flarend et al. 1997). 
Water and food consumption provide ~ 0.1 and 3.5 to 10 mg of Al, respectively, to typical 
daily Al intake by humans (Table 1). The products of the Al contribution from food and 
water to the diet × the percentage absorbed (for water 0.1 mg Al consumed daily × 0.3% 
absorption, delivering 0.3 µg; for food 3.5 to 10 mg Al consumed daily × 0.1% absorption, 
delivering 7.5 µg of Al to systemic circulation) suggest food provides ~ 25-fold more Al to 
systemic circulation than does drinking water. This suggests food is the largest single source 
of Al for the typical human. As food additives are the single largest source of Al in food, 
they are the greatest contributor to the daily Al intake of the human who is not exposed to 
other major Al sources (oral antacids, immunization and vaccination injections, occupational 
exposure and total parenteral nutrition). 
10.2 Distribution 
Normal adult Al content is (in mg/kg wet weight unless stated otherwise): lung: 20, bone: 1 
to 3 mg/kg dry weight, liver and spleen: 1, kidney: 0.5, heart: 0.45, muscle: 0.4, brain: 0.35, 
and blood: 0.002. Approximately 60, 25, 10, 3, 1, 0.3, 0.25 and 0.2% of the Al body burden is 
in the bone, lung, muscle, liver, brain, heart, kidney and spleen, respectively (Yokel 1997; 
Priest 2004). Aluminum localizes at the mineralization front and in osteoid of bone. 
Aluminum in lung may be from environmentally-derived particles, occupational exposure, 
and distribution from blood. Approximately 80% of an intravenous dose of aluminum 
citrate was excreted within a week, suggesting the remainder was retained within the body, 
some of which was excreted over a longer time (Priest et al. 1995). This indicates that Al 
accumulates in the body during continuous intake, even in subjects with normal renal 
function. Brain, bone, liver and serum Al concentrations increase with age (Stitch 1957; 
Zapatero et al. 1995; Markesbery et al. 1984; Roider and Drasch 1999; Shimizu et al. 1994; 
Hellström et al. 2005).  
The terminal half-life (t½) of Al has been found to be quite long in the rat and human 
(reviewed in (Krewski et al. 2007)). The whole-body t½ was estimated to be ~50 years in one 
human who received an intravenous injection of 26Al citrate, based on whole-body 26Al 
monitoring (Priest 2004). The t½ of Al in the rat brain has been estimated to be from ~ 150 
days to considerably greater (Yokel et al., 2001b; Yumoto et al., 2003). The lack of a good 
understanding of allometric scaling of metal elimination rates for rat to human make it 
difficult to predict the human brain Al t½. Given the large percentage of Al in bone, it 
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Aluminum associates avidly with transferrin in the blood, which binds > 90 of Al in the 
blood. In the cerebrospinal fluid, and presumably brain extracellular fluid, ~90 of the Al is 
believed to be associated with citrate (calculated by Dr. Wesley Harris; Yokel and 
McNamara 2001).  
10.4 Excretion 
The kidneys account for > 95% of Al excretion, presumably by glomerular filtration of 
aluminum citrate. Humans who daily consume 3.5 to 10 mg of Al would be expected to 
excrete 4 to 12 μg, generating a typical urinary Al concentration of 2 to 10 μg/L. Reduced or 
absent renal function creates the risk of Al accumulation and toxicity. The biliary route 
accounts for most of the remaining excreted Al. 
11. The most susceptible population to aluminum toxicity  
Those who have impaired or no renal function are at the greater risk of Al toxicity because 
of their reduced ability to excrete it. In a study, patients with chronic renal insufficiency who 
used Al kitchen utensils for > 1 year were divided into two groups, one that continued to do 
so for 3 months; the other used stainless steel utensils. The latter group showed a 
significantly greater decrease in serum Al and daily urine Al excretion. These results suggest 
Al kitchen utensils may be a significant Al source for this population (Lin et al. 1997). When 
foods provide more Al in the diet than cookware, as is usually the case, one might expect 
foods that contain considerable Al to have an even greater contribution to the Al body 
burden of patients with chronic renal insufficiency than produced by Al kitchen utensils. 
12. The primary known adverse health effects of aluminum in the human 
There is no good evidence that Al is essential or beneficial for the human. Aluminum can 
produce toxicity to the central nervous, skeletal and hematopoietic systems. It can produce 
an encephalopathy in renal-impaired humans (dialysis encephalopathy), cognitive deficits 
in young children, a low-turnover bone disease, a microcytic hypochromic anemia, and has 
been implicated as an environmental factor that may contribute to some neurodegenerative 
diseases, including Alzheimer’s disease.  
The toxicity of Al has been extensively reviewed by the World Health Organization, for the 
US Department of Health and Human Services, and most extensively by a multi-national 
group led by Daniel Krewski (WHO 1997; ATSDR 2008; Krewski et al. 2007). When 
hemodialysis was initially extensively used, some patients developed a progressive 
encephalopathy that was fatal within 6 months. Dialysis (associated) encephalopathy (aka: 
dialysis dementia) is characterized by dyspraxia, dysarthria, emotional changes, trembling, 
ataxia, myoclonus, and fatal convulsions. It is associated with elevated levels of Al in the 
brain, and serum Al > 80 μg/L (Nieboer et al. 1995). Dialysis encephalopathy was due to Al 
contamination of the dialysis fluids and administration of Al-based phosphate binders to 
form an insoluble Al phosphate in the intestine, facilitating phosphate elimination, a goal 
not well achieved by dialysis. The renal dialysis patient is highly susceptible to Al 
accumulation and toxicity from Al in dialysis fluids because the Al can diffuse across the 
dialysis membrane, it rapidly and very strongly binds to transferrin in the blood, and these  
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patients lack the primary route of Al elimination, renal function. Exposure to lower levels of 
Al than those that caused Al-induced encephalopathy can produce a low turnover bone 
disease and a microcytic anemia.  
12.1 Aluminum-induced bone disease 
Aluminum-induced low-turnover bone disease is manifest as osteomalacia and an 
adynamic bone disease (Bushinsky 1997). Aluminum-induced bone disease in dialysis 
patients is seen when serum Al is > 30 μg/L and when stains show Al at 30% of the 
trabecular bone surface (Landeghem et al. 1998; Malluche and Monier-Faugere 1994). 
12.2 Aluminum-Induced microcytic anemia 
A microcytic, hypochromic anemia is associated with elevated plasma Al in chronic renal 
failure patients (Jeffery et al. 1996).  
12.3 Evidence for and against a role of aluminum in Alzheimer’s Disease 
Aluminum has been implicated in the etiology of Alzheimer's disease (AD) (Kawahara 
2005; Spencer 2000; Gupta et al. 2005; Krewski et al. 2007; Bondy 2010; Tomljenovic 2011). 
Hallmark neuropathological signs include neurofibrillary tangles (NFTs), senile plaques 
(SP), and cerebrovascular amyloid. Early onset AD usually has a familial link, due to gene 
mutations which result in increased secretion of neurotoxic amyloid β protein (Aβ). No 
specific gene mutations have been associated with late-onset/sporadic forms of AD which 
account for 85 to 95% of AD cases. The lack of identified hereditary links for the majority 
of AD cases suggests environmental factors are likely to interact with other factors to 
cause this disease. Aluminum is one of the suggested environmental contributors. The 
genesis of the hypothesis that Al plays a role in the etiology of AD was an observation 
reported in 1965 of neurofibrillary degeneration in rabbit brain after intracerebral Al 
injection, which resembled, but was not identical to, the NFTs of AD (Klatzo, Wisniewski, 
and Streicher 1965). Similarly, the neuropathology in dialysis encephalopathy is different 
from that seen in AD. The observation of elevated Al in post-mortem brain samples (that 
typically weighed scores of milligrams) of humans with AD reported in 1973 was 
interpreted as suggesting a role for Al in AD (Crapper, Krishnan, and Dalton 1973). This 
was followed by many studies, some of which found a few-fold or smaller increase of the 
Al concentration in AD victim brains than in controls, and some which did not. Studies 
investigating an elevated level of Al in AD brain using microprobe techniques, such as 
energy dispersive (electron probe) X-ray microanalysis, secondary ion mass spectrometry, 
and laser microprobe mass spectroscopy which can quantify Al within a cell, NFT or SP, 
as well as Al-selective stains, have also produced mixed results (Yokel 2000). If Al is 
elevated in AD brain, it is not reflected in cerebrospinal fluid Al, which has generally not 
been found to be elevated (Kapaki et al. 1993). Even if Al is elevated in AD brain, it does 
not prove cause and effect. The neuronal degeneration of AD may result in accumulation 
of metals, such as Al.  
Another approach to address the potential role of Al in AD is the epidemiological study of 
the association between the concentration of Al in drinking water and AD incidence, 
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results of many such studies are not consistent. The majority reported an increased risk of 
AD associated with higher drinking water Al concentration. Some of the differences were 
statistically significant. A major review published in 2007 conducted a risk characterization 
of the route of Al intake, the exposure level of concern, and Al exposure in the general 
population and calculated a margin of exposure (ratio of the exposure level of concern to the 
exposure level) (Krewski et al. 2007). The exposure level of concern was based on an 
epidemiological study that showed a relative risk of AD of 2.14 associated with a drinking 
water Al concentration > 100 μg/L (Rondeau et al. 2000).  
Given that Al bioavailability from water is not considerably greater than from food, studies 
assessing a putative link between Al in drinking water and AD might be mis-focused, and 
studies investigating a possible association between Al in food and cognitive impairment, 
dementia and AD might be more relevant. However, these are much more difficult to 
conduct, due to the multiple sources of Al in foods. It has been stated by US FDA employees 
that no clinical syndrome has been noted for the very low intake of dietary Al (Humphreys 
and Bolger 1997). It was also suggested that the risk of adverse effects of dietary Al, if there 
are any, is extremely low (Soni et al. 2001). The only published study addressing the 
potential association between Al in food and dementia was a preliminary study of 23 newly-
diagnosed AD patients and 23 matched non-demented controls to ascertain the relationship 
between consumption of foods generally high in Al during the previous 5 years and 
dementia. The results showed increased odds ratios for many food categories. However, the 
results were only significant for the category containing pancakes, waffles, biscuits, muffins, 
cornbread and corn tortillas (Rogers and Simon 1999). 
13. Determination of aluminum body burden and its treatment 
Determination of elevated body burden of Al might be made by quantification of Al in 
blood. However, this is quite difficult because the blood Al concentration of the normal 
healthy human is very low, thought to be < 6 μg/ml, and probably ~ 2 μg/ml (Daniela et al. 
2002; House 1992; Valkonen and Aitio 1997), and due to its ubiquitous nature, sample 
contamination is very easily obtained. The desferrioxamine test, a single injection of 5 
mg/kg this chelator, has been used to assess Al body burden, as evidenced by an increase in 
serum Al and urinary Al clearance. The test dose is used because steady-state serum Al 
concentrations do not correlate well with the Al deposition in bone and soft tissues that 
results from long-term Al exposure (Yokel 2002; Seo et al. 2007). Up to 5 mg/kg of 
desferrioxamine once or twice weekly has been shown to be safe and effective for long-term 
treatment of Al overload, and reduction of Al-induced encephalopathy, bone disease and 
anemia (Kan et al. 2010). 
14. Aluminum toxicity in the premature infant 
Another high risk group for Al toxicity is premature infants who are fed intravenously, 
because they do not tolerate oral feeding. The total parenteral nutrition feeding solutions 
given intravenously can contain significant Al, which is primarily derived from the calcium 
gluconate and phosphates used as components of the solution. As this feeding solution is 
given intravenously, and therefore 100% bioavailable, to premature infants whose kidneys 
are not fully matured and therefore less able to excrete the Al, they are at risk of sufficient Al 
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accumulation to develop metabolic bone disease, cholestatic hepatitis, and reduction of 
mental development. To address this concern the U.S. Food and Drug Administration 
adopted a labeling requirement for Al in large and small volume parenterals used to 
prepare total parenteral nutrition solutions. This has not solved the problem. 
15. Summary 
For the typical human, food additives provide the largest source of daily Al intake, 
exceeding water by several orders of magnitude, the latter having been implicated as a 
contributing factor to dementia, specifically Alzheimer’s disease. The food additive 
contributing the greatest amount of Al to the diet is SALP, used in its acidic form as a 
leavening agent in baked goods and in its basic form as an emulsifying agent in cheese. 
Acidic SALP is an approved food additive in most countries. Basic SALP is approved for use 
in many fewer countries. There has been debate for a century about the safety of Al as a food 
additive. This debate continues, and is reflected in recently changed established tolerable 
intake and minimal risk levels and changes under consideration. It has been noted that there 
is no good evidence of adverse health effects attributed to Al from food, that this issue has 
not been adequately directly assessed, and that those who lack good renal function, and 
therefore unable to efficiently eliminate Al, are at greatest risk of Al-induced toxicity, 
perhaps from food. As with the controversy concerning a possible role of Al in the etiology 
of Alzheimer’s disease, the controversy about possible adverse effects of Al as a food 
additive will continue until more definitive demonstration of safety or untoward effect is 
demonstrated.  
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results of many such studies are not consistent. The majority reported an increased risk of 
AD associated with higher drinking water Al concentration. Some of the differences were 
statistically significant. A major review published in 2007 conducted a risk characterization 
of the route of Al intake, the exposure level of concern, and Al exposure in the general 
population and calculated a margin of exposure (ratio of the exposure level of concern to the 
exposure level) (Krewski et al. 2007). The exposure level of concern was based on an 
epidemiological study that showed a relative risk of AD of 2.14 associated with a drinking 
water Al concentration > 100 μg/L (Rondeau et al. 2000).  
Given that Al bioavailability from water is not considerably greater than from food, studies 
assessing a putative link between Al in drinking water and AD might be mis-focused, and 
studies investigating a possible association between Al in food and cognitive impairment, 
dementia and AD might be more relevant. However, these are much more difficult to 
conduct, due to the multiple sources of Al in foods. It has been stated by US FDA employees 
that no clinical syndrome has been noted for the very low intake of dietary Al (Humphreys 
and Bolger 1997). It was also suggested that the risk of adverse effects of dietary Al, if there 
are any, is extremely low (Soni et al. 2001). The only published study addressing the 
potential association between Al in food and dementia was a preliminary study of 23 newly-
diagnosed AD patients and 23 matched non-demented controls to ascertain the relationship 
between consumption of foods generally high in Al during the previous 5 years and 
dementia. The results showed increased odds ratios for many food categories. However, the 
results were only significant for the category containing pancakes, waffles, biscuits, muffins, 
cornbread and corn tortillas (Rogers and Simon 1999). 
13. Determination of aluminum body burden and its treatment 
Determination of elevated body burden of Al might be made by quantification of Al in 
blood. However, this is quite difficult because the blood Al concentration of the normal 
healthy human is very low, thought to be < 6 μg/ml, and probably ~ 2 μg/ml (Daniela et al. 
2002; House 1992; Valkonen and Aitio 1997), and due to its ubiquitous nature, sample 
contamination is very easily obtained. The desferrioxamine test, a single injection of 5 
mg/kg this chelator, has been used to assess Al body burden, as evidenced by an increase in 
serum Al and urinary Al clearance. The test dose is used because steady-state serum Al 
concentrations do not correlate well with the Al deposition in bone and soft tissues that 
results from long-term Al exposure (Yokel 2002; Seo et al. 2007). Up to 5 mg/kg of 
desferrioxamine once or twice weekly has been shown to be safe and effective for long-term 
treatment of Al overload, and reduction of Al-induced encephalopathy, bone disease and 
anemia (Kan et al. 2010). 
14. Aluminum toxicity in the premature infant 
Another high risk group for Al toxicity is premature infants who are fed intravenously, 
because they do not tolerate oral feeding. The total parenteral nutrition feeding solutions 
given intravenously can contain significant Al, which is primarily derived from the calcium 
gluconate and phosphates used as components of the solution. As this feeding solution is 
given intravenously, and therefore 100% bioavailable, to premature infants whose kidneys 
are not fully matured and therefore less able to excrete the Al, they are at risk of sufficient Al 
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accumulation to develop metabolic bone disease, cholestatic hepatitis, and reduction of 
mental development. To address this concern the U.S. Food and Drug Administration 
adopted a labeling requirement for Al in large and small volume parenterals used to 
prepare total parenteral nutrition solutions. This has not solved the problem. 
15. Summary 
For the typical human, food additives provide the largest source of daily Al intake, 
exceeding water by several orders of magnitude, the latter having been implicated as a 
contributing factor to dementia, specifically Alzheimer’s disease. The food additive 
contributing the greatest amount of Al to the diet is SALP, used in its acidic form as a 
leavening agent in baked goods and in its basic form as an emulsifying agent in cheese. 
Acidic SALP is an approved food additive in most countries. Basic SALP is approved for use 
in many fewer countries. There has been debate for a century about the safety of Al as a food 
additive. This debate continues, and is reflected in recently changed established tolerable 
intake and minimal risk levels and changes under consideration. It has been noted that there 
is no good evidence of adverse health effects attributed to Al from food, that this issue has 
not been adequately directly assessed, and that those who lack good renal function, and 
therefore unable to efficiently eliminate Al, are at greatest risk of Al-induced toxicity, 
perhaps from food. As with the controversy concerning a possible role of Al in the etiology 
of Alzheimer’s disease, the controversy about possible adverse effects of Al as a food 
additive will continue until more definitive demonstration of safety or untoward effect is 
demonstrated.  
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1. Introduction 
Blood is a rich source of iron and proteins of high nutritional and functional quality. Because 
of the high protein content of blood, generally about 18% [1], it is sometimes referred to as 
“liquid protein” [2]. It has been estimated that the approximately 1,500,000 tons of porcine 
blood produced yearly in China has a protein content equivalent to that of 2,000,000 tons of 
meat or 2,500,000 tons of eggs [3]. Thus, a valuable protein source is lost if animal blood is 
discarded as waste and this is compounded by the resulting serious environmental 
pollution problems. Many countries require that animal blood be disposed off in an 
environmentally friendly manner, which is a capital intensive process. Accordingly, to 
eliminate a sizeable pollution hazard and prevent the loss of a valuable protein source, 
efforts have been made to ensure the utilization of animal blood on a massive scale. A 
further incentive is the increased profits to be made through adding value to the blood. 
The environmental, nutritional and economic benefits derived from the maximal utilization 
of animal blood, coupled with recent advances in blood collection and processing 
techniques, have led to a myriad of blood protein ingredients becoming available for use  
in foods and dietary supplements to serve specific needs (Table 1). By 2001, it was  
estimated that the food industry was utilizing 30% of the blood produced in 
slaughterhouses [4]. Current utilization likely surpasses this figure, though there is no data 
to confirm this. Plasma, the liquid portion of blood remaining after the blood cells [white 
blood cells (WBCs), red blood cells (RBCs), and platelets] have been removed, is most 
widely used in the food industry because it is neutral in taste and devoid of the dark color 
associated with the red blood cells (and hence whole blood) [5]. The traditional use of whole 
blood and its separated red blood cells as ingredients in food products is generally restricted 
to such products as blood sausages where the black color is both expected and acceptable [2]. 
The cellular portion of blood (and for that matter whole blood) has not enjoyed widespread 
usage in the food industry as a result of its heme component, which imparts an undesirable 
color, odor and metallic taste to the final product [6,7]. Even in trace quantities hemoglobin 
imparts a dark-brown color to foods [8]. Their use is also restricted because the cellular 
fraction is thought to have a higher microbial load, although this has been disproved [9]. 
The amount of cellular fraction-derived products used in food has traditionally been limited 
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associated with the red blood cells (and hence whole blood) [5]. The traditional use of whole 
blood and its separated red blood cells as ingredients in food products is generally restricted 
to such products as blood sausages where the black color is both expected and acceptable [2]. 
The cellular portion of blood (and for that matter whole blood) has not enjoyed widespread 
usage in the food industry as a result of its heme component, which imparts an undesirable 
color, odor and metallic taste to the final product [6,7]. Even in trace quantities hemoglobin 
imparts a dark-brown color to foods [8]. Their use is also restricted because the cellular 
fraction is thought to have a higher microbial load, although this has been disproved [9]. 
The amount of cellular fraction-derived products used in food has traditionally been limited 






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 1. Examples of blood-derived protein ingredients used as food additives and dietary 
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product [10]. This notwithstanding, recent efforts have focused on improving the utility of 
the cellular fraction in food proteins by removing the heme component using various 
techniques [6, 11-16] to produce an off-white product known in the food industry as globin 
or decolorized blood. Many of these treatments, however, are either not cost-effective, 
impart a salty or bitter taste to the globin recovered [17], or are only partially successful in 
alleviating the dark color associated with the heme component [8]. Thus, further processing 
methods continue to be devised to produce globin that lacks the bitter taste and has a whiter 
appearance. One such method involves treating RBCs recovered from blood with papain to 
release the heme, followed by further treatment with a bleaching agent, sodium 
hypochlorite. The isolated globin is almost tasteless with a white color [17]. 
Despite the technical successes achieved, animal blood proteins remain underutilized, 
largely due to consumer concerns. This paper reviews some of the specific uses of blood 
proteins in both the meat and non-meat industries and discusses the consumer issues 
hindering its maximal utilization.  
2. Meat industry 
The meat industry uses the bulk of the blood proteins employed as ingredients in the food 
industry, mainly as a binder but also as natural color enhancers, emulsifiers, fat replacers 
and meat curing agents. These will be discussed in turn below. However, some limited 
usages, for example as biodegradable natural casings for sausage products, will not be 
considered as such blood-based films have a relatively high solubility which may limit their 
application [18]. 
2.1 Binder 
Binders have traditionally been used in meat products to counter the textural and sensorial 
changes brought about by processing. In addition to absorbing the moisture that is released 
from meat during thermal processing, they are used to bind water and fat to stabilize meat 
emulsions in ground meat products [19]. The development of comminuted or emulsion type 
meat systems that incorporate binders allows more efficient utilization of tough meat from 
spent animals. The partial replacement of meat with binders reduces product costs while 
improving, or at least maintaining, the nutritional and organoleptic qualities of the final 
product [20]. Binders have a macromolecular structure that has the capacity to form 
matrices that retain aroma and nutrients and also entrap large amounts of water in such a 
manner that exudation is prevented [21]. They are also used in the restructuring of meat, 
which is geared towards the transformation of lower value cuts and quality trimmings into 
consumer-ready products of higher value that resemble intact muscles such as steaks, chops 
or roasts. Meat restructuring is also driven by increasing consumer demand for exact 
portions in commercial meat and fish products.  
Blood plasma and isolated blood proteins are both used as binders in the meat industry. 
Plasma functions as a binder in meat systems due to its ability to form gels upon heating, 
while the performances of plasma proteins are comparable, if not superior, to other binders. 
In terms of binding properties, blood plasma may be an alternative to the egg albumen 
traditionally used in the food industry for binding purposes [22], and remains the standard 
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which is geared towards the transformation of lower value cuts and quality trimmings into 
consumer-ready products of higher value that resemble intact muscles such as steaks, chops 
or roasts. Meat restructuring is also driven by increasing consumer demand for exact 
portions in commercial meat and fish products.  
Blood plasma and isolated blood proteins are both used as binders in the meat industry. 
Plasma functions as a binder in meat systems due to its ability to form gels upon heating, 
while the performances of plasma proteins are comparable, if not superior, to other binders. 
In terms of binding properties, blood plasma may be an alternative to the egg albumen 
traditionally used in the food industry for binding purposes [22], and remains the standard 





less effective than egg white powder, though still better than other binders (meat powders, 
gelatin, wheat gluten, isolated soy protein, and a combination of sodium alginate and 
calcium carbonate [23]). However, this study pointed out that the superiority of egg white 
powder as a binder over plasma powder was based solely on muscle to muscle binding; 
accurate muscle food product binding should consider not only muscle-to-muscle binding 
but also muscle-to-fat and fat-to-fat binding and plasma powders exhibited higher muscle to 
fat and fat to fat binding compared to egg white powder [23]. At acid pH, plasma produces 
soft and exuding gels and so is not effective as a gelling agent or capable of water retention 
in products with a low pH such as fermented products, as these functional properties are 
strongly affected by changes in the protein structure brought about by the acidic 
environment [24]. Subjecting porcine plasma to simultaneous treatment with microbial 
transglutaminase and high hydrostatic pressure has been shown to improve the gelling 
properties of porcine plasma under acidic conditions [25]. 
Besides their excellent functionality as binders, the utilization of blood proteins in the 
preparation of restructured meats offers a number of health and industry benefits. In the 
past, preparation of restructured muscle products required tumbling meat pieces with salt 
to extract soluble protein for meat binding. This tumbling action, however, damages the 
texture of the product and the use of salt is also a concern for consumers who are aware of 
the link between the sodium content of food and the increased risk of cardiovascular and 
bone disease [26, 27]. Conventionally, the process also involved the use of heat to bind the 
myofibrillar proteins extracted from the meat by the combined salt and tumbling action, and 
as such was referred to as hot-set binding [28]. The problem with the hot-set method is that 
the product must be sold either pre-cooked or frozen because product binding is very low in 
the raw state. A cold set binding agent that relies on the physiological clot forming action of 
the plasma proteins fibrinogen and thrombin is available commercially as Fibrimex®, and 
can be obtained from both bovine and porcine sources. Fibrimex® is produced through a 
patented process by the Dutch company Sonac BV and its binding action is based on the 
transformation of fibrinogen into fibrin by the action of thrombin. The fibrin produced then 
interacts with collagen, enabling the binding of meat pieces in reconstituted meat [29]. 
Fibrimex® produces restructured meat that can be sold in the chilled or raw state, with an 
eating quality comparable to that of cuts from intact muscles. The cold-set method utilized 
reduces oxidative rancidity [30] and discoloration [31], both of which are common with the 
hot-set method. A further advantage is that it develops sufficient bonds to eliminate the 
cavities [29] invariably created in the meat pieces during deboning. Products made with this 
cold-set binder are more versatile, as they can be treated and cooked in ways similar to fresh 
meat. Sonac BV also produces a cold set binder known as Plasma Powder FG, a plasma 
product with an increased fibrinogen concentration.    
Two other commonly used cold set binders in the industry are ActivaTM TG-RM (a 
transglutaminase obtained from microbial sources) and alginate (a polysaccharide that 
works in combination with a divalent cation). Compared to ActivaTM TG-RM, Fibrimex® 
has been reported to produce less binding in both raw and cooked restructured pork [32]. 
Several studies have reported that restructured beef steaks formulated with Fibrimex® 
produced a weaker bind compared with alginate. However, once cooked, Fibrimex® steaks 
were found to have a binding strength equal or stronger than that of steaks restructured 
with alginate [33, 34]. Interestingly, other researchers have reported the binding strength of 
both raw and cooked steaks formulated with Fibrimex® to be stronger than those 
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reformulated with alginate [35]. In this study, whereas some of the sensory panelists scored 
alginate formulated meat samples as bland or lacking uniformity in texture, no such 
unfavorable comments were made regarding the ActivaTM and FibrimexTM samples. 
Nevertheless, all three binders were rated as producing satisfactory binding in re-formed 
steaks and having overall acceptability [35]. These perceived differences may arise as a 
result of differences in the experimental procedure, for example the type of muscle used and 
the amount and proportion of binder used. More research is needed to identify the optimum 
amount of plasma proteins to utilize in particular meat products to achieve the desired 
results.  
2.2 Natural color enhancer 
Color is known to be one of the main factors used by consumers when evaluating the 
quality and freshness of meat products. The trend towards natural colorants due to adverse 
reactions to some artificial food dyes (and their impurities) [36, 37] has resulted in the 
substitution of artificial colorants with natural ones where technologically feasible. Although 
there are many safe natural sources of colorants, their suitability for use in foodstuffs 
depends largely on the availability of the raw material. In this sense, hemoglobin, which is 
obtained from slaughtered animals, represents a good source of natural red colorant given 
the large quantities of blood generated daily. It is important to note that the use of hemoglobin 
as a colorant has the added benefit of combating iron deficiency, which will be discussed in 
detail in a later section of this paper. However, its red color is unstable and largely 
dependent on the oxidation state of the heme iron. Oxyhemoglobin, the dioxygen ferrous form 
is bright red in color but when the heme iron is oxidized to Fe3+ the resulting hemoprotein, 
known as methemoglobin (metHb), has a characteristic brown color that is undesirable. 
Fortunately, the concentration of metHb in mammalian red blood cells is typically only 1 to 
3% of the total pigment, mainly as a result of the presence of metHb reductase [38]. 
However, the processing techniques utilized to preserve the shelf life and ensure the safety 
of the product, greatly increase the amount of metHb due to hemoglobin autooxidation [39]. 
Although spray-drying is a good way to preserve the red blood cell fraction, even better 
than freeze drying [39], and is a necessary step to ensure the microbial quality of blood-
derived ingredients, oxidation of the hemoglobin may continue during the storage of the 
spray-dried powder. Because of the unstable nature of hemoglobin, its use as a food 
ingredient is only possible once it has been stabilized. Hence, hemoglobin powders that are 
used as food colors are treated with protecting agents that form complexes with hemoglobin, 
prevent oxygen accessibility to heme iron and ultimately reduce hemoglobin auto-oxidation. 
The following few paragraphs will look at some of the hemoglobin-stabilizing techniques 
employed to make hemoglobin more useful as a natural colorant in meat products.  
Chelating agents such as nicotinic acid and nicotinamide that have the ability to form 
complexes with the heme moiety have been reported to be effective in preventing 
hemoglobin auto-oxidation during drying and subsequent storage [40]. Nicotinic acid at a 
concentration of 2% w/v has been found to considerably retard the deterioration of 
hemoglobin concentrate during both spray-drying and subsequent storage. A positive effect 
was also detected with 2.5% w/v of nicotinamide, though the results were not as impressive 
as for nicotinic acid. However, in the presence of starch gels nicotinamide proved better at 
stabilizing the red color of hemoglobin in comparison with nicotinic acid [39]. The use of 
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to be a harmful vasodilator [41]. Conversion of hemoglobin into the more stable and 
organoleptically acceptable carboxyhemoglobin by saturation with carbon monoxide (CO) 
has been proposed as an alternative method to stabilize hemoglobin. The underlying 
principle of the technique is based on the strong affinity between CO and hemoglobin [42] 
and the low dissociation of the complex [43] that provides a strong and enduring linkage of 
the CO to hemoglobin, which can thus tolerate cooking and/or dehydration. In addition, 
CO-treated blood has a redder color and hence greater potential for use in meat product 
formulations [44]. Studies have shown that CO-treated porcine spray-dried blood stored in 
low oxygen transmission rate (OTR) bags retained an acceptable reddish color after 12 
weeks of storage compared to untreated dry blood, which turned brown immediately upon 
drying. Comparatively, CO-treated porcine spray-dried blood in high oxygen transmission 
rate (OTR) packaging presented color indices similar to those of untreated blood after 12 
weeks of storage. The authors explained that the observed difference could be as a result of 
the oxygen permeability of the high OTR bags and light oxidation, which caused the 
otherwise stable carboxyhemoglobin to turn brown [45]. Liquid porcine blood treated with 
CO at different pH levels (7.4, 6.7, and 6.0) and kept under refrigeration for 4 days 
maintained a more stable and attractive red color than fresh blood. The study was restricted 
to 4 days of refrigerated storage as this is the typical period for which the bacterial count 
remains acceptably low and hence the blood maintains a safe microbiological profile, 
allowing its safe utilization as a food ingredient [44]. There are currently several such 
hemoglobin-containing products available for use as natural color enhancers in meat 
products. However, effective stabilizing methods for hemoglobin remain an issue. It is 
possible that shifting the focus to the development of better packaging technology may 
avoid the need to use stabilizing agents, resulting in the production of hemoglobin-based 
colorants that are both safe and more natural.  
2.3 Emulsifier 
Emulsifiers are utilized in emulsified meat products such as frankfurters, pate, luncheon 
meat and mortadella to bind meat proteins, fat and water in a stable emulsion. Emulsifiers 
also help redistribute the fat finely throughout the product so the right texture is 
obtained. Emulsifiers often substitute for fat in association with other ingredients in low-
fat meat products to give the final product sensory qualities comparable to those of their 
full-fat versions. The food industry has access to a wide range of emulsifiers suitable for 
use in foods and, in particular, meat products though these tend to be proteins. Proteins 
are the most common emulsifying agents in the food industry because they occur 
naturally and are generally both non-toxic and widely available [46]. Proteins that are 
used as emulsifiers are obtained from a variety of sources, both animal and plant. 
Processors, however, generally prefer animal proteins because they are better emulsifiers 
than plant proteins. Amongst the emulsifiers obtained from animal sources, casein and its 
salt derivatives are the most popular and are widely used in the food industry for this 
purpose. Less expensive protein sources with comparable emulsifying capacities are being 
sought to replace casein, which is expensive because of its high processing costs [47]. This 
is particularly important in developing countries, where milk products as casein must be 
imported.  
Blood proteins have been found to have emulsifying properties that are comparable, and 
even in some situations, superior to those of casein and can therefore adequately replace 
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casein as the emulsifying agent in meat products. Silva and others [47] compared the 
emulsifying properties of sodium caseinate (SC) and globin isolated either by the acidified 
acetone (AG) method or the carboxymethyl cellulose (CG) method in the absence and 
presence of salt. In the absence of salt AG and CG showed a higher emulsifying capacity 
(EC), which measures the ability of the emulsifier to migrate to the oil-water interface, than 
SC. When salt was present, however, SC showed a higher EC than globins. The emulsifying 
activity index (EAI), which measures the ability of the emulsifier to stay in the oil-water 
interface immediately after the emulsion has formed, was greatest for AG with salt present. 
In the absence of salt, both SC and AG exhibited EAIs that were greater than that of CG.  
At no and very low salt concentrations there was no difference in emulsion stability (ES) (a 
measure of the ability of the emulsifier to stay in the oil-water interface after storage for a 
while or heating of the emulsion) among all three proteins. ES was, however, greater for CA 
for a salt concentration of 0.25mol/L. Since the emulsifying property is a cooperative 
function of EC, EAI, and ES, it seems that casein as an emulsifier has an edge over globin in 
high salt products. This would, however, not be an advantage in the food industry, which is 
tending to minimize the use of salt in its products because of the problems associated with 
high salt consumption mentioned above.  
Globin also compares favorably to other proteins used as emulsifiers in meat products and 
food products in general. Crenwelge and others [48] compared the emulsifying capacities of 
globin with those of cotton seed, soy and milk proteins and reported that globin had the best 
emulsifying capacity. The emulsifying activity of globin was greater (EAI of 28) than that of 
either hemoglobin or ovalbumin, with EAI values of 14 and 8, respectively. Other authors 
have also reported globin to have emulsifying activity superior to that of hemoglobin and 
ovalbumin, although BSA, which had an EAI value of 31, was higher. A combination of 
peptic hydrolysis and the addition of carboxymethyl cellulose (CMC) to globin successfully 
raised the emulsifying activity of globin to above that of bovine serum albumin (BSA) [49]. 
All the blood proteins (globin, BSA, hemoglobin) have been shown to be better emulsifiers 
than egg (ovalbumin), which is generally considered to have good emulsifying properties. 
However, plasma is reported to have better emulsifying capacity than globin when 
incorporated into sausages and it can be incorporated into meat products at higher inclusion 
levels than globin without jeopardizing the visual appeal of the product because the 
decolorized product retains a reddish hue that is transferred to the final product [50]. 
In summary, blood proteins have excellent emulsifying capacity and can adequately replace 
casein and egg in emulsified meat systems. Blood proteins such as hemoglobin, when used 
as emulsifiers, have the added advantage of providing a good source of heme iron. 
Compared to casein and egg, both of which are potent allergens and are thus among the "big 
eight" allergens covered under the Food Allergen Labeling and Consumer Protection Act 
(FALCPA) law, blood proteins do not present a problem of inducing allergic reactions. In 
situations involving highly salted products, however, plasma or globin that has undergone 
further processing such as a combination of peptic hydrolysis and CMC addition to enhance 
its emulsifying capacity are likely to be the best option.  
2.4 Fat replacer 
Fat plays an essential role in the diet as a source of vitamins, essential fatty acids and energy 
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casein as the emulsifying agent in meat products. Silva and others [47] compared the 
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2.4 Fat replacer 
Fat plays an essential role in the diet as a source of vitamins, essential fatty acids and energy 





properties, juiciness and overall appearance and palatability of processed meats [52]. On the 
other hand, empirical data has shown a correlation between dietary fat and cardio-vascular 
disease (CVD) and some types of cancers (colon, breast and prostate). Thus, for today's 
health conscious consumers, reducing dietary fat is a major consideration. The meat 
industry has been seriously affected by adverse publicity due to the high fat content and 
unhealthy fatty acid composition of their products, particularly those that include 
emulsified meat. For example, the minimum fat content in finely ground meat emulsion 
type products such as frankfurters, dry fermented sausages, and spreadable dry sausages 
are about 10%, 20-30%, and 20%, respectively [53] and this includes considerable amounts of 
saturated fatty acids. In response to consumer demand, the food industry has developed an 
assortment of low-fat meat products but given the important physico-chemical and sensory 
role that is played by fat, replacing fat in food products is a daunting task: if not properly 
done, the sensory appeal of the product will be severely jeopardized. Thus, low-fat meat 
varieties that are not acceptable in terms of taste and appearance will simply not sell, 
regardless of any health benefits [54].  
Studies have shown blood proteins to have potential as fat replacers in meat products, 
contributing soluble proteins while at the same time reducing costs. They also reduce the 
caloric content of food for every gram of fat replaced, since proteins contain fewer calories 
than fat. In addition blood proteins are a natural product and hence in line with present day 
consumer demands for natural foodstuffs. In a study by Viana and others [55], replacing the 
fat with globin, plasma, and a combination of plasma and globin resulted in ham pates with 
25%, 35% and 35% less fat, respectively. Among the treatments, the reduction in fat 
observed was not statistically different. The use of these fat replacers also resulted in an 
increase in moisture and protein content with no observed change in aroma, taste and 
consistency. The color of pate was, however, reduced in all the treatments containing blood 
proteins in comparison with control samples with no added blood protein. Reduction in 
color on addition of fat replacers is not peculiar to blood proteins as this occurrence has also 
been reported with the incorporation of other fat replacers in meat products by several 
authors, as cited by [56]. In short, fat influences the color of meat products and reducing its 
level will invariably affect the color attributes of the product.  
The use of blood proteins as fat replacers compared favorably with other commercially 
available fat replacers, as shown by the results of several studies. Confrades and others [57] 
compared the effect of plasma and soy fiber as fat replacers in bologna sausage, concluding 
that plasma protein had a greater influence on the binding and textural properties of 
bologna than soy fiber and was hence a better choice. Desmond and others [58] evaluated 
the sensory, chemical and physical properties of low-fat beef burgers formulated with 
nineteen different commercially available fat replacers including Plasma Powder U70 and 
Protoplus® U70, both of which are blood-derived products. They reported that beef burgers 
formulated with these blood proteins had poor overall quality and flavor attributes. It is 
worth noting, however, that burgers containing these blood proteins had individual sensory 
traits that were superior to burgers containing other fat replacers. For example, the 
moistness and juiciness of burgers formulated with Protoplus® U70 was superior to 15 of 
the 17 non-blood derived fat replacers tested. Burgers containing Protoplus® U70 were 
rated as having the best overall texture, together with three other non-blood fat replacers. 
Inclusion of these blood proteins also produced physical characteristics that were superior 
to most of the other fat replacers used. For example, beef burger containing these blood 
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proteins had % cook yields that were greater than 13 of the 17 other fat replacers tested. 
Similarly, the WHC of beef burgers containing Plasma Powder U70 and Protoplus70 were 
superior to 15 and 12 other fat replacers, respectively.  
Blood proteins therefore provide a cheaper alternative protein for use as fat replacers in the 
production of low-fat meat products. However, this may not satisfy some consumers due to 
the non-meaty flavor resulting from their inclusion. Guzman and others [59] have attributed 
the lower meaty scores when blood proteins are incorporated to the specific flavor 
characteristics contributed by each type of blood protein. Since a single ingredient is 
unlikely to produce the desired effect as a fat-replacer in the production of low-fat meat 
products [57], combining plasma proteins with other fat replacers with superior meaty 
flavor characteristics promises to be a worthwhile approach.  
2.5 Curing agent 
Nitrite plays a multifunctional role in the curing process of meat. It is responsible for the red 
color [60, 61], and characteristics and desirable flavor of cured meats [62, 63]. It may also 
influence the texture of the product through the promotion of protein cross-linking [64]. 
Furthermore, nitrite acts as an antimicrobial agent [65, 66]. Although nitrite continues to be 
the most widely used of all food additives, its use has come under scrutiny in recent years. 
This is because nitrite has a tendency to react with amines, amides, amino acids and related 
compounds present in the meat to produce carcinogenic N-nitroso compounds. In addition, 
ingested nitrite (in the form of residual nitrite) may react with various substances in the 
gastrointestinal tract (GIT) to produce these N-nitroso compounds [67, 68]. Various studies 
have confirmed the presence of volatile N-nitrosamines in cured meat compounds, though 
there are differences in both the type and the quantities reported by different authors [69]. 
To address these issues, efforts are being made to reduce the amount of nitrite used in the 
curing system or to develop alternative methods of curing that avoid the use of nitrite 
altogether. The latter approach may be the best option; the most attractive and reliable 
method for preventing the formation of N-nitroso compounds is the total elimination of 
nitrite from the curing process [70]. However, finding a viable alternative for nitrite in the 
meat curing process is problematic as it is extremely difficult to find a single compound that 
can fully reproduce the multifunctional role of nitrite described above. To date, no single 
agent has been identified that is capable of replacing nitrite. The best option may be the use 
of a composite mixture containing no nitrite but instead comprising a colorant, an antioxidant, 
and an antimicrobial agent, among others, to produce nitrite-free cured meats [71].  
One of the colorants suggested for use in a composite nitrite-free cocktail for meat curing is 
cooked cured meat pigment (CCMP), which when added to meat prior to cooking 
duplicates the color typical of nitrite-cured meats. CCMP, a mono and/or di-nitric oxide 
hemochrome, is synthesized directly or indirectly through a hemin intermediate. The 
pigment is prepared by reacting bovine or porcine red blood cells with a nitrosating agent 
and at least one reducing agent at a suitable elevated temperature. The resultant product is 
either spray-dried or freeze-dried to obtain a powder. The pigment may also be treated with 
a starch and a binding agent (e.g. gum) to stabilize the pigment [72]. Addition of CCMP to 
comminuted pork meat at levels of 3 to 30mg/kg produced a pink color after heat-treatment 
that was visually similar to that of nitrite-treated pork [73]. Although the best performance 
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performance in dark meats has been found to be satisfactory [71]. Results support CCMP as 
a healthy substitute for nitrite salt, as CCMP has been found not to be mutagenic compared 
to nitrite. The use of CCMP in meat emulsions therefore results in a drastic reduction in the 
residual nitrite that contributes to the formation of carcinogenic N-nitroso compounds in the 
GIT [69].  
Though CCMP was initially developed for use in cured meat products to duplicate the 
characteristic red color associated with the use of nitrite, it has also been found to have 
antioxidant properties similar to those of nitrite [74]. At the time of writing, CCMP is not yet 
available commercially, possibly due to its unstable nature although this is being improved 
with the use of stabilizers. Further studies to include the addition of antimicrobials in the 
formulation of CCMP to duplicate all three major functions of nitrite in cured meats may 
make possible the commercialization of this product in the near future.  
3. Non-meat usage 
Although the meat industry remains the predominant user of blood proteins, other sectors 
of the food industry also utilize them in the production of such items as baked goods, 
dietary supplements and functional foods, usually as egg replacers, protein supplements, 
iron supplements or a source of bioactive compounds. Some of these uses will be reviewed 
in this section. 
3.1 Egg replacer 
In baked goods such as cakes, egg proteins play an important role in defining such final 
product characteristics as cake volume and texture due to the unique foaming, emulsifying, 
and heat coagulation properties of eggs [75]. Among the various ingredients utilized in 
baked goods, eggs are the most costly [76] and they are also a significant source of 
cholesterol. The use of alternative ingredients to partially or totally replace eggs in baked 
goods is therefore of interest to processors not only to reduce cost but to provide lower 
cholesterol baked goods varieties. Blood proteins have been found to serve as useful egg 
replacers, as reported by several authors. Spray-dried plasma protein concentrates marketed 
for diverse use in food processing, including as egg replacers, are sold at a cost of only about 
one-third that of spray-dried egg whites [76].  
Lee and others [76] evaluated the sensory and physical properties of white layer cakes made 
by substituting egg (as dried egg white) either partially (25%, 50% and 70%) or totally 
(100%) with spray-dried plasma. The authors reported that cake volume was not affected by 
egg replacement, although cake symmetry decreased at 75% and 100% substitution. In terms 
of shrinkage, cakes formulated using partial replacement had lower shinkage values than 
control cakes made entirely with dried egg white; those formulated with total replacement 
of egg with plasma produced shrinkage that did not differ significantly from the control 
cakes. This suggests that so far as critical quality indices such as volume and shrinkage are 
involved, replacing egg with plasma produced superior products, particularly at partial 
replacement. It is worth noting that the authors reported that replacing egg with plasma at 
all levels resulted in products with darker and tanner crust and crumb, but these differences 
notwithstanding, trained panels liked the control cakes and those prepared with partial or 
total replacement of egg with plasma equally. The same study [76] utilized a blend of 90% 
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enzymatically hydrolyzed plasma and 10% beef stock as a replacement for eggs in the 
formulation of devil’s food cake, a whole-egg product. The results are not relevant here, 
however, due to the inclusion of beef stock which makes it difficult to deduce which 
product effects can be ascribed to the inclusion of plasma only. In a similar study, Johnson 
and others [77] investigated the feasibility of replacing egg white and whole egg with freeze-
dried plasma in the manufacture of white and yellow layer cakes, respectively. In the latter 
case, 1.3% lecithin was added to compensate for the natural phospholipid content of whole 
egg. The control cakes consisted of 14% egg white solids and 3% added salt, whereas the 
experimental cakes contained 18.6% plasma solids with no added salt. The formulation was 
selected to ensure equivalent protein and salt concentrations for the plasma and egg-white 
control cakes. The authors reported that cakes made with plasma were at least equal if not 
greater in volume and also shrank less than the egg-white control cakes. In the case of the 
yellow layer cakes, the volumes of those made with plasma solids was between 7 and 15% 
less than those made with whole egg at equivalent protein levels. They concluded that blood 
plasma was effective in replacing all the egg white or whole egg in cakes and hence shows 
potential as a low cost egg substitute for use by the baking industry.  
Decolorized bovine blood has also been considered as a replacement for egg white in white 
layer cakes. Although cakes made with decolorized blood had volumes comparable to those 
made with egg white, cakes made with decolorized blood had an objectionable flavor [78]. 
The poor sensory quality of cakes formulated with decolorized blood may be due to residual 
heme. Raeker and Johnson [79] also compared the baking properties of egg white and 
plasma and their component proteins, reporting that cakes made with egg whites had 
slightly greater volumes than their counterparts made with freeze or spray-dried plasma, 
though the differences were not significant. Among the blood proteins, only γ-globulin had 
baking properties superior to those of plasma. They also noted that separating fibrinogen 
(which by itself produced the smallest cake volume among the blood plasma proteins) from 
plasma increased cake volumes. However, given that the primary purpose of using blood 
proteins as a substitute for eggs in baked goods is to reduce costs, the additional expense 
incurred by fractionating plasma into its component proteins appears counterproductive 
and there appears to be no incentive for using fractionated plasma proteins for this purpose.  
In summary, plasma proteins can be very effective low cost alternatives for replacing eggs in 
baked goods. The use of blood proteins derived from the cellular fraction, as decolorized 
bovine blood leads to the production of baked goods with objectionable odor, however, and 
further research is needed to counter the flavor defect associated with its use. Also, since the 
main objective of replacing eggs with plasma is to reduce cost, the use of expensive 
fractionated blood proteins for this purpose cannot be justified. The removal of fibrinogen 
from plasma, leading to an increase in cake volumes, may be a practicable means of 
improving the efficiency of plasma for this purpose, as separation of this component from 
plasma by centrifugation would be relatively inexpensive. 
3.2 Protein supplement 
Protein malnutrition is a major problem in developing countries during the transitional 
phase of weaning in infants, retarding their physical and mental development. Introducing 
weaning foods containing the right quality and quantity of protein during this transitional 
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necessary preventive measure [80]. In many developing countries, diets that are used to 
supplement breast feeding during the transition from exclusive breast feeding to a mixed 
diet (between the ages of 6 to 8 months) and thereafter as a major breakfast meal (between 
age 1 to 6 years) are usually produced from maize flour [81, 82]. Kwashiorkor, a severe 
protein deficiency disease that is common in some parts of the world has been linked to the 
quality and quantity of protein in maize when it is the sole source of protein for infants [83]. 
Unfortunately, animal proteins such as milk and meat that contain high quality proteins in 
good quantities tend to be expensive and not readily available in developing countries. 
Consequently, concerted efforts by researchers, government and international bodies to 
eliminate protein malnutrition have generally been directed towards the use of plant 
proteins (e.g. from legumes and soy) as substitutes for animal proteins to supplement grains 
and cereals in the formulation of weaning diets. However, these plant proteins have lower 
protein levels, lack essential amino acids, and/or contain antinutritive factors [84-86]. 
Processing plant proteins such as soy to eliminate their antinutritive factors greatly increases 
the cost and hence defeats the purpose of their use as a low-cost high quality protein to 
substitute for animal proteins. The extreme processes involved also reduce the protein 
quality of the final product due to denaturation [87]. Studies with newly weaned pigs have 
established that incorporating blood proteins into their feeds accelerates daily weight gains 
[88-89]. Similar results have been observed in newly weaned mice [90], indicating that the 
benefits of including blood proteins in the diet is not species-specific. Thus, blood proteins, 
which are abundant, cheap, readily available, devoid of antinutrients, have a good amino 
acid profile, and a proven track record in animal nutrition, have been suggested for use as 
protein supplements in infant formula to tackle protein malnutrition. Several studies that 
have investigated the feasibility of using blood proteins as protein supplements to combat 
protein malnutrition in developing countries are highlighted below.  
Begin and others [91] compared the effect of supplementing a maize diet with bovine serum 
concentrate (BSC) alone or in combination with multiple micronutrients (MMN), or with 
whey protein concentrate alone or with MMN (as the control) on the physical growth and 
micronutrient status of 132 Guatemalan infants between the ages of 6 to 8 months who 
completed the 8-month long study. Over the period of the study, the subjects gained about 
1.8kg in weight and about 8cm in length, which corresponds to approximately 63% and 75% 
of the expected weight and length gain, respectively, for their age counterparts in North 
America. The increase in growth by treatment group was not, however, significant. So far as 
micronutrient status was concerned, the authors reported that infants who received a 
combination of WPC and MMN showed higher final serum ferritin concentrations than 
those receiving a combination of BSC and MMN. All other markers of micronutrient status 
were the same. Their conclusion was that supplementation with BSC or with BSC and MMN 
was not effective in preventing growth stunting of young children in a peri-urban setting in 
Guatemala, although they did not specify the basis for this conclusion. It seems likely that 
their conclusions were based on a comparison with North American children, which is not a 
good yardstick as growth charts in these regions differ from those used by the WHO. They 
did, however, note that the children who received the supplements containing bovine serum 
concentrate consumed about 12% less of the amount administered in comparison to those 
who received diets containing WPC. This suggests that the flavor of BSC was less popular 
with the children. It is possible that if more of the maize diet supplemented with BSC had 
been consumed by the children, the growth rate recorded for this group may have surpassed 
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that of the control group consuming whey supplements. Nonetheless, the results of this study 
demonstrate that blood proteins can adequately replace other animal proteins such as whey.  
The adequacy of blood proteins as protein supplements has also been demonstrated by 
Oshodi and others [92] who investigated in vitro protein digestibility (using a multienzyme 
digesting system comprising trypisn, chymotrypsin, and peptidase), amino acid profile and 
available iron of an infant weaning food prepared from maize flour and bovine blood. Their 
results indicated an improved digestibility when blood protein concentrate was added to 
the maize. The amino acid profile of the formula was also satisfactory in meeting the 
essential amino acid requirement for infants as specified by the FAO/WHO joint committee 
[80]. The iron content of the formula was double that of maize alone. In this study [92], the 
bovine blood powder concentrate used was so bland in taste that its addition to the maize 
flour did not alter the overall flavor. This contrasts with the study discussed earlier where 
the blends containing BSC appeared to be less liked than those containing WPC, which is 
understandable as the subjects were still suckling and therefore not accustomed to unusual 
tastes (in this case BSC; WPC is similar to milk). In a related study by Lembcke and others 
[93], older children (between the ages of 9 and 25 months) admitted for rehabilitation for 
severe cases of protein deficiency (manifested as marasmus and kwashiorkor) were fed diets 
in which 25% or 50% of the dietary protein normally provided by milk was substituted with 
an equivalent protein from spray-dried bovine serum. Here, the formulas containing the 
spray-dried bovine serum were well accepted by the children Also, weight gain on the test 
diets was no different from those on the control diet. It is important to note, however, that in 
this study [93] the milk fat in the spray-dried bovine serum diet was partially replaced by 
vegetable oil. The addition of fat, which plays a critical role in the organoleptic quality of 
foods, could also be responsible for the greater acceptability of the product in this case.  
The studies outlined above support the use of bovine blood proteins as efficient protein 
supplements in cereal and grain based weaning and infant diets as a measure to tackle 
protein malnutrition problems in developing countries. However, if the target consumers 
are infants that are starting to consume solid foods, the addition of vegetable oil or other 
flavors may be necessary to improve the palatability and consequent acceptability of 
formulas. Where anemic children are involved, the use of bovine blood instead of plasma or 
serum offers a useful way to combat this condition owing to the heme content of blood.  
3.3 Iron supplement 
Iron deficiency is the most common nutritional deficiency in the world affecting about 20% 
of the world’s population, with women and children at greater risk [94]. It is induced in part 
by plant-based diets that typically contain non-heme iron, a form of iron that is poorly 
absorbed [95, 96]. In infants, iron deficiency can delay normal infant motor and mental 
function [97. 98]. Iron deficiency manifesting as anemia in pregnant women increases the 
risk of small or preterm babies [99], which are more likely to suffer from health problems or 
die in the first year of life. It can also cause fatigue in adults, impairing their ability to do 
physical work [100]. Several strategies are commonly directed at combating iron deficiency, 
including supplementation with capsules and tablets and fortification of processed foods. 
However, in developing countries, food-based strategies remain the most sustainable 
approach for addressing iron and other micronutrient deficiencies [101]. Fortifying staple 
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essentially unaffected by other dietary factors [102], has therefore been suggested as a 
measure to overcome the problem of iron deficiency. Heme iron is known to result in less 
gastrointestinal discomfort and oxidative stress than non-heme iron [103, 104]. Dietary 
sources of heme iron are only of animal origin such as meat and liver, which is often a 
problem in developing countries where animal products are expensive and not readily 
available. As bovine blood has the largest amount of heme iron than any animal source [105] 
and is readily available, it has therefore been suggested for the fortification of staple foods. 
The success of blood-fortified foods in addressing iron deficiency has been reported by 
several researchers.  
Kikafunda and Sserumaga [105] investigated the physical, chemical, microbiological and 
shelf life characteristics of bovine blood powder and the sensory attributes of a bean sauce 
fortified with it and found that the fortified bean sauce was less liked than the non-fortified 
counterpart in terms of all the sensory attributes (color, flavor and overall acceptability) 
considered. This is understandable, as the presence of the heme moiety generally imparts an 
objectionable color and flavor to the final product. It is worth noting, however, that although 
the fortified bean sauce was less liked it was not rejected outright. As children are among 
the most vulnerable groups affected, the introduction of heme iron fortified foods into 
school lunch programs becomes a viable way to combat this problem. The suitability of such 
an approach has been demonstrated by Walter and others [106], who investigated the effect 
of bovine-hemoglobin-fortified cookies on the iron status of school children in a nationwide 
school lunch program in Chile. Average serum ferritin values in both boys and girls were 
greater in the heme-fortified cookie. In addition, the fortified cookie group had a remarkably 
low prevalence of anemia. These benefits were achieved at virtually no cost as the 
researchers estimated that the additional expense of fortifying the cookies increased the cost 
by only $0.53 per child per year. As far as taste was concerned, the fortified cookies were 
virtually indistinguishable from the non-fortified cookies. It is possible that the different 
ingredients utilized in the formulation of the hemoglobin-fortified cookies may have 
masked the characteristic flavor of hemoglobin, rendering it imperceptible in this case. Some 
skeptics have opined that it is impractical to use hemoglobin as an iron supplement because 
it is low in iron (0.35%) [107], poorly soluble at low gastric pH [107], and its absorption is 
usually less than iron absorption from muscle [108, 109]. Heme iron polypeptide (HIP), a 
soluble heme moiety with an attached polypeptide obtained from the enzymatic digestion of 
bovine or porcine hemoglobin has been developed to overcome these concerns. The hydrolysis 
action enhances iron absorption by preventing the formation of large insoluble heme 
polymers [107]. Examples of commercially available HIP products are Proferrin® (Colorado 
Biolabs Inc., Frederick, CO) and Aprofer 1000® (APC Europe, S.A., Barcelona, Spain). The 
effectiveness of HIP as an iron supplement has been demonstrated by several researchers.  
Quintero-Gutierrez and others [110] evaluated the bioavailability of a heme iron concentrate 
product incorporated into a chocolate flavor biscuit filling in sandwich-type biscuits using 
the pig as a human model. The heme iron was prepared by isolating hemoglobin from 
porcine blood followed by enzyme hydrolysis and subsequent separation of globin from the 
heme group using ultrafiltration. Twenty pigs with slightly induced iron deficiency at 
weaning were divided into the study group (fed a low iron diet [452.7mg/kg] and sandwich 
biscuits with the heme iron fortified chocolate flavor filling) and the control group (fed 
normal food containing 537.1mg/kg of ferrous sulphate). The bioavailability of heme iron in 
the study group was 23% greater than that of the control group despite the fact that the 
 
The Use of Blood and Derived Products as Food Additives 
 
243 
control group consumed greater amounts of iron. The study group also exhibited better 
weight increase and reduced mortality compared to the control group. The product had a 
good sensory and functional appeal as it had a chocolate color and smell, creamy 
appearance, and appropriate spreadability. The same research group went on to evaluate 
the acceptability and bioavailability of the heme iron enriched chocolate flavor biscuit filling 
in sandwich-type biscuits in adolescent girls living in a rural area of Mexico [111]. The girls 
were divided into three groups: the placebo control (PC) group (consisting of girls with the 
highest hemoglobin levels at baseline, who were given non-fortified biscuits), and two study 
groups one of which was given an iron sulfate fortified biscuit and the other a heme iron 
fortified biscuit. The iron content for both types of fortified biscuits was the same. The two 
study groups included both anemic and non-anemic girls. The researchers observed that 
iron bioavailability in the heme fortified biscuit group was 23.7% higher than that in the iron 
sulfate fortified biscuit group, indicating that the heme fortification was well absorbed and 
tolerated. At the end of the study, serum ferritin concentrations, a measure of the amount of 
iron stored in the body, were reduced in the control group and the iron sulfate fortified 
biscuit group, but not in the heme iron fortified biscuit group. Other studies have confirmed 
that supplementing with HIP produces a better iron status in terms of better iron absorption 
and higher storage (serum ferritin levels) compared to iron salts [112, 113]. 
The findings of these studies agree that hemoglobin provides a low-cost heme-iron source 
that can conveniently be used to fortify commonly consumed staples in order to address 
problems associated with iron deficiency. However, though enzymatic hydrolysis increases 
the iron absorption, the process will add to the cost and may not be suitable in all 
developing countries. Other ways to increase the iron absorption of hemoglobin without 
adding to the cost therefore requires further study. Also, in certain situations the addition of 
flavor components may be desirable to make the final product more acceptable. 
3.4 Bioactive compounds  
Functional foods have begun to attract a lot of attention because of the growing belief that 
foods should possess health-promoting qualities. Recent physiological and biochemical 
research has shown that the protein in food not only furnishes amino acids but also provides 
bioactive peptides after digestion or food processing [114]. Consequently, bioactive peptides 
produced from both animal and plant sources are now being widely investigated and have 
been reported to have antibacterial [115, 116], opioid [117], antitumor [118], antioxidant [119, 
120], and angiotensin I-converting enzyme (ACE) inhibitory (anti-hypertensive) [121, 122] 
activities. Bioactive peptides derived from food proteins are considered milder and safer 
than synthetic drugs and are easily absorbed [123]. Non-conventional food sources are also 
being investigated; animal blood, which is both abundant and readily available but greatly 
underutilized as a protein source, is therefore being actively studied as a potential source of 
bioactive peptides.  
Present day dietary habits have led to an increase in the prevalence of cardiovascular 
diseases, as evidenced by the fact that hypertension-related diseases make up half of the 
most common causes of death [124]. The renin-angiotensin-aldosterone system controls 
blood pressure and ACE plays a critical role by converting the non-active angiotensin I in 
blood into its active form, angiotensin II through hydrolysis. This, in turn, causes blood 
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nonapeptide that causes blood vessels to extend, by removing amino acids from its C-
terminus, contributing to the rise in blood pressure. Thus, repressing ACE activity with ACE 
inhibitors lowers blood pressure [125]. However, ACE inhibitor drugs such as captopril, 
enalapril, alacepril and lisinopril that are utilized as anti-hypertensive drugs have a number 
of side effects such as cough, taste disturbance and skin rashes [126]. Accordingly, natural 
food-based anti-hypertensive alternatives may offer a valuable alternative.  
Wei and Chiang [127] investigated the possibility of hydrolyzing porcine blood proteins 
using an enzyme mixture in a membrane reactor for the production of bioactive peptides. 
Red blood cells, plasma and defibrinated blood isolated from porcine blood were used as 
the substrates for hydrolysis. Of the three fractions, the red blood cells had the highest ACE 
inhibitor and antioxidant activities. The unpleasant dark red color of blood was also lost 
during the process, resulting in the production of a pleasant golden yellow colored product 
and rendering it more useful in the production of anti-hypertensive functional foods. Yu 
and others [123] also described the isolation and characterization of ACE inhibitor peptides 
from porcine hemoglobin. Three enzymes (papain, trypsin and pepsin) were used in the 
digestion of the globin isolated from hemoglobin and the most active hydrolysates from the 
peptic digestion identified. The peptides exhibiting ACE inhibitor activity were identified as 
LGFPTTKTYFPHF and VVYPWT, with the former been identified as a novel peptide. The 
two ACE-inhibitor peptides both competitively inhibited ACE and maintained the 
inhibitory activity even after incubation with GIT proteases. There is now a protein 
supplement product, Rifle High Powered Protein Powder, Chocolate (Theta Brothers Sports 
Nutrition Inc., Brick, NJ) on the market for body builders that contains a patented bioactive 
peptide from hemoglobin hydrolysate designated as VVYP. Although the manufacturers do 
not mention the role of this peptide in the formula, its inclusion is probably designed to 
offset any rise in blood pressure brought about by intense body building exercises. The ACE 
inhibitor activity of blood seems not to be species specific, as in addition to its demonstrated 
effect in porcine and bovine blood it has also been demonstrated in chicken blood 
hydrolysate [128], where of the three enzymes used (Alcalase, Prozyme 6, and Protease N), 
the alcalase digested chicken blood produced the highest ACE-inhibition activities.  
According to the CDC (Centers for Disease Control), three pathogens (Salmonella, Listeria, 
and Toxoplasma), are responsible for 1,500 deaths each year in the US, representing more 
than 75% of those caused by known pathogens. Given the current context of food safety, 
protection utilizing natural products as preservatives could be beneficial for safe storage 
and distribution of meat products [129], which are often responsible for outbreaks of food-
borne diseases. This is particularly important as some of the proposed means of addressing 
food-borne diseases such as irradiation are unacceptable for many consumers, who are 
increasingly demanding natural products. Blood is known to contain important elements 
(antibodies and leukocytes) that fight against infection. Turning to blood proteins as sources 
of anti-bacterial peptides is, therefore, justified and a number of researchers have investigated 
the anti-bacterial properties of peptides isolated from animal blood. Nedjar-Arroume and 
others [129] identified four antibacterial peptides in bovine hemoglobin. The total hemoglobin 
isolate obtained by peptic hydrolysis was found to inhibit the microorganisms Micrococcus 
luteus, Listeria innocua, Escherichia coli, and Salmonella enteritidis. Antibacterial activity towards 
the latter two organisms is of particular importance, as both organisms are frequently 
implicated in food-borne illnesses. Froidevaux and others [130] have also demonstrated the 
anti-bacterial activity of pepsin-digested bovine hemoglobin. The antibacterial peptide in 
 
The Use of Blood and Derived Products as Food Additives 
 
245 
this case was the 1-23 fragment (VLSAADKGNVKAAWGKVGGHAAE) of the alpha chain 
of bovine hemoglobin and it exhibited antibacterial activity towards Micrococcus luteus, 
which is a bacterial strain commonly used as a sensitive strain for the detection of antibiotic 
substances. They did not, however, test the efficacy of the isolated peptide against common 
food borne pathogens, which is important because antibacterial activity against Micrococcus 
luteus does not necessary imply antibacterial activity towards other organisms, as was 
pointed out by Nedjar-Arroume and others [29].  
Lipid peroxidation is a serious concern for food manufacturers because it results in the 
production of undesirable off-flavors and potentially toxic reaction products. Oxidation of 
membranes and lipoproteins in the human circulatory system has been identified as the culprit 
in the pathogenesis of vascular diseases such as atherosclerosis and hypertension [131]. Many 
synthetic antioxidants, including butylated hydroxytoluene (BHT), butylated hydroxyanisole 
(BHA) and propyl gallate, are commonly utilized in food formulations to inhibit lipid 
peroxidation. However, the use of these synthetic antioxidants is strictly regulated because 
they represent a potential health hazard. The antioxidant activity of blood protein peptides has 
therefore been studied and demonstrated to offer an effective natural alternative to synthetic 
antioxidants. Xu and others [132] investigated the antioxidant activity of porcine plasma 
hydrolysate obtained by pepsin and papain digestion in a peroxidation system of aqueous 
linoleic acid. Both the pepsin and papain digested hydrolysates exhibited significant activities 
against linoleic acid oxidation and good DPPH free radical scavenging ability. However, the 
chelating power of the pepsin-digested hydrolysate was greater than that of the papain-
digested hydrolysate. Their recommendation was therefore that pepsin digested porcine 
plasma hydrolysate has the potential to serve as a potent natural antioxidant in foodstuffs. 
Albumin, a major protein in blood [133] is considered a major circulating antioxidant in the 
blood and Bishop and others [134] have reported that albumin protects cultured cells from 
oxygen radical damage. An in vitro study has also shown that albumin protects human low-
density lipoproteins from oxidation [135]. Wang and others [136] therefore sought to 
examine the antioxidant ability of crude plasma and globulin hydrolysates and also that of 
the peptide fractions. Of these, the peptide fractions were found to have better lipid 
peroxidation inhibitory activity than vitamin E, a known antioxidant, while the antioxidant 
properties of both the crude hydrolysates and small molecular weight peptide fractions of 
albumin were superior to those of globulin. The authors noted that the hydrolyzation 
process was both easy and economical, and hence amenable to large-scale production. 
Blood clearly has the potential to serve as a useful source of valuable peptides with anti-
hypertensive, antioxidant, and anti-bacterial properties, among others. Several bioactive 
peptides that offer other health benefits such as analgesic and antinociception (reduction in 
pain sensitivity) activities have also been isolated from blood proteins; the review article by 
Gomes and others [137] provides more detailed information on some of these peptides that 
have been isolated from blood. However, there is still work to be done in the area of in vivo 
studies, as most of these demonstrated activities of blood peptides have been in vitro.  
4. Consumer concerns 
Despite the immense efforts devoted to ensuring that blood proteins are maximally utilized 
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blood proteins are unsafe, the possibility of their fraudulent usage, and ethical issues prevent 
the realization of this objective. Interestingly, the available scientific data suggests that some 
of these concerns are actually groundless, as will be explained below. However, the anxiety 
expressed by consumers is real and warrants a concerted effort by government, processors 
and researchers to allay these fears and hence ensure the maximal utilization of blood proteins.  
4.1 Fraudulent usage 
The largest user of blood proteins in food is the meat industry. The economic advantage to 
be derived from their fraudulent use makes this a significant concern. Partial replacement of 
lean meat with blood plasma content offers a major economic incentive to the manufacturer, 
as the addition of 2% of blood plasma to a meat product can boost yield by 4 to 5% and 
substitute for up to 10% of the lean meat content [138]. It is therefore tempting for rogue 
manufacturers and food service providers to fraudulently utilize these blood proteins for 
economic gain. A typical case is the use of Fibrimex® as a meat binder, discussed earlier in 
Section 2.1. In May 2010, the EU voted to ban the use of Fibrimex® as the EU believes the 
product has no proven benefit and its usage carries an unacceptably high risk of misleading 
consumers. The concern was that Fibrimex®-reconstituted meat products would find their 
way into meat dishes served in restaurants, given the higher prices that can be obtained for 
pieces of meat sold as a single meat product. Legislators considered that consumers should 
be able to trust that the meat they are buying is a real steak and not simply pieces of meat 
glued together. The ban, however, never took effect as in accordance with Commission 
directive 2010/67/EU, Fibrimex® is permitted for use as a food additive for reconstituting 
food. In the US, where Fibrimex® is permitted at usage levels up to 10% [139] doubts about 
its usage such as those expressed in the EU have not been an issue. Interestingly, at no point 
did other products such as ActivaTM TG-RM and alginate used for the same purpose as 
Fibrimex® come under scrutiny in the EU regarding their potential for fraudulent use. The 
same is true for Plasma FG, which is also derived from blood and produced by the same 
company for the same purpose. Such inconsistencies in regulations lead consumers to doubt 
the quality of these blood proteins. Efforts to ensure that their usage is not abused for 
economic gain at the restaurant level are, however, necessary as the problem has not yet 
been properly addressed. The development of effective methods for monitoring their 
presence in food products, along with frequent restaurant auditing by the appropriate 
authorities, is necessary to address this concern.  
4.2 Religion and ethical reasons 
Certain individuals, for example Jews and Muslims, do not consume blood because of the 
religious dictates enshrined in the Kosher and Halal dietary laws, respectively. Whereas 
some of these dietary laws concerning certain foods are not explicit and are therefore subject 
to individual interpretation, both codes unequivocally forbid the consumption of blood. In 
most parts of the world, particularly in the developing countries, animal slaughter is almost 
exclusively performed by Muslims, who condemn the use of blood as a food item. This is 
probably one of the main reasons why blood consumption by humans globally is very low 
[105].  
Others such as vegans avoid consuming products of animal origin for ethical reasons. It is 
therefore imperative that appropriate labeling laws compelling manufacturers to declare the 
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presence of these blood proteins in simple and understandable layman’s terms (as is the case 
with allergen labeling), are enforced to help the above-mentioned group of individuals to 
make the right food choices. In this respect, whilst many of the labeling laws are explicit and 
adequate, others may have to be revised. For example, beef blood is an acceptable ingredient 
for beef patties provided the product name is qualified as “Beef and Blood Patties” or “Beef 
Patties with Blood” [139]. Clear and explicit labeling is extremely helpful in protecting the 
interests of individuals who must avoid consuming food containing blood. This is not 
always the case, however; the permitted usage of Fibrimex® (as thrombin and fibrinogen) is 
contingent on the conspicuous display of the terms “Beef Fibrinogen and Thrombin”, “Beef 
Fibrin” or “Fibrin” as product name qualifiers on the label [139]. Such technical labeling 
provisions are unhelpful and may have to be revised.  
The situation is even worse when these blood proteins are used as ingredients in dietary 
supplements. Several of these dietary supplements have brand names on the label that 
include no indication that they are blood-derived. For example, Proferrin® lists no explicit 
information on the label that indicates HIP is derived from bovine hemoglobin (and hence 
from bovine blood). The only information given as to the source of the heme is that “Heme 
is a natural form of iron derived from animal sources and is intended for individuals 
seeking to maintain normal iron levels.” A similar issue pertains to some of the dietary 
supplements on the market that contain Immunolin®; while some products such as Immune 
Advantage (Now Foods, Bloomingdale, IL) clearly state on the label that Immunolin® is 
derived from bovine serum, other products such as Daily Immune Defense (Distributed by 
Doctor’s Best, Inc., San Clemente, CA) and ImmunAssure (Schiff Nutrition Group, Inc., Salt 
Lake City, UT) give no indication that Immunolin® is blood-derived. Interestingly, as the 
labeling regulations stand these manufacturers are not violating the law, as the labeling laws 
require them only to list the names of ingredients. Declaring the source of the ingredients is 
voluntary [140]. 
Certainly, the lax labeling regulations regarding the use of blood proteins as food 
ingredients, particularly in dietary supplements, fails to adequately protect individuals 
seeking to avoid consuming these products for religious and ethical reasons. Better labeling 
is vital to ensure that the interests of such people are protected and to boost consumer 
confidence in such products, thus promotinge efforts to ensure the full-scale utilization of 
blood proteins.  
4.3 Health reasons 
The belief that blood provides a haven for pathogens and toxic metabolites is another reason 
why some people avoid consuming blood. This concern, though genuine, is not exclusive to 
blood products; in general, foods of animal origin are easily contaminated with spoilage 
microorganisms and possibly pathogens through improper processing and handing [141]. 
Blood taken from a healthy animal is essentially sterile, so any contamination must be due 
to the bleeding technique and the drainage system employed during collection [142]. Both 
manufacturers and processors have instituted measures to guarantee the safety of these 
blood proteins. In the US, federal regulation 9 CFR 310.20 monitors blood that enters the 
food chain, ensuring that it originates from official establishments whose livestock and 
carcasses have passed inspection. The use of closed-draining systems in the collection of 
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exposure to the atmosphere. As a further safety measure, the collected blood is associated 
with the individual animals or batches of animals from which the blood was sourced until 
inspected to prevent uninspected blood from entering the food chain [143]. Collected and 
inspected blood is transported in refrigerated and dedicated isothermal stainless steel trucks 
to the processing plant to prevent any possible re-contamination. On arrival at the 
manufacturing plant, quality assurance (QA) and quality control (QC) procedures are 
performed on the received blood prior to spray-drying at high temperatures to inactivate 
any pathogens that may be present. Using Fibrimex® as an example, it is the opinion of the 
European Commission Scientific Panel on Food Additives, Flavourings, Processing Aids 
and Materials in Contact with Food that its use as a food additive is not of concern from the 
safety point of view [144].  
There are situations where liquid blood (or plasma) is utilized as an ingredient in foods, 
although such usage is only allowed in formulations that will undergo heat-treatment. 
However, considering the highly perishable nature of blood, where blood is used in the 
liquid form extra precautions through a mandatory HACCP system may be necessary. 
Ramos-Clamont and others noted that the use of a HACCP system in a pilot plant ensured 
that isolated blood fractions had excellent microbiological quality [145]. Thus, there is still 
scope for more improvements to be implemented to guarantee the quality of these blood 
ingredients. For example, it has been argued that the use of blood proteins as binders in 
meat products has a relatively high risk of bacterial contamination because pathogenic and 
spoilage microorganisms on the surfaces of the meat and trim pieces become internalized. 
This is compounded by the fact that these binders work on the cold-set method. Although 
such health concerns arise because of the process and not the ingredients per se, they 
nonetheless require attention. Incorporation of bacteria growth inhibitors such as nisin (a 
broad-spectrum bacteriocin) in the formulation of restructured meats, which has been found 
to be effective in reducing undesirable bacteria in such products [146], may be one way to 
address this problem.  
5. Conclusions 
As this review has shown, blood proteins provide an economic and readily available 
alternative source of proteins and irons for use in foods and dietary supplements to address 
a wide range of functional and nutritional needs. Its additional benefits as a source of 
bioactive peptides with anti-hypertensive, anti-bacterial, analgesic, and antinociception 
properties have the potential to provide safer and cheaper alternatives to conventional 
drugs, which tend to be expensive and have unwelcome side effects. Efforts to ensure large-
scale utilization of blood proteins as food additives should be encouraged because of the 
economic, nutritional, health and environmental benefits conveyed. This is particularly true 
in developing countries, where traditional sources of proteins and irons are either expensive 
or are unavailable. However, even as the industry strives to achieve greater utilization of 
blood as a food additive, consumer concerns related to religious and ethical issues must be 
addressed through the concerted effort of regulators, producers and researchers to develop 
accurate and concise labeling based on adequate labeling regulations and the development 
of effective blood detection methods to enforce regulations. On the issue of the safety of 
these products, making HACCP a mandatory requirement for plants that produce blood 
proteins, providing third world countries with the necessary expertise and equipment for 
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their production, and educating the public about the safety of these blood proteins, will 
encourage consumer confidence in these products and, consequently, their greater 
utilization.  
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address this problem.  
5. Conclusions 
As this review has shown, blood proteins provide an economic and readily available 
alternative source of proteins and irons for use in foods and dietary supplements to address 
a wide range of functional and nutritional needs. Its additional benefits as a source of 
bioactive peptides with anti-hypertensive, anti-bacterial, analgesic, and antinociception 
properties have the potential to provide safer and cheaper alternatives to conventional 
drugs, which tend to be expensive and have unwelcome side effects. Efforts to ensure large-
scale utilization of blood proteins as food additives should be encouraged because of the 
economic, nutritional, health and environmental benefits conveyed. This is particularly true 
in developing countries, where traditional sources of proteins and irons are either expensive 
or are unavailable. However, even as the industry strives to achieve greater utilization of 
blood as a food additive, consumer concerns related to religious and ethical issues must be 
addressed through the concerted effort of regulators, producers and researchers to develop 
accurate and concise labeling based on adequate labeling regulations and the development 
of effective blood detection methods to enforce regulations. On the issue of the safety of 
these products, making HACCP a mandatory requirement for plants that produce blood 
proteins, providing third world countries with the necessary expertise and equipment for 
 
The Use of Blood and Derived Products as Food Additives 
 
249 
their production, and educating the public about the safety of these blood proteins, will 
encourage consumer confidence in these products and, consequently, their greater 
utilization.  
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Food Additive
Edited by Yehia El-Samragy
Edited by Yehia El-Samragy
A food additive is defined as a substance not normally consumed as a food in itself and 
not normally used as a characteristic ingredient of food whether or not it has nutritive 
value. Food additives are natural or manufactured substances, which are added to food 
to restore colors lost during processing. They provide sweetness, prevent deterioration 
during storage and guard against food poisoning (preservatives).  This book provides a 
review of traditional and non-traditional food preservation approaches and ingredients 
used as food additives. It also provides detailed knowledge for the evaluation of the 
agro-industrial wastes based on their great potential for the production of industrially 
relevant food additives. Furthermore the assessment of potential reproductive and 
developmental toxicity perspectives of some newly synthesized food additives on 
market has been covered. Finally, the identification of the areas relevant for future 
research has been pointed out indicating that there is more and more information 
needed to explore the possibility of the implementation of some other materials to be 
used as food additives.
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